ID   B3KX39_HUMAN            Unreviewed;      1034 AA.
AC   B3KX39;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 63.
DE   SubName: Full=cDNA FLJ44690 fis, clone BRACE3013418, highly similar to Homo sapiens ankyrin 1, erythrocytic (ANK1), transcript variant 2, mRNA {ECO:0000313|EMBL:BAG54351.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG54351.1};
RN   [1] {ECO:0000313|EMBL:BAG54351.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:BAG54351.1};
RA   Oshima A., Takahashi-Fujii A., Tanase T., Imose N., Takeuchi K.,
RA   Arita M., Musashino K., Yuuki H., Hara H., Sugiyama T., Irie R.,
RA   Otsuki T., Sato H., Wakamatsu A., Ishii S., Yamamoto J., Isono Y.,
RA   Kawai-Hio Y., Saito K., Nishikawa T., Kimura K., Yamashita H.,
RA   Matsuo K., Nakamura Y., Sekine M., Kikuchi H., Kanda K., Wagatsuma M.,
RA   Murakawa K., Kanehori K., Sugiyama A., Kawakami B., Suzuki Y.,
RA   Sugano S., Nagahari K., Masuho Y., Nagai K., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK126647; BAG54351.1; -; mRNA.
DR   RefSeq; NP_065210.2; NM_020477.2.
DR   UniGene; Hs.654438; -.
DR   UniGene; Hs.667377; -.
DR   UniGene; Hs.708861; -.
DR   ProteinModelPortal; B3KX39; -.
DR   PeptideAtlas; B3KX39; -.
DR   PRIDE; B3KX39; -.
DR   DNASU; 286; -.
DR   GeneID; 286; -.
DR   CTD; 286; -.
DR   PharmGKB; PA24798; -.
DR   eggNOG; KOG4177; Eukaryota.
DR   eggNOG; COG0666; LUCA.
DR   GenomeRNAi; 286; -.
DR   Genevisible; B3KX39; HS.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   CDD; cd00204; ANK; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR000488; Death_domain.
DR   InterPro; IPR000906; ZU5_dom.
DR   Pfam; PF00531; Death; 1.
DR   Pfam; PF00791; ZU5; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 2.
DR   SMART; SM00005; DEATH; 1.
DR   SMART; SM00218; ZU5; 1.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 2.
DR   PROSITE; PS50017; DEATH_DOMAIN; 1.
DR   PROSITE; PS51145; ZU5; 2.
PE   2: Evidence at transcript level;
KW   ANK repeat {ECO:0000256|PROSITE-ProRule:PRU00023};
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN        1     94       ANK_REP_REGION.
FT                                {ECO:0000259|PROSITE:PS50297}.
FT   REPEAT        8     40       ANK. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00023}.
FT   REPEAT       41     73       ANK. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00023}.
FT   DOMAIN      229    384       ZU5. {ECO:0000259|PROSITE:PS51145}.
FT   DOMAIN      386    532       ZU5. {ECO:0000259|PROSITE:PS51145}.
FT   DOMAIN      719    803       Death. {ECO:0000259|PROSITE:PS50017}.
FT   COILED      345    365       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1034 AA;  115228 MW;  696555E3E876AD8D CRC64;
     MVDATTRMGY TPLHVASHYG NIKLVKFLLQ HQADVNAKTK LGYSPLHQAA QQGHTDIVTL
     LLKNGASPNE VSSDGTTPLA IAKRLGYISV TDVLKVVTDE TSFVLVSDKH RMSFPETVDE
     ILDVSEDEGT AHITIMGEEL ISFKAERRDS RDVDEEKELL DFVPKLDQVV ESPAIPRIPC
     AMPETVVIRS EEQEQASKEY DEDSLIPSSP ATETSDNISP VASPVHTGFL VSFMVDARGG
     SMRGSRHNGL RVVIPPRTCA APTRITCRLV KPQKLSTPPP LAEEEGLASR IIALGPTGAQ
     FLSPVIVEIP HFASHGRGDR ELVVLRSENG SVWKEHRSRY GESYLDQILN GMDEELGSLE
     ELEKKRVCRI ITTDFPLYFV IMSRLCQDYD TIGPEGGSLK SKLVPLVQAT FPENAVTKRV
     KLALQAQPVP DELVTKLLGN QATFSPIVTV EPRRRKFHRP IGLRIPLPPS WTDNPRDSGE
     GDTTSLRLLC SVIGGTDQAQ WEDITGTTKL VYANECANFT TNVSARFWLS DCPRTAEAVN
     FATLLYKELT AVPYMAKFVI FAKMNDPREG RLRCYCMTDD KVDKTLEQHE NFVEVARSRD
     IEVLEGMSLF AELSGNLVPV KKAAQQRSFH FQSFRENRLA MPVKVRDSSR EPGGSLSFLR
     KAMKYEDTQH ILCHLNITMP PCAKGSGAED RRRTPTPLAL RYSILSESTP GSLSGTEQAE
     MKMAVISEHL GLSWAELARE LQFSVEDINR IRVENPNSLL EQSVALLNLW VIREGQNANM
     ENLYTALQSI DRGEIVNMLE GSGRQSRNLK PDRRHTDRDY SLSPSQMNGH QRGQARITHS
     PTVSQVTERS QDRLQDWDAD GSIVSYLQDA AQGSWQEEVT QGPHSFQGTS TMTEGLEPGG
     SQEYEKVLVS VSEHTWTEQP EAESSQADRD RRQQGQEEQV QEAKNTFTQV VQGNEFQNIP
     GEQVTEEQFT DEQGNIVTKK IIRKVVRQID LSSADAAQEH EEVELRGSGL QPDLIEGRKG
     AQIVKRASLK RGKQ
//
ID   ANK1_HUMAN              Reviewed;        1881 AA.
AC   P16157; A0PJN8; A6NJ23; E5RFL7; O43400; Q13768; Q53ER1; Q59FP2;
AC   Q8N604; Q99407;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   28-MAR-2018, entry version 204.
DE   RecName: Full=Ankyrin-1;
DE            Short=ANK-1;
DE   AltName: Full=Ankyrin-R;
DE   AltName: Full=Erythrocyte ankyrin;
GN   Name=ANK1; Synonyms=ANK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ER1 AND ER2), PROTEIN SEQUENCE OF
RP   3-30; 733-753; 828-871; 959-1003; 1106-1128; 1149-1168; 1282-1288;
RP   1345-1367; 1383-1427; 1601-1626; 1686-1700 AND 1763-1772, AND VARIANTS
RP   ALA-750 AND ILE-1075.
RC   TISSUE=Hematopoietic;
RX   PubMed=2137557; DOI=10.1038/344036a0;
RA   Lux S.E., John K.M., Bennett V.;
RT   "Analysis of cDNA for human erythrocyte ankyrin indicates a repeated
RT   structure with homology to tissue-differentiation and cell-cycle
RT   control proteins.";
RL   Nature 344:36-42(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ER1; ER5 AND ER16), AND VARIANTS
RP   ILE-1075 AND ILE-1546.
RX   PubMed=1689849; DOI=10.1073/pnas.87.5.1730;
RA   Lambert S., Yu H., Prchal J.T., Lawler J., Ruff P., Speicher D.,
RA   Cheung M.C., Kan Y.W., Palek J.;
RT   "cDNA sequence for human erythrocyte ankyrin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:1730-1734(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, AND VARIANTS
RP   LEU-991 AND ILE-1075.
RX   PubMed=9235914; DOI=10.1074/jbc.272.31.19220;
RA   Gallagher P.G., Tse W.T., Scarpa A.L., Lux S.E., Forget B.G.;
RT   "Structure and organization of the human ankyrin-1 gene. Basis for
RT   complexity of pre-mRNA processing.";
RL   J. Biol. Chem. 272:19220-19228(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS MU17; MU18; MU19 AND MU20),
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   TISSUE=Skeletal muscle;
RX   PubMed=9430667; DOI=10.1074/jbc.273.3.1339;
RA   Gallagher P.G., Forget B.G.;
RT   "An alternate promoter directs expression of a truncated, muscle-
RT   specific isoform of the human ankyrin 1 gene.";
RL   J. Biol. Chem. 273:1339-1348(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM BR21), AND VARIANT
RP   ILE-1075.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS MU17; 22 AND 23).
RC   TISSUE=B-cell, and Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 5-12; 403-422; 797-814; 862-877 AND 899-912,
RP   DOMAINS SPTB AND SLC4A1 BINDING, AND VARIANT ASP-1286.
RX   PubMed=2141335;
RA   Davis L.H., Bennett V.;
RT   "Mapping the binding sites of human erythrocyte ankyrin for the anion
RT   exchanger and spectrin.";
RL   J. Biol. Chem. 265:10589-10596(1990).
RN   [10]
RP   PROTEIN SEQUENCE OF 99-110; 129-169 AND 233-248, INTERACTION WITH
RP   HIF1AN, AND HYDROXYLATION AT ASN-105; ASN-233; ASN-431; ASN-464;
RP   ASN-629; ASN-662; ASP-695; ASN-728 AND ASN-761.
RX   PubMed=21177872; DOI=10.1074/jbc.M110.193540;
RA   Yang M., Ge W., Chowdhury R., Claridge T.D., Kramer H.B.,
RA   Schmierer B., McDonough M.A., Gong L., Kessler B.M., Ratcliffe P.J.,
RA   Coleman M.L., Schofield C.J.;
RT   "Asparagine and aspartate hydroxylation of the cytoskeletal ankyrin
RT   family is catalyzed by factor-inhibiting hypoxia-inducible factor.";
RL   J. Biol. Chem. 286:7648-7660(2011).
RN   [11]
RP   INTERACTION WITH SLC4A1.
RX   PubMed=7665627; DOI=10.1074/jbc.270.37.22050;
RA   Michaely P., Bennett V.;
RT   "The ANK repeats of erythrocyte ankyrin form two distinct but
RT   cooperative binding sites for the erythrocyte anion exchanger.";
RL   J. Biol. Chem. 270:22050-22057(1995).
RN   [12]
RP   INTERACTION WITH TTN.
RX   PubMed=12444090; DOI=10.1074/jbc.M209012200;
RA   Kontrogianni-Konstantopoulos A., Bloch R.J.;
RT   "The hydrophilic domain of small ankyrin-1 interacts with the two N-
RT   terminal immunoglobulin domains of titin.";
RL   J. Biol. Chem. 278:3985-3991(2003).
RN   [13]
RP   SUBCELLULAR LOCATION, INTERACTION WITH OBSCN, AND MUTAGENESIS OF
RP   THR-1824; LYS-1826; ARG-1829 AND LYS-1830.
RX   PubMed=12527750; DOI=10.1083/jcb.200208109;
RA   Bagnato P., Barone V., Giacomello E., Rossi D., Sorrentino V.;
RT   "Binding of an ankyrin-1 isoform to obscurin suggests a molecular link
RT   between the sarcoplasmic reticulum and myofibrils in striated
RT   muscles.";
RL   J. Cell Biol. 160:245-253(2003).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-429; SER-759; SER-781;
RP   SER-856; THR-1378; THR-1380; SER-1396; SER-1486; SER-1666; SER-1671;
RP   SER-1686; SER-1690 AND SER-1696, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-781; SER-817; SER-834;
RP   SER-856; SER-1428; SER-1523 AND SER-1533, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 402-827, AND FUNCTION OF ANK
RP   REPEAT DOMAIN.
RX   PubMed=12456646; DOI=10.1093/emboj/cdf651;
RA   Michaely P., Tomchick D.R., Machius M., Anderson R.G.;
RT   "Crystal structure of a 12 ANK repeat stack from human ankyrinR.";
RL   EMBO J. 21:6387-6396(2002).
RN   [20]
RP   STRUCTURE BY NMR OF 1392-1497.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the DEATH domain of ankyrin-1.";
RL   Submitted (APR-2008) to the PDB data bank.
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 911-1233, AND DOMAINS ZU5.
RX   PubMed=22310050; DOI=10.1016/j.jmb.2012.01.041;
RA   Yasunaga M., Ipsaro J.J., Mondragon A.;
RT   "Structurally similar but functionally diverse ZU5 domains in human
RT   erythrocyte ankyrin.";
RL   J. Mol. Biol. 417:336-350(2012).
RN   [22]
RP   VARIANT SPH1 ILE-463.
RX   PubMed=8640229; DOI=10.1038/ng0696-214;
RA   Eber S.W., Gonzalez J.M., Lux M.L., Scarpa A.L., Tse W.T.,
RA   Dornwell M., Herbers J., Kugler W., Oezcan R., Pekrun A.,
RA   Gallagher P.G., Schroeter W., Forget B.G., Lux S.E.;
RT   "Ankyrin-1 mutations are a major cause of dominant and recessive
RT   hereditary spherocytosis.";
RL   Nat. Genet. 13:214-218(1996).
RN   [23]
RP   VARIANTS SPH1 ARG-276 AND THR-1054.
RX   PubMed=11102985;
RX   DOI=10.1002/1098-1004(200012)16:6<529::AID-HUMU13>3.0.CO;2-N;
RA   Leite R.C.A., Basseres D.S., Ferreira J.S., Alberto F.L., Costa F.F.,
RA   Saad S.T.O.;
RT   "Low frequency of ankyrin mutations in hereditary spherocytosis:
RT   identification of three novel mutations.";
RL   Hum. Mutat. 16:529-529(2000).
RN   [24]
RP   VARIANT [LARGE SCALE ANALYSIS] HIS-332.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Attaches integral membrane proteins to cytoskeletal
CC       elements; binds to the erythrocyte membrane protein band 4.2, to
CC       Na-K ATPase, to the lymphocyte membrane protein GP85, and to the
CC       cytoskeletal proteins fodrin, tubulin, vimentin and desmin.
CC       Erythrocyte ankyrins also link spectrin (beta chain) to the
CC       cytoplasmic domain of the erythrocytes anion exchange protein;
CC       they retain most or all of these binding functions.
CC       {ECO:0000269|PubMed:12456646}.
CC   -!- FUNCTION: Isoform Mu17 together with obscurin in skeletal muscle
CC       may provide a molecular link between the sarcoplasmic reticulum
CC       and myofibrils. {ECO:0000269|PubMed:12456646}.
CC   -!- SUBUNIT: Interacts with a number of integral membrane proteins and
CC       cytoskeletal proteins. Interacts (via N-terminus) with
CC       SPTB/spectrin (beta chain). Interacts (via N-terminus ANK repeats)
CC       with SLC4A1/erythrocyte membrane protein band 3 (via cytoplasmic
CC       N-terminus). Also interacts with TTN/titin. Isoform Mu17 interacts
CC       with OBSCN isoform 3/obscurin. Interacts with HIF1AN.
CC       {ECO:0000269|PubMed:12444090, ECO:0000269|PubMed:12527750,
CC       ECO:0000269|PubMed:21177872, ECO:0000269|PubMed:7665627}.
CC   -!- INTERACTION:
CC       Q5VST9-3:OBSCN; NbExp=8; IntAct=EBI-941819, EBI-941921;
CC   -!- SUBCELLULAR LOCATION: Isoform Er1: Cytoplasm, cytoskeleton.
CC       Note=Probably the other erythrocyte (Er) isoforms, are located
CC       near the surface of erythrocytic plasma membrane.
CC   -!- SUBCELLULAR LOCATION: Isoform Mu17: Membrane. Cytoplasm,
CC       myofibril, sarcomere, M line. Note=Colocalizes with OBSCN isoform
CC       3/obscurin at the M line in differentiated skeletal muscle cells.
CC   -!- SUBCELLULAR LOCATION: Isoform Mu18: Sarcoplasmic reticulum
CC       {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform Mu19: Sarcoplasmic reticulum
CC       {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform Mu20: Sarcoplasmic reticulum
CC       {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=23;
CC       Name=Er1; Synonyms=1, 2.1;
CC         IsoId=P16157-1; Sequence=Displayed;
CC         Note=Major erythrocyte-specific isoform. Produced by alternative
CC         promoter usage.;
CC       Name=Er2; Synonyms=2, 2.2;
CC         IsoId=P16157-4; Sequence=VSP_018442;
CC         Note=Predominant form of minor erythrocyte-specific isoforms.
CC         Produced by alternative splicing of isoform Er1.;
CC       Name=Er3; Synonyms=3;
CC         IsoId=P16157-5; Sequence=VSP_018449;
CC         Note=Produced by alternative splicing of isoform Er1.;
CC       Name=Er4; Synonyms=4;
CC         IsoId=P16157-6; Sequence=VSP_018442, VSP_018449;
CC         Note=Produced by alternative splicing of isoform Er1.;
CC       Name=Er5; Synonyms=5;
CC         IsoId=P16157-3; Sequence=VSP_000266;
CC         Note=Produced by alternative splicing of isoform Er1.;
CC       Name=Er6; Synonyms=6;
CC         IsoId=P16157-7; Sequence=VSP_018442, VSP_000266;
CC         Note=Produced by alternative splicing of isoform Er1.;
CC       Name=Er7; Synonyms=7;
CC         IsoId=P16157-8; Sequence=VSP_018447;
CC         Note=Produced by alternative splicing of isoform Er1.;
CC       Name=Er8; Synonyms=8;
CC         IsoId=P16157-9; Sequence=VSP_018442, VSP_018447;
CC       Name=Er9; Synonyms=9;
CC         IsoId=P16157-10; Sequence=VSP_018445;
CC         Note=Produced by alternative splicing of isoform Er1.;
CC       Name=Er10; Synonyms=10;
CC         IsoId=P16157-11; Sequence=VSP_018442, VSP_018445;
CC         Note=Produced by alternative splicing of isoform Er1.;
CC       Name=Er11; Synonyms=11;
CC         IsoId=P16157-12; Sequence=VSP_018450;
CC         Note=Produced by alternative splicing of isoform Er1.;
CC       Name=Er12; Synonyms=12;
CC         IsoId=P16157-13; Sequence=VSP_018442, VSP_018450;
CC         Note=Produced by alternative splicing of isoform Er1.;
CC       Name=Er13; Synonyms=13;
CC         IsoId=P16157-14; Sequence=VSP_018451;
CC         Note=Produced by alternative splicing of isoform Er1.;
CC       Name=Er14; Synonyms=14;
CC         IsoId=P16157-15; Sequence=VSP_018442, VSP_018451;
CC         Note=Produced by alternative splicing of isoform Er1.;
CC       Name=Er15; Synonyms=15;
CC         IsoId=P16157-16; Sequence=VSP_018448;
CC         Note=Produced by alternative splicing of isoform Er1.;
CC       Name=Er16;
CC         IsoId=P16157-2; Sequence=VSP_000264, VSP_000265;
CC         Note=Produced by alternative splicing of isoform Er1.;
CC       Name=Mu17; Synonyms=ank1.5, muscle-specific 1;
CC         IsoId=P16157-17; Sequence=VSP_018440, VSP_018443, VSP_000266;
CC         Note=Produced by alternative promoter usage. Ref.4 (AAC01950)
CC         sequence is in conflict in position: 63:T->P. {ECO:0000305};
CC       Name=Mu18; Synonyms=ank1.6, muscle-specific 2;
CC         IsoId=P16157-18; Sequence=VSP_018440, VSP_018443, VSP_018448;
CC         Note=Produced by alternative splicing of isoform Mu17.;
CC       Name=Mu19; Synonyms=muscle-specific 3;
CC         IsoId=P16157-19; Sequence=VSP_018440, VSP_018443, VSP_018445;
CC         Note=Produced by alternative splicing of isoform Mu17.;
CC       Name=Mu20; Synonyms=muscle-specific 4;
CC         IsoId=P16157-20; Sequence=VSP_018440, VSP_018444, VSP_018446;
CC         Note=Produced by alternative splicing of isoform Mu17.;
CC       Name=Br21;
CC         IsoId=P16157-21; Sequence=VSP_018439, VSP_018441, VSP_018449;
CC         Note=No experimental confirmation available. Produced by
CC         alternative splicing of isoform Er1.;
CC       Name=22;
CC         IsoId=P16157-22; Sequence=VSP_018440, VSP_018443, VSP_045439;
CC         Note=Produced by alternative splicing.;
CC       Name=23;
CC         IsoId=P16157-23; Sequence=VSP_018440, VSP_018443;
CC   -!- TISSUE SPECIFICITY: Isoform Mu17, isoform Mu18, isoform Mu19 and
CC       isoform Mu20 are expressed in skeletal muscle. Isoform Br21 is
CC       expressed in brain. {ECO:0000269|PubMed:9430667}.
CC   -!- DOMAIN: The 55 kDa regulatory domain is involved in regulating
CC       binding of SPTB/spectrin (beta chain) and SLC4A1/erythrocyte
CC       membrane protein band 3.
CC   -!- DOMAIN: The ANK repeat region forms a spiral around a large
CC       central cavity and is involved in binding of ion transporters.
CC   -!- DOMAIN: The tandem configuration of the two ZU5 and the UPA
CC       domains forms a structural supramodule termed ZZU. ZU5-1 mediates
CC       interaction with beta-spectrin, and the ZU5-1/UPA interface is
CC       required for ankyrin's function other than binding to spectrin (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Regulated by phosphorylation.
CC   -!- PTM: Palmitoylated.
CC   -!- PTM: Hydroxylated by HIF1AN at several asparagine and 1 aspartate
CC       residue within ANK repeat region. Hydroxylation seems to increase
CC       the conformational stability of this region and may also modulate
CC       protein-protein interactions mediated by the ANK repeat region.
CC       {ECO:0000269|PubMed:21177872}.
CC   -!- DISEASE: Spherocytosis 1 (SPH1) [MIM:182900]: A form of
CC       spherocytosis, a hematologic disorder leading to chronic hemolytic
CC       anemia and characterized by numerous abnormally shaped
CC       erythrocytes which are generally spheroidal. SPH1 is characterized
CC       by severe hemolytic anemia. Inheritance can be autosomal dominant
CC       or autosomal recessive. Patients with homozygous mutations have a
CC       more severe disorder. {ECO:0000269|PubMed:11102985,
CC       ECO:0000269|PubMed:8640229}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB47805.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Ankyrin entry;
CC       URL="https://en.wikipedia.org/wiki/Ankyrin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X16609; CAA34610.1; -; mRNA.
DR   EMBL; X16609; CAA34611.1; -; mRNA.
DR   EMBL; M28880; AAA51732.1; -; mRNA.
DR   EMBL; U50133; AAB47805.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; U50092; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50093; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50094; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50095; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50096; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50097; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50098; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50099; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50100; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50101; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50102; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50103; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50104; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50105; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50106; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50107; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50108; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50109; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50110; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50111; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50112; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50113; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50114; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50115; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50116; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50117; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50118; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50119; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50120; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50121; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50122; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50123; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50124; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50125; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50126; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50127; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50128; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50129; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50130; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50131; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; U50132; AAB47805.1; JOINED; Genomic_DNA.
DR   EMBL; AF005213; AAC01950.1; -; mRNA.
DR   EMBL; AB209418; BAD92655.1; -; mRNA.
DR   EMBL; AK223578; BAD97298.1; -; mRNA.
DR   EMBL; AC027702; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC113133; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471080; EAW63243.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63244.1; -; Genomic_DNA.
DR   EMBL; BC030957; AAH30957.1; -; mRNA.
DR   EMBL; BC117121; AAI17122.1; -; mRNA.
DR   EMBL; BC014467; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS47849.1; -. [P16157-21]
DR   CCDS; CCDS55227.1; -. [P16157-23]
DR   CCDS; CCDS6119.1; -. [P16157-1]
DR   CCDS; CCDS6120.1; -. [P16157-22]
DR   CCDS; CCDS6121.1; -. [P16157-3]
DR   CCDS; CCDS6122.1; -. [P16157-17]
DR   PIR; A35049; A35049.
DR   PIR; S08275; SJHUK.
DR   RefSeq; NP_000028.3; NM_000037.3. [P16157-3]
DR   RefSeq; NP_001135917.1; NM_001142445.1. [P16157-23]
DR   RefSeq; NP_001135918.1; NM_001142446.1. [P16157-21]
DR   RefSeq; NP_065208.2; NM_020475.2. [P16157-5]
DR   RefSeq; NP_065209.2; NM_020476.2. [P16157-1]
DR   RefSeq; NP_065210.2; NM_020477.2. [P16157-4]
DR   RefSeq; NP_065211.2; NM_020478.4. [P16157-17]
DR   RefSeq; NP_065213.2; NM_020480.4. [P16157-22]
DR   UniGene; Hs.654438; -.
DR   UniGene; Hs.667377; -.
DR   UniGene; Hs.708861; -.
DR   PDB; 1N11; X-ray; 2.70 A; A=402-827.
DR   PDB; 2YQF; NMR; -; A=1394-1497.
DR   PDB; 2YVI; X-ray; 1.92 A; A=1394-1497.
DR   PDB; 3F59; X-ray; 2.00 A; A/B/C/D=911-1068.
DR   PDB; 3KBT; X-ray; 2.75 A; C/D=911-1068.
DR   PDB; 3KBU; X-ray; 2.75 A; C/D=911-1068.
DR   PDB; 3UD1; X-ray; 2.00 A; A/B/C=911-1233.
DR   PDB; 3UD2; X-ray; 2.21 A; A/B/C=911-1233.
DR   PDBsum; 1N11; -.
DR   PDBsum; 2YQF; -.
DR   PDBsum; 2YVI; -.
DR   PDBsum; 3F59; -.
DR   PDBsum; 3KBT; -.
DR   PDBsum; 3KBU; -.
DR   PDBsum; 3UD1; -.
DR   PDBsum; 3UD2; -.
DR   ProteinModelPortal; P16157; -.
DR   SMR; P16157; -.
DR   BioGrid; 106783; 23.
DR   IntAct; P16157; 3.
DR   STRING; 9606.ENSP00000265709; -.
DR   TCDB; 8.A.28.1.2; the ankyrin (ankyrin) family.
DR   iPTMnet; P16157; -.
DR   PhosphoSitePlus; P16157; -.
DR   BioMuta; ANK1; -.
DR   DMDM; 116241246; -.
DR   MaxQB; P16157; -.
DR   PaxDb; P16157; -.
DR   PeptideAtlas; P16157; -.
DR   PRIDE; P16157; -.
DR   DNASU; 286; -.
DR   Ensembl; ENST00000265709; ENSP00000265709; ENSG00000029534. [P16157-21]
DR   Ensembl; ENST00000289734; ENSP00000289734; ENSG00000029534. [P16157-3]
DR   Ensembl; ENST00000314214; ENSP00000319123; ENSG00000029534. [P16157-17]
DR   Ensembl; ENST00000347528; ENSP00000339620; ENSG00000029534. [P16157-1]
DR   Ensembl; ENST00000348036; ENSP00000297744; ENSG00000029534. [P16157-22]
DR   Ensembl; ENST00000522543; ENSP00000430368; ENSG00000029534. [P16157-23]
DR   GeneID; 286; -.
DR   KEGG; hsa:286; -.
DR   UCSC; uc003xoc.4; human. [P16157-1]
DR   CTD; 286; -.
DR   DisGeNET; 286; -.
DR   EuPathDB; HostDB:ENSG00000029534.19; -.
DR   GeneCards; ANK1; -.
DR   HGNC; HGNC:492; ANK1.
DR   HPA; CAB016057; -.
DR   HPA; HPA004842; -.
DR   HPA; HPA056953; -.
DR   MalaCards; ANK1; -.
DR   MIM; 182900; phenotype.
DR   MIM; 612641; gene.
DR   neXtProt; NX_P16157; -.
DR   OpenTargets; ENSG00000029534; -.
DR   Orphanet; 251066; 8p11.2 deletion syndrome.
DR   Orphanet; 822; Hereditary spherocytosis.
DR   PharmGKB; PA24798; -.
DR   eggNOG; KOG4177; Eukaryota.
DR   eggNOG; COG0666; LUCA.
DR   GeneTree; ENSGT00840000129677; -.
DR   HOGENOM; HOG000237351; -.
DR   HOVERGEN; HBG004234; -.
DR   InParanoid; P16157; -.
DR   KO; K10380; -.
DR   OMA; AWNGYTP; -.
DR   OrthoDB; EOG091G00GN; -.
DR   PhylomeDB; P16157; -.
DR   TreeFam; TF351263; -.
DR   Reactome; R-HSA-445095; Interaction between L1 and Ankyrins.
DR   Reactome; R-HSA-447038; NrCAM interactions.
DR   Reactome; R-HSA-447041; CHL1 interactions.
DR   Reactome; R-HSA-447043; Neurofascin interactions.
DR   Reactome; R-HSA-6807878; COPI-mediated anterograde transport.
DR   ChiTaRS; ANK1; human.
DR   EvolutionaryTrace; P16157; -.
DR   GeneWiki; ANK1; -.
DR   GenomeRNAi; 286; -.
DR   PMAP-CutDB; P16157; -.
DR   PRO; PR:P16157; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000029534; -.
DR   CleanEx; HS_ANK1; -.
DR   ExpressionAtlas; P16157; baseline and differential.
DR   Genevisible; P16157; HS.
DR   GO; GO:0030673; C:axolemma; IEA:Ensembl.
DR   GO; GO:0016323; C:basolateral plasma membrane; NAS:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; NAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0031430; C:M band; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:Ensembl.
DR   GO; GO:0042383; C:sarcolemma; IEA:Ensembl.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0014731; C:spectrin-associated cytoskeleton; IDA:BHF-UCL.
DR   GO; GO:0030018; C:Z disc; IEA:Ensembl.
DR   GO; GO:0051117; F:ATPase binding; IPI:BHF-UCL.
DR   GO; GO:0008093; F:cytoskeletal adaptor activity; IDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0030507; F:spectrin binding; IDA:BHF-UCL.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc.
DR   GO; GO:0005198; F:structural molecule activity; NAS:UniProtKB.
DR   GO; GO:0007010; P:cytoskeleton organization; NAS:UniProtKB.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; IDA:BHF-UCL.
DR   GO; GO:0006887; P:exocytosis; NAS:UniProtKB.
DR   GO; GO:0045199; P:maintenance of epithelial cell apical/basal polarity; TAS:UniProtKB.
DR   GO; GO:0010638; P:positive regulation of organelle organization; IEA:Ensembl.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IMP:BHF-UCL.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   CDD; cd00204; ANK; 6.
DR   Gene3D; 1.25.40.20; -; 3.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR000488; Death_domain.
DR   InterPro; IPR000906; ZU5_dom.
DR   Pfam; PF00023; Ank; 2.
DR   Pfam; PF12796; Ank_2; 9.
DR   Pfam; PF00531; Death; 1.
DR   Pfam; PF00791; ZU5; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 23.
DR   SMART; SM00005; DEATH; 1.
DR   SMART; SM00218; ZU5; 1.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   SUPFAM; SSF48403; SSF48403; 2.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 20.
DR   PROSITE; PS50017; DEATH_DOMAIN; 1.
DR   PROSITE; PS51145; ZU5; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative promoter usage; Alternative splicing;
KW   ANK repeat; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Disease mutation; Elliptocytosis;
KW   Hereditary hemolytic anemia; Hydroxylation; Lipoprotein; Membrane;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Sarcoplasmic reticulum.
FT   CHAIN         1   1881       Ankyrin-1.
FT                                /FTId=PRO_0000066883.
FT   REPEAT       44     73       ANK 1.
FT   REPEAT       77    106       ANK 2.
FT   REPEAT      110    139       ANK 3.
FT   REPEAT      143    172       ANK 4.
FT   REPEAT      174    201       ANK 5.
FT   REPEAT      205    234       ANK 6.
FT   REPEAT      238    267       ANK 7.
FT   REPEAT      271    300       ANK 8.
FT   REPEAT      304    333       ANK 9.
FT   REPEAT      337    366       ANK 10.
FT   REPEAT      370    399       ANK 11.
FT   REPEAT      403    432       ANK 12.
FT   REPEAT      436    465       ANK 13.
FT   REPEAT      469    498       ANK 14.
FT   REPEAT      502    531       ANK 15.
FT   REPEAT      535    564       ANK 16.
FT   REPEAT      568    597       ANK 17.
FT   REPEAT      601    630       ANK 18.
FT   REPEAT      634    663       ANK 19.
FT   REPEAT      667    696       ANK 20.
FT   REPEAT      700    729       ANK 21.
FT   REPEAT      733    762       ANK 22.
FT   REPEAT      766    795       ANK 23.
FT   DOMAIN      913   1068       ZU5 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00485}.
FT   DOMAIN     1070   1216       ZU5 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00485}.
FT   DOMAIN     1403   1487       Death. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00064}.
FT   REGION        1    827       89 kDa domain.
FT   REGION     1234   1362       UPA domain. {ECO:0000250}.
FT   REGION     1383   1881       55 kDa regulatory domain.
FT   MOD_RES     105    105       (3S)-3-hydroxyasparagine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:21177872}.
FT   MOD_RES     233    233       (3S)-3-hydroxyasparagine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:21177872}.
FT   MOD_RES     429    429       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     431    431       (3S)-3-hydroxyasparagine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:21177872}.
FT   MOD_RES     464    464       (3S)-3-hydroxyasparagine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:21177872}.
FT   MOD_RES     629    629       (3S)-3-hydroxyasparagine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:21177872}.
FT   MOD_RES     662    662       (3S)-3-hydroxyasparagine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:21177872}.
FT   MOD_RES     695    695       (3S)-3-hydroxyaspartate; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:21177872}.
FT   MOD_RES     728    728       (3S)-3-hydroxyasparagine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:21177872}.
FT   MOD_RES     759    759       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     761    761       (3S)-3-hydroxyasparagine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:21177872}.
FT   MOD_RES     781    781       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     817    817       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     834    834       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     856    856       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     961    961       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q02357}.
FT   MOD_RES    1073   1073       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q02357}.
FT   MOD_RES    1082   1082       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q02357}.
FT   MOD_RES    1378   1378       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1380   1380       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1390   1390       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q02357}.
FT   MOD_RES    1392   1392       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q02357}.
FT   MOD_RES    1396   1396       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1400   1400       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q02357}.
FT   MOD_RES    1428   1428       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1486   1486       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1523   1523       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1533   1533       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1617   1617       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q02357}.
FT   MOD_RES    1666   1666       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1671   1671       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1686   1686       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1690   1690       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1696   1696       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1   1725       Missing (in isoform Mu17, isoform Mu18,
FT                                isoform Mu19, isoform Mu20, isoform 22
FT                                and isoform 23).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9430667}.
FT                                /FTId=VSP_018440.
FT   VAR_SEQ       1      9       MPYSVGFRE -> MAQAAKQLKKIKDIEAQALQEQKEKEES
FT                                NRKRRNRSRDRKKK (in isoform Br21).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_018439.
FT   VAR_SEQ     820    820       E -> EGTAHITIM (in isoform Br21).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_018441.
FT   VAR_SEQ    1513   1874       Missing (in isoform Er16).
FT                                {ECO:0000303|PubMed:1689849}.
FT                                /FTId=VSP_000264.
FT   VAR_SEQ    1514   1675       Missing (in isoform Er2, isoform Er4,
FT                                isoform Er6, isoform Er8, isoform Er10,
FT                                isoform Er12 and isoform Er14).
FT                                {ECO:0000303|PubMed:2137557}.
FT                                /FTId=VSP_018442.
FT   VAR_SEQ    1726   1798       TQGPHSFQGTSTMTEGLEPGGSQEYEKVLVSVSEHTWTEQP
FT                                EAESSQADRDRRQQGQEEQVQEAKNTFTQVVQ -> MWTFV
FT                                TQLLVTLVLLSFFLVSCQNVMHIVRGSLCFVLKHIHQELDK
FT                                ELGESEGLSDDEETISTRVVRRRVFLK (in isoform
FT                                Mu17, isoform Mu18, isoform Mu19, isoform
FT                                22 and isoform 23).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9430667}.
FT                                /FTId=VSP_018443.
FT   VAR_SEQ    1726   1798       TQGPHSFQGTSTMTEGLEPGGSQEYEKVLVSVSEHTWTEQP
FT                                EAESSQADRDRRQQGQEEQVQEAKNTFTQVVQ -> MWTFV
FT                                TQLLVTLVLLSFFLVSCQNVMHIVRGSLCFVLKHIHQ (in
FT                                isoform Mu20).
FT                                {ECO:0000303|PubMed:9430667}.
FT                                /FTId=VSP_018444.
FT   VAR_SEQ    1799   1881       GNEFQNIPGEQVTEEQFTDEQGNIVTKKIIRKVVRQIDLSS
FT                                ADAAQEHEEVTVEGPLEDPSELEVDIDYFMKHSKDHTSTPN
FT                                P -> VELRGSGLQPDLIEGRKGAQIVKRASLKRGKQ (in
FT                                isoform Mu20).
FT                                {ECO:0000303|PubMed:9430667}.
FT                                /FTId=VSP_018446.
FT   VAR_SEQ    1799   1873       Missing (in isoform Er9, isoform Er10 and
FT                                isoform Mu19).
FT                                {ECO:0000303|PubMed:9430667}.
FT                                /FTId=VSP_018445.
FT   VAR_SEQ    1826   1872       Missing (in isoform 22).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_045439.
FT   VAR_SEQ    1827   1881       IIRKVVRQIDLSSADAAQEHEEVTVEGPLEDPSELEVDIDY
FT                                FMKHSKDHTSTPNP -> VELRGSGLQPDLIEGRKGAQIVK
FT                                RASLKRGKQ (in isoform Er15 and isoform
FT                                Mu18). {ECO:0000303|PubMed:9430667}.
FT                                /FTId=VSP_018448.
FT   VAR_SEQ    1827   1873       Missing (in isoform Er7 and isoform Er8).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_018447.
FT   VAR_SEQ    1849   1873       Missing (in isoform Er3, isoform Er4 and
FT                                isoform Br21). {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_018449.
FT   VAR_SEQ    1850   1881       TVEGPLEDPSELEVDIDYFMKHSKDHTSTPNP -> ELRGS
FT                                GLQPDLIEGRKGAQIVKRASLKRGKQ (in isoform
FT                                Er5, isoform Er6 and isoform Mu17).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:1689849,
FT                                ECO:0000303|PubMed:9430667}.
FT                                /FTId=VSP_000266.
FT   VAR_SEQ    1874   1881       DHTSTPNP -> VELRGSGLQPDLIEGRKGAQIVKRASLKR
FT                                GKQ (in isoform Er11 and isoform Er12).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_018450.
FT   VAR_SEQ    1874   1881       DHTSTPNP -> VLRRPRPWGTQRHHCCLALPGRLHDTSLH
FT                                SPLYELSLQSLFSLVGSVSAPPCRSFRSSACVLPVFAICPA
FT                                FCLCCCLQVELRGSGLQPDLIEGRKGAQIVKRASLKRGKQ
FT                                (in isoform Er13 and isoform Er14).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_018451.
FT   VAR_SEQ    1875   1875       H -> D (in isoform Er16).
FT                                {ECO:0000303|PubMed:1689849}.
FT                                /FTId=VSP_000265.
FT   VARIANT      21     21       R -> T.
FT                                /FTId=VAR_000595.
FT   VARIANT     276    276       L -> R (in SPH1).
FT                                {ECO:0000269|PubMed:11102985}.
FT                                /FTId=VAR_054991.
FT   VARIANT     332    332       D -> H (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035605.
FT   VARIANT     463    463       V -> I (in SPH1; dbSNP:rs140085544).
FT                                {ECO:0000269|PubMed:8640229}.
FT                                /FTId=VAR_000596.
FT   VARIANT     619    619       R -> H (in Brueggen; dbSNP:rs2304877).
FT                                /FTId=VAR_000597.
FT   VARIANT     733    733       L -> I (in dbSNP:rs11778936).
FT                                /FTId=VAR_028769.
FT   VARIANT     750    750       V -> A. {ECO:0000269|PubMed:2137557}.
FT                                /FTId=VAR_000598.
FT   VARIANT     832    832       R -> Q (in dbSNP:rs34523608).
FT                                /FTId=VAR_061012.
FT   VARIANT     845    845       D -> E.
FT                                /FTId=VAR_000599.
FT   VARIANT     991    991       V -> L. {ECO:0000269|PubMed:9235914}.
FT                                /FTId=VAR_026411.
FT   VARIANT    1054   1054       I -> T (in SPH1).
FT                                {ECO:0000269|PubMed:11102985}.
FT                                /FTId=VAR_054992.
FT   VARIANT    1075   1075       T -> I (in dbSNP:rs35213384).
FT                                {ECO:0000269|PubMed:1689849,
FT                                ECO:0000269|PubMed:2137557,
FT                                ECO:0000269|PubMed:9235914,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_048263.
FT   VARIANT    1126   1126       A -> P (in dbSNP:rs504465).
FT                                /FTId=VAR_028770.
FT   VARIANT    1192   1192       T -> P (in dbSNP:rs486770).
FT                                /FTId=VAR_028771.
FT   VARIANT    1286   1286       E -> D. {ECO:0000269|PubMed:2141335}.
FT                                /FTId=VAR_000601.
FT   VARIANT    1325   1325       M -> V (in dbSNP:rs10093583).
FT                                /FTId=VAR_028772.
FT   VARIANT    1392   1392       S -> T.
FT                                /FTId=VAR_000600.
FT   VARIANT    1546   1546       V -> I (in dbSNP:rs1060130).
FT                                {ECO:0000269|PubMed:1689849}.
FT                                /FTId=VAR_028773.
FT   VARIANT    1592   1592       D -> N (in Duesseldorf).
FT                                /FTId=VAR_000602.
FT   MUTAGEN    1824   1824       T->P: Abolishes interaction with OBSCN
FT                                (in isoform Mu17).
FT                                {ECO:0000269|PubMed:12527750}.
FT   MUTAGEN    1826   1826       K->E: Abolishes interaction with OBSCN
FT                                (in isoform Mu17).
FT                                {ECO:0000269|PubMed:12527750}.
FT   MUTAGEN    1829   1829       R->G: Abolishes interaction with OBSCN
FT                                (in isoform Mu17).
FT                                {ECO:0000269|PubMed:12527750}.
FT   MUTAGEN    1830   1830       K->E: Abolishes interaction with OBSCN
FT                                (in isoform Mu17).
FT                                {ECO:0000269|PubMed:12527750}.
FT   CONFLICT    230    230       A -> S (in Ref. 2; AAA51732).
FT                                {ECO:0000305}.
FT   CONFLICT    801    801       K -> L (in Ref. 3; AAB47805).
FT                                {ECO:0000305}.
FT   CONFLICT    845    845       D -> R (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    902    902       I -> T (in Ref. 3; AAB47805).
FT                                {ECO:0000305}.
FT   HELIX       407    414       {ECO:0000244|PDB:1N11}.
FT   HELIX       417    425       {ECO:0000244|PDB:1N11}.
FT   STRAND      433    435       {ECO:0000244|PDB:1N11}.
FT   HELIX       440    447       {ECO:0000244|PDB:1N11}.
FT   HELIX       450    459       {ECO:0000244|PDB:1N11}.
FT   HELIX       473    480       {ECO:0000244|PDB:1N11}.
FT   HELIX       483    492       {ECO:0000244|PDB:1N11}.
FT   HELIX       506    513       {ECO:0000244|PDB:1N11}.
FT   HELIX       516    524       {ECO:0000244|PDB:1N11}.
FT   HELIX       539    545       {ECO:0000244|PDB:1N11}.
FT   HELIX       549    557       {ECO:0000244|PDB:1N11}.
FT   HELIX       572    578       {ECO:0000244|PDB:1N11}.
FT   HELIX       582    588       {ECO:0000244|PDB:1N11}.
FT   HELIX       589    591       {ECO:0000244|PDB:1N11}.
FT   HELIX       605    611       {ECO:0000244|PDB:1N11}.
FT   HELIX       615    623       {ECO:0000244|PDB:1N11}.
FT   HELIX       638    644       {ECO:0000244|PDB:1N11}.
FT   HELIX       648    655       {ECO:0000244|PDB:1N11}.
FT   TURN        656    658       {ECO:0000244|PDB:1N11}.
FT   HELIX       671    678       {ECO:0000244|PDB:1N11}.
FT   HELIX       681    690       {ECO:0000244|PDB:1N11}.
FT   HELIX       704    710       {ECO:0000244|PDB:1N11}.
FT   HELIX       715    722       {ECO:0000244|PDB:1N11}.
FT   HELIX       737    743       {ECO:0000244|PDB:1N11}.
FT   HELIX       747    755       {ECO:0000244|PDB:1N11}.
FT   STRAND      765    767       {ECO:0000244|PDB:1N11}.
FT   HELIX       770    776       {ECO:0000244|PDB:1N11}.
FT   HELIX       780    789       {ECO:0000244|PDB:1N11}.
FT   STRAND      914    919       {ECO:0000244|PDB:3F59}.
FT   STRAND      924    927       {ECO:0000244|PDB:3F59}.
FT   TURN        930    932       {ECO:0000244|PDB:3UD1}.
FT   STRAND      935    938       {ECO:0000244|PDB:3F59}.
FT   STRAND      942    945       {ECO:0000244|PDB:3KBT}.
FT   STRAND      947    954       {ECO:0000244|PDB:3F59}.
FT   HELIX       956    958       {ECO:0000244|PDB:3F59}.
FT   STRAND      959    961       {ECO:0000244|PDB:3KBU}.
FT   STRAND      970    973       {ECO:0000244|PDB:3KBT}.
FT   STRAND      975    980       {ECO:0000244|PDB:3F59}.
FT   STRAND      984    994       {ECO:0000244|PDB:3F59}.
FT   STRAND     1000   1003       {ECO:0000244|PDB:3KBT}.
FT   STRAND     1006   1015       {ECO:0000244|PDB:3F59}.
FT   STRAND     1018   1020       {ECO:0000244|PDB:3KBT}.
FT   HELIX      1026   1028       {ECO:0000244|PDB:3F59}.
FT   HELIX      1029   1033       {ECO:0000244|PDB:3F59}.
FT   HELIX      1043   1049       {ECO:0000244|PDB:3F59}.
FT   STRAND     1051   1058       {ECO:0000244|PDB:3F59}.
FT   STRAND     1061   1067       {ECO:0000244|PDB:3F59}.
FT   STRAND     1074   1076       {ECO:0000244|PDB:3UD1}.
FT   STRAND     1081   1084       {ECO:0000244|PDB:3UD1}.
FT   STRAND     1092   1095       {ECO:0000244|PDB:3UD1}.
FT   STRAND     1099   1102       {ECO:0000244|PDB:3UD1}.
FT   STRAND     1104   1111       {ECO:0000244|PDB:3UD1}.
FT   HELIX      1115   1122       {ECO:0000244|PDB:3UD1}.
FT   STRAND     1131   1138       {ECO:0000244|PDB:3UD1}.
FT   STRAND     1140   1150       {ECO:0000244|PDB:3UD1}.
FT   HELIX      1153   1157       {ECO:0000244|PDB:3UD1}.
FT   STRAND     1165   1167       {ECO:0000244|PDB:3UD2}.
FT   STRAND     1169   1175       {ECO:0000244|PDB:3UD1}.
FT   STRAND     1195   1197       {ECO:0000244|PDB:3UD1}.
FT   STRAND     1200   1207       {ECO:0000244|PDB:3UD1}.
FT   STRAND     1210   1215       {ECO:0000244|PDB:3UD1}.
FT   HELIX      1219   1221       {ECO:0000244|PDB:3UD1}.
FT   HELIX      1222   1232       {ECO:0000244|PDB:3UD1}.
FT   TURN       1398   1402       {ECO:0000244|PDB:2YVI}.
FT   HELIX      1403   1414       {ECO:0000244|PDB:2YVI}.
FT   HELIX      1415   1417       {ECO:0000244|PDB:2YVI}.
FT   HELIX      1418   1424       {ECO:0000244|PDB:2YVI}.
FT   HELIX      1429   1438       {ECO:0000244|PDB:2YVI}.
FT   HELIX      1443   1458       {ECO:0000244|PDB:2YVI}.
FT   HELIX      1459   1461       {ECO:0000244|PDB:2YVI}.
FT   HELIX      1464   1473       {ECO:0000244|PDB:2YVI}.
FT   HELIX      1477   1483       {ECO:0000244|PDB:2YVI}.
SQ   SEQUENCE   1881 AA;  206265 MW;  49466F6F915019EC CRC64;
     MPYSVGFREA DAATSFLRAA RSGNLDKALD HLRNGVDINT CNQNGLNGLH LASKEGHVKM
     VVELLHKEII LETTTKKGNT ALHIAALAGQ DEVVRELVNY GANVNAQSQK GFTPLYMAAQ
     ENHLEVVKFL LENGANQNVA TEDGFTPLAV ALQQGHENVV AHLINYGTKG KVRLPALHIA
     ARNDDTRTAA VLLQNDPNPD VLSKTGFTPL HIAAHYENLN VAQLLLNRGA SVNFTPQNGI
     TPLHIASRRG NVIMVRLLLD RGAQIETKTK DELTPLHCAA RNGHVRISEI LLDHGAPIQA
     KTKNGLSPIH MAAQGDHLDC VRLLLQYDAE IDDITLDHLT PLHVAAHCGH HRVAKVLLDK
     GAKPNSRALN GFTPLHIACK KNHVRVMELL LKTGASIDAV TESGLTPLHV ASFMGHLPIV
     KNLLQRGASP NVSNVKVETP LHMAARAGHT EVAKYLLQNK AKVNAKAKDD QTPLHCAARI
     GHTNMVKLLL ENNANPNLAT TAGHTPLHIA AREGHVETVL ALLEKEASQA CMTKKGFTPL
     HVAAKYGKVR VAELLLERDA HPNAAGKNGL TPLHVAVHHN NLDIVKLLLP RGGSPHSPAW
     NGYTPLHIAA KQNQVEVARS LLQYGGSANA ESVQGVTPLH LAAQEGHAEM VALLLSKQAN
     GNLGNKSGLT PLHLVAQEGH VPVADVLIKH GVMVDATTRM GYTPLHVASH YGNIKLVKFL
     LQHQADVNAK TKLGYSPLHQ AAQQGHTDIV TLLLKNGASP NEVSSDGTTP LAIAKRLGYI
     SVTDVLKVVT DETSFVLVSD KHRMSFPETV DEILDVSEDE GEELISFKAE RRDSRDVDEE
     KELLDFVPKL DQVVESPAIP RIPCAMPETV VIRSEEQEQA SKEYDEDSLI PSSPATETSD
     NISPVASPVH TGFLVSFMVD ARGGSMRGSR HNGLRVVIPP RTCAAPTRIT CRLVKPQKLS
     TPPPLAEEEG LASRIIALGP TGAQFLSPVI VEIPHFASHG RGDRELVVLR SENGSVWKEH
     RSRYGESYLD QILNGMDEEL GSLEELEKKR VCRIITTDFP LYFVIMSRLC QDYDTIGPEG
     GSLKSKLVPL VQATFPENAV TKRVKLALQA QPVPDELVTK LLGNQATFSP IVTVEPRRRK
     FHRPIGLRIP LPPSWTDNPR DSGEGDTTSL RLLCSVIGGT DQAQWEDITG TTKLVYANEC
     ANFTTNVSAR FWLSDCPRTA EAVNFATLLY KELTAVPYMA KFVIFAKMND PREGRLRCYC
     MTDDKVDKTL EQHENFVEVA RSRDIEVLEG MSLFAELSGN LVPVKKAAQQ RSFHFQSFRE
     NRLAMPVKVR DSSREPGGSL SFLRKAMKYE DTQHILCHLN ITMPPCAKGS GAEDRRRTPT
     PLALRYSILS ESTPGSLSGT EQAEMKMAVI SEHLGLSWAE LARELQFSVE DINRIRVENP
     NSLLEQSVAL LNLWVIREGQ NANMENLYTA LQSIDRGEIV NMLEGSGRQS RNLKPDRRHT
     DRDYSLSPSQ MNGYSSLQDE LLSPASLGCA LSSPLRADQY WNEVAVLDAI PLAATEHDTM
     LEMSDMQVWS AGLTPSLVTA EDSSLECSKA EDSDATGHEW KLEGALSEEP RGPELGSLEL
     VEDDTVDSDA TNGLIDLLEQ EEGQRSEEKL PGSKRQDDAT GAGQDSENEV SLVSGHQRGQ
     ARITHSPTVS QVTERSQDRL QDWDADGSIV SYLQDAAQGS WQEEVTQGPH SFQGTSTMTE
     GLEPGGSQEY EKVLVSVSEH TWTEQPEAES SQADRDRRQQ GQEEQVQEAK NTFTQVVQGN
     EFQNIPGEQV TEEQFTDEQG NIVTKKIIRK VVRQIDLSSA DAAQEHEEVT VEGPLEDPSE
     LEVDIDYFMK HSKDHTSTPN P
//
ID   E9PK91_HUMAN            Unreviewed;       871 AA.
AC   E9PK91;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   25-APR-2018, entry version 56.
DE   SubName: Full=Bcl-2-associated transcription factor 1 {ECO:0000313|Ensembl:ENSP00000435441};
GN   Name=BCLAF1 {ECO:0000313|Ensembl:ENSP00000435441};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000435441, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000435441}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [4] {ECO:0000213|PubMed:17487921}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17487921; DOI=10.1002/elps.200600782;
RA   Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
RT   "Toward a global characterization of the phosphoproteome in prostate
RT   cancer cells: identification of phosphoproteins in the LNCaP cell
RT   line.";
RL   Electrophoresis 28:2027-2034(2007).
RN   [5] {ECO:0000213|PubMed:17924679}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [6] {ECO:0000213|PubMed:19367720}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [7] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8] {ECO:0000213|PubMed:18318008}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [9] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [11] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [13] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [15] {ECO:0000313|Ensembl:ENSP00000435441}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [16] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18] {ECO:0000213|PubMed:25218447}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [19] {ECO:0000213|PubMed:25114211}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [20] {ECO:0000213|PubMed:25772364}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 Orchestrates Chromatin Modifiers in Response to DNA Damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [21] {ECO:0000213|PubMed:25755297}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurethsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide Analysis of SUMOylation Dynamics in Response to
RT   Replication Stress Reveals Novel Small Ubiquitin-like Modified Target
RT   Proteins and Acceptor Lysines Relevant for Genome Stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [22] {ECO:0000213|PubMed:28112733}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL121713; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_005267294.1; XM_005267237.3.
DR   UniGene; Hs.486542; -.
DR   ProteinModelPortal; E9PK91; -.
DR   EPD; E9PK91; -.
DR   MaxQB; E9PK91; -.
DR   PRIDE; E9PK91; -.
DR   Ensembl; ENST00000527536; ENSP00000435441; ENSG00000029363.
DR   GeneID; 9774; -.
DR   UCSC; uc063rsl.1; human.
DR   CTD; 9774; -.
DR   EuPathDB; HostDB:ENSG00000029363.15; -.
DR   HGNC; HGNC:16863; BCLAF1.
DR   OpenTargets; ENSG00000029363; -.
DR   GeneTree; ENSGT00530000063211; -.
DR   ChiTaRS; BCLAF1; human.
DR   GenomeRNAi; 9774; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000029363; -.
DR   ExpressionAtlas; E9PK91; baseline and differential.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0006915; P:apoptotic process; IEA:InterPro.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:2001022; P:positive regulation of response to DNA damage stimulus; IEA:InterPro.
DR   InterPro; IPR026668; Bcl-2_assoc_TF1.
DR   InterPro; IPR029199; THRAP3_BCLAF1.
DR   PANTHER; PTHR15268; PTHR15268; 2.
DR   PANTHER; PTHR15268:SF4; PTHR15268:SF4; 2.
DR   Pfam; PF15440; THRAP3_BCLAF1; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:E9PK91,
KW   ECO:0000213|MaxQB:E9PK91, ECO:0000213|PeptideAtlas:E9PK91};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   COILED      849    871       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   871 AA;  100406 MW;  931366D5EF9B9C13 CRC64;
     MGRSNSRSHS SRSKSRSQSS SRSRSRSHSR KKRYSSRSRS RTYSRSRSRD RMYSRDYRRD
     YRNNRGMRRP YGYRGRGRGY YQGGGGRYHR GGYRPVWNRR HSRSPRRGRS RSRSPKRRSV
     SSQRSRSRSR RSYRSSRSPR SSSSRSSSPY SKSPVSKRRG SQEKQTKKAE GEPQEESPLK
     SKSQEEPKDT FEHDPSESID EFNKSSATSG DIWPGLSAYD NSPRSPHSPS PIATPPSQSS
     SCSDAPMLST VHSAKNTPSQ HSHSIQHSPE RSGSGSVGNG SSRYSPSQNS PIHHIPSRRS
     PAKTIAPQNA PRDESRGRSS FYPDGGDQET AKTGKFLKRF TDEESRVFLL DRGNTRDKEA
     SKEKGSEKGR AEGEWEDQEA LDYFSDKESG KQKFNDSEGD DTEETEDYRQ FRKSVLADQG
     KSFATASHRN TEEEGLKYKS KVSLKGNRES DGFREEKNYK LKETGYVVER PSTTKDKHKE
     EDKNSERITV KKETQSPEQV KSEKLKDLFD YSPPLHKNLD AREKSTFREE SPLRIKMIAS
     DSHRPEVKLK MAPVPLDDSN RPASLTKDRL LASTLVHSVK KEQEFRSIFD HIKLPQASKS
     TSESFIQHIV SLVHHVKEQY FKSAAMTLNE RFTSYQKATE EHSTRQKSPE IHRRIDISPS
     TLRKHTRLAG EERVFKEENQ KGDKKLRCDS ADLRHDIDRR RKERSKERGD SKGSRESSGS
     RKQEKTPKDY KEYKSYKDDS KHKREQDHSR SSSSSASPSS PSSREEKESK KEREEEFKTH
     HEMKEYSGFA GVSRPRGTFH DDRDDGVDYW AKRGRGRGTF QRGRGRFNFK KSGSSPKWTH
     DKYQGDGIVE DEEETMENNE EKKDRRKEEK E
//
ID   BCLF1_HUMAN             Reviewed;         920 AA.
AC   Q9NYF8; A2RU75; B7ZM58; E1P586; Q14673; Q86WU6; Q86WY0;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2004, sequence version 2.
DT   25-APR-2018, entry version 162.
DE   RecName: Full=Bcl-2-associated transcription factor 1;
DE            Short=Btf;
DE   AltName: Full=BCLAF1 and THRAP3 family member 1;
GN   Name=BCLAF1; Synonyms=BTF, KIAA0164;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3).
RX   PubMed=10330179; DOI=10.1128/MCB.19.6.4390;
RA   Kasof G.M., Goyal L., White E.;
RT   "Btf, a novel death-promoting transcriptional repressor that interacts
RT   with Bcl-2-related proteins.";
RL   Mol. Cell. Biol. 19:4390-4404(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=8724849; DOI=10.1093/dnares/3.1.17;
RA   Nagase T., Seki N., Ishikawa K., Tanaka A., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. V.
RT   The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 3:17-24(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ISOFORM 1).
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-676 (ISOFORM 4).
RC   TISSUE=Brain, Pancreas, Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 168-182; 189-204; 256-271; 284-298; 304-312;
RP   319-332; 394-409; 422-439; 461-475; 505-517; 525-534; 537-548;
RP   551-581; 587-593; 623-631; 654-664; 785-796; 832-842 AND 846-852,
RP   PHOSPHORYLATION AT SER-177; SER-268; SER-290; SER-512; SER-531 AND
RP   SER-658, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Heiserich L., Boulahbel H., Gottlieb E.;
RL   Submitted (APR-2008) to UniProtKB.
RN   [7]
RP   INTERACTION WITH EMD.
RX   PubMed=15009215; DOI=10.1111/j.1432-1033.2004.04007.x;
RA   Haraguchi T., Holaska J.M., Yamane M., Koujin T., Hashiguchi N.,
RA   Mori C., Wilson K.L., Hiraoka Y.;
RT   "Emerin binding to Btf, a death-promoting transcriptional repressor,
RT   is disrupted by a missense mutation that causes Emery-Dreifuss
RT   muscular dystrophy.";
RL   Eur. J. Biochem. 271:1035-1045(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-177; SER-389; SER-397;
RP   THR-402; SER-531 AND SER-648, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-397, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Prostate cancer;
RX   PubMed=17487921; DOI=10.1002/elps.200600782;
RA   Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
RT   "Toward a global characterization of the phosphoproteome in prostate
RT   cancer cells: identification of phosphoproteins in the LNCaP cell
RT   line.";
RL   Electrophoresis 28:2027-2034(2007).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [11]
RP   FUNCTION, AND IDENTIFICATION IN THE SNARP COMPLEX.
RX   PubMed=18794151; DOI=10.1158/0008-5472.CAN-08-1217;
RA   Bracken C.P., Wall S.J., Barre B., Panov K.I., Ajuh P.M.,
RA   Perkins N.D.;
RT   "Regulation of cyclin D1 RNA stability by SNIP1.";
RL   Cancer Res. 68:7621-7628(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-397, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181; SER-222; SER-264;
RP   SER-268; TYR-284; SER-290; THR-341; SER-385; SER-389; SER-397;
RP   THR-402; SER-512; SER-531; SER-578 AND SER-658, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-177 AND SER-397, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-177; SER-222; SER-290;
RP   SER-385; SER-397; THR-402 AND SER-512, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-152 AND LYS-437, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-102; SER-104; SER-177;
RP   SER-196; SER-198; SER-222; SER-268; SER-290; SER-297; SER-385;
RP   SER-397; THR-402; SER-472; SER-496; SER-502; SER-512; SER-531;
RP   THR-566; SER-578; SER-658 AND SER-690, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-177; SER-196; SER-198;
RP   SER-222; SER-268; SER-285; SER-290; SER-385; SER-397; THR-494;
RP   SER-496; SER-512; SER-531; SER-658; SER-660 AND SER-760, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   IDENTIFICATION IN THE WTAP COMPLEX, AND SUBCELLULAR LOCATION.
RX   PubMed=24100041; DOI=10.1074/jbc.M113.500397;
RA   Horiuchi K., Kawamura T., Iwanari H., Ohashi R., Naito M., Kodama T.,
RA   Hamakubo T.;
RT   "Identification of Wilms' tumor 1-associating protein complex and its
RT   role in alternative splicing and the cell cycle.";
RL   J. Biol. Chem. 288:33292-33302(2013).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-177; SER-196; SER-198;
RP   SER-222; SER-259; SER-262; SER-264; SER-268; SER-285; SER-290;
RP   SER-300; SER-315; THR-341; THR-355; TYR-383; SER-385; SER-397;
RP   THR-402; SER-422; SER-427; THR-431; SER-450; SER-472; SER-496;
RP   SER-512; SER-525; SER-531; SER-559; SER-564; SER-578; SER-658;
RP   SER-660; THR-661 AND SER-690, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-177; TYR-219; SER-222;
RP   SER-259; SER-264; SER-285; SER-290; SER-385; SER-389; SER-397; SER-648
RP   AND SER-658, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339
RP   (ISOFORM 4), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-809, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [25]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-332; LYS-413; LYS-437;
RP   LYS-462; LYS-491; LYS-501; LYS-548; LYS-550; LYS-580; LYS-676; LYS-778
RP   AND LYS-831, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [26]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-580 AND LYS-831, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [27]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-491; LYS-580; LYS-676 AND
RP   LYS-831, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [28]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-421; LYS-437; LYS-457;
RP   LYS-501; LYS-536; LYS-548; LYS-550; LYS-580 AND LYS-676, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [29]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-188; LYS-332; LYS-413;
RP   LYS-421; LYS-437; LYS-457; LYS-462; LYS-491; LYS-492; LYS-501;
RP   LYS-536; LYS-548; LYS-550; LYS-567; LYS-580; LYS-593; LYS-599;
RP   LYS-622; LYS-676; LYS-778; LYS-784; LYS-831 AND LYS-911, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Death-promoting transcriptional repressor. May be
CC       involved in cyclin-D1/CCND1 mRNA stability through the SNARP
CC       complex which associates with both the 3'end of the CCND1 gene and
CC       its mRNA. {ECO:0000269|PubMed:18794151}.
CC   -!- SUBUNIT: Interacts with Bcl-2 related proteins, EMD, with the
CC       adenovirus E1B 19 kDa protein and with DNA. Component of the SNARP
CC       complex which consists at least of SNIP1, SNW1, THRAP3, BCLAF1 and
CC       PNN. Component of the WTAP complex composed of WTAP, ZC3H13,
CC       CBLL1, KIAA1429, RBM15, BCLAF1 and THRAP3.
CC       {ECO:0000269|PubMed:15009215, ECO:0000269|PubMed:18794151,
CC       ECO:0000269|PubMed:24100041}.
CC   -!- INTERACTION:
CC       P10415:BCL2; NbExp=2; IntAct=EBI-437804, EBI-77694;
CC       P50402:EMD; NbExp=3; IntAct=EBI-437804, EBI-489887;
CC       P61981:YWHAG; NbExp=2; IntAct=EBI-437804, EBI-359832;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Nucleus speckle
CC       {ECO:0000269|PubMed:24100041}. Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:24100041}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9NYF8-1; Sequence=Displayed;
CC       Name=2; Synonyms=Btf-l;
CC         IsoId=Q9NYF8-2; Sequence=VSP_010369;
CC       Name=3; Synonyms=Btf-s, BP-1;
CC         IsoId=Q9NYF8-3; Sequence=VSP_010369, VSP_010370;
CC       Name=4;
CC         IsoId=Q9NYF8-4; Sequence=VSP_010371;
CC         Note=Contains a phosphoserine at position 339.
CC         {ECO:0000244|PubMed:24275569};
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- PTM: Citrullinated by PADI4. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the BCLAF1/THRAP3 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH47687.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH47887.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH56894.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH63846.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAA11481.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/BCLAF1ID43164ch6q23.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF249273; AAF64304.1; -; mRNA.
DR   EMBL; D79986; BAA11481.2; ALT_INIT; mRNA.
DR   EMBL; AL121713; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW47950.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW47951.1; -; Genomic_DNA.
DR   EMBL; BC047687; AAH47687.1; ALT_SEQ; mRNA.
DR   EMBL; BC047887; AAH47887.1; ALT_SEQ; mRNA.
DR   EMBL; BC056894; AAH56894.1; ALT_SEQ; mRNA.
DR   EMBL; BC063846; AAH63846.1; ALT_SEQ; mRNA.
DR   EMBL; BC132780; AAI32781.1; -; mRNA.
DR   EMBL; BC144281; AAI44282.1; -; mRNA.
DR   CCDS; CCDS47485.1; -. [Q9NYF8-4]
DR   CCDS; CCDS47486.1; -. [Q9NYF8-3]
DR   CCDS; CCDS5177.1; -. [Q9NYF8-1]
DR   CCDS; CCDS75525.1; -. [Q9NYF8-2]
DR   RefSeq; NP_001070908.1; NM_001077440.1. [Q9NYF8-3]
DR   RefSeq; NP_001070909.1; NM_001077441.1. [Q9NYF8-4]
DR   RefSeq; NP_001287967.1; NM_001301038.1. [Q9NYF8-2]
DR   RefSeq; NP_055554.1; NM_014739.2. [Q9NYF8-1]
DR   UniGene; Hs.486542; -.
DR   ProteinModelPortal; Q9NYF8; -.
DR   BioGrid; 115118; 120.
DR   IntAct; Q9NYF8; 74.
DR   MINT; Q9NYF8; -.
DR   STRING; 9606.ENSP00000435210; -.
DR   iPTMnet; Q9NYF8; -.
DR   PhosphoSitePlus; Q9NYF8; -.
DR   SwissPalm; Q9NYF8; -.
DR   BioMuta; BCLAF1; -.
DR   DMDM; 47605556; -.
DR   EPD; Q9NYF8; -.
DR   MaxQB; Q9NYF8; -.
DR   PaxDb; Q9NYF8; -.
DR   PeptideAtlas; Q9NYF8; -.
DR   PRIDE; Q9NYF8; -.
DR   Ensembl; ENST00000353331; ENSP00000229446; ENSG00000029363. [Q9NYF8-3]
DR   Ensembl; ENST00000392348; ENSP00000376159; ENSG00000029363. [Q9NYF8-3]
DR   Ensembl; ENST00000527759; ENSP00000434826; ENSG00000029363. [Q9NYF8-2]
DR   Ensembl; ENST00000530767; ENSP00000436501; ENSG00000029363. [Q9NYF8-4]
DR   Ensembl; ENST00000531224; ENSP00000435210; ENSG00000029363. [Q9NYF8-1]
DR   GeneID; 9774; -.
DR   KEGG; hsa:9774; -.
DR   UCSC; uc003qgw.2; human. [Q9NYF8-1]
DR   CTD; 9774; -.
DR   DisGeNET; 9774; -.
DR   EuPathDB; HostDB:ENSG00000029363.15; -.
DR   GeneCards; BCLAF1; -.
DR   HGNC; HGNC:16863; BCLAF1.
DR   HPA; HPA006484; -.
DR   HPA; HPA006669; -.
DR   HPA; HPA027770; -.
DR   MIM; 612588; gene.
DR   neXtProt; NX_Q9NYF8; -.
DR   OpenTargets; ENSG00000029363; -.
DR   PharmGKB; PA134868035; -.
DR   eggNOG; ENOG410IJCD; Eukaryota.
DR   eggNOG; ENOG4110X68; LUCA.
DR   GeneTree; ENSGT00530000063211; -.
DR   HOVERGEN; HBG050681; -.
DR   InParanoid; Q9NYF8; -.
DR   KO; K13087; -.
DR   OMA; TSHRNTE; -.
DR   OrthoDB; EOG091G03HU; -.
DR   PhylomeDB; Q9NYF8; -.
DR   TreeFam; TF335939; -.
DR   ChiTaRS; BCLAF1; human.
DR   GeneWiki; BCLAF1; -.
DR   GenomeRNAi; 9774; -.
DR   PRO; PR:Q9NYF8; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000029363; -.
DR   CleanEx; HS_BCLAF1; -.
DR   ExpressionAtlas; Q9NYF8; baseline and differential.
DR   Genevisible; Q9NYF8; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0003677; F:DNA binding; IDA:MGI.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; TAS:UniProtKB.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:MGI.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:MGI.
DR   GO; GO:2000144; P:positive regulation of DNA-templated transcription, initiation; IMP:UniProtKB.
DR   GO; GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IMP:UniProtKB.
DR   GO; GO:2001022; P:positive regulation of response to DNA damage stimulus; IMP:UniProtKB.
DR   GO; GO:0043620; P:regulation of DNA-templated transcription in response to stress; IMP:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR026668; Bcl-2_assoc_TF1.
DR   InterPro; IPR029199; THRAP3_BCLAF1.
DR   PANTHER; PTHR15268; PTHR15268; 1.
DR   PANTHER; PTHR15268:SF4; PTHR15268:SF4; 1.
DR   Pfam; PF15440; THRAP3_BCLAF1; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Citrullination; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; DNA-binding; Isopeptide bond;
KW   Methylation; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN         1    920       Bcl-2-associated transcription factor 1.
FT                                /FTId=PRO_0000064888.
FT   COMPBIAS    141    148       Poly-Ser.
FT   COMPBIAS    749    763       Poly-Ser.
FT   MOD_RES     102    102       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     104    104       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     152    152       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     177    177       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|Ref.6}.
FT   MOD_RES     181    181       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     196    196       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     198    198       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     219    219       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     222    222       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     259    259       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     262    262       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     264    264       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     268    268       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|Ref.6}.
FT   MOD_RES     284    284       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     285    285       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     290    290       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|Ref.6}.
FT   MOD_RES     297    297       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     300    300       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     315    315       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     332    332       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8K019}.
FT   MOD_RES     341    341       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     355    355       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     383    383       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     385    385       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     389    389       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     397    397       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:17487921,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19367720,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     402    402       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     421    421       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8K019}.
FT   MOD_RES     422    422       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     427    427       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     431    431       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     437    437       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     450    450       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     472    472       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     475    475       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8K019}.
FT   MOD_RES     494    494       Phosphothreonine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     496    496       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     502    502       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     512    512       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|Ref.6}.
FT   MOD_RES     525    525       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     531    531       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|Ref.6}.
FT   MOD_RES     559    559       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     564    564       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     566    566       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     578    578       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     648    648       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     658    658       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|Ref.6}.
FT   MOD_RES     660    660       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     661    661       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     690    690       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     760    760       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     803    803       Citrulline. {ECO:0000250}.
FT   MOD_RES     809    809       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   CROSSLNK    188    188       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    332    332       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    413    413       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    421    421       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    437    437       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    457    457       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    462    462       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    491    491       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    492    492       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    501    501       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    536    536       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    548    548       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    550    550       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    567    567       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    580    580       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK    580    580       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    593    593       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    599    599       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    622    622       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    676    676       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    778    778       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    784    784       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    831    831       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK    831    831       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    911    911       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ      35     36       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:10330179,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_010369.
FT   VAR_SEQ     339    511       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_010371.
FT   VAR_SEQ     800    848       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10330179}.
FT                                /FTId=VSP_010370.
FT   VARIANT      66     66       G -> A (in dbSNP:rs9942517).
FT                                /FTId=VAR_059591.
FT   VARIANT     209    209       S -> C (in dbSNP:rs6940018).
FT                                /FTId=VAR_050692.
FT   VARIANT     459    459       Y -> D (in dbSNP:rs1967446).
FT                                /FTId=VAR_050693.
FT   VARIANT     461    461       L -> H (in dbSNP:rs1967445).
FT                                /FTId=VAR_050694.
FT   VARIANT     629    629       N -> S (in dbSNP:rs7381749).
FT                                /FTId=VAR_050695.
FT   VARIANT     875    875       R -> C (in dbSNP:rs34541670).
FT                                /FTId=VAR_050696.
FT   CONFLICT      4      4       S -> A (in Ref. 1; AAF64304).
FT                                {ECO:0000305}.
SQ   SEQUENCE   920 AA;  106122 MW;  8892B98E54F52C20 CRC64;
     MGRSNSRSHS SRSKSRSQSS SRSRSRSHSR KKRYSSRSRS RTYSRSRSRD RMYSRDYRRD
     YRNNRGMRRP YGYRGRGRGY YQGGGGRYHR GGYRPVWNRR HSRSPRRGRS RSRSPKRRSV
     SSQRSRSRSR RSYRSSRSPR SSSSRSSSPY SKSPVSKRRG SQEKQTKKAE GEPQEESPLK
     SKSQEEPKDT FEHDPSESID EFNKSSATSG DIWPGLSAYD NSPRSPHSPS PIATPPSQSS
     SCSDAPMLST VHSAKNTPSQ HSHSIQHSPE RSGSGSVGNG SSRYSPSQNS PIHHIPSRRS
     PAKTIAPQNA PRDESRGRSS FYPDGGDQET AKTGKFLKRF TDEESRVFLL DRGNTRDKEA
     SKEKGSEKGR AEGEWEDQEA LDYFSDKESG KQKFNDSEGD DTEETEDYRQ FRKSVLADQG
     KSFATASHRN TEEEGLKYKS KVSLKGNRES DGFREEKNYK LKETGYVVER PSTTKDKHKE
     EDKNSERITV KKETQSPEQV KSEKLKDLFD YSPPLHKNLD AREKSTFREE SPLRIKMIAS
     DSHRPEVKLK MAPVPLDDSN RPASLTKDRL LASTLVHSVK KEQEFRSIFD HIKLPQASKS
     TSESFIQHIV SLVHHVKEQY FKSAAMTLNE RFTSYQKATE EHSTRQKSPE IHRRIDISPS
     TLRKHTRLAG EERVFKEENQ KGDKKLRCDS ADLRHDIDRR RKERSKERGD SKGSRESSGS
     RKQEKTPKDY KEYKSYKDDS KHKREQDHSR SSSSSASPSS PSSREEKESK KEREEEFKTH
     HEMKEYSGFA GVSRPRGTFF RIRGRGRARG VFAGTNTGPN NSNTTFQKRP KEEEWDPEYT
     PKSKKYFLHD DRDDGVDYWA KRGRGRGTFQ RGRGRFNFKK SGSSPKWTHD KYQGDGIVED
     EEETMENNEE KKDRRKEEKE
//
ID   A8K694_HUMAN            Unreviewed;       454 AA.
AC   A8K694;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   31-JAN-2018, entry version 57.
DE   SubName: Full=cDNA FLJ78712, highly similar to Homo sapiens bone morphogenetic protein 5 (BMP5), mRNA {ECO:0000313|EMBL:BAF84248.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF84248.1};
RN   [1] {ECO:0000313|EMBL:BAF84248.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAF84248.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|SAAS:SAAS00581915}.
CC   -!- SIMILARITY: Belongs to the TGF-beta family.
CC       {ECO:0000256|RuleBase:RU000354, ECO:0000256|SAAS:SAAS00581927}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK291559; BAF84248.1; -; mRNA.
DR   RefSeq; NP_001316683.1; NM_001329754.1.
DR   RefSeq; NP_066551.1; NM_021073.3.
DR   UniGene; Hs.296648; -.
DR   UniGene; Hs.656729; -.
DR   GeneID; 653; -.
DR   KEGG; hsa:653; -.
DR   CTD; 653; -.
DR   eggNOG; KOG3900; Eukaryota.
DR   eggNOG; ENOG410XT8Z; LUCA.
DR   HOVERGEN; HBG004860; -.
DR   KO; K04663; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW.
DR   Gene3D; 2.10.90.10; -; 1.
DR   InterPro; IPR029034; Cystine-knot_cytokine.
DR   InterPro; IPR001839; TGF-b_C.
DR   InterPro; IPR001111; TGF-b_propeptide.
DR   InterPro; IPR015615; TGF-beta-rel.
DR   InterPro; IPR017948; TGFb_CS.
DR   PANTHER; PTHR11848; PTHR11848; 1.
DR   Pfam; PF00019; TGF_beta; 1.
DR   Pfam; PF00688; TGFb_propeptide; 1.
DR   SMART; SM00204; TGFB; 1.
DR   SUPFAM; SSF57501; SSF57501; 1.
DR   PROSITE; PS00250; TGF_BETA_1; 1.
DR   PROSITE; PS51362; TGF_BETA_2; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00516088};
KW   Growth factor {ECO:0000256|RuleBase:RU000354,
KW   ECO:0000256|SAAS:SAAS00516085};
KW   Secreted {ECO:0000256|SAAS:SAAS00516087}.
FT   DOMAIN      335    454       TGF_BETA_2.
FT                                {ECO:0000259|PROSITE:PS51362}.
SQ   SEQUENCE   454 AA;  51751 MW;  22B8A64A3CBCF3EE CRC64;
     MHLTVFLLKG IVGFLWSCWV LVGYAKGGLG DNHVHSSFIY RRLRNHERRE IQREILSILG
     LPHRPRPFSP GKQASSAPLF MLDLYNAMTN EENPEESEYS VRASLAEETR GARKGYPASP
     NGYPRRIQLS RTTPLTTQSP PLASLHDTNF LNDADMVMSF VNLVERDKDF SHQRRHYKEF
     RFDLTQIPHG EAVTAAEFRI YKDRSNNRFE NETIKISIYQ IIKEYTNRDA DLFLLDTRKA
     QALDLGWLVF DITVTSNHWV INPQNNLGLQ LCAETGDGRS INVKSAGLVG RQGPQSKQPF
     MVAFFKASEV LLRSVRAANK RKNQNRNKSS SHQDSSRMSS VGDYNTSEQK QACKKHELYV
     SFRDLGWQDW IIAPEGYAAF YCDGECSFPL NAHMNATNHA IVQTLVHLMF PDHVPKPCCA
     PTKLNAISVL YFDDSSNVIL KKYRNMVVRS CGCH
//
ID   M9VUD0_HUMAN            Unreviewed;       454 AA.
AC   M9VUD0;
DT   26-JUN-2013, integrated into UniProtKB/TrEMBL.
DT   26-JUN-2013, sequence version 1.
DT   28-MAR-2018, entry version 42.
DE   SubName: Full=Bone morphogenenic protein-5 {ECO:0000313|EMBL:AGJ83825.1};
DE   SubName: Full=Bone morphogenetic protein 5 {ECO:0000313|EMBL:EAX04447.1};
GN   Name=BMP5 {ECO:0000313|EMBL:AGJ83825.1};
GN   ORFNames=hCG_21659 {ECO:0000313|EMBL:EAX04447.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AGJ83825.1};
RN   [1] {ECO:0000313|EMBL:EAX04447.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX04447.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:AGJ83825.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hong S.M., Sung H.S.;
RT   "Expression of Recombinant Human Bone Morphogenetic Protein-5 (rhBMP5)
RT   in Bombyx mori.";
RL   Submitted (DEC-2012) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|SAAS:SAAS00581915}.
CC   -!- SIMILARITY: Belongs to the TGF-beta family.
CC       {ECO:0000256|RuleBase:RU000354, ECO:0000256|SAAS:SAAS00581927}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KC485577; AGJ83825.1; -; mRNA.
DR   EMBL; CH471081; EAX04447.1; -; Genomic_DNA.
DR   RefSeq; NP_066551.1; NM_021073.3.
DR   UniGene; Hs.296648; -.
DR   UniGene; Hs.656729; -.
DR   GeneID; 653; -.
DR   KEGG; hsa:653; -.
DR   CTD; 653; -.
DR   EuPathDB; HostDB:ENSG00000112175.7; -.
DR   eggNOG; KOG3900; Eukaryota.
DR   eggNOG; ENOG410XT8Z; LUCA.
DR   KO; K04663; -.
DR   OMA; KEYPNRD; -.
DR   OrthoDB; EOG091G0C2J; -.
DR   GenomeRNAi; 653; -.
DR   Bgee; ENSG00000112175; -.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0031982; C:vesicle; IEA:Ensembl.
DR   GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW.
DR   GO; GO:1905069; P:allantois development; IEA:Ensembl.
DR   GO; GO:0097065; P:anterior head development; IEA:Ensembl.
DR   GO; GO:0048738; P:cardiac muscle tissue development; IEA:Ensembl.
DR   GO; GO:0060411; P:cardiac septum morphogenesis; IEA:Ensembl.
DR   GO; GO:0060710; P:chorio-allantoic fusion; IEA:Ensembl.
DR   GO; GO:0043583; P:ear development; IEA:Ensembl.
DR   GO; GO:0003272; P:endocardial cushion formation; IEA:Ensembl.
DR   GO; GO:0061384; P:heart trabecula morphogenesis; IEA:Ensembl.
DR   GO; GO:0030902; P:hindbrain development; IEA:Ensembl.
DR   GO; GO:0030539; P:male genitalia development; IEA:Ensembl.
DR   GO; GO:0021502; P:neural fold elevation formation; IEA:Ensembl.
DR   GO; GO:0007389; P:pattern specification process; IEA:Ensembl.
DR   GO; GO:0003344; P:pericardium morphogenesis; IEA:Ensembl.
DR   GO; GO:0060037; P:pharyngeal system development; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; IEA:Ensembl.
DR   Gene3D; 2.10.90.10; -; 1.
DR   InterPro; IPR029034; Cystine-knot_cytokine.
DR   InterPro; IPR001839; TGF-b_C.
DR   InterPro; IPR001111; TGF-b_propeptide.
DR   InterPro; IPR015615; TGF-beta-rel.
DR   InterPro; IPR017948; TGFb_CS.
DR   PANTHER; PTHR11848; PTHR11848; 1.
DR   Pfam; PF00019; TGF_beta; 1.
DR   Pfam; PF00688; TGFb_propeptide; 1.
DR   SMART; SM00204; TGFB; 1.
DR   SUPFAM; SSF57501; SSF57501; 1.
DR   PROSITE; PS00250; TGF_BETA_1; 1.
DR   PROSITE; PS51362; TGF_BETA_2; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00516088};
KW   Growth factor {ECO:0000256|RuleBase:RU000354,
KW   ECO:0000256|SAAS:SAAS00516085};
KW   Secreted {ECO:0000256|SAAS:SAAS00516087}.
FT   DOMAIN      335    454       TGF_BETA_2.
FT                                {ECO:0000259|PROSITE:PS51362}.
SQ   SEQUENCE   454 AA;  51737 MW;  631277413CCC22EE CRC64;
     MHLTVFLLKG IVGFLWSCWV LVGYAKGGLG DNHVHSSFIY RRLRNHERRE IQREILSILG
     LPHRPRPFSP GKQASSAPLF MLDLYNAMTN EENPEESEYS VRASLAEETR GARKGYPASP
     NGYPRRIQLS RTTPLTTQSP PLASLHDTNF LNDADMVMSF VNLVERDKDF SHQRRHYKEF
     RFDLTQIPHG EAVTAAEFRI YKDRSNNRFE NETIKISIYQ IIKEYTNRDA DLFLLDTRKA
     QALDVGWLVF DITVTSNHWV INPQNNLGLQ LCAETGDGRS INVKSAGLVG RQGPQSKQPF
     MVAFFKASEV LLRSVRAANK RKNQNRNKSS SHQDSSRMSS VGDYNTSEQK QACKKHELYV
     SFRDLGWQDW IIAPEGYAAF YCDGECSFPL NAHMNATNHA IVQTLVHLMF PDHVPKPCCA
     PTKLNAISVL YFDDSSNVIL KKYRNMVVRS CGCH
//
ID   BMP5_HUMAN              Reviewed;         454 AA.
AC   P22003; B4E0Y4; Q9H547; Q9NTM5;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1991, sequence version 1.
DT   28-MAR-2018, entry version 170.
DE   RecName: Full=Bone morphogenetic protein 5;
DE            Short=BMP-5;
DE   Flags: Precursor;
GN   Name=BMP5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Bone;
RX   PubMed=2263636; DOI=10.1073/pnas.87.24.9843;
RA   Celeste A.J., Iannazzi J.A., Taylor R.C., Hewick R.M., Rosen V.,
RA   Wang E.A., Wozney J.M.;
RT   "Identification of transforming growth factor beta family members
RT   present in bone-inductive protein purified from bovine bone.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:9843-9847(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung, and Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Induces cartilage and bone formation.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P22003-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P22003-2; Sequence=VSP_056841;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in the lung and liver.
CC   -!- SIMILARITY: Belongs to the TGF-beta family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Bone morphogenetic protein 5
CC       entry;
CC       URL="https://en.wikipedia.org/wiki/Bone_morphogenetic_protein_5";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M60314; AAA36736.1; -; mRNA.
DR   EMBL; AK303576; BAG64596.1; -; mRNA.
DR   EMBL; AL133386; CAB81657.2; -; Genomic_DNA.
DR   EMBL; AL137178; CAB81657.2; JOINED; Genomic_DNA.
DR   EMBL; AL137178; CAC12765.2; -; Genomic_DNA.
DR   EMBL; AL133386; CAC12765.2; JOINED; Genomic_DNA.
DR   EMBL; BC027958; AAH27958.1; -; mRNA.
DR   CCDS; CCDS4958.1; -. [P22003-1]
DR   PIR; A39263; BMHU5.
DR   RefSeq; NP_001316683.1; NM_001329754.1. [P22003-2]
DR   RefSeq; NP_066551.1; NM_021073.3. [P22003-1]
DR   UniGene; Hs.296648; -.
DR   UniGene; Hs.656729; -.
DR   ProteinModelPortal; P22003; -.
DR   BioGrid; 107121; 3.
DR   IntAct; P22003; 2.
DR   STRING; 9606.ENSP00000359866; -.
DR   iPTMnet; P22003; -.
DR   PhosphoSitePlus; P22003; -.
DR   BioMuta; BMP5; -.
DR   DMDM; 115075; -.
DR   PaxDb; P22003; -.
DR   PeptideAtlas; P22003; -.
DR   PRIDE; P22003; -.
DR   DNASU; 653; -.
DR   Ensembl; ENST00000370830; ENSP00000359866; ENSG00000112175. [P22003-1]
DR   GeneID; 653; -.
DR   KEGG; hsa:653; -.
DR   UCSC; uc003pcq.4; human. [P22003-1]
DR   CTD; 653; -.
DR   DisGeNET; 653; -.
DR   EuPathDB; HostDB:ENSG00000112175.7; -.
DR   GeneCards; BMP5; -.
DR   HGNC; HGNC:1072; BMP5.
DR   MIM; 112265; gene.
DR   neXtProt; NX_P22003; -.
DR   OpenTargets; ENSG00000112175; -.
DR   PharmGKB; PA25382; -.
DR   eggNOG; KOG3900; Eukaryota.
DR   eggNOG; ENOG410XT8Z; LUCA.
DR   GeneTree; ENSGT00760000118883; -.
DR   HOGENOM; HOG000249476; -.
DR   HOVERGEN; HBG004860; -.
DR   InParanoid; P22003; -.
DR   KO; K04663; -.
DR   OMA; KEYPNRD; -.
DR   OrthoDB; EOG091G0C2J; -.
DR   PhylomeDB; P22003; -.
DR   TreeFam; TF316134; -.
DR   GeneWiki; Bone_morphogenetic_protein_5; -.
DR   GenomeRNAi; 653; -.
DR   PRO; PR:P22003; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000112175; -.
DR   CleanEx; HS_BMP5; -.
DR   ExpressionAtlas; P22003; baseline and differential.
DR   Genevisible; P22003; HS.
DR   GO; GO:0005615; C:extracellular space; ISS:BHF-UCL.
DR   GO; GO:0031982; C:vesicle; ISS:BHF-UCL.
DR   GO; GO:0070700; F:BMP receptor binding; IDA:MGI.
DR   GO; GO:0005125; F:cytokine activity; IBA:GO_Central.
DR   GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0005160; F:transforming growth factor beta receptor binding; IBA:GO_Central.
DR   GO; GO:1905069; P:allantois development; ISS:BHF-UCL.
DR   GO; GO:0097065; P:anterior head development; IEA:Ensembl.
DR   GO; GO:0030509; P:BMP signaling pathway; IBA:GO_Central.
DR   GO; GO:0048738; P:cardiac muscle tissue development; ISS:BHF-UCL.
DR   GO; GO:0060411; P:cardiac septum morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0051216; P:cartilage development; IEA:UniProtKB-KW.
DR   GO; GO:0060710; P:chorio-allantoic fusion; ISS:BHF-UCL.
DR   GO; GO:0043583; P:ear development; IEA:Ensembl.
DR   GO; GO:0003272; P:endocardial cushion formation; ISS:BHF-UCL.
DR   GO; GO:0061384; P:heart trabecula morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0030902; P:hindbrain development; ISS:BHF-UCL.
DR   GO; GO:0030539; P:male genitalia development; IEA:Ensembl.
DR   GO; GO:0032348; P:negative regulation of aldosterone biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL.
DR   GO; GO:2000065; P:negative regulation of cortisol biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0010719; P:negative regulation of epithelial to mesenchymal transition; NAS:BHF-UCL.
DR   GO; GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; NAS:BHF-UCL.
DR   GO; GO:0043569; P:negative regulation of insulin-like growth factor receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0071676; P:negative regulation of mononuclear cell migration; NAS:BHF-UCL.
DR   GO; GO:0010894; P:negative regulation of steroid biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0021502; P:neural fold elevation formation; ISS:BHF-UCL.
DR   GO; GO:0001503; P:ossification; IEA:UniProtKB-KW.
DR   GO; GO:0007389; P:pattern specification process; IEA:Ensembl.
DR   GO; GO:0003344; P:pericardium morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0060037; P:pharyngeal system development; ISS:BHF-UCL.
DR   GO; GO:1900006; P:positive regulation of dendrite development; IDA:BHF-UCL.
DR   GO; GO:2000105; P:positive regulation of DNA-dependent DNA replication; IDA:BHF-UCL.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0042981; P:regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IBA:GO_Central.
DR   GO; GO:0001501; P:skeletal system development; NAS:UniProtKB.
DR   GO; GO:0060395; P:SMAD protein signal transduction; IBA:GO_Central.
DR   GO; GO:0003323; P:type B pancreatic cell development; IDA:BHF-UCL.
DR   Gene3D; 2.10.90.10; -; 1.
DR   InterPro; IPR029034; Cystine-knot_cytokine.
DR   InterPro; IPR001839; TGF-b_C.
DR   InterPro; IPR001111; TGF-b_propeptide.
DR   InterPro; IPR015615; TGF-beta-rel.
DR   InterPro; IPR017948; TGFb_CS.
DR   PANTHER; PTHR11848; PTHR11848; 1.
DR   Pfam; PF00019; TGF_beta; 1.
DR   Pfam; PF00688; TGFb_propeptide; 1.
DR   SMART; SM00204; TGFB; 1.
DR   SUPFAM; SSF57501; SSF57501; 1.
DR   PROSITE; PS00250; TGF_BETA_1; 1.
DR   PROSITE; PS51362; TGF_BETA_2; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Chondrogenesis;
KW   Cleavage on pair of basic residues; Complete proteome; Cytokine;
KW   Developmental protein; Differentiation; Disulfide bond; Glycoprotein;
KW   Growth factor; Osteogenesis; Polymorphism; Reference proteome;
KW   Secreted; Signal.
FT   SIGNAL        1     30       {ECO:0000255}.
FT   PROPEP       31    316       {ECO:0000255}.
FT                                /FTId=PRO_0000033866.
FT   CHAIN       317    454       Bone morphogenetic protein 5.
FT                                /FTId=PRO_0000033867.
FT   CARBOHYD    211    211       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    327    327       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    345    345       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    395    395       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    353    419       {ECO:0000250}.
FT   DISULFID    382    451       {ECO:0000250}.
FT   DISULFID    386    453       {ECO:0000250}.
FT   DISULFID    418    418       Interchain. {ECO:0000250}.
FT   VAR_SEQ     369    405       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056841.
FT   VARIANT       2      2       H -> Y (in dbSNP:rs9475437).
FT                                /FTId=VAR_047054.
FT   VARIANT     121    121       N -> S (in dbSNP:rs35124644).
FT                                /FTId=VAR_061896.
SQ   SEQUENCE   454 AA;  51737 MW;  631277413CCC22EE CRC64;
     MHLTVFLLKG IVGFLWSCWV LVGYAKGGLG DNHVHSSFIY RRLRNHERRE IQREILSILG
     LPHRPRPFSP GKQASSAPLF MLDLYNAMTN EENPEESEYS VRASLAEETR GARKGYPASP
     NGYPRRIQLS RTTPLTTQSP PLASLHDTNF LNDADMVMSF VNLVERDKDF SHQRRHYKEF
     RFDLTQIPHG EAVTAAEFRI YKDRSNNRFE NETIKISIYQ IIKEYTNRDA DLFLLDTRKA
     QALDVGWLVF DITVTSNHWV INPQNNLGLQ LCAETGDGRS INVKSAGLVG RQGPQSKQPF
     MVAFFKASEV LLRSVRAANK RKNQNRNKSS SHQDSSRMSS VGDYNTSEQK QACKKHELYV
     SFRDLGWQDW IIAPEGYAAF YCDGECSFPL NAHMNATNHA IVQTLVHLMF PDHVPKPCCA
     PTKLNAISVL YFDDSSNVIL KKYRNMVVRS CGCH
//
ID   B2R907_HUMAN            Unreviewed;       404 AA.
AC   B2R907;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   31-JAN-2018, entry version 60.
DE   SubName: Full=cDNA, FLJ94149, highly similar to Homo sapiens CD209 antigen (CD209), mRNA {ECO:0000313|EMBL:BAG36354.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG36354.1};
RN   [1] {ECO:0000313|EMBL:BAG36354.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Synovial membrane tissue {ECO:0000313|EMBL:BAG36354.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK313585; BAG36354.1; -; mRNA.
DR   RefSeq; NP_001138365.1; NM_001144893.1.
DR   RefSeq; NP_001138366.1; NM_001144894.1.
DR   RefSeq; NP_001138367.1; NM_001144895.1.
DR   RefSeq; NP_001138368.1; NM_001144896.1.
DR   RefSeq; NP_001138369.1; NM_001144897.1.
DR   RefSeq; NP_001138371.1; NM_001144899.1.
DR   RefSeq; NP_066978.1; NM_021155.3.
DR   UniGene; Hs.278694; -.
DR   PeptideAtlas; B2R907; -.
DR   PRIDE; B2R907; -.
DR   GeneID; 30835; -.
DR   KEGG; hsa:30835; -.
DR   CTD; 30835; -.
DR   PharmGKB; PA26199; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   eggNOG; ENOG410XPJ1; LUCA.
DR   HOVERGEN; HBG050992; -.
DR   KO; K06563; -.
DR   GenomeRNAi; 30835; -.
DR   Genevisible; B2R907; HS.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   CDD; cd03590; CLECT_DC-SIGN_like; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR033989; CD209-like_CTLD.
DR   InterPro; IPR016187; CTDL_fold.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00660837};
KW   Lectin {ECO:0000256|SAAS:SAAS00709395}.
FT   DOMAIN      263    378       C-type lectin.
FT                                {ECO:0000259|PROSITE:PS50041}.
SQ   SEQUENCE   404 AA;  45776 MW;  A23FA1F0014535E0 CRC64;
     MSDSKEPRLQ QLGLLEEEQL RGLGFRQTRG YKSLAGCLGH GPLVLQLLSF TLLAGLLVQV
     SKVPSSISQE QSRQDAIYQN LTQLKAAVGE LSEKSKLQEI YQELTQLKAA VGELPEKSKL
     QEIYQELTRL KAAVGELPEK SKLQEIYQEL TWLEAAVGEL PEKSKMQEIY QELTRLKAAV
     GELPEKSKQQ EIYQELTRLK AAVGELPEKS KQQEIYQELT RLKAAVGELP EKSKQQEIYQ
     ELTQLKAAVE RLCHPCPWEW TFFQGNCYFM SNSQRNWHDS ITACKEVGAQ LVVIKSAEEQ
     NFLQLQSSRS NRFTWMGLSD LNQEGTWQWV DGSPLLPSFK QYWNRGEPNN VGEEDCAEFS
     GNGWNDDKCN LAKFWICKKS AASCSRDEEQ FLSPAPATPN PPPA
//
ID   B4E2A8_HUMAN            Unreviewed;       135 AA.
AC   B4E2A8;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 64.
DE   SubName: Full=cDNA FLJ61677, highly similar to CD209 antigen {ECO:0000313|EMBL:BAG65070.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG65070.1};
RN   [1] {ECO:0000313|EMBL:BAG65070.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAG65070.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK304190; BAG65070.1; -; mRNA.
DR   RefSeq; NP_001138371.1; NM_001144899.1.
DR   UniGene; Hs.278694; -.
DR   PeptideAtlas; B4E2A8; -.
DR   PRIDE; B4E2A8; -.
DR   GeneID; 30835; -.
DR   CTD; 30835; -.
DR   PharmGKB; PA26199; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   eggNOG; ENOG410XPJ1; LUCA.
DR   HOGENOM; HOG000013222; -.
DR   HOVERGEN; HBG050992; -.
DR   GenomeRNAi; 30835; -.
DR   Genevisible; B4E2A8; HS.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   CDD; cd03590; CLECT_DC-SIGN_like; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR033989; CD209-like_CTLD.
DR   InterPro; IPR016187; CTDL_fold.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00660837};
KW   Lectin {ECO:0000256|SAAS:SAAS00709395}.
FT   DOMAIN        1    109       C-type lectin.
FT                                {ECO:0000259|PROSITE:PS50041}.
SQ   SEQUENCE   135 AA;  15186 MW;  5BAFCEDE6E84250A CRC64;
     MSNSQRNWHD SITACKEVGA QLVVIKSAEE QNFLQLQSSR SNRFTWMGLS DLNQEGTWQW
     VDGSPLLPSF KQYWNRGEPN NVGEEDCAEF SGNGWNDDKC NLAKFWICKK SAASCSRDEE
     QFLSPAPATP NPPPA
//
ID   M0R0P0_HUMAN            Unreviewed;       268 AA.
AC   M0R0P0;
DT   03-APR-2013, integrated into UniProtKB/TrEMBL.
DT   03-APR-2013, sequence version 1.
DT   25-APR-2018, entry version 50.
DE   SubName: Full=CD209 antigen {ECO:0000313|Ensembl:ENSP00000471348};
DE   SubName: Full=CD209 antigen, isoform CRA_b {ECO:0000313|EMBL:EAW68992.1};
GN   Name=CD209 {ECO:0000313|EMBL:EAW68992.1,
GN   ECO:0000313|Ensembl:ENSP00000471348};
GN   ORFNames=hCG_22558 {ECO:0000313|EMBL:EAW68992.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000471348, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW68992.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000471348, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3] {ECO:0000313|EMBL:EAW68992.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|Ensembl:ENSP00000471348}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2013) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC008763; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC008812; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471139; EAW68992.1; -; Genomic_DNA.
DR   RefSeq; NP_001138365.1; NM_001144893.1.
DR   UniGene; Hs.278694; -.
DR   PeptideAtlas; M0R0P0; -.
DR   Ensembl; ENST00000593821; ENSP00000471348; ENSG00000090659.
DR   GeneID; 30835; -.
DR   UCSC; uc002mhw.3; human.
DR   CTD; 30835; -.
DR   EuPathDB; HostDB:ENSG00000090659.17; -.
DR   HGNC; HGNC:1641; CD209.
DR   OpenTargets; ENSG00000090659; -.
DR   GeneTree; ENSGT00760000118924; -.
DR   GenomeRNAi; 30835; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000090659; -.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   CDD; cd03590; CLECT_DC-SIGN_like; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR033989; CD209-like_CTLD.
DR   InterPro; IPR016187; CTDL_fold.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00660837};
KW   Lectin {ECO:0000256|SAAS:SAAS00709395};
KW   Proteomics identification {ECO:0000213|MaxQB:M0R0P0,
KW   ECO:0000213|PeptideAtlas:M0R0P0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      127    242       C-type lectin.
FT                                {ECO:0000259|PROSITE:PS50041}.
SQ   SEQUENCE   268 AA;  30470 MW;  BB89AF2DA0CC3A72 CRC64;
     MSDSKEPRLQ QLGLLVSKVP SSISQEQSRQ DAIYQNLTQL KAAVGELSEK SKLQEIYQEL
     TQLKAAVGEL PEKSKLQEIY QELTRLKAAV GELPEKSKLQ EIYQELTWLK AAVERLCHPC
     PWEWTFFQGN CYFMSNSQRN WHDSITACKE VGAQLVVIKS AEEQNFLQLQ SSRSNRFTWM
     GLSDLNQEGT WQWVDGSPLL PSFKQYWNRG EPNNVGEEDC AEFSGNGWND DKCNLAKFWI
     CKKSAASCSR DEEQFLSPAP ATPNPPPA
//
ID   CD209_HUMAN             Reviewed;         404 AA.
AC   Q9NNX6; A8KAM4; A8MVQ9; G5E9C4; Q2TB19; Q96QP7; Q96QP8; Q96QP9;
AC   Q96QQ0; Q96QQ1; Q96QQ2; Q96QQ3; Q96QQ4; Q96QQ5; Q96QQ6; Q96QQ7;
AC   Q96QQ8;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   28-FEB-2018, entry version 164.
DE   RecName: Full=CD209 antigen;
DE   AltName: Full=C-type lectin domain family 4 member L;
DE   AltName: Full=Dendritic cell-specific ICAM-3-grabbing non-integrin 1;
DE            Short=DC-SIGN;
DE            Short=DC-SIGN1;
DE   AltName: CD_antigen=CD209;
GN   Name=CD209; Synonyms=CLEC4L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, FUNCTION
RP   (MICROBIAL INFECTION), AND INTERACTION WITH HIV-1 GP120.
RC   TISSUE=Placenta;
RX   PubMed=1518869; DOI=10.1073/pnas.89.17.8356;
RA   Curtis B.M., Scharnowske S., Watson A.J.;
RT   "Sequence and expression of a membrane-associated C-type lectin that
RT   exhibits CD4-independent binding of human immunodeficiency virus
RT   envelope glycoprotein gp 120.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:8356-8360(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=10975799; DOI=10.4049/jimmunol.165.6.2937;
RA   Soilleux E.J., Barten R., Trowsdale J.;
RT   "DC-SIGN, a related gene, DC-SIGNR, and CD23 form a cluster on
RT   19p13.";
RL   J. Immunol. 165:2937-2942(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=11257134; DOI=10.1084/jem.193.6.671;
RA   Bashirova A.A., Geijtenbeek T.B.H., van Duijnhoven G.C.F.,
RA   van Vliet S.J., Eilering J.B.G., Martin M.P., Wu L., Martin T.D.,
RA   Viebig N., Knolle P.A., Kewalramani V.N., van Kooyk Y., Carrington M.;
RT   "A dendritic cell-specific intercellular adhesion molecule 3-grabbing
RT   nonintegrin (DC-SIGN)-related protein is highly expressed on human
RT   liver sinusoidal endothelial cells and promotes HIV-1 infection.";
RL   J. Exp. Med. 193:671-678(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4; 5; 6; 7; 8; 9; 10; 11
RP   AND 12), ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=11337487; DOI=10.1074/jbc.M009807200;
RA   Mummidi S., Catano G., Lam L., Hoefle A., Telles V., Begum K.,
RA   Jimenez F., Ahuja S.S., Ahuja S.K.;
RT   "Extensive repertoire of membrane-bound and soluble dendritic cell-
RT   specific ICAM-3-grabbing nonintegrin 1 (DC-SIGN1) and DC-SIGN2
RT   isoforms. Inter-individual variation in expression of DC-SIGN
RT   transcripts.";
RL   J. Biol. Chem. 276:33196-33212(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 10).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH ICAM3.
RX   PubMed=10721995; DOI=10.1016/S0092-8674(00)80694-7;
RA   Geijtenbeek T.B.H., Kwon D.S., Torensma R., van Vliet S.J.,
RA   van Duijnhoven G.C.F., Middel J., Cornelissen I.L., Nottet H.S.,
RA   Kewalramani V.N., Littman D.R., Figdor C.G., van Kooyk Y.;
RT   "DC-SIGN, a dendritic cell-specific HIV-1-binding protein that
RT   enhances trans-infection of T cells.";
RL   Cell 100:587-597(2000).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH ICAM2.
RX   PubMed=11017109; DOI=10.1038/79815;
RA   Geijtenbeek T.B.H., Krooshoop D.J., Bleijs D.A., van Vliet S.J.,
RA   van Duijnhoven G.C.F., Grabovsky V., Alon R., Figdor C.G.,
RA   van Kooyk Y.;
RT   "DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking.";
RL   Nat. Immunol. 1:353-357(2000).
RN   [11]
RP   SUBUNIT, AND LIGAND-BINDING.
RX   PubMed=11384997; DOI=10.1074/jbc.M104565200;
RA   Mitchell D.A., Fadden A.J., Drickamer K.;
RT   "A novel mechanism of carbohydrate recognition by the C-type lectins
RT   DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent
RT   ligands.";
RL   J. Biol. Chem. 276:28939-28945(2001).
RN   [12]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH CYTOMEGALOVIRUS
RP   GLYCOPROTEIN B (GB).
RX   PubMed=12433371; DOI=10.1016/S1074-7613(02)00447-8;
RA   Halary F., Amara A., Lortat-Jacob H., Messerle M., Delaunay T.,
RA   Houles C., Fieschi F., Arenzana-Seisdedos F., Moreau J.-F.,
RA   Dechanet-Merville J.;
RT   "Human cytomegalovirus binding to DC-SIGN is required for dendritic
RT   cell infection and target cell trans-infection.";
RL   Immunity 17:653-664(2002).
RN   [13]
RP   FUNCTION (MICROBIAL INFECTION), INTERACTION WITH ICAM 3 AND HIV-1
RP   GP120, AND MUTAGENESIS OF ASP-320; GLU-324; GLU-347; ASN-349; ASN-350;
RP   ASP-355; ASN-365 AND ASP-366.
RX   PubMed=11799126; DOI=10.1074/jbc.M111532200;
RA   Geijtenbeek T.B.H., van Duijnhoven G.C.F., van Vliet S.J., Krieger E.,
RA   Vriend G., Figdor C.G., van Kooyk Y.;
RT   "Identification of different binding sites in the dendritic cell-
RT   specific receptor DC-SIGN for intercellular adhesion molecule 3 and
RT   HIV-1.";
RL   J. Biol. Chem. 277:11314-11320(2002).
RN   [14]
RP   FUNCTION, AND MUTAGENESIS OF 14-LEU-LEU-15.
RX   PubMed=11859097; DOI=10.4049/jimmunol.168.5.2118;
RA   Engering A., Geijtenbeek T.B.H., van Vliet S.J., Wijers M.,
RA   van Liempt E., Demaurex N., Lanzavecchia A., Fransen J., Figdor C.G.,
RA   Piguet V., van Kooyk Y.;
RT   "The dendritic cell-specific adhesion receptor DC-SIGN internalizes
RT   antigen for presentation to T cells.";
RL   J. Immunol. 168:2118-2126(2002).
RN   [15]
RP   ROLE IN HIV-1 INFECTION.
RX   PubMed=11825572; DOI=10.1016/S1074-7613(02)00259-5;
RA   Kwon D.S., Gregorio G., Bitton N., Hendrickson W.A., Littman D.R.;
RT   "DC-SIGN-mediated internalization of HIV is required for trans-
RT   enhancement of T cell infection.";
RL   Immunity 16:135-144(2002).
RN   [16]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HIV-1 GP120;
RP   HIV-2 GP120; SIV GP120 AND EBOLA GLYCOPROTEINS.
RX   PubMed=12502850; DOI=10.1128/JVI.77.2.1337-1346.2003;
RA   Lin G., Simmons G., Poehlmann S., Baribaud F., Ni H., Leslie G.J.,
RA   Haggarty B.S., Bates P., Weissman D., Hoxie J.A., Doms R.W.;
RT   "Differential N-linked glycosylation of human immunodeficiency virus
RT   and Ebola virus envelope glycoproteins modulates interactions with DC-
RT   SIGN and DC-SIGNR.";
RL   J. Virol. 77:1337-1346(2003).
RN   [17]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH DENGUE VIRUS
RP   ENVELOPE E PROTEIN.
RX   PubMed=12682107; DOI=10.1084/jem.20021840;
RA   Tassaneetrithep B., Burgess T.H., Granelli-Piperno A.,
RA   Trumpfheller C., Finke J., Sun W., Eller M.A., Pattanapanyasat K.,
RA   Sarasombath S., Birx D.L., Steinman R.M., Schlesinger S.,
RA   Marovich M.A.;
RT   "DC-SIGN (CD209) mediates dengue virus infection of human dendritic
RT   cells.";
RL   J. Exp. Med. 197:823-829(2003).
RN   [18]
RP   FUNCTION (MICROBIAL INFECTION) IN HIV-1 INFECTION.
RX   PubMed=12692233; DOI=10.1128/JVI.77.9.5313-5323.2003;
RA   Nobile C., Moris A., Porrot F., Sol-Foulon N., Schwartz O.;
RT   "Inhibition of human immunodeficiency virus type 1 Env-mediated fusion
RT   by DC-SIGN.";
RL   J. Virol. 77:5313-5323(2003).
RN   [19]
RP   FUNCTION.
RX   PubMed=12574325; DOI=10.4049/jimmunol.170.4.1635;
RA   Appelmelk B.J., van Die I., van Vliet S.J., Vandenbroucke-Grauls C.M.,
RA   Geijtenbeek T.B.H., van Kooyk Y.;
RT   "Carbohydrate profiling identifies new pathogens that interact with
RT   dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic
RT   cells.";
RL   J. Immunol. 170:1635-1639(2003).
RN   [20]
RP   REVIEW ON ROLE IN HIV-1 INFECTION AND ON PATHOGEN BINDING.
RX   PubMed=12949494; DOI=10.1038/nri1182;
RA   van Kooyk Y., Geijtenbeek T.B.H.;
RT   "DC-SIGN: escape mechanism for pathogens.";
RL   Nat. Rev. Immunol. 3:697-709(2003).
RN   [21]
RP   REVIEW ON ROLE IN HIV-1 INFECTION.
RX   PubMed=12960229; DOI=10.1189/jlb.0503208;
RA   Turville S., Wilkinson J., Cameron P., Dable J., Cunningham A.L.;
RT   "The role of dendritic cell C-type lectin receptors in HIV
RT   pathogenesis.";
RL   J. Leukoc. Biol. 74:710-718(2003).
RN   [22]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH EBOLAVIRUS
RP   GLYCOPROTEIN.
RX   PubMed=12504546; DOI=10.1006/viro.2002.1730;
RA   Simmons G., Reeves J.D., Grogan C.C., Vandenberghe L.H., Baribaud F.,
RA   Whitbeck J.C., Burke E., Buchmeier M.J., Soilleux E.J., Riley J.L.,
RA   Doms R.W., Bates P., Poehlmann S.;
RT   "DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection
RT   of macrophages and endothelial cells.";
RL   Virology 305:115-123(2003).
RN   [23]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HCV E2
RP   GLYCOPROTEIN.
RX   PubMed=15371595; DOI=10.1073/pnas.0405695101;
RA   Cormier E.G., Durso R.J., Tsamis F., Boussemart L., Manix C.,
RA   Olson W.C., Gardner J.P., Dragic T.;
RT   "L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver
RT   cells by hepatitis C virus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:14067-14072(2004).
RN   [24]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH SARS CORONAVIRUS
RP   GLYCOPROTEIN.
RX   PubMed=15140961; DOI=10.1128/JVI.78.11.5642-5650.2004;
RA   Yang Z.Y., Huang Y., Ganesh L., Leung K., Kong W.P., Schwartz O.,
RA   Subbarao K., Nabel G.J.;
RT   "pH-dependent entry of severe acute respiratory syndrome coronavirus
RT   is mediated by the spike glycoprotein and enhanced by dendritic cell
RT   transfer through DC-SIGN.";
RL   J. Virol. 78:5642-5650(2004).
RN   [25]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH MARBURG VIRUS
RP   GLYCOPROTEIN.
RX   PubMed=15479853; DOI=10.1128/JVI.78.21.12090-12095.2004;
RA   Marzi A., Gramberg T., Simmons G., Moeller P., Rennekamp A.J.,
RA   Krumbiegel M., Geier M., Eisemann J., Turza N., Saunier B.,
RA   Steinkasserer A., Becker S., Bates P., Hofmann H., Poehlmann S.;
RT   "DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus
RT   and the S protein of severe acute respiratory syndrome coronavirus.";
RL   J. Virol. 78:12090-12095(2004).
RN   [26]
RP   INTERACTION WITH CEACAM1.
RX   PubMed=16246332; DOI=10.1016/j.febslet.2005.09.089;
RA   van Gisbergen K.P., Ludwig I.S., Geijtenbeek T.B., van Kooyk Y.;
RT   "Interactions of DC-SIGN with Mac-1 and CEACAM1 regulate contact
RT   between dendritic cells and neutrophils.";
RL   FEBS Lett. 579:6159-6168(2005).
RN   [27]
RP   POLYMORPHISM, AND INVOLVEMENT IN SUSCEPTIBILITY TO DENGUE VIRUS
RP   INFECTION.
RX   PubMed=15838506; DOI=10.1038/ng1550;
RA   Sakuntabhai A., Turbpaiboon C., Casademont I., Chuansumrit A.,
RA   Lowhnoo T., Kajaste-Rudnitski A., Kalayanarooj S.M.,
RA   Tangnararatchakit K., Tangthawornchaikul N., Vasanawathana S.,
RA   Chaiyaratana W., Yenchitsomanus P.T., Suriyaphol P., Avirutnan P.,
RA   Chokephaibulkit K., Matsuda F., Yoksan S., Jacob Y., Lathrop G.M.,
RA   Malasit P., Despres P., Julier C.;
RT   "A variant in the CD209 promoter is associated with severity of dengue
RT   disease.";
RL   Nat. Genet. 37:507-513(2005).
RN   [28]
RP   FUNCTION (MICROBIAL INFECTION) BY M.TUBERCULOSIS.
RX   PubMed=16092920; DOI=10.1042/BJ20050709;
RA   Pitarque S., Herrmann J.L., Duteyrat J.L., Jackson M., Stewart G.R.,
RA   Lecointe F., Payre B., Schwartz O., Young D.B., Marchal G.,
RA   Lagrange P.H., Puzo G., Gicquel B., Nigou J., Neyrolles O.;
RT   "Deciphering the molecular bases of Mycobacterium tuberculosis binding
RT   to the lectin DC-SIGN reveals an underestimated complexity.";
RL   Biochem. J. 392:615-624(2005).
RN   [29]
RP   FUNCTION (MICROBIAL INFECTION), AND INVOLVEMENT IN M.TUBERCULOSIS
RP   SUSCEPTIBILITY.
RX   PubMed=16379498; DOI=10.1371/journal.pmed.0030020;
RA   Barreiro L.B., Neyrolles O., Babb C.L., Tailleux L., Quach H.,
RA   McElreavey K., Helden P.D., Hoal E.G., Gicquel B., Quintana-Murci L.;
RT   "Promoter variation in the DC-SIGN-encoding gene CD209 is associated
RT   with tuberculosis.";
RL   PLoS Med. 3:230-235(2006).
RN   [30]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH MEASLES VIRUS
RP   HEMAGGLUTININ.
RX   PubMed=16537615; DOI=10.1128/JVI.80.7.3477-3486.2006;
RA   de Witte L., Abt M., Schneider-Schaulies S., van Kooyk Y.,
RA   Geijtenbeek T.B.;
RT   "Measles virus targets DC-SIGN to enhance dendritic cell infection.";
RL   J. Virol. 80:3477-3486(2006).
RN   [31]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH WEST-NILE VIRUS
RP   ENVELOPE GLYCOPROTEIN.
RX   PubMed=16415006; DOI=10.1128/JVI.80.3.1290-1301.2006;
RA   Davis C.W., Nguyen H.Y., Hanna S.L., Sanchez M.D., Doms R.W.,
RA   Pierson T.C.;
RT   "West Nile virus discriminates between DC-SIGN and DC-SIGNR for
RT   cellular attachment and infection.";
RL   J. Virol. 80:1290-1301(2006).
RN   [32]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HEPATITIS C VIRUS
RP   E1 AND E2 PROTEINS.
RX   PubMed=16816373; DOI=10.2353/ajpath.2006.051191;
RA   Lai W.K., Sun P.J., Zhang J., Jennings A., Lalor P.F., Hubscher S.,
RA   McKeating J.A., Adams D.H.;
RT   "Expression of DC-SIGN and DC-SIGNR on human sinusoidal endothelium: a
RT   role for capturing hepatitis C virus particles.";
RL   Am. J. Pathol. 169:200-208(2006).
RN   [33]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH M.BOVIS PROTEINS.
RX   PubMed=21203928; DOI=10.1007/s13238-010-0101-3;
RA   Carroll M.V., Sim R.B., Bigi F., Jaekel A., Antrobus R.,
RA   Mitchell D.A.;
RT   "Identification of four novel DC-SIGN ligands on Mycobacterium bovis
RT   BCG.";
RL   Protein Cell 1:859-870(2010).
RN   [34]
RP   INTERACTION WITH C1QBP.
RX   PubMed=22700724; DOI=10.1182/blood-2011-07-369728;
RA   Hosszu K.K., Valentino A., Vinayagasundaram U., Vinayagasundaram R.,
RA   Joyce M.G., Ji Y., Peerschke E.I., Ghebrehiwet B.;
RT   "DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the
RT   surface of monocyte-derived immature dendritic cells.";
RL   Blood 120:1228-1236(2012).
RN   [35]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HERPES SIMPLEX
RP   VIRUS SURFACE PROTEINS.
RX   PubMed=18796707; DOI=10.1099/vir.0.2008/003129-0;
RA   de Jong M.A., de Witte L., Bolmstedt A., van Kooyk Y.,
RA   Geijtenbeek T.B.;
RT   "Dendritic cells mediate herpes simplex virus infection and
RT   transmission through the C-type lectin DC-SIGN.";
RL   J. Gen. Virol. 89:2398-2409(2008).
RN   [36]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH INFLUENZAVIRUS
RP   HEMAGGLUTININ.
RX   PubMed=21191006; DOI=10.1128/JVI.01705-10;
RA   Londrigan S.L., Turville S.G., Tate M.D., Deng Y.M., Brooks A.G.,
RA   Reading P.C.;
RT   "N-linked glycosylation facilitates sialic acid-independent attachment
RT   and entry of influenza A viruses into cells expressing DC-SIGN or L-
RT   SIGN.";
RL   J. Virol. 85:2990-3000(2011).
RN   [37]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH RIFT FEVER VALLEY
RP   VIRUS GLYCOPROTEIN G.
RX   PubMed=21767814; DOI=10.1016/j.chom.2011.06.007;
RA   Lozach P.Y., Kuehbacher A., Meier R., Mancini R., Bitto D., Bouloy M.,
RA   Helenius A.;
RT   "DC-SIGN as a receptor for phleboviruses.";
RL   Cell Host Microbe 10:75-88(2011).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 254-382 IN COMPLEX WITH
RP   GLCNAC(2)-MAN(3) PENTASACCHARIDE.
RX   PubMed=11739956; DOI=10.1126/science.1066371;
RA   Feinberg H., Mitchell D.A., Drickamer K., Weis W.I.;
RT   "Structural basis for selective recognition of oligosaccharides by DC-
RT   SIGN and DC-SIGNR.";
RL   Science 294:2163-2166(2001).
RN   [39]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HUMAN
RP   CYTOMEGALOVIRUS /HHV-5 SURFACE PROTEINS.
RX   PubMed=22496863; DOI=10.1371/journal.pone.0034795;
RA   Haspot F., Lavault A., Sinzger C., Laib Sampaio K., Stierhof Y.D.,
RA   Pilet P., Bressolette-Bodin C., Halary F.;
RT   "Human cytomegalovirus entry into dendritic cells occurs via a
RT   macropinocytosis-like pathway in a pH-independent and cholesterol-
RT   dependent manner.";
RL   PLoS ONE 7:E34795-E34795(2012).
RN   [40]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH RESPIRATORY
RP   SYNCYTIAL VIRUS GLYCOPROTEIN G.
RX   PubMed=22090124; DOI=10.1128/JVI.06096-11;
RA   Johnson T.R., McLellan J.S., Graham B.S.;
RT   "Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and
RT   L-SIGN to activate ERK1 and ERK2.";
RL   J. Virol. 86:1339-1347(2012).
RN   [41]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH JAPANESE
RP   ENCEPHALITIS VIRUS E PROTEIN.
RX   PubMed=24623090; DOI=10.1007/s00705-014-2042-2;
RA   Shimojima M., Takenouchi A., Shimoda H., Kimura N., Maeda K.;
RT   "Distinct usage of three C-type lectins by Japanese encephalitis
RT   virus: DC-SIGN, DC-SIGNR, and LSECtin.";
RL   Arch. Virol. 159:2023-2031(2014).
RN   [42]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH LASSA VIRUS
RP   GLYCOPROTEIN.
RX   PubMed=23966408; DOI=10.1128/JVI.01893-13;
RA   Goncalves A.R., Moraz M.L., Pasquato A., Helenius A., Lozach P.Y.,
RA   Kunz S.;
RT   "Role of DC-SIGN in Lassa virus entry into human dendritic cells.";
RL   J. Virol. 87:11504-11515(2013).
RN   [43]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=22440960; DOI=10.1016/j.coviro.2011.12.005;
RA   Backovic M., Rey F.A.;
RT   "Virus entry: old viruses, new receptors.";
RL   Curr. Opin. Virol. 2:4-13(2012).
CC   -!- FUNCTION: Pathogen-recognition receptor expressed on the surface
CC       of immature dendritic cells (DCs) and involved in initiation of
CC       primary immune response. Thought to mediate the endocytosis of
CC       pathogens which are subsequently degraded in lysosomal
CC       compartments. The receptor returns to the cell membrane surface
CC       and the pathogen-derived antigens are presented to resting T-cells
CC       via MHC class II proteins to initiate the adaptive immune
CC       response. {ECO:0000269|PubMed:11859097}.
CC   -!- FUNCTION: On DCs it is a high affinity receptor for ICAM2 and
CC       ICAM3 by binding to mannose-like carbohydrates. May act as a DC
CC       rolling receptor that mediates transendothelial migration of DC
CC       presursors from blood to tissues by binding endothelial ICAM2.
CC       Seems to regulate DC-induced T-cell proliferation by binding to
CC       ICAM3 on T-cells in the immunological synapse formed between DC
CC       and T-cells. {ECO:0000269|PubMed:10721995,
CC       ECO:0000269|PubMed:11017109, ECO:0000269|PubMed:12574325}.
CC   -!- FUNCTION: (Microbial infection) Acts as an attachment receptor for
CC       HIV-1 and HIV-2. {ECO:0000269|PubMed:11799126,
CC       ECO:0000269|PubMed:12502850, ECO:0000269|PubMed:1518869}.
CC   -!- FUNCTION: (Microbial infection) Acts as an attachment receptor for
CC       Ebolavirus. {ECO:0000269|PubMed:12502850,
CC       ECO:0000269|PubMed:12504546}.
CC   -!- FUNCTION: (Microbial infection) Acts as an attachment receptor for
CC       Cytomegalovirus. {ECO:0000269|PubMed:12433371,
CC       ECO:0000269|PubMed:22496863}.
CC   -!- FUNCTION: (Microbial infection) Acts as an attachment receptor for
CC       HCV. {ECO:0000269|PubMed:15371595, ECO:0000269|PubMed:16816373}.
CC   -!- FUNCTION: (Microbial infection) Acts as an attachment receptor for
CC       Dengue virus. {ECO:0000269|PubMed:12682107}.
CC   -!- FUNCTION: (Microbial infection) Acts as an attachment receptor for
CC       Measles virus. {ECO:0000269|PubMed:16537615}.
CC   -!- FUNCTION: (Microbial infection) Acts as an attachment receptor for
CC       Herpes simplex virus 1. {ECO:0000269|PubMed:18796707}.
CC   -!- FUNCTION: (Microbial infection) Acts as an attachment receptor for
CC       Influenzavirus A. {ECO:0000269|PubMed:21191006}.
CC   -!- FUNCTION: (Microbial infection) Acts as an attachment receptor for
CC       SARS coronavirus. {ECO:0000269|PubMed:15140961}.
CC   -!- FUNCTION: (Microbial infection) Acts as an attachment receptor for
CC       Japanese encephalitis virus. {ECO:0000269|PubMed:24623090}.
CC   -!- FUNCTION: (Microbial infection) Acts as an attachment receptor for
CC       Lassa virus (PubMed:23966408). Acts as an attachment receptor for
CC       Marburg virusn. {ECO:0000269|PubMed:15479853}.
CC   -!- FUNCTION: (Microbial infection) Acts as an attachment receptor for
CC       Respiratory syncytial virus. {ECO:0000269|PubMed:22090124}.
CC   -!- FUNCTION: (Microbial infection) Acts as an attachment receptor for
CC       Rift valley fever virus and uukuniemi virus.
CC       {ECO:0000269|PubMed:21767814}.
CC   -!- FUNCTION: (Microbial infection) Acts as an attachment receptor for
CC       West-nile virus. {ECO:0000269|PubMed:16415006}.
CC   -!- FUNCTION: (Microbial infection) Probably recognizes in a calcium-
CC       dependent manner high mannose N-linked oligosaccharides in a
CC       variety of bacterial pathogen antigens, including Leishmania
CC       pifanoi LPG, Lewis-x antigen in Helicobacter pylori LPS, mannose
CC       in Klebsiella pneumonae LPS, di-mannose and tri-mannose in
CC       Mycobacterium tuberculosis ManLAM and Lewis-x antigen in
CC       Schistosoma mansoni SEA (PubMed:16379498). Recognition of
CC       M.tuberculosis by dendritic cells occurs partially via this
CC       molecule (PubMed:16092920, PubMed:21203928).
CC       {ECO:0000269|PubMed:16092920, ECO:0000269|PubMed:16379498,
CC       ECO:0000269|PubMed:21203928}.
CC   -!- SUBUNIT: Homotetramer. Interacts with C1QBP; the interaction is
CC       indicative for a C1q:C1QBP:CD209 signaling complex. Interacts with
CC       ICAM2 and ICAM3 by binding to mannose-like carbohydrates.
CC       Interacts (via C-type lectin domain) with CEACAM1 (via Lewis X
CC       moieties); this interaction is regulated by the glycosylation
CC       pattern of CEACAM1 on cell types and regulates contact between
CC       dendritic cells and neutrophils (PubMed:16246332).
CC       {ECO:0000269|PubMed:10721995, ECO:0000269|PubMed:11017109,
CC       ECO:0000269|PubMed:11384997, ECO:0000269|PubMed:11739956,
CC       ECO:0000269|PubMed:16246332, ECO:0000269|PubMed:22700724}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HIV-1 and HIV-2
CC       gp120 (PubMed:11799126, PubMed:12502850, PubMed:1518869).
CC       {ECO:0000269|PubMed:11799126, ECO:0000269|PubMed:12502850,
CC       ECO:0000269|PubMed:1518869}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with ebolavirus envelope
CC       glycoproteins (PubMed:12502850, PubMed:12504546).
CC       {ECO:0000269|PubMed:12502850, ECO:0000269|PubMed:12504546}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with cytomegalovirus gB
CC       protein (PubMed:12433371, PubMed:22496863).
CC       {ECO:0000269|PubMed:12433371, ECO:0000269|PubMed:22496863}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HCV E2 protein
CC       (PubMed:15371595, PubMed:16816373). {ECO:0000269|PubMed:15371595,
CC       ECO:0000269|PubMed:16816373}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with dengue virus major
CC       envelope protein E. {ECO:0000269|PubMed:12682107}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with measles
CC       hemagglutinin. {ECO:0000269|PubMed:16537615}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with herpes simplex virus
CC       1 surface proteins. {ECO:0000269|PubMed:18796707}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Influenzavirus A
CC       hemagglutinin. {ECO:0000269|PubMed:21191006}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with SARS coronavirus
CC       glycoprotein. {ECO:0000269|PubMed:15140961}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Japanese
CC       encephalitis virus E protein. {ECO:0000269|PubMed:24623090}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Lassa virus
CC       Glycoprotein. {ECO:0000269|PubMed:23966408}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with marburg virus
CC       glycoprotein. {ECO:0000269|PubMed:15479853}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Respiratory
CC       syncytial virus glycoprotein G. {ECO:0000269|PubMed:22090124}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Rift valley fever
CC       virus and uukuniemi virus envelope glycoprotein.
CC       {ECO:0000269|PubMed:21767814}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with west-nile virus
CC       envelope glycoprotein. {ECO:0000269|PubMed:16415006}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with whole M.bovis cells
CC       in a Ca(2+)-dependent and independent manner; in vitro experiments
CC       suggest it interacts with CH60.1 (groL1), DnaK, GADPH (gap) and
CC       LrpG (PubMed:21203928). {ECO:0000269|PubMed:21203928}.
CC   -!- INTERACTION:
CC       Q03463:- (xeno); NbExp=2; IntAct=EBI-9257341, EBI-9257330;
CC       Q08AM6:VAC14; NbExp=3; IntAct=EBI-9257341, EBI-2107455;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane {ECO:0000305};
CC       Single-pass type II membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cell membrane {ECO:0000305};
CC       Single-pass type II membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Cell membrane {ECO:0000305};
CC       Single-pass type II membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 4: Cell membrane {ECO:0000305};
CC       Single-pass type II membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 5: Cell membrane {ECO:0000305};
CC       Single-pass type II membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 6: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 7: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 8: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 9: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 10: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 11: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 12: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=12;
CC         Comment=Additional isoforms seem to exist. Several splicing
CC         events may be used independently in a modular way. Deletion of
CC         the transmembrane domain encoding exon through alternative
CC         splicing produces soluble isoforms.
CC         {ECO:0000269|PubMed:11337487};
CC       Name=1; Synonyms=mDC-SIGN1A type I;
CC         IsoId=Q9NNX6-1; Sequence=Displayed;
CC       Name=2; Synonyms=mDC-SIGN1A type II;
CC         IsoId=Q9NNX6-2; Sequence=VSP_010049;
CC       Name=3; Synonyms=mDC-SIGN1A type III;
CC         IsoId=Q9NNX6-3; Sequence=VSP_010044;
CC       Name=4; Synonyms=mDC-SIGN1A type IV;
CC         IsoId=Q9NNX6-4; Sequence=VSP_010042;
CC       Name=5; Synonyms=mDC-SIGN1B type I;
CC         IsoId=Q9NNX6-5; Sequence=VSP_010037;
CC       Name=6; Synonyms=sDC-SIGN1A type I;
CC         IsoId=Q9NNX6-6; Sequence=VSP_010041;
CC       Name=7; Synonyms=sDC-SIGN1A type II;
CC         IsoId=Q9NNX6-7; Sequence=VSP_010038;
CC       Name=8; Synonyms=sDC-SIGN1A type III;
CC         IsoId=Q9NNX6-8; Sequence=VSP_010038, VSP_010043;
CC       Name=9; Synonyms=sDC-SIGN1A type IV;
CC         IsoId=Q9NNX6-9; Sequence=VSP_010039, VSP_010040;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=10; Synonyms=sDC-SIGN1B type I;
CC         IsoId=Q9NNX6-10; Sequence=VSP_010037, VSP_010041;
CC       Name=11; Synonyms=sDC-SIGN1B type II;
CC         IsoId=Q9NNX6-11; Sequence=VSP_010037, VSP_010041, VSP_010047;
CC       Name=12; Synonyms=sDC-SIGN1B type III;
CC         IsoId=Q9NNX6-12; Sequence=VSP_010037, VSP_010041, VSP_010048,
CC                                   VSP_010050;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in dendritic cells and
CC       in DC-residing tissues. Also found in placental macrophages,
CC       endothelial cells of placental vascular channels, peripheral blood
CC       mononuclear cells, and THP-1 monocytes.
CC       {ECO:0000269|PubMed:11257134, ECO:0000269|PubMed:11337487}.
CC   -!- DOMAIN: The tandem repeat domain, also called neck domain,
CC       mediates oligomerization.
CC   -!- POLYMORPHISM: Genetic variations in the CD209 promoter determine
CC       M.tuberculosis susceptibility [MIM:607948] (PubMed:16379498).
CC       {ECO:0000305|PubMed:16379498}.
CC   -!- POLYMORPHISM: Genetic variations in CD209 may influence
CC       susceptibility or resistance to dengue virus infection, as well as
CC       disease progression and severity [MIM:614371]. A promoter
CC       polymorphism in the CD209 gene is associated with protection from
CC       dengue fever, but not dengue hemorrhagic fever.
CC   -!- MISCELLANEOUS: In vitro, is a receptor for HIV-1 and transmits
CC       HIV-1 either in trans without DC infection, or in cis following a
CC       DC infection to permissive T-cells to induce a robust infection.
CC       Bound HIV-1 remains infectious over a prolonged period of time and
CC       it is proposed that bound HIV-1 is not degraded but protected in
CC       non-lysosomal acidic organelles within the DCs close to the cell
CC       membrane thus contributing to the HIV-1 infectious potential
CC       during transport by DCs from the periphery to lymphoid organs.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK91858.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=DC-SIGN entry;
CC       URL="https://en.wikipedia.org/wiki/DC-SIGN";
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=DC-SIGN;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Ctlect_00121";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M98457; AAF77072.1; -; mRNA.
DR   EMBL; AF209479; AAG13814.1; -; Genomic_DNA.
DR   EMBL; AF290886; AAK20997.1; -; mRNA.
DR   EMBL; AY042221; AAK91846.1; -; mRNA.
DR   EMBL; AY042222; AAK91847.1; -; mRNA.
DR   EMBL; AY042223; AAK91848.1; -; mRNA.
DR   EMBL; AY042224; AAK91849.1; -; mRNA.
DR   EMBL; AY042225; AAK91850.1; -; mRNA.
DR   EMBL; AY042226; AAK91851.1; -; mRNA.
DR   EMBL; AY042227; AAK91852.1; -; mRNA.
DR   EMBL; AY042228; AAK91853.1; -; mRNA.
DR   EMBL; AY042229; AAK91854.1; -; mRNA.
DR   EMBL; AY042230; AAK91855.1; -; mRNA.
DR   EMBL; AY042231; AAK91856.1; -; mRNA.
DR   EMBL; AY042232; AAK91857.1; -; mRNA.
DR   EMBL; AY042233; AAK91858.1; ALT_SEQ; mRNA.
DR   EMBL; AK293089; BAF85778.1; -; mRNA.
DR   EMBL; AC008763; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC008812; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471139; EAW68991.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW68993.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW68997.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW68998.1; -; Genomic_DNA.
DR   EMBL; BC110615; AAI10616.1; -; mRNA.
DR   CCDS; CCDS12186.1; -. [Q9NNX6-1]
DR   CCDS; CCDS45949.1; -. [Q9NNX6-7]
DR   CCDS; CCDS45950.1; -. [Q9NNX6-6]
DR   CCDS; CCDS45951.1; -. [Q9NNX6-2]
DR   CCDS; CCDS45952.1; -. [Q9NNX6-3]
DR   CCDS; CCDS59344.1; -. [Q9NNX6-8]
DR   PIR; A46274; A46274.
DR   RefSeq; NP_001138365.1; NM_001144893.1.
DR   RefSeq; NP_001138366.1; NM_001144894.1. [Q9NNX6-7]
DR   RefSeq; NP_001138367.1; NM_001144895.1. [Q9NNX6-3]
DR   RefSeq; NP_001138368.1; NM_001144896.1. [Q9NNX6-6]
DR   RefSeq; NP_001138369.1; NM_001144897.1. [Q9NNX6-2]
DR   RefSeq; NP_066978.1; NM_021155.3. [Q9NNX6-1]
DR   UniGene; Hs.278694; -.
DR   PDB; 1K9I; X-ray; 2.50 A; A/B/C/D/E/F/G/H/I/J=250-404.
DR   PDB; 1SL4; X-ray; 1.55 A; A=250-404.
DR   PDB; 1SL5; X-ray; 1.80 A; A=250-388.
DR   PDB; 2B6B; EM; 25.00 A; D=251-404.
DR   PDB; 2IT5; X-ray; 2.40 A; A=250-388.
DR   PDB; 2IT6; X-ray; 1.95 A; A=250-404.
DR   PDB; 2XR5; X-ray; 1.42 A; A=254-404.
DR   PDB; 2XR6; X-ray; 1.35 A; A=250-404.
DR   PDBsum; 1K9I; -.
DR   PDBsum; 1SL4; -.
DR   PDBsum; 1SL5; -.
DR   PDBsum; 2B6B; -.
DR   PDBsum; 2IT5; -.
DR   PDBsum; 2IT6; -.
DR   PDBsum; 2XR5; -.
DR   PDBsum; 2XR6; -.
DR   ProteinModelPortal; Q9NNX6; -.
DR   SMR; Q9NNX6; -.
DR   BioGrid; 119051; 14.
DR   DIP; DIP-60629N; -.
DR   IntAct; Q9NNX6; 3.
DR   STRING; 9606.ENSP00000315477; -.
DR   BindingDB; Q9NNX6; -.
DR   ChEMBL; CHEMBL1795114; -.
DR   iPTMnet; Q9NNX6; -.
DR   PhosphoSitePlus; Q9NNX6; -.
DR   BioMuta; CD209; -.
DR   DMDM; 46396012; -.
DR   REPRODUCTION-2DPAGE; Q9NNX6; -.
DR   PaxDb; Q9NNX6; -.
DR   PeptideAtlas; Q9NNX6; -.
DR   PRIDE; Q9NNX6; -.
DR   Ensembl; ENST00000204801; ENSP00000204801; ENSG00000090659. [Q9NNX6-7]
DR   Ensembl; ENST00000315591; ENSP00000315407; ENSG00000090659. [Q9NNX6-6]
DR   Ensembl; ENST00000315599; ENSP00000315477; ENSG00000090659. [Q9NNX6-1]
DR   Ensembl; ENST00000354397; ENSP00000346373; ENSG00000090659. [Q9NNX6-2]
DR   Ensembl; ENST00000394161; ENSP00000377716; ENSG00000090659. [Q9NNX6-4]
DR   Ensembl; ENST00000601256; ENSP00000470658; ENSG00000090659. [Q9NNX6-12]
DR   Ensembl; ENST00000601951; ENSP00000468827; ENSG00000090659. [Q9NNX6-10]
DR   Ensembl; ENST00000602261; ENSP00000471137; ENSG00000090659. [Q9NNX6-3]
DR   GeneID; 30835; -.
DR   KEGG; hsa:30835; -.
DR   UCSC; uc002mhr.3; human. [Q9NNX6-1]
DR   CTD; 30835; -.
DR   DisGeNET; 30835; -.
DR   EuPathDB; HostDB:ENSG00000090659.17; -.
DR   GeneCards; CD209; -.
DR   HGNC; HGNC:1641; CD209.
DR   HPA; CAB032436; -.
DR   HPA; CAB033831; -.
DR   MalaCards; CD209; -.
DR   MIM; 604672; gene+phenotype.
DR   MIM; 607948; phenotype.
DR   MIM; 614371; phenotype.
DR   neXtProt; NX_Q9NNX6; -.
DR   OpenTargets; ENSG00000090659; -.
DR   PharmGKB; PA26199; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   eggNOG; ENOG410XPJ1; LUCA.
DR   GeneTree; ENSGT00760000118924; -.
DR   HOVERGEN; HBG050992; -.
DR   InParanoid; Q9NNX6; -.
DR   KO; K06563; -.
DR   OMA; NLAKFWI; -.
DR   OrthoDB; EOG091G0G9W; -.
DR   PhylomeDB; Q9NNX6; -.
DR   TreeFam; TF333341; -.
DR   Reactome; R-HSA-5621575; CD209 (DC-SIGN) signaling.
DR   Reactome; R-HSA-8851680; Butyrophilin (BTN) family interactions.
DR   EvolutionaryTrace; Q9NNX6; -.
DR   GeneWiki; DC-SIGN; -.
DR   GenomeRNAi; 30835; -.
DR   PRO; PR:Q9NNX6; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000090659; -.
DR   ExpressionAtlas; Q9NNX6; baseline and differential.
DR   Genevisible; Q9NNX6; HS.
DR   GO; GO:0009986; C:cell surface; HDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; NAS:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:CAFA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0043657; C:host cell; IEA:GOC.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; TAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; NAS:UniProtKB.
DR   GO; GO:0005537; F:mannose binding; TAS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042605; F:peptide antigen binding; NAS:UniProtKB.
DR   GO; GO:0046790; F:virion binding; TAS:UniProtKB.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0019882; P:antigen processing and presentation; NAS:UniProtKB.
DR   GO; GO:0097323; P:B cell adhesion; IDA:UniProtKB.
DR   GO; GO:0009988; P:cell-cell recognition; TAS:UniProtKB.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; TAS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; NAS:UniProtKB.
DR   GO; GO:0075733; P:intracellular transport of virus; TAS:UniProtKB.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; NAS:UniProtKB.
DR   GO; GO:0019048; P:modulation by virus of host morphology or physiology; TAS:UniProtKB.
DR   GO; GO:0046968; P:peptide antigen transport; NAS:UniProtKB.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; IDA:UniProtKB.
DR   GO; GO:0042129; P:regulation of T cell proliferation; IDA:MGI.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0019079; P:viral genome replication; NAS:UniProtKB.
DR   GO; GO:0019062; P:virion attachment to host cell; TAS:UniProtKB.
DR   CDD; cd03590; CLECT_DC-SIGN_like; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR033989; CD209-like_CTLD.
DR   InterPro; IPR016187; CTDL_fold.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Alternative splicing; Calcium;
KW   Cell adhesion; Cell membrane; Complete proteome; Disulfide bond;
KW   Endocytosis; Glycoprotein; Host cell receptor for virus entry;
KW   Host-virus interaction; Immunity; Innate immunity; Lectin;
KW   Mannose-binding; Membrane; Metal-binding; Polymorphism; Receptor;
KW   Reference proteome; Repeat; Secreted; Signal-anchor; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    404       CD209 antigen.
FT                                /FTId=PRO_0000046595.
FT   TOPO_DOM      1     37       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM     38     58       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000305}.
FT   TOPO_DOM     59    404       Extracellular. {ECO:0000305}.
FT   REPEAT       96    118       1.
FT   REPEAT      119    141       2.
FT   REPEAT      142    164       3.
FT   REPEAT      165    187       4.
FT   REPEAT      188    210       5.
FT   REPEAT      211    233       6.
FT   REPEAT      234    257       7.
FT   DOMAIN      263    378       C-type lectin. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00040}.
FT   REGION       96    257       7 X approximate tandem repeats.
FT   MOTIF        14     15       Endocytosis signal.
FT   MOTIF        16     18       Endocytosis signal. {ECO:0000255}.
FT   MOTIF        31     34       Endocytosis signal. {ECO:0000255}.
FT   METAL       347    347       Calcium.
FT   METAL       349    349       Calcium.
FT   METAL       351    351       Calcium; via carbonyl oxygen.
FT   METAL       354    354       Calcium.
FT   METAL       365    365       Calcium.
FT   METAL       366    366       Calcium.
FT   CARBOHYD     80     80       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    256    267
FT   DISULFID    284    377
FT   DISULFID    356    369
FT   VAR_SEQ       1     15       MSDSKEPRLQQLGLL -> MASACPGSDFTSIHS (in
FT                                isoform 5, isoform 10, isoform 11 and
FT                                isoform 12).
FT                                {ECO:0000303|PubMed:11337487,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_010037.
FT   VAR_SEQ      16     59       Missing (in isoform 7 and isoform 8).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010038.
FT   VAR_SEQ      30     34       GYKSL -> RNQKC (in isoform 9).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010039.
FT   VAR_SEQ      35    404       Missing (in isoform 9).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010040.
FT   VAR_SEQ      36     59       Missing (in isoform 6, isoform 10,
FT                                isoform 11 and isoform 12).
FT                                {ECO:0000303|PubMed:11337487,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_010041.
FT   VAR_SEQ      74    309       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010042.
FT   VAR_SEQ     142    233       Missing (in isoform 8).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010043.
FT   VAR_SEQ     158    249       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010044.
FT   VAR_SEQ     191    236       Missing (in isoform 11).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010047.
FT   VAR_SEQ     301    321       NFLQLQSSRSNRFTWMGLSDL -> LQAVLEQRRAQQRWGG
FT                                RLRGI (in isoform 12).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010048.
FT   VAR_SEQ     301    306       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010049.
FT   VAR_SEQ     322    404       Missing (in isoform 12).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010050.
FT   VARIANT     168    168       E -> D (in dbSNP:rs11465377).
FT                                /FTId=VAR_050104.
FT   VARIANT     214    214       E -> D (in dbSNP:rs11465377).
FT                                /FTId=VAR_036689.
FT   VARIANT     242    242       L -> V (in dbSNP:rs11465380).
FT                                /FTId=VAR_036690.
FT   VARIANT     382    382       A -> S (in dbSNP:rs11465393).
FT                                /FTId=VAR_050105.
FT   MUTAGEN      14     15       LL->AA: Loss of antigen internalization
FT                                by endocytosis.
FT                                {ECO:0000269|PubMed:11859097}.
FT   MUTAGEN     320    320       D->A: Loss of binding to ICAM3 and HIV-1
FT                                gp120. {ECO:0000269|PubMed:11799126}.
FT   MUTAGEN     324    324       E->A: Loss of binding to ICAM3 and HIV-1
FT                                gp120. {ECO:0000269|PubMed:11799126}.
FT   MUTAGEN     347    347       E->Q: Loss of binding to ICAM3 and HIV-1
FT                                gp120. {ECO:0000269|PubMed:11799126}.
FT   MUTAGEN     349    349       N->D: Loss of binding to ICAM3 and HIV-1
FT                                gp120. {ECO:0000269|PubMed:11799126}.
FT   MUTAGEN     350    350       N->A: Loss of binding to ICAM3 and HIV-1
FT                                gp120. {ECO:0000269|PubMed:11799126}.
FT   MUTAGEN     355    355       D->A: Loss of binding to ICAM3 and HIV-1
FT                                gp120. {ECO:0000269|PubMed:11799126}.
FT   MUTAGEN     365    365       N->D: Loss of binding to ICAM3 and HIV-1
FT                                gp120. {ECO:0000269|PubMed:11799126}.
FT   MUTAGEN     366    366       D->A: Loss of binding to ICAM3 and HIV-1
FT                                gp120. {ECO:0000269|PubMed:11799126}.
FT   CONFLICT    152    152       W -> Q (in Ref. 4; AAK91848).
FT                                {ECO:0000305}.
FT   STRAND      261    263       {ECO:0000244|PDB:2XR6}.
FT   STRAND      266    270       {ECO:0000244|PDB:2XR6}.
FT   HELIX       277    286       {ECO:0000244|PDB:2XR6}.
FT   HELIX       297    310       {ECO:0000244|PDB:2XR6}.
FT   STRAND      314    323       {ECO:0000244|PDB:2XR6}.
FT   STRAND      326    329       {ECO:0000244|PDB:2XR6}.
FT   HELIX       337    342       {ECO:0000244|PDB:2XR6}.
FT   STRAND      356    360       {ECO:0000244|PDB:2XR6}.
FT   STRAND      363    367       {ECO:0000244|PDB:2XR6}.
FT   STRAND      373    380       {ECO:0000244|PDB:2XR6}.
FT   TURN        381    383       {ECO:0000244|PDB:2XR6}.
SQ   SEQUENCE   404 AA;  45775 MW;  A23FA246014533C0 CRC64;
     MSDSKEPRLQ QLGLLEEEQL RGLGFRQTRG YKSLAGCLGH GPLVLQLLSF TLLAGLLVQV
     SKVPSSISQE QSRQDAIYQN LTQLKAAVGE LSEKSKLQEI YQELTQLKAA VGELPEKSKL
     QEIYQELTRL KAAVGELPEK SKLQEIYQEL TWLKAAVGEL PEKSKMQEIY QELTRLKAAV
     GELPEKSKQQ EIYQELTRLK AAVGELPEKS KQQEIYQELT RLKAAVGELP EKSKQQEIYQ
     ELTQLKAAVE RLCHPCPWEW TFFQGNCYFM SNSQRNWHDS ITACKEVGAQ LVVIKSAEEQ
     NFLQLQSSRS NRFTWMGLSD LNQEGTWQWV DGSPLLPSFK QYWNRGEPNN VGEEDCAEFS
     GNGWNDDKCN LAKFWICKKS AASCSRDEEQ FLSPAPATPN PPPA
//
ID   X6RB12_HUMAN            Unreviewed;       243 AA.
AC   X6RB12;
DT   11-JUN-2014, integrated into UniProtKB/TrEMBL.
DT   11-JUN-2014, sequence version 1.
DT   28-MAR-2018, entry version 33.
DE   SubName: Full=CD209 antigen {ECO:0000313|Ensembl:ENSP00000377728};
GN   Name=CD209 {ECO:0000313|Ensembl:ENSP00000377728};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000377728, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000377728, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000377728}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (APR-2014) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC008763; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC008812; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001138371.1; NM_001144899.1.
DR   UniGene; Hs.278694; -.
DR   ProteinModelPortal; X6RB12; -.
DR   SMR; X6RB12; -.
DR   PeptideAtlas; X6RB12; -.
DR   PRIDE; X6RB12; -.
DR   Ensembl; ENST00000394173; ENSP00000377728; ENSG00000090659.
DR   GeneID; 30835; -.
DR   UCSC; uc010xju.2; human.
DR   CTD; 30835; -.
DR   EuPathDB; HostDB:ENSG00000090659.17; -.
DR   HGNC; HGNC:1641; CD209.
DR   OpenTargets; ENSG00000090659; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   eggNOG; ENOG410XPJ1; LUCA.
DR   GeneTree; ENSGT00760000118924; -.
DR   GenomeRNAi; 30835; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000090659; -.
DR   ExpressionAtlas; X6RB12; baseline and differential.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   CDD; cd03590; CLECT_DC-SIGN_like; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR033989; CD209-like_CTLD.
DR   InterPro; IPR016187; CTDL_fold.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00660837};
KW   Lectin {ECO:0000256|SAAS:SAAS00709395};
KW   Proteomics identification {ECO:0000213|MaxQB:X6RB12,
KW   ECO:0000213|PeptideAtlas:X6RB12};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      102    217       C-type lectin.
FT                                {ECO:0000259|PROSITE:PS50041}.
SQ   SEQUENCE   243 AA;  27366 MW;  E2DD8A5F2B3B7AF6 CRC64;
     MSDSKEPRLQ QLGLLEEEQL RGLGFRQTRG YKSLAGCLGH GPLVLQLLSF TLLAGLLVQV
     SKVPSSISQE QSRQDAIYQN LTQLKAAVER LCHPCPWEWT FFQGNCYFMS NSQRNWHDSI
     TACKEVGAQL VVIKSAEEQN FLQLQSSRSN RFTWMGLSDL NQEGTWQWVD GSPLLPSFKQ
     YWNRGEPNNV GEEDCAEFSG NGWNDDKCNL AKFWICKKSA ASCSRDEEQF LSPAPATPNP
     PPA
//
ID   CNBD1_HUMAN             Reviewed;         436 AA.
AC   Q8NA66;
DT   26-JUN-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   28-FEB-2018, entry version 103.
DE   RecName: Full=Cyclic nucleotide-binding domain-containing protein 1;
GN   Name=CNBD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK093121; BAC04062.1; -; mRNA.
DR   EMBL; BC117326; AAI17327.1; -; mRNA.
DR   EMBL; BC117328; AAI17329.1; -; mRNA.
DR   CCDS; CCDS55259.1; -.
DR   RefSeq; NP_775809.1; NM_173538.2.
DR   UniGene; Hs.246284; -.
DR   ProteinModelPortal; Q8NA66; -.
DR   STRING; 9606.ENSP00000430073; -.
DR   CarbonylDB; Q8NA66; -.
DR   iPTMnet; Q8NA66; -.
DR   PhosphoSitePlus; Q8NA66; -.
DR   BioMuta; CNBD1; -.
DR   DMDM; 74729846; -.
DR   PaxDb; Q8NA66; -.
DR   PeptideAtlas; Q8NA66; -.
DR   PRIDE; Q8NA66; -.
DR   DNASU; 168975; -.
DR   Ensembl; ENST00000518476; ENSP00000430073; ENSG00000176571.
DR   GeneID; 168975; -.
DR   KEGG; hsa:168975; -.
DR   UCSC; uc003ydy.3; human.
DR   CTD; 168975; -.
DR   DisGeNET; 168975; -.
DR   EuPathDB; HostDB:ENSG00000176571.11; -.
DR   GeneCards; CNBD1; -.
DR   HGNC; HGNC:26663; CNBD1.
DR   HPA; HPA025037; -.
DR   HPA; HPA027469; -.
DR   HPA; HPA027786; -.
DR   neXtProt; NX_Q8NA66; -.
DR   OpenTargets; ENSG00000176571; -.
DR   PharmGKB; PA142672090; -.
DR   eggNOG; ENOG410IIAY; Eukaryota.
DR   eggNOG; ENOG4111GJP; LUCA.
DR   GeneTree; ENSGT00390000001688; -.
DR   HOGENOM; HOG000171012; -.
DR   HOVERGEN; HBG072652; -.
DR   InParanoid; Q8NA66; -.
DR   OMA; TEDDCEI; -.
DR   OrthoDB; EOG091G0GYX; -.
DR   PhylomeDB; Q8NA66; -.
DR   TreeFam; TF337630; -.
DR   ChiTaRS; CNBD1; human.
DR   GenomeRNAi; 168975; -.
DR   PRO; PR:Q8NA66; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000176571; -.
DR   CleanEx; HS_CNBD1; -.
DR   ExpressionAtlas; Q8NA66; baseline and differential.
DR   Genevisible; Q8NA66; HS.
DR   CDD; cd00038; CAP_ED; 1.
DR   Gene3D; 2.60.120.10; -; 2.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   SUPFAM; SSF51206; SSF51206; 3.
DR   PROSITE; PS50042; CNMP_BINDING_3; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Polymorphism; Reference proteome.
FT   CHAIN         1    436       Cyclic nucleotide-binding domain-
FT                                containing protein 1.
FT                                /FTId=PRO_0000291777.
FT   NP_BIND     322    436       cNMP.
FT   COMPBIAS     21     24       Poly-Pro.
FT   VARIANT      64     64       D -> N (in dbSNP:rs10504829).
FT                                /FTId=VAR_032859.
FT   VARIANT      69     69       Q -> K (in dbSNP:rs16894901).
FT                                /FTId=VAR_032860.
FT   VARIANT     257    257       M -> V (in dbSNP:rs60556175).
FT                                /FTId=VAR_061108.
SQ   SEQUENCE   436 AA;  50224 MW;  16ABA68561881EA1 CRC64;
     MPMSSLPAAI LSHMTAINNV PPPPLHSIPN LKKSKHINYG QLNALCHIRG QHSRSMSNIL
     SAHDTFMKQY PKVFLHQKPR LPKLFKQEEQ RELNEGKEES QHQQPDDSNN IAVHVQRAHG
     GHILYRPKRA TEKFEEFLAI LKKLPIHRTP YEHKTVWKFL KTIPDLTFQL NDKHLKTLSK
     TVFSETWLKG STVVANDGFY VILKGLARPQ TNVYKNLIEG SDSPDSFISQ SFHSFIWSEE
     FKNSTLAEMY LPSYDSMLSK WSTFGTLEVM PQNESETQMF SVVTEDDCEI LKIPAKGYAK
     IKEEKIKLEN MQKLKLIRMC PYYEEWPTLS IYELIALLKW KKFPPGHVIV ESGNIISFVG
     YINSGCCNIY RSIIGFVKLR SNKVKRSQKL VYMGKLKEKE SFGEISVLLQ VPFTCTIITK
     KEVEMAIIED KDLFVA
//
ID   Q5JY65_HUMAN            Unreviewed;       836 AA.
AC   Q5JY65;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   28-MAR-2018, entry version 92.
DE   SubName: Full=Crooked neck-like protein 1 {ECO:0000313|Ensembl:ENSP00000366544};
GN   Name=CRNKL1 {ECO:0000313|Ensembl:ENSP00000366544};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000366544, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000366544, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [2] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [4] {ECO:0000313|Ensembl:ENSP00000366544}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL035454; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001265554.1; NM_001278625.1.
DR   UniGene; Hs.171342; -.
DR   ProteinModelPortal; Q5JY65; -.
DR   IntAct; Q5JY65; 3.
DR   EPD; Q5JY65; -.
DR   MaxQB; Q5JY65; -.
DR   PRIDE; Q5JY65; -.
DR   Ensembl; ENST00000377327; ENSP00000366544; ENSG00000101343.
DR   GeneID; 51340; -.
DR   UCSC; uc002wrt.3; human.
DR   CTD; 51340; -.
DR   EuPathDB; HostDB:ENSG00000101343.14; -.
DR   HGNC; HGNC:15762; CRNKL1.
DR   OpenTargets; ENSG00000101343; -.
DR   eggNOG; KOG1915; Eukaryota.
DR   eggNOG; ENOG410XQJF; LUCA.
DR   GeneTree; ENSGT00550000074931; -.
DR   HOGENOM; HOG000207972; -.
DR   HOVERGEN; HBG051046; -.
DR   ChiTaRS; CRNKL1; human.
DR   GenomeRNAi; 51340; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000101343; -.
DR   ExpressionAtlas; Q5JY65; baseline and differential.
DR   GO; GO:0006396; P:RNA processing; IEA:InterPro.
DR   Gene3D; 1.25.40.10; -; 3.
DR   InterPro; IPR003107; HAT.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   Pfam; PF02184; HAT; 2.
DR   SMART; SM00386; HAT; 13.
DR   SUPFAM; SSF48452; SSF48452; 2.
DR   PROSITE; PS50293; TPR_REGION; 2.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:Q5JY65,
KW   ECO:0000213|MaxQB:Q5JY65, ECO:0000213|PeptideAtlas:Q5JY65};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      230    331       TPR_REGION.
FT                                {ECO:0000259|PROSITE:PS50293}.
FT   DOMAIN      594    661       TPR_REGION.
FT                                {ECO:0000259|PROSITE:PS50293}.
FT   COILED      236    256       {ECO:0000256|SAM:Coils}.
FT   COILED      716    743       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   836 AA;  99173 MW;  B199BC385A8E9090 CRC64;
     MTATVENLTF QKDTLGNAVD KNRRHGSTEP LVLAWSSQFR RLTWGCALDA LHRSPCVAAS
     QHGVTHLIRS SRTPHSTRCR KEDAQPGHHG NGAASVTAQA RGQRSVLQVP LPVPRSCLFS
     ESFVVSVSSQ SRFLASVPGT GVQRSTAADM AASTAAGKQR IPKVAKVKNK APAEVQITAE
     QLLREAKERE LELLPPPPQQ KITDEEELND YKLRKRKTFE DNIRKNRTVI SNWIKYAQWE
     ESLKEIQRAR SIYERALDVD YRNITLWLKY AEMEMKNRQV NHARNIWDRA ITTLPRVNQF
     WYKYTYMEEM LGNVAGARQV FERWMEWQPE EQAWHSYINF ELRYKEVDRA RTIYERFVLV
     HPDVKNWIKY ARFEEKHAYF AHARKVYERA VEFFGDEHMD EHLYVAFAKF EENQKEFERV
     RVIYKYALDR ISKQDAQELF KNYTIFEKKF GDRRGIEDII VSKRRFQYEE EVKANPHNYD
     AWFDYLRLVE SDAEAEAVRE VYERAIANVP PIQEKRHWKR YIYLWINYAL YEELEAKDPE
     RTRQVYQASL ELIPHKKFTF AKMWILYAQF EIRQKNLSLA RRALGTSIGK CPKNKLFKVY
     IELELQLREF DRCRKLYEKF LEFGPENCTS WIKFAELETI LGDIDRARAI YELAISQPRL
     DMPEVLWKSY IDFEIEQEET ERTRNLYRRL LQRTQHVKVW ISFAQFELSS GKEGSLTKCR
     QIYEEANKTM RNCEEKEERL MLLESWRSFE EEFGTASDKE RVDKLMPEKV KKRRKVQTDD
     GSDAGWEEYF DYIFPEDAAN QPNLKLLAMA KLWKKQQQEK EDAEHHPDED VDESES
//
ID   Q69YP1_HUMAN            Unreviewed;       728 AA.
AC   Q69YP1;
DT   13-SEP-2004, integrated into UniProtKB/TrEMBL.
DT   13-SEP-2004, sequence version 1.
DT   28-FEB-2018, entry version 66.
DE   SubName: Full=Uncharacterized protein DKFZp762M013 {ECO:0000313|EMBL:CAH10656.1};
DE   Flags: Fragment;
GN   Name=DKFZp762M013 {ECO:0000313|EMBL:CAH10656.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAH10656.1};
RN   [1] {ECO:0000313|EMBL:CAH10656.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Melanoma {ECO:0000313|EMBL:CAH10656.1};
RG   The German cDNA Consortium;
RA   Koehrer K., Beyer A., Mewes H.W., Weil B., Amid C., Osanger A.,
RA   Fobo G., Han M., Wiemann S.;
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL832435; CAH10656.1; -; mRNA.
DR   RefSeq; NP_001265554.1; NM_001278625.1.
DR   RefSeq; NP_001265555.1; NM_001278626.1.
DR   RefSeq; NP_001265556.1; NM_001278627.1.
DR   RefSeq; NP_001265557.1; NM_001278628.1.
DR   RefSeq; NP_057736.4; NM_016652.5.
DR   UniGene; Hs.171342; -.
DR   ProteinModelPortal; Q69YP1; -.
DR   PRIDE; Q69YP1; -.
DR   GeneID; 51340; -.
DR   KEGG; hsa:51340; -.
DR   CTD; 51340; -.
DR   eggNOG; KOG1915; Eukaryota.
DR   eggNOG; ENOG410XQJF; LUCA.
DR   HOVERGEN; HBG051046; -.
DR   KO; K12869; -.
DR   GenomeRNAi; 51340; -.
DR   GO; GO:0006396; P:RNA processing; IEA:InterPro.
DR   Gene3D; 1.25.40.10; -; 3.
DR   InterPro; IPR003107; HAT.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   Pfam; PF02184; HAT; 2.
DR   SMART; SM00386; HAT; 13.
DR   SUPFAM; SSF48452; SSF48452; 2.
DR   PROSITE; PS50293; TPR_REGION; 2.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN      122    223       TPR_REGION.
FT                                {ECO:0000259|PROSITE:PS50293}.
FT   DOMAIN      486    553       TPR_REGION.
FT                                {ECO:0000259|PROSITE:PS50293}.
FT   COILED      128    148       {ECO:0000256|SAM:Coils}.
FT   COILED      608    635       {ECO:0000256|SAM:Coils}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:CAH10656.1}.
SQ   SEQUENCE   728 AA;  87367 MW;  35A849094C0AE8AE CRC64;
     VPLPVPRSCL FSESFVVSVS SQSRFLASVP GTGVQRSAAA DMAASTAAGK QRIPKVAKVK
     NKAPAEVQIT AEQLLREAKE RELELLPPPP QQKITDEEEL NDYKLRKRKT FEDNIRKNRT
     VISNWIKYAQ WEESLKEIQR ARSIYERALD VDYRNITLWL KYAEMEMKNR QVNHARNIWD
     RAITTLPRVN QFWYKYTYME EMLGNVAGAR QVFERWMEWQ PEEQAWHSYI NFELRYKEVD
     RARTIYERFV LVHPDVKNWI KYARFEEKHA YFAHARKVYE RAVEFFGDEH MDEHLYVAFA
     KFEENQKEFE RVRVIYKYAL DRISKQDAQE LFKNYTIFEK KFGDRRGIED IIVSKRRFQY
     EEEVKANPHN YDAWFDYLRL VESDAEAEAV REVYERAIAN VPPIQEKRHW KRYIYLWINY
     ALYEELEAKD PERTRQVYQA SLELIPHKKF TFAKMWILYA QFEIRQKNLS LARRALGTSI
     GKCPKNKLFK VYIELELQLR EFDRCRKLYE KFLEFGPENC TSWIKFAELE TILGDIDRAR
     AIYELAISQP RLDMPEVLWK SYIDFEIEQE ETERTRNLYR RLLQRTQHVK VWISFAQFEL
     SSGKEGSLTK CRQIYEEANK TMRNCEEKEE RLMLLESWRS FEEEFGTASD KERVDKLMPE
     KVKKRRKVQT DDGSDAGWEE YFDYIFPEDA ANQPNLKLLA MAKLWKKQQQ EKEDAEHHPD
     EDVDESES
//
ID   CRNL1_HUMAN             Reviewed;         848 AA.
AC   Q9BZJ0; A8K9T4; Q5JY64; Q8WYI5; Q9BZI9; Q9BZJ1; Q9BZJ2; Q9GZW7;
AC   Q9H8F8; Q9NQH5; Q9NYD8;
DT   01-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   15-MAY-2007, sequence version 4.
DT   25-APR-2018, entry version 152.
DE   RecName: Full=Crooked neck-like protein 1;
DE   AltName: Full=Crooked neck homolog;
DE            Short=hCrn;
GN   Name=CRNKL1; Synonyms=CRN; ORFNames=CGI-201, MSTP021;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4 AND 5), TISSUE
RP   SPECIFICITY, AND VARIANT ARG-35.
RX   PubMed=11342225; DOI=10.1016/S0167-4781(00)00295-5;
RA   Lai C.-H., Chiu J.-Y., Lin W.-C.;
RT   "Identification of the human crooked neck gene by comparative gene
RT   identification.";
RL   Biochim. Biophys. Acta 1517:449-454(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ISOFORMS 1 AND 2), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND IDENTIFICATION IN SPLICEOSOMAL
RP   COMPLEX WITH HPRP8BP AND SNRPB2.
RC   TISSUE=T lymphoblast;
RX   PubMed=12084575; DOI=10.1016/S0167-4781(02)00368-8;
RA   Chung S., Zhou Z., Huddleston K.A., Harrison D.A., Reed R.,
RA   Coleman T.A., Rymond B.C.;
RT   "Crooked neck is a component of the human spliceosome and implicated
RT   in the splicing process.";
RL   Biochim. Biophys. Acta 1576:287-297(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 2).
RC   TISSUE=Heart;
RA   Xu Y.Y., Sun L.Z., Wu Q.Y., Liu Y.Q., Liu B., Zhao B., Wang X.Y.,
RA   Song L., Ye J., Sheng H., Gao Y., Zhang C.L., Zhang J., Wei Y.J.,
RA   Sun Y.H., Jiang Y.X., Zhao X.W., Liu S., Liu L.S., Ding J.F.,
RA   Gao R.L., Qiang B.Q., Yuan J.G., Liew C.C., Zhao M.S., Hui R.T.;
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN THE
RP   SPLICEOSOMAL C COMPLEX, FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=11991638; DOI=10.1017/S1355838202021088;
RA   Jurica M.S., Licklider L.J., Gygi S.P., Grigorieff N., Moore M.J.;
RT   "Purification and characterization of native spliceosomes suitable for
RT   three-dimensional structural analysis.";
RL   RNA 8:426-439(2002).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12801913; DOI=10.1093/jb/mvg079;
RA   Amada N., Tezuka T., Mayeda A., Araki K., Takei N., Todokoro K.,
RA   Nawa H.;
RT   "A novel rat orthologue and homologue for the Drosophila crooked neck
RT   gene in neural stem cells and their immediate descendants.";
RL   J. Biochem. 133:615-623(2003).
RN   [8]
RP   INTERACTION WITH PPIL2 AND HSP90.
RX   PubMed=15189447; DOI=10.1111/j.1356-9597.2004.00742.x;
RA   Hatakeyama S., Matsumoto M., Yada M., Nakayama K.I.;
RT   "Interaction of U-box-type ubiquitin-protein ligases (E3s) with
RT   molecular chaperones.";
RL   Genes Cells 9:533-548(2004).
RN   [9]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2 (ISOFORM 2), CLEAVAGE OF
RP   INITIATOR METHIONINE [LARGE SCALE ANALYSIS] (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-503, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13] {ECO:0000244|PDB:5XJC}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.60 ANGSTROMS), FUNCTION, SUBUNIT,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=28502770; DOI=10.1016/j.cell.2017.04.033;
RA   Zhang X., Yan C., Hang J., Finci L.I., Lei J., Shi Y.;
RT   "An Atomic Structure of the Human Spliceosome.";
RL   Cell 169:918-929(2017).
RN   [14] {ECO:0000244|PDB:5MQF}
RP   STRUCTURE BY ELECTRON MICROSCOPY (5.90 ANGSTROMS), FUNCTION, SUBUNIT,
RP   SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=28076346; DOI=10.1038/nature21079;
RA   Bertram K., Agafonov D.E., Liu W.T., Dybkov O., Will C.L.,
RA   Hartmuth K., Urlaub H., Kastner B., Stark H., Luhrmann R.;
RT   "Cryo-EM structure of a human spliceosome activated for step 2 of
RT   splicing.";
RL   Nature 542:318-323(2017).
CC   -!- FUNCTION: Involved in pre-mRNA splicing process.
CC       {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:12084575,
CC       ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770}.
CC   -!- SUBUNIT: Identified in the spliceosome C complex (PubMed:11991638,
CC       PubMed:28502770, PubMed:28076346). Present in a spliceosome
CC       complex assembled in vitro containing CRNKL1, HPRP8BP and SNRPB2
CC       (PubMed:12084575). Isoform 2 seems to be predominant in the
CC       spliceosome complex (PubMed:12084575). Interacts with PPIL2 (via
CC       the PPIase cyclophilin-type domain); they may form a trimeric
CC       complex with HSP90 (PubMed:15189447).
CC       {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:12084575,
CC       ECO:0000269|PubMed:15189447}.
CC   -!- INTERACTION:
CC       Q8WUD4:CCDC12; NbExp=2; IntAct=EBI-1049701, EBI-2557572;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11991638,
CC       ECO:0000269|PubMed:12801913, ECO:0000269|PubMed:28076346,
CC       ECO:0000269|PubMed:28502770}. Nucleus speckle
CC       {ECO:0000269|PubMed:12084575}. Note=Colocalizes with core
CC       spliceosomal snRNP proteins (PubMed:12084575).
CC       {ECO:0000269|PubMed:12084575}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=Type-II;
CC         IsoId=Q9BZJ0-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=Q9BZJ0-2; Sequence=VSP_002058;
CC         Note=Initiator Met-1 is removed. Contains a N-acetylalanine at
CC         position 2. {ECO:0000244|PubMed:22814378};
CC       Name=3;
CC         IsoId=Q9BZJ0-3; Sequence=VSP_002059;
CC       Name=4; Synonyms=Type-III;
CC         IsoId=Q9BZJ0-4; Sequence=VSP_002059, VSP_002062;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=5; Synonyms=type-IV;
CC         IsoId=Q9BZJ0-5; Sequence=VSP_002060, VSP_002061;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC   -!- TISSUE SPECIFICITY: Widely expressed (PubMed:11342225). Highly
CC       expressed in testis (PubMed:12084575). Not detected in brain and
CC       lung (PubMed:12084575). {ECO:0000269|PubMed:11342225,
CC       ECO:0000269|PubMed:12084575}.
CC   -!- SIMILARITY: Belongs to the crooked-neck family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14303.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB14485.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF255443; AAF65571.2; -; mRNA.
DR   EMBL; AF318302; AAK01924.1; -; mRNA.
DR   EMBL; AF318303; AAK01925.1; -; mRNA.
DR   EMBL; AF318304; AAK01926.1; -; mRNA.
DR   EMBL; AF318305; AAK01927.1; -; mRNA.
DR   EMBL; AF111802; AAL39004.1; -; mRNA.
DR   EMBL; AK023246; BAB14485.1; ALT_INIT; mRNA.
DR   EMBL; AK023728; BAB14659.1; -; mRNA.
DR   EMBL; AK292799; BAF85488.1; -; mRNA.
DR   EMBL; AL035454; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK022908; BAB14303.1; ALT_INIT; mRNA.
DR   CCDS; CCDS33446.1; -. [Q9BZJ0-1]
DR   CCDS; CCDS63238.1; -. [Q9BZJ0-2]
DR   CCDS; CCDS63239.1; -. [Q9BZJ0-3]
DR   RefSeq; NP_001265554.1; NM_001278625.1.
DR   RefSeq; NP_001265555.1; NM_001278626.1.
DR   RefSeq; NP_001265556.1; NM_001278627.1.
DR   RefSeq; NP_001265557.1; NM_001278628.1. [Q9BZJ0-2]
DR   RefSeq; NP_057736.4; NM_016652.5. [Q9BZJ0-1]
DR   UniGene; Hs.171342; -.
DR   PDB; 5MQF; EM; 5.90 A; O=1-848.
DR   PDB; 5XJC; EM; 3.60 A; J=1-848.
DR   PDBsum; 5MQF; -.
DR   PDBsum; 5XJC; -.
DR   ProteinModelPortal; Q9BZJ0; -.
DR   SMR; Q9BZJ0; -.
DR   BioGrid; 119487; 71.
DR   CORUM; Q9BZJ0; -.
DR   IntAct; Q9BZJ0; 18.
DR   MINT; Q9BZJ0; -.
DR   STRING; 9606.ENSP00000366557; -.
DR   iPTMnet; Q9BZJ0; -.
DR   PhosphoSitePlus; Q9BZJ0; -.
DR   BioMuta; CRNKL1; -.
DR   DMDM; 147744555; -.
DR   EPD; Q9BZJ0; -.
DR   MaxQB; Q9BZJ0; -.
DR   PaxDb; Q9BZJ0; -.
DR   PeptideAtlas; Q9BZJ0; -.
DR   PRIDE; Q9BZJ0; -.
DR   DNASU; 51340; -.
DR   Ensembl; ENST00000377340; ENSP00000366557; ENSG00000101343. [Q9BZJ0-1]
DR   Ensembl; ENST00000496549; ENSP00000428436; ENSG00000101343. [Q9BZJ0-5]
DR   Ensembl; ENST00000536226; ENSP00000440733; ENSG00000101343. [Q9BZJ0-2]
DR   GeneID; 51340; -.
DR   KEGG; hsa:51340; -.
DR   UCSC; uc002wrs.5; human. [Q9BZJ0-1]
DR   CTD; 51340; -.
DR   DisGeNET; 51340; -.
DR   EuPathDB; HostDB:ENSG00000101343.14; -.
DR   GeneCards; CRNKL1; -.
DR   H-InvDB; HIX0015678; -.
DR   HGNC; HGNC:15762; CRNKL1.
DR   MIM; 610952; gene.
DR   neXtProt; NX_Q9BZJ0; -.
DR   OpenTargets; ENSG00000101343; -.
DR   PharmGKB; PA26886; -.
DR   eggNOG; KOG1915; Eukaryota.
DR   eggNOG; ENOG410XQJF; LUCA.
DR   GeneTree; ENSGT00550000074931; -.
DR   HOVERGEN; HBG051046; -.
DR   InParanoid; Q9BZJ0; -.
DR   KO; K12869; -.
DR   OMA; FTFSKIW; -.
DR   OrthoDB; EOG091G040G; -.
DR   PhylomeDB; Q9BZJ0; -.
DR   TreeFam; TF300305; -.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   ChiTaRS; CRNKL1; human.
DR   GenomeRNAi; 51340; -.
DR   PRO; PR:Q9BZJ0; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000101343; -.
DR   ExpressionAtlas; Q9BZJ0; baseline and differential.
DR   Genevisible; Q9BZJ0; HS.
DR   GO; GO:0071012; C:catalytic step 1 spliceosome; IBA:GO_Central.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0071014; C:post-mRNA release spliceosomal complex; IBA:GO_Central.
DR   GO; GO:0071011; C:precatalytic spliceosome; IBA:GO_Central.
DR   GO; GO:0071010; C:prespliceosome; IBA:GO_Central.
DR   GO; GO:0000974; C:Prp19 complex; IBA:GO_Central.
DR   GO; GO:0005681; C:spliceosomal complex; IDA:UniProtKB.
DR   GO; GO:0071007; C:U2-type catalytic step 2 spliceosome; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IDA:UniProtKB.
DR   GO; GO:0000245; P:spliceosomal complex assembly; IDA:UniProtKB.
DR   Gene3D; 1.25.40.10; -; 3.
DR   InterPro; IPR003107; HAT.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   Pfam; PF02184; HAT; 2.
DR   SMART; SM00386; HAT; 13.
DR   SUPFAM; SSF48452; SSF48452; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   mRNA processing; mRNA splicing; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Spliceosome.
FT   CHAIN         1    848       Crooked neck-like protein 1.
FT                                /FTId=PRO_0000205719.
FT   REPEAT      222    254       HAT 1.
FT   REPEAT      256    288       HAT 2.
FT   REPEAT      290    322       HAT 3.
FT   REPEAT      324    355       HAT 4.
FT   REPEAT      357    388       HAT 5.
FT   REPEAT      390    425       HAT 6.
FT   REPEAT      427    461       HAT 7.
FT   REPEAT      471    503       HAT 8.
FT   REPEAT      505    539       HAT 9.
FT   REPEAT      549    585       HAT 10.
FT   REPEAT      587    618       HAT 11.
FT   REPEAT      620    652       HAT 12.
FT   REPEAT      654    688       HAT 13.
FT   REPEAT      690    721       HAT 14.
FT   REPEAT      726    767       HAT 15.
FT   REPEAT      769    807       HAT 16.
FT   REPEAT      809    834       HAT 17.
FT   REGION      411    628       Mediates interaction with HSP90.
FT                                {ECO:0000250|UniProtKB:P63154}.
FT   COMPBIAS    207    210       Poly-Pro.
FT   MOD_RES     503    503       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    161       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11342225,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_002058.
FT   VAR_SEQ      23     74       TSRLELRSYSLAGRHGSTEPLVLAWSSQFRRLTWGCALDAL
FT                                HRSPCVAASQH -> ILASLLVSTALPTSSAAPGRRTPRAA
FT                                ARRTRSLVTMETVPPPSRLKREVKGQ (in isoform
FT                                5). {ECO:0000303|PubMed:11342225}.
FT                                /FTId=VSP_002060.
FT   VAR_SEQ      23     34       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:11342225}.
FT                                /FTId=VSP_002059.
FT   VAR_SEQ      75    848       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:11342225}.
FT                                /FTId=VSP_002061.
FT   VAR_SEQ     117    848       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:11342225}.
FT                                /FTId=VSP_002062.
FT   VARIANT      35     35       G -> R (in dbSNP:rs7508949).
FT                                {ECO:0000269|PubMed:11342225}.
FT                                /FTId=VAR_024995.
FT   VARIANT      51     51       F -> L (in dbSNP:rs2273058).
FT                                /FTId=VAR_049318.
FT   VARIANT     111    111       Q -> H (in dbSNP:rs2255258).
FT                                /FTId=VAR_049319.
FT   VARIANT     158    158       T -> A (in dbSNP:rs2255255).
FT                                /FTId=VAR_049320.
FT   VARIANT     843    843       V -> I (in dbSNP:rs35201190).
FT                                /FTId=VAR_049321.
FT   CONFLICT    213    213       K -> R (in Ref. 1; AAF65571/AAK01924/
FT                                AAK01925). {ECO:0000305}.
FT   CONFLICT    513    513       V -> A (in Ref. 4; BAB14659).
FT                                {ECO:0000305}.
SQ   SEQUENCE   848 AA;  100452 MW;  E30A39E981BC50AC CRC64;
     MTATVENLTF QKDTLGNAVD KNTSRLELRS YSLAGRHGST EPLVLAWSSQ FRRLTWGCAL
     DALHRSPCVA ASQHGVTHLI RSSRTPHSTR CRKEDAQPGH HGNGAASVTA QARGQRSVLQ
     VPLPVPRSCL FSESFVVSVS SQSRFLASVP GTGVQRSTAA DMAASTAAGK QRIPKVAKVK
     NKAPAEVQIT AEQLLREAKE RELELLPPPP QQKITDEEEL NDYKLRKRKT FEDNIRKNRT
     VISNWIKYAQ WEESLKEIQR ARSIYERALD VDYRNITLWL KYAEMEMKNR QVNHARNIWD
     RAITTLPRVN QFWYKYTYME EMLGNVAGAR QVFERWMEWQ PEEQAWHSYI NFELRYKEVD
     RARTIYERFV LVHPDVKNWI KYARFEEKHA YFAHARKVYE RAVEFFGDEH MDEHLYVAFA
     KFEENQKEFE RVRVIYKYAL DRISKQDAQE LFKNYTIFEK KFGDRRGIED IIVSKRRFQY
     EEEVKANPHN YDAWFDYLRL VESDAEAEAV REVYERAIAN VPPIQEKRHW KRYIYLWINY
     ALYEELEAKD PERTRQVYQA SLELIPHKKF TFAKMWILYA QFEIRQKNLS LARRALGTSI
     GKCPKNKLFK VYIELELQLR EFDRCRKLYE KFLEFGPENC TSWIKFAELE TILGDIDRAR
     AIYELAISQP RLDMPEVLWK SYIDFEIEQE ETERTRNLYR RLLQRTQHVK VWISFAQFEL
     SSGKEGSLTK CRQIYEEANK TMRNCEEKEE RLMLLESWRS FEEEFGTASD KERVDKLMPE
     KVKKRRKVQT DDGSDAGWEE YFDYIFPEDA ANQPNLKLLA MAKLWKKQQQ EKEDAEHHPD
     EDVDESES
//
ID   CTND1_HUMAN             Reviewed;         968 AA.
AC   O60716; A8K939; O15088; O60713; O60714; O60715; O60935; Q6DHZ7;
AC   Q6RBX8; Q9UP71; Q9UP72; Q9UP73;
DT   11-JUL-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   28-MAR-2018, entry version 182.
DE   RecName: Full=Catenin delta-1;
DE   AltName: Full=Cadherin-associated Src substrate;
DE            Short=CAS;
DE   AltName: Full=p120 catenin;
DE            Short=p120(ctn);
DE   AltName: Full=p120(cas);
GN   Name=CTNND1; Synonyms=KIAA0384;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RC   TISSUE=Fetal kidney;
RX   PubMed=9653641; DOI=10.1006/geno.1998.5325;
RA   Keirsebilck A., Bonne S., Staes K., van Hengel J., Nollet F.,
RA   Reynolds A., van Roy F.;
RT   "Molecular cloning of the human p120ctn catenin gene (CTNND1):
RT   expression of multiple alternatively spliced isoforms.";
RL   Genomics 50:129-146(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1AC).
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1AC).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS CYS-217; CYS-464 AND
RP   LYS-915.
RG   NIEHS SNPs program;
RL   Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1A).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION BY FER, AND INTERACTION WITH FER.
RX   PubMed=7623846; DOI=10.1128/MCB.15.8.4553;
RA   Kim L., Wong T.W.;
RT   "The cytoplasmic tyrosine kinase FER is associated with the catenin-
RT   like substrate pp120 and is activated by growth factors.";
RL   Mol. Cell. Biol. 15:4553-4561(1995).
RN   [8]
RP   INTERACTION WITH ZBTB33.
RX   PubMed=10207085; DOI=10.1128/MCB.19.5.3614;
RA   Daniel J.M., Reynolds A.B.;
RT   "The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain
RT   zinc finger transcription factor.";
RL   Mol. Cell. Biol. 19:3614-3623(1999).
RN   [9]
RP   ALTERNATIVE INITIATION, ALTERNATIVE SPLICING, SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=11896187;
RA   Aho S., Levansuo L., Montonen O., Kari C., Rodeck U., Uitto J.;
RT   "Specific sequences in p120ctn determine subcellular distribution of
RT   its multiple isoforms involved in cellular adhesion of normal and
RT   malignant epithelial cells.";
RL   J. Cell Sci. 115:1391-1402(2002).
RN   [10]
RP   PHOSPHORYLATION, AND DEPHOSPHORYLATION BY PTPRJ.
RX   PubMed=12370829; DOI=10.1038/sj.onc.1205858;
RA   Holsinger L.J., Ward K., Duffield B., Zachwieja J., Jallal B.;
RT   "The transmembrane receptor protein tyrosine phosphatase DEP1
RT   interacts with p120(ctn).";
RL   Oncogene 21:7067-7076(2002).
RN   [11]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=14699141; DOI=10.1074/jbc.M306057200;
RA   Kondapalli J., Flozak A.S., Albuquerque M.L.C.;
RT   "Laminar shear stress differentially modulates gene expression of p120
RT   catenin, Kaiso transcription factor, and vascular endothelial cadherin
RT   in human coronary artery endothelial cells.";
RL   J. Biol. Chem. 279:11417-11424(2004).
RN   [12]
RP   INTERACTION WITH CDH1; GNA12 AND GNA13, AND SUBCELLULAR LOCATION.
RX   PubMed=15240885; DOI=10.1073/pnas.0401366101;
RA   Krakstad B.F., Ardawatia V.V., Aragay A.M.;
RT   "A role for Galpha12/Galpha13 in p120ctn regulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:10314-10319(2004).
RN   [13]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH NANOS1.
RX   PubMed=17047063; DOI=10.1158/0008-5472.CAN-05-3096;
RA   Strumane K., Bonnomet A., Stove C., Vandenbroucke R.,
RA   Nawrocki-Raby B., Bruyneel E., Mareel M., Birembaut P., Berx G.,
RA   van Roy F.;
RT   "E-cadherin regulates human Nanos1, which interacts with p120ctn and
RT   induces tumor cell migration and invasion.";
RL   Cancer Res. 66:10007-10015(2006).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47; SER-268; SER-269;
RP   SER-349 AND SER-352, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [16]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17115030; DOI=10.1038/ncb1504;
RA   Wolf A., Keil R., Gotzl O., Mun A., Schwarze K., Lederer M.,
RA   Huttelmaier S., Hatzfeld M.;
RT   "The armadillo protein p0071 regulates Rho signalling during
RT   cytokinesis.";
RL   Nat. Cell Biol. 8:1432-1440(2006).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Prostate cancer;
RX   PubMed=17487921; DOI=10.1002/elps.200600782;
RA   Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
RT   "Toward a global characterization of the phosphoproteome in prostate
RT   cancer cells: identification of phosphoproteins in the LNCaP cell
RT   line.";
RL   Electrophoresis 28:2027-2034(2007).
RN   [18]
RP   INTERACTION WITH GLIS2, AND FUNCTION.
RX   PubMed=17344476; DOI=10.1091/mbc.E06-10-0941;
RA   Hosking C.R., Ulloa F., Hogan C., Ferber E.C., Figueroa A.,
RA   Gevaert K., Birchmeier W., Briscoe J., Fujita Y.;
RT   "The transcriptional repressor Glis2 is a novel binding partner for
RT   p120 catenin.";
RL   Mol. Biol. Cell 18:1918-1927(2007).
RN   [19]
RP   PHOSPHORYLATION AT TYR-112 BY FYN.
RX   PubMed=17194753; DOI=10.1128/MCB.01974-06;
RA   Castano J., Solanas G., Casagolda D., Raurell I., Villagrasa P.,
RA   Bustelo X.R., Garcia de Herreros A., Dunach M.;
RT   "Specific phosphorylation of p120-catenin regulatory domain
RT   differently modulates its binding to RhoA.";
RL   Mol. Cell. Biol. 27:1745-1757(2007).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-288, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47; SER-230 AND SER-288,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-889 (ISOFORM 1),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-910 (ISOFORM 1A),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-916 (ISOFORM 1AC),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-895 (ISOFORM 1C),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-835 (ISOFORM 2),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-856 (ISOFORM 2A),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-862 (ISOFORM 2AC),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-841 (ISOFORM 2C),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-788 (ISOFORM 3),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-809 (ISOFORM 3A),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-815 (ISOFORM 3AC),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-794 (ISOFORM 3C),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-566 (ISOFORM 4),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-587 (ISOFORM 4A),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-593 (ISOFORM 4AC),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-572 (ISOFORM 4C), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [23]
RP   PHOSPHORYLATION AT SER-288 BY PAK5.
RX   PubMed=20564219; DOI=10.1002/jcb.22639;
RA   Wong L.E., Reynolds A.B., Dissanayaka N.T., Minden A.;
RT   "p120-catenin is a binding partner and substrate for Group B Pak
RT   kinases.";
RL   J. Cell. Biochem. 110:1244-1254(2010).
RN   [24]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-4; SER-47; SER-811; THR-916 AND SER-920, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-230; SER-320; SER-349;
RP   SER-847; SER-857; SER-859; SER-864; SER-879 AND SER-920, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [27]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [28]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-47; THR-59;
RP   SER-252; SER-268; SER-269; SER-288; SER-346; SER-349; SER-352;
RP   SER-861; SER-864; THR-869; THR-906 AND SER-920, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125; SER-225; SER-252;
RP   SER-268; SER-269; SER-346; SER-349; SER-352; SER-617; SER-847;
RP   SER-857; SER-864; TYR-865; SER-868; THR-869; SER-920 AND SER-943, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [31]
RP   INVOLVEMENT IN BCDS2, AND VARIANTS BCDS2 365-GLN--ILE-968 DEL AND
RP   700-ARG--ILE-968 DEL.
RX   PubMed=28301459; DOI=10.1038/gim.2017.11;
RA   Ghoumid J., Stichelbout M., Jourdain A.S., Frenois F.,
RA   Lejeune-Dumoulin S., Alex-Cordier M.P., Lebrun M., Guerreschi P.,
RA   Duquennoy-Martinot V., Vinchon M., Ferri J., Jung M., Vicaire S.,
RA   Vanlerberghe C., Escande F., Petit F., Manouvrier-Hanu S.;
RT   "Blepharocheilodontic syndrome is a CDH1 pathway-related disorder due
RT   to mutations in CDH1 and CTNND1.";
RL   Genet. Med. 19:1013-1021(2017).
RN   [32]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-421; LYS-517 AND LYS-882,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 324-937 IN COMPLEX WITH CDH1,
RP   FUNCTION, SUBUNIT, AND MUTAGENESIS OF TRP-363; LYS-401; LYS-444;
RP   TRP-477 AND ASN-478.
RX   PubMed=20371349; DOI=10.1016/j.cell.2010.01.017;
RA   Ishiyama N., Lee S.H., Liu S., Li G.Y., Smith M.J., Reichardt L.F.,
RA   Ikura M.;
RT   "Dynamic and static interactions between p120 catenin and E-cadherin
RT   regulate the stability of cell-cell adhesion.";
RL   Cell 141:117-128(2010).
CC   -!- FUNCTION: Binds to and inhibits the transcriptional repressor
CC       ZBTB33, which may lead to activation of target genes of the Wnt
CC       signaling pathway (By similarity). Associates with and regulates
CC       the cell adhesion properties of both C-, E- and N-cadherins, being
CC       critical for their surface stability. Implicated both in cell
CC       transformation by SRC and in ligand-induced receptor signaling
CC       through the EGF, PDGF, CSF-1 and ERBB2 receptors. Promotes GLIS2
CC       C-terminal cleavage. {ECO:0000250, ECO:0000269|PubMed:17344476,
CC       ECO:0000269|PubMed:20371349}.
CC   -!- SUBUNIT: Belongs to a multiprotein cell-cell adhesion complex that
CC       also contains E-cadherin/CDH1, alpha-catenin/CTNNA1, beta-
CC       catenin/CTNNB1, and gamma-catenin/JUP (PubMed:20371349,
CC       PubMed:15240885). Binds to the C-terminal fragment of PSEN1 and
CC       mutually competes for CDH1. Interacts with ZBTB33
CC       (PubMed:10207085). Interacts with GLIS2 (PubMed:17344476).
CC       Interacts with FER (PubMed:7623846). Interacts with NANOS1 (via N-
CC       terminal region) (PubMed:17047063). Interacts (via N-terminus)
CC       with GNA12; the interaction regulates CDH1-mediated cell-cell
CC       adhesion (PubMed:15240885). Interacts with GNA13
CC       (PubMed:15240885). {ECO:0000269|PubMed:10207085,
CC       ECO:0000269|PubMed:15240885, ECO:0000269|PubMed:17047063,
CC       ECO:0000269|PubMed:17344476, ECO:0000269|PubMed:20371349,
CC       ECO:0000269|PubMed:7623846}.
CC   -!- INTERACTION:
CC       P09803:Cdh1 (xeno); NbExp=3; IntAct=EBI-702059, EBI-984420;
CC       P00533:EGFR; NbExp=4; IntAct=EBI-701927, EBI-297353;
CC       Q7Z6J6:FRMD5; NbExp=3; IntAct=EBI-701927, EBI-727282;
CC       Q8NC69:KCTD6; NbExp=3; IntAct=EBI-702059, EBI-2511344;
CC       Q8WY41:NANOS1; NbExp=2; IntAct=EBI-9634525, EBI-9630165;
CC       Q6IQ23:PLEKHA7; NbExp=5; IntAct=EBI-701927, EBI-2125301;
CC       O14495:PLPP3; NbExp=9; IntAct=EBI-701927, EBI-766232;
CC       Q12913:PTPRJ; NbExp=5; IntAct=EBI-701927, EBI-2264500;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15240885,
CC       ECO:0000269|PubMed:17047063}. Nucleus
CC       {ECO:0000269|PubMed:11896187, ECO:0000269|PubMed:17115030}. Cell
CC       membrane {ECO:0000269|PubMed:15240885,
CC       ECO:0000269|PubMed:17047063}. Note=Interaction with GLIS2 promotes
CC       nuclear translocation (By similarity). Detected at cell-cell
CC       contacts (PubMed:15240885, PubMed:17047063). NANOS1 induces its
CC       translocation from sites of cell-cell contact to the cytoplasm
CC       (PubMed:17047063). CDH1 enhances cell membrane localization
CC       (PubMed:15240885). Isoforms 4A and 1AB are excluded from the
CC       nucleus (PubMed:11896187). {ECO:0000250|UniProtKB:P30999,
CC       ECO:0000269|PubMed:11896187, ECO:0000269|PubMed:15240885,
CC       ECO:0000269|PubMed:17047063}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1A: Nucleus
CC       {ECO:0000269|PubMed:11896187}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2A: Nucleus
CC       {ECO:0000269|PubMed:11896187}.
CC   -!- SUBCELLULAR LOCATION: Isoform 3A: Nucleus
CC       {ECO:0000269|PubMed:11896187}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=32;
CC         Comment=Isoforms result of a combination of four transcription
CC         start sites and three alternatively spliced exons(A, B and C).;
CC       Name=1ABC;
CC         IsoId=O60716-1; Sequence=Displayed;
CC       Name=1AB;
CC         IsoId=O60716-2; Sequence=VSP_006743;
CC         Note=Contains a nuclear localization signal (NLS) domain at
CC         positions 622-629. {ECO:0000250|UniProtKB:P30999};
CC       Name=1AC;
CC         IsoId=O60716-3; Sequence=VSP_006745;
CC         Note=Contains a phosphothreonine at position 916.
CC         {ECO:0000244|PubMed:18669648};
CC       Name=1BC;
CC         IsoId=O60716-4; Sequence=VSP_006744;
CC       Name=1A;
CC         IsoId=O60716-5; Sequence=VSP_006743, VSP_006745;
CC         Note=Contains a phosphothreonine at position 910 (Ref.21).
CC         Contains a nuclear localization signal (NLS) domain at positions
CC         622-629 (By similarity). {ECO:0000244|PubMed:18669648,
CC         ECO:0000250|UniProtKB:P30999};
CC       Name=1B;
CC         IsoId=O60716-6; Sequence=VSP_006743, VSP_006744;
CC         Note=Contains a nuclear localization signal (NLS) domain at
CC         positions 622-629. {ECO:0000250|UniProtKB:P30999};
CC       Name=1C;
CC         IsoId=O60716-7; Sequence=VSP_006744, VSP_006745;
CC         Note=Contains a phosphothreonine at position 895.
CC         {ECO:0000244|PubMed:18669648};
CC       Name=1;
CC         IsoId=O60716-8; Sequence=VSP_006743, VSP_006744, VSP_006745;
CC         Note=Contains a nuclear localization signal (NLS) domain at
CC         positions 622-629. Contains a phosphothreonine at position 889.
CC         {ECO:0000244|PubMed:18669648, ECO:0000250|UniProtKB:P30999};
CC       Name=2ABC;
CC         IsoId=O60716-9; Sequence=VSP_006740;
CC       Name=2AB;
CC         IsoId=O60716-10; Sequence=VSP_006740, VSP_006743;
CC         Note=Contains a nuclear localization signal (NLS) domain at
CC         positions 568-575. {ECO:0000250|UniProtKB:P30999};
CC       Name=2AC;
CC         IsoId=O60716-11; Sequence=VSP_006740, VSP_006745;
CC         Note=Contains a phosphothreonine at position 862.
CC         {ECO:0000244|PubMed:18669648};
CC       Name=2BC;
CC         IsoId=O60716-12; Sequence=VSP_006740, VSP_006744;
CC       Name=2A;
CC         IsoId=O60716-13; Sequence=VSP_006740, VSP_006743, VSP_006745;
CC         Note=Contains a phosphothreonine at position 856 (Ref.21).
CC         Contains a nuclear localization signal (NLS) domain at positions
CC         622-629. {ECO:0000244|PubMed:18669648,
CC         ECO:0000250|UniProtKB:P30999};
CC       Name=2B;
CC         IsoId=O60716-14; Sequence=VSP_006740, VSP_006743, VSP_006744;
CC         Note=Contains a nuclear localization signal (NLS) domain at
CC         positions 622-629. {ECO:0000250|UniProtKB:P30999};
CC       Name=2C;
CC         IsoId=O60716-15; Sequence=VSP_006740, VSP_006744, VSP_006745;
CC         Note=Contains a phosphothreonine at position 841.
CC         {ECO:0000244|PubMed:18669648};
CC       Name=2;
CC         IsoId=O60716-16; Sequence=VSP_006740, VSP_006743, VSP_006744,
CC                                   VSP_006745;
CC         Note=Contains a nuclear localization signal (NLS) domain at
CC         positions 622-629. Contains a phosphothreonine at position 835.
CC         {ECO:0000244|PubMed:18669648, ECO:0000250|UniProtKB:P30999};
CC       Name=3ABC;
CC         IsoId=O60716-17; Sequence=VSP_006741;
CC       Name=3AB;
CC         IsoId=O60716-18; Sequence=VSP_006741, VSP_006743;
CC         Note=Contains a nuclear localization signal (NLS) domain at
CC         positions 521-528. {ECO:0000250|UniProtKB:P30999};
CC       Name=3AC;
CC         IsoId=O60716-19; Sequence=VSP_006741, VSP_006745;
CC         Note=Contains a phosphothreonine at position 815.
CC         {ECO:0000244|PubMed:18669648};
CC       Name=3BC;
CC         IsoId=O60716-20; Sequence=VSP_006741, VSP_006744;
CC       Name=3A;
CC         IsoId=O60716-21; Sequence=VSP_006741, VSP_006743, VSP_006745;
CC         Note=Contains a phosphothreonine at position 809 (Ref.21).
CC         Contains a nuclear localization signal (NLS) domain at positions
CC         521-528. {ECO:0000244|PubMed:18669648,
CC         ECO:0000250|UniProtKB:P30999};
CC       Name=3B;
CC         IsoId=O60716-22; Sequence=VSP_006741, VSP_006743, VSP_006744;
CC         Note=Contains a nuclear localization signal (NLS) domain at
CC         positions 521-528. {ECO:0000250|UniProtKB:P30999};
CC       Name=3C;
CC         IsoId=O60716-23; Sequence=VSP_006741, VSP_006744, VSP_006745;
CC         Note=Contains a phosphothreonine at position 794.
CC         {ECO:0000244|PubMed:18669648};
CC       Name=3;
CC         IsoId=O60716-24; Sequence=VSP_006741, VSP_006743, VSP_006744,
CC                                   VSP_006745;
CC         Note=Contains a phosphothreonine at position 788 (Ref.21).
CC         Contains a nuclear localization signal (NLS) domain at positions
CC         521-528 (By similarity). {ECO:0000244|PubMed:18669648,
CC         ECO:0000250|UniProtKB:P30999};
CC       Name=4ABC;
CC         IsoId=O60716-25; Sequence=VSP_006742;
CC       Name=4AB;
CC         IsoId=O60716-26; Sequence=VSP_006742, VSP_006743;
CC         Note=Contains a nuclear localization signal (NLS) domain at
CC         positions 299-306 (By similarity).
CC         {ECO:0000250|UniProtKB:P30999};
CC       Name=4AC;
CC         IsoId=O60716-27; Sequence=VSP_006742, VSP_006745;
CC         Note=Contains a phosphothreonine at position 593.
CC         {ECO:0000244|PubMed:18669648};
CC       Name=4BC;
CC         IsoId=O60716-28; Sequence=VSP_006742, VSP_006744;
CC       Name=4A;
CC         IsoId=O60716-29; Sequence=VSP_006742, VSP_006743, VSP_006745;
CC         Note=Contains a nuclear localization signal (NLS) domain at
CC         positions 299-306 (By similarity). Contains a phosphothreonine
CC         at position 587. {ECO:0000244|PubMed:18669648,
CC         ECO:0000250|UniProtKB:P30999};
CC       Name=4B;
CC         IsoId=O60716-30; Sequence=VSP_006742, VSP_006743, VSP_006744;
CC         Note=Contains a nuclear localization signal (NLS) domain at
CC         positions 299-306 (By similarity).
CC         {ECO:0000250|UniProtKB:P30999};
CC       Name=4C;
CC         IsoId=O60716-31; Sequence=VSP_006742, VSP_006744, VSP_006745;
CC         Note=Contains a phosphothreonine at position 572.
CC         {ECO:0000244|PubMed:18669648};
CC       Name=4;
CC         IsoId=O60716-32; Sequence=VSP_006742, VSP_006743, VSP_006744,
CC                                   VSP_006745;
CC         Note=Contains a phosphothreonine at position 566 (Ref.21).
CC         Contains a nuclear localization signal (NLS) domain at positions
CC         299-306 (By similarity). {ECO:0000244|PubMed:18669648,
CC         ECO:0000250|UniProtKB:P30999};
CC   -!- TISSUE SPECIFICITY: Expressed in vascular endothelium. Melanocytes
CC       and melanoma cells primarily express the long isoform 1A, whereas
CC       keratinocytes express shorter isoforms, especially 3A. The
CC       shortest isoform 4A, is detected in normal keratinocytes and
CC       melanocytes, and generally lost from cells derived from squamous
CC       cell carcinomas or melanomas. The C-terminal alternatively spliced
CC       exon B is present in the p120ctn transcripts in the colon,
CC       intestine and prostate, but lost in several tumor tissues derived
CC       from these organs. {ECO:0000269|PubMed:11896187,
CC       ECO:0000269|PubMed:14699141}.
CC   -!- INDUCTION: Induced in vascular endothelium by wounding. This
CC       effect is potentiated by prior laminar shear stress, which
CC       enhances wound closure. {ECO:0000269|PubMed:14699141}.
CC   -!- DOMAIN: A possible nuclear localization signal exists in all
CC       isoforms where Asp-626--631-Arg are deleted.
CC   -!- DOMAIN: ARM repeats 1 to 5 mediate interaction with cadherins.
CC   -!- PTM: Phosphorylated by FER and other protein-tyrosine kinases.
CC       Phosphorylated at Ser-288 by PAK5. Dephosphorylated by PTPRJ.
CC       {ECO:0000269|PubMed:12370829, ECO:0000269|PubMed:17194753,
CC       ECO:0000269|PubMed:20564219, ECO:0000269|PubMed:7623846}.
CC   -!- DISEASE: Blepharocheilodontic syndrome 2 (BCDS2) [MIM:617681]: A
CC       form of blepharocheilodontic syndrome, a rare autosomal dominant
CC       disorder. It is characterized by lower eyelid ectropion, upper
CC       eyelid distichiasis, euryblepharon, bilateral cleft lip and
CC       palate, and features of ectodermal dysplasia, including hair
CC       anomalies, conical teeth and tooth agenesis. An additional rare
CC       manifestation is imperforate anus. There is considerable
CC       phenotypic variability among affected individuals.
CC       {ECO:0000269|PubMed:28301459}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the beta-catenin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA20838.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/ctnnd1/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CTNND1ID40197ch11q11.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF062319; AAC39804.1; -; mRNA.
DR   EMBL; AF062323; AAC39808.1; -; mRNA.
DR   EMBL; AF062341; AAC39826.1; -; mRNA.
DR   EMBL; AF062342; AAC39827.1; -; mRNA.
DR   EMBL; AF062322; AAC39807.1; -; mRNA.
DR   EMBL; AF062326; AAC39811.1; -; mRNA.
DR   EMBL; AF062328; AAC39813.1; -; mRNA.
DR   EMBL; AF062338; AAC39823.1; -; mRNA.
DR   EMBL; AF062324; AAC39809.1; -; mRNA.
DR   EMBL; AF062327; AAC39812.1; -; mRNA.
DR   EMBL; AF062329; AAC39814.1; -; mRNA.
DR   EMBL; AF062330; AAC39815.1; -; mRNA.
DR   EMBL; AF062331; AAC39816.1; -; mRNA.
DR   EMBL; AF062333; AAC39818.1; -; mRNA.
DR   EMBL; AF062334; AAC39819.1; -; mRNA.
DR   EMBL; AF062335; AAC39820.1; -; mRNA.
DR   EMBL; AF062336; AAC39821.1; -; mRNA.
DR   EMBL; AF062339; AAC39824.1; -; mRNA.
DR   EMBL; AF062340; AAC39825.1; -; mRNA.
DR   EMBL; AF062343; AAC39828.1; -; mRNA.
DR   EMBL; AF062317; AAC39802.1; -; mRNA.
DR   EMBL; AF062325; AAC39810.1; -; mRNA.
DR   EMBL; AF062332; AAC39817.1; -; mRNA.
DR   EMBL; AF062344; AAC39829.1; -; mRNA.
DR   EMBL; AF062321; AAC39806.1; -; mRNA.
DR   EMBL; AF062320; AAC39805.1; -; mRNA.
DR   EMBL; AF062337; AAC39822.1; -; mRNA.
DR   EMBL; AF062318; AAC39803.1; -; mRNA.
DR   EMBL; AB002382; BAA20838.2; ALT_INIT; mRNA.
DR   EMBL; AK292554; BAF85243.1; -; mRNA.
DR   EMBL; AY505564; AAR84236.1; -; Genomic_DNA.
DR   EMBL; AP001931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC075795; AAH75795.1; -; mRNA.
DR   CCDS; CCDS44604.1; -. [O60716-1]
DR   CCDS; CCDS44605.1; -. [O60716-2]
DR   CCDS; CCDS44606.1; -. [O60716-5]
DR   CCDS; CCDS44607.1; -. [O60716-6]
DR   CCDS; CCDS44608.1; -. [O60716-17]
DR   CCDS; CCDS44609.1; -. [O60716-21]
DR   CCDS; CCDS53632.1; -. [O60716-19]
DR   CCDS; CCDS53633.1; -. [O60716-18]
DR   CCDS; CCDS53634.1; -. [O60716-22]
DR   CCDS; CCDS55763.1; -. [O60716-9]
DR   CCDS; CCDS55764.1; -. [O60716-11]
DR   CCDS; CCDS55765.1; -. [O60716-10]
DR   CCDS; CCDS55766.1; -. [O60716-13]
DR   CCDS; CCDS55767.1; -. [O60716-14]
DR   CCDS; CCDS73290.1; -. [O60716-3]
DR   RefSeq; NP_001078927.1; NM_001085458.1. [O60716-1]
DR   RefSeq; NP_001078928.1; NM_001085459.1. [O60716-2]
DR   RefSeq; NP_001078929.1; NM_001085460.1. [O60716-5]
DR   RefSeq; NP_001078930.1; NM_001085461.1. [O60716-5]
DR   RefSeq; NP_001078931.1; NM_001085462.1. [O60716-5]
DR   RefSeq; NP_001078932.1; NM_001085463.1. [O60716-17]
DR   RefSeq; NP_001078933.1; NM_001085464.1. [O60716-18]
DR   RefSeq; NP_001078934.1; NM_001085465.1. [O60716-22]
DR   RefSeq; NP_001078935.1; NM_001085466.1. [O60716-19]
DR   RefSeq; NP_001078936.1; NM_001085467.1. [O60716-21]
DR   RefSeq; NP_001078937.1; NM_001085468.1. [O60716-21]
DR   RefSeq; NP_001078938.1; NM_001085469.1. [O60716-21]
DR   RefSeq; NP_001193812.1; NM_001206883.1. [O60716-9]
DR   RefSeq; NP_001193813.1; NM_001206884.1. [O60716-11]
DR   RefSeq; NP_001193814.1; NM_001206885.1. [O60716-3]
DR   RefSeq; NP_001193815.1; NM_001206886.1. [O60716-10]
DR   RefSeq; NP_001193816.1; NM_001206887.1. [O60716-14]
DR   RefSeq; NP_001193817.1; NM_001206888.1. [O60716-13]
DR   RefSeq; NP_001193818.1; NM_001206889.1. [O60716-13]
DR   RefSeq; NP_001193819.1; NM_001206890.1. [O60716-21]
DR   RefSeq; NP_001193820.1; NM_001206891.1. [O60716-13]
DR   RefSeq; NP_001322.1; NM_001331.2. [O60716-6]
DR   UniGene; Hs.166011; -.
DR   PDB; 3L6X; X-ray; 2.40 A; A=324-937.
DR   PDB; 3L6Y; X-ray; 3.00 A; A/C/E=324-937.
DR   PDBsum; 3L6X; -.
DR   PDBsum; 3L6Y; -.
DR   ProteinModelPortal; O60716; -.
DR   SMR; O60716; -.
DR   BioGrid; 107881; 63.
DR   CORUM; O60716; -.
DR   DIP; DIP-33850N; -.
DR   ELM; O60716; -.
DR   IntAct; O60716; 53.
DR   MINT; O60716; -.
DR   STRING; 9606.ENSP00000382004; -.
DR   CarbonylDB; O60716; -.
DR   iPTMnet; O60716; -.
DR   PhosphoSitePlus; O60716; -.
DR   SwissPalm; O60716; -.
DR   BioMuta; CTNND1; -.
DR   EPD; O60716; -.
DR   MaxQB; O60716; -.
DR   PaxDb; O60716; -.
DR   PeptideAtlas; O60716; -.
DR   PRIDE; O60716; -.
DR   DNASU; 1500; -.
DR   Ensembl; ENST00000358694; ENSP00000351527; ENSG00000198561. [O60716-5]
DR   Ensembl; ENST00000361332; ENSP00000354823; ENSG00000198561. [O60716-2]
DR   Ensembl; ENST00000361391; ENSP00000354785; ENSG00000198561. [O60716-6]
DR   Ensembl; ENST00000361796; ENSP00000354907; ENSG00000198561. [O60716-3]
DR   Ensembl; ENST00000399050; ENSP00000382004; ENSG00000198561. [O60716-1]
DR   Ensembl; ENST00000415361; ENSP00000403518; ENSG00000198561. [O60716-17]
DR   Ensembl; ENST00000426142; ENSP00000409930; ENSG00000198561. [O60716-21]
DR   Ensembl; ENST00000428599; ENSP00000413586; ENSG00000198561. [O60716-5]
DR   Ensembl; ENST00000524630; ENSP00000436543; ENSG00000198561. [O60716-5]
DR   Ensembl; ENST00000525902; ENSP00000434672; ENSG00000198561. [O60716-27]
DR   Ensembl; ENST00000526357; ENSP00000433334; ENSG00000198561. [O60716-10]
DR   Ensembl; ENST00000526772; ENSP00000433158; ENSG00000198561. [O60716-29]
DR   Ensembl; ENST00000526938; ENSP00000432041; ENSG00000198561. [O60716-7]
DR   Ensembl; ENST00000527467; ENSP00000434900; ENSG00000198561. [O60716-25]
DR   Ensembl; ENST00000528232; ENSP00000435266; ENSG00000198561. [O60716-19]
DR   Ensembl; ENST00000528621; ENSP00000432243; ENSG00000198561. [O60716-13]
DR   Ensembl; ENST00000529526; ENSP00000436323; ENSG00000198561. [O60716-13]
DR   Ensembl; ENST00000529873; ENSP00000435494; ENSG00000198561. [O60716-14]
DR   Ensembl; ENST00000529986; ENSP00000437156; ENSG00000198561. [O60716-21]
DR   Ensembl; ENST00000530094; ENSP00000437327; ENSG00000198561. [O60716-18]
DR   Ensembl; ENST00000530748; ENSP00000436744; ENSG00000198561. [O60716-11]
DR   Ensembl; ENST00000531014; ENSP00000432623; ENSG00000198561. [O60716-26]
DR   Ensembl; ENST00000532245; ENSP00000434017; ENSG00000198561. [O60716-21]
DR   Ensembl; ENST00000532463; ENSP00000432075; ENSG00000198561. [O60716-21]
DR   Ensembl; ENST00000532649; ENSP00000435379; ENSG00000198561. [O60716-13]
DR   Ensembl; ENST00000532787; ENSP00000434949; ENSG00000198561. [O60716-22]
DR   Ensembl; ENST00000532844; ENSP00000433276; ENSG00000198561. [O60716-9]
DR   Ensembl; ENST00000533667; ENSP00000437051; ENSG00000198561. [O60716-30]
DR   Ensembl; ENST00000534579; ENSP00000435789; ENSG00000198561. [O60716-13]
DR   GeneID; 1500; -.
DR   KEGG; hsa:1500; -.
DR   UCSC; uc001nli.5; human. [O60716-1]
DR   CTD; 1500; -.
DR   DisGeNET; 1500; -.
DR   EuPathDB; HostDB:ENSG00000198561.13; -.
DR   GeneCards; CTNND1; -.
DR   HGNC; HGNC:2515; CTNND1.
DR   HPA; CAB003837; -.
DR   HPA; HPA015954; -.
DR   HPA; HPA015955; -.
DR   MIM; 601045; gene.
DR   MIM; 617681; phenotype.
DR   neXtProt; NX_O60716; -.
DR   OpenTargets; ENSG00000198561; -.
DR   PharmGKB; PA27016; -.
DR   eggNOG; KOG1048; Eukaryota.
DR   eggNOG; ENOG410Y21Q; LUCA.
DR   GeneTree; ENSGT00760000119167; -.
DR   HOVERGEN; HBG004284; -.
DR   InParanoid; O60716; -.
DR   KO; K05690; -.
DR   OMA; HSYDDST; -.
DR   OrthoDB; EOG091G018C; -.
DR   PhylomeDB; O60716; -.
DR   TreeFam; TF321877; -.
DR   Reactome; R-HSA-418990; Adherens junctions interactions.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-8876493; InlA-mediated entry of Listeria monocytogenes into host cells.
DR   SignaLink; O60716; -.
DR   SIGNOR; O60716; -.
DR   ChiTaRS; CTNND1; human.
DR   EvolutionaryTrace; O60716; -.
DR   GeneWiki; CTNND1; -.
DR   GenomeRNAi; 1500; -.
DR   PRO; PR:O60716; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000198561; -.
DR   ExpressionAtlas; O60716; baseline and differential.
DR   Genevisible; O60716; HS.
DR   GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IMP:BHF-UCL.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0030426; C:growth cone; IEA:Ensembl.
DR   GO; GO:0030027; C:lamellipodium; IEA:Ensembl.
DR   GO; GO:0030496; C:midbody; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005915; C:zonula adherens; IEA:Ensembl.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0034332; P:adherens junction organization; TAS:Reactome.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0007155; P:cell adhesion; NAS:ProtInc.
DR   GO; GO:0098609; P:cell-cell adhesion; IEA:InterPro.
DR   GO; GO:0035635; P:entry of bacterium into host cell; TAS:Reactome.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000225; Armadillo.
DR   InterPro; IPR028439; Catenin_d1.
DR   InterPro; IPR028435; Plakophilin/d_Catenin.
DR   PANTHER; PTHR10372; PTHR10372; 1.
DR   PANTHER; PTHR10372:SF6; PTHR10372:SF6; 1.
DR   Pfam; PF00514; Arm; 3.
DR   SMART; SM00185; ARM; 7.
DR   SUPFAM; SSF48371; SSF48371; 2.
DR   PROSITE; PS50176; ARM_REPEAT; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation;
KW   Alternative splicing; Cell adhesion; Cell membrane; Coiled coil;
KW   Complete proteome; Cytoplasm; Disease mutation; Ectodermal dysplasia;
KW   Isopeptide bond; Membrane; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Ubl conjugation; Wnt signaling pathway.
FT   CHAIN         1    968       Catenin delta-1.
FT                                /FTId=PRO_0000064296.
FT   REPEAT      358    395       ARM 1.
FT   REPEAT      398    437       ARM 2.
FT   REPEAT      441    475       ARM 3.
FT   REPEAT      476    516       ARM 4.
FT   REPEAT      534    573       ARM 5.
FT   REPEAT      583    624       ARM 6.
FT   REPEAT      653    693       ARM 7.
FT   REPEAT      700    739       ARM 8.
FT   REPEAT      740    780       ARM 9.
FT   REPEAT      781    826       ARM 10.
FT   COILED       10     46       {ECO:0000255}.
FT   SITE        401    401       Essential for interaction with cadherins.
FT   SITE        478    478       Essential for interaction with cadherins.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES       4      4       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      47     47       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      59     59       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     112    112       Phosphotyrosine; by FYN.
FT                                {ECO:0000269|PubMed:17194753}.
FT   MOD_RES     125    125       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     217    217       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P30999}.
FT   MOD_RES     221    221       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P30999}.
FT   MOD_RES     225    225       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     228    228       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P30999}.
FT   MOD_RES     230    230       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     252    252       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     257    257       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P30999}.
FT   MOD_RES     268    268       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     269    269       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     280    280       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P30999}.
FT   MOD_RES     288    288       Phosphoserine; by PAK5.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:20564219}.
FT   MOD_RES     291    291       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P30999}.
FT   MOD_RES     300    300       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P30999}.
FT   MOD_RES     304    304       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P30999}.
FT   MOD_RES     320    320       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     346    346       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     617    617       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     713    713       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P30999}.
FT   MOD_RES     811    811       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     847    847       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     857    857       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     859    859       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     861    861       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     864    864       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     865    865       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     868    868       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     869    869       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     879    879       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     899    899       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P30999}.
FT   MOD_RES     904    904       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P30999}.
FT   MOD_RES     906    906       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     916    916       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     920    920       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     943    943       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CROSSLNK    421    421       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    517    517       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    882    882       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1    323       Missing (in isoform 4ABC, isoform 4AB,
FT                                isoform 4AC, isoform 4BC, isoform 4A,
FT                                isoform 4B, isoform 4C and isoform 4).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_006742.
FT   VAR_SEQ       1    101       Missing (in isoform 3ABC, isoform 3AB,
FT                                isoform 3AC, isoform 3BC, isoform 3A,
FT                                isoform 3B, isoform 3C and isoform 3).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_006741.
FT   VAR_SEQ       1     54       Missing (in isoform 2ABC, isoform 2AB,
FT                                isoform 2AC, isoform 2BC, isoform 2A,
FT                                isoform 2B, isoform 2C and isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_006740.
FT   VAR_SEQ     626    631       Missing (in isoform 1AB, isoform 1A,
FT                                isoform 1B, isoform 1, isoform 2AB,
FT                                isoform 2A, isoform 2B, isoform 2,
FT                                isoform 3AB, isoform 3A, isoform 3B,
FT                                isoform 3, isoform 4AB, isoform 4A,
FT                                isoform 4B and isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_006743.
FT   VAR_SEQ     880    900       Missing (in isoform 1BC, isoform 1B,
FT                                isoform 1C, isoform 1, isoform 2BC,
FT                                isoform 2B, isoform 2C, isoform 2,
FT                                isoform 3BC, isoform 3B, isoform 3C,
FT                                isoform 3, isoform 4BC, isoform 4B,
FT                                isoform 4C and isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_006744.
FT   VAR_SEQ     937    965       Missing (in isoform 1AC, isoform 1A,
FT                                isoform 1C, isoform 1, isoform 2AC,
FT                                isoform 2A, isoform 2C, isoform 2,
FT                                isoform 3AC, isoform 3A, isoform 3C,
FT                                isoform 3, isoform 4AC, isoform 4A,
FT                                isoform 4C and isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9205841}.
FT                                /FTId=VSP_006745.
FT   VARIANT     171    171       S -> F (in dbSNP:rs11229133).
FT                                /FTId=VAR_038255.
FT   VARIANT     217    217       Y -> C (in dbSNP:rs11570194).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_020929.
FT   VARIANT     365    968       Missing (in BCDS2).
FT                                {ECO:0000269|PubMed:28301459}.
FT                                /FTId=VAR_079395.
FT   VARIANT     464    464       R -> C (in dbSNP:rs11570199).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_020930.
FT   VARIANT     700    968       Missing (in BCDS2).
FT                                {ECO:0000269|PubMed:28301459}.
FT                                /FTId=VAR_079396.
FT   VARIANT     915    915       R -> K (in dbSNP:rs11570222).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_020931.
FT   MUTAGEN     363    363       W->A: Severely disrupts cadherin
FT                                interaction.
FT                                {ECO:0000269|PubMed:20371349}.
FT   MUTAGEN     401    401       K->M: Complete loss of cadherin
FT                                interaction.
FT                                {ECO:0000269|PubMed:20371349}.
FT   MUTAGEN     444    444       K->M: Severely disrupts cadherin
FT                                interaction.
FT                                {ECO:0000269|PubMed:20371349}.
FT   MUTAGEN     477    477       W->A: Severely disrupts cadherin
FT                                interaction.
FT                                {ECO:0000269|PubMed:20371349}.
FT   MUTAGEN     478    478       N->A: Complete loss of cadherin
FT                                interaction.
FT                                {ECO:0000269|PubMed:20371349}.
FT   CONFLICT    319    319       R -> M (in Ref. 2; BAA20838).
FT                                {ECO:0000305}.
FT   CONFLICT    380    380       D -> G (in Ref. 6; AAH75795).
FT                                {ECO:0000305}.
FT   HELIX       368    374       {ECO:0000244|PDB:3L6X}.
FT   HELIX       380    394       {ECO:0000244|PDB:3L6X}.
FT   HELIX       398    406       {ECO:0000244|PDB:3L6X}.
FT   HELIX       409    415       {ECO:0000244|PDB:3L6X}.
FT   HELIX       416    418       {ECO:0000244|PDB:3L6X}.
FT   HELIX       422    435       {ECO:0000244|PDB:3L6X}.
FT   STRAND      437    439       {ECO:0000244|PDB:3L6X}.
FT   HELIX       441    449       {ECO:0000244|PDB:3L6X}.
FT   HELIX       452    462       {ECO:0000244|PDB:3L6X}.
FT   HELIX       466    479       {ECO:0000244|PDB:3L6X}.
FT   HELIX       483    485       {ECO:0000244|PDB:3L6X}.
FT   HELIX       486    492       {ECO:0000244|PDB:3L6X}.
FT   HELIX       494    500       {ECO:0000244|PDB:3L6X}.
FT   HELIX       502    506       {ECO:0000244|PDB:3L6X}.
FT   HELIX       524    537       {ECO:0000244|PDB:3L6X}.
FT   HELIX       542    550       {ECO:0000244|PDB:3L6X}.
FT   HELIX       554    567       {ECO:0000244|PDB:3L6X}.
FT   HELIX       574    587       {ECO:0000244|PDB:3L6X}.
FT   HELIX       590    593       {ECO:0000244|PDB:3L6X}.
FT   HELIX       655    660       {ECO:0000244|PDB:3L6X}.
FT   HELIX       662    674       {ECO:0000244|PDB:3L6X}.
FT   HELIX       678    692       {ECO:0000244|PDB:3L6X}.
FT   HELIX       697    706       {ECO:0000244|PDB:3L6X}.
FT   HELIX       709    717       {ECO:0000244|PDB:3L6X}.
FT   HELIX       718    720       {ECO:0000244|PDB:3L6X}.
FT   HELIX       724    738       {ECO:0000244|PDB:3L6X}.
FT   HELIX       744    757       {ECO:0000244|PDB:3L6X}.
FT   STRAND      759    763       {ECO:0000244|PDB:3L6X}.
FT   HELIX       766    768       {ECO:0000244|PDB:3L6X}.
FT   HELIX       772    786       {ECO:0000244|PDB:3L6X}.
FT   HELIX       790    798       {ECO:0000244|PDB:3L6X}.
FT   HELIX       801    809       {ECO:0000244|PDB:3L6X}.
FT   STRAND      812    814       {ECO:0000244|PDB:3L6X}.
FT   HELIX       816    830       {ECO:0000244|PDB:3L6X}.
FT   HELIX       833    840       {ECO:0000244|PDB:3L6X}.
FT   TURN        841    843       {ECO:0000244|PDB:3L6X}.
FT   HELIX       846    849       {ECO:0000244|PDB:3L6X}.
SQ   SEQUENCE   968 AA;  108170 MW;  D5C37489A891F292 CRC64;
     MDDSEVESTA SILASVKEQE AQFEKLTRAL EEERRHVSAQ LERVRVSPQD ANPLMANGTL
     TRRHQNGRFV GDADLERQKF SDLKLNGPQD HSHLLYSTIP RMQEPGQIVE TYTEEDPEGA
     MSVVSVETSD DGTTRRTETT VKKVVKTVTT RTVQPVAMGP DGLPVDASSV SNNYIQTLGR
     DFRKNGNGGP GPYVGQAGTA TLPRNFHYPP DGYSRHYEDG YPGGSDNYGS LSRVTRIEER
     YRPSMEGYRA PSRQDVYGPQ PQVRVGGSSV DLHRFHPEPY GLEDDQRSMG YDDLDYGMMS
     DYGTARRTGT PSDPRRRLRS YEDMIGEEVP SDQYYWAPLA QHERGSLASL DSLRKGGPPP
     PNWRQPELPE VIAMLGFRLD AVKSNAAAYL QHLCYRNDKV KTDVRKLKGI PVLVGLLDHP
     KKEVHLGACG ALKNISFGRD QDNKIAIKNC DGVPALVRLL RKARDMDLTE VITGTLWNLS
     SHDSIKMEIV DHALHALTDE VIIPHSGWER EPNEDCKPRH IEWESVLTNT AGCLRNVSSE
     RSEARRKLRE CDGLVDALIF IVQAEIGQKD SDSKLVENCV CLLRNLSYQV HREIPQAERY
     QEAAPNVANN TGPHAASCFG AKKGKDEWFS RGKKPIEDPA NDTVDFPKRT SPARGYELLF
     QPEVVRIYIS LLKESKTPAI LEASAGAIQN LCAGRWTYGR YIRSALRQEK ALSAIADLLT
     NEHERVVKAA SGALRNLAVD ARNKELIGKH AIPNLVKNLP GGQQNSSWNF SEDTVISILN
     TINEVIAENL EAAKKLRETQ GIEKLVLINK SGNRSEKEVR AAALVLQTIW GYKELRKPLE
     KEGWKKSDFQ VNLNNASRSQ SSHSYDDSTL PLIDRNQKSD KKPDREEIQM SNMGSNTKSL
     DNNYSTPNER GDHNRTLDRS GDLGDMEPLK GTTPLMQDEG QESLEEELDV LVLDDEGGQV
     SYPSMQKI
//
ID   B7Z1F5_HUMAN            Unreviewed;       420 AA.
AC   B7Z1F5; F5H7Q9;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   25-APR-2018, entry version 64.
DE   SubName: Full=Cytochrome P450 2C8 {ECO:0000313|Ensembl:ENSP00000442343};
DE   SubName: Full=cDNA FLJ59467, highly similar to Cytochrome P450 2C8 (EC 1.14.14.1) {ECO:0000313|EMBL:BAH11491.1};
GN   Name=CYP2C8 {ECO:0000313|Ensembl:ENSP00000442343};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH11491.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000442343, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2] {ECO:0000313|EMBL:BAH11491.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Breast {ECO:0000313|EMBL:BAH11491.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000442343}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [4] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [5] {ECO:0000313|Ensembl:ENSP00000485110}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (OCT-2014) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family.
CC       {ECO:0000256|RuleBase:RU000461}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL359672; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK293327; BAH11491.1; -; mRNA.
DR   RefSeq; NP_001185782.1; NM_001198853.1.
DR   RefSeq; NP_001185783.1; NM_001198854.1.
DR   RefSeq; NP_001185784.1; NM_001198855.1.
DR   UniGene; Hs.709188; -.
DR   PeptideAtlas; B7Z1F5; -.
DR   DNASU; 1558; -.
DR   Ensembl; ENST00000539050; ENSP00000442343; ENSG00000138115.
DR   Ensembl; ENST00000623108; ENSP00000485110; ENSG00000138115.
DR   GeneID; 1558; -.
DR   UCSC; uc010qoa.2; human.
DR   CTD; 1558; -.
DR   EuPathDB; HostDB:ENSG00000138115.13; -.
DR   HGNC; HGNC:2622; CYP2C8.
DR   OpenTargets; ENSG00000138115; -.
DR   eggNOG; KOG0156; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00880000137861; -.
DR   HOVERGEN; HBG015789; -.
DR   ChiTaRS; CYP2C8; human.
DR   GenomeRNAi; 1558; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000138115; -.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro.
DR   Gene3D; 1.10.630.10; -; 1.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   InterPro; IPR036396; Cyt_P450_sf.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Heme {ECO:0000256|RuleBase:RU000461};
KW   Iron {ECO:0000256|RuleBase:RU000461};
KW   Metal-binding {ECO:0000256|RuleBase:RU000461};
KW   Monooxygenase {ECO:0000256|RuleBase:RU000461};
KW   Oxidoreductase {ECO:0000256|RuleBase:RU000461};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:B7Z1F5};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   420 AA;  47786 MW;  E74FEC3C5A3453AF CRC64;
     MNPIVVFHGY EAVKEALIDN GEEFSGRGNS PISQRITKGL GIISSNGKRW KEIRRFSLTT
     LRNFGMGKRS IEDRVQEEAH CLVEELRKTK ASPCDPTFIL GCAPCNVICS VVFQKRFDYK
     DQNFLTLMKR FNENFRILNS PWIQVCNNFP LLIDCFPGTH NKVLKNVALT RSYIREKVKE
     HQASLDVNNP RDFIDCFLIK MEQEKDNQKS EFNIENLVGT VADLFVAGTE TTSTTLRYGL
     LLLLKHPEVT AKVQEEIDHV IGRHRSPCMQ DRSHMPYTDA VVHEIQRYSD LVPTGVPHAV
     TTDTKFRNYL IPKGTTIMAL LTSVLHDDKE FPNPNIFDPG HFLDKNGNFK KSDYFMPFSA
     GKRICAGEGL ARMELFLFLT TILQNFNLKS VDDLKNLNTT AVTKGIVSLP PSYQICFIPV
//
ID   CP2C8_HUMAN             Reviewed;         490 AA.
AC   P10632; A8K9N8; B0AZN2; B7Z1F6; Q5VX93; Q8WWB1; Q9UCZ9;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 2.
DT   28-FEB-2018, entry version 199.
DE   RecName: Full=Cytochrome P450 2C8;
DE            EC=1.14.14.1 {ECO:0000269|PubMed:7574697};
DE   AltName: Full=CYPIIC8;
DE   AltName: Full=Cytochrome P450 IIC2;
DE   AltName: Full=Cytochrome P450 MP-12;
DE   AltName: Full=Cytochrome P450 MP-20;
DE   AltName: Full=Cytochrome P450 form 1;
DE   AltName: Full=S-mephenytoin 4-hydroxylase;
GN   Name=CYP2C8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-264.
RC   TISSUE=Liver;
RX   PubMed=3500169;
RA   Okino S.T., Quattrochi L.C., Pendurthi U.R., McBride O.W., Tukey R.H.;
RT   "Characterization of multiple human cytochrome P-450 1 cDNAs. The
RT   chromosomal localization of the gene and evidence for alternate RNA
RT   splicing.";
RL   J. Biol. Chem. 262:16072-16079(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=3697070; DOI=10.1093/nar/15.23.10053;
RA   Kimura S., Pastewka J., Gelboin H.V., Gonzalez F.J.;
RT   "cDNA and amino acid sequences of two members of the human P450IIC
RT   gene subfamily.";
RL   Nucleic Acids Res. 15:10053-10054(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-264.
RX   PubMed=2009263; DOI=10.1021/bi00227a012;
RA   Romkes M., Faletto M.B., Blaisdell J.A., Raucy J.L., Goldstein J.A.;
RT   "Cloning and expression of complementary DNAs for multiple members of
RT   the human cytochrome P450IIC subfamily.";
RL   Biochemistry 30:3247-3255(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS LYS-139 AND ARG-399.
RC   TISSUE=Liver, and Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LYS-139; VAL-244;
RP   MET-264; PHE-269 AND ARG-399.
RG   NIEHS SNPs program;
RL   Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-56.
RC   TISSUE=Blood;
RX   PubMed=1707679; DOI=10.1016/0167-4781(91)90138-C;
RA   Ged C., Beaune P.;
RT   "Isolation of the human cytochrome P-450 IIC8 gene: multiple
RT   glucocorticoid responsive elements in the 5' region.";
RL   Biochim. Biophys. Acta 1088:433-435(1991).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-15, NUCLEOTIDE SEQUENCE [MRNA] OF 6-490,
RP   FUNCTION, CATALYTIC ACTIVITY, AND VARIANT LEU-411.
RC   TISSUE=Kidney;
RX   PubMed=7574697; DOI=10.1006/abbi.1995.1438;
RA   Zeldin D.C., DuBois R.N., Falck J.R., Capdevila J.H.;
RT   "Molecular cloning, expression and characterization of an endogenous
RT   human cytochrome P450 arachidonic acid epoxygenase isoform.";
RL   Arch. Biochem. Biophys. 322:76-86(1995).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 11-490 (ISOFORM 1), AND VARIANTS
RP   ASP-154; LYS-193; ARG-249 AND LEU-411.
RC   TISSUE=Liver;
RX   PubMed=3196692; DOI=10.1021/bi00418a039;
RA   Ged C., Umbenhauer D.R., Bellew T.M., Bork R.W., Srivastava P.K.,
RA   Shinriki N., Lloyd R.S., Guengerich F.P.;
RT   "Characterization of cDNAs, mRNAs, and proteins related to human liver
RT   microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase.";
RL   Biochemistry 27:6929-6940(1988).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 34-382 (ISOFORM 1), AND VARIANT LYS-139.
RX   PubMed=2729895; DOI=10.1111/j.1469-1809.1989.tb01119.x;
RA   Shephard E.A., Phillips I.R., Santisteban I., Palmer C.N., Povey S.;
RT   "Cloning, expression and chromosomal localization of a member of the
RT   human cytochrome P450IIC gene sub-family.";
RL   Ann. Hum. Genet. 53:23-31(1989).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 281-490 (ISOFORM 1), AND VARIANT
RP   ARG-399.
RX   PubMed=2216732; DOI=10.1093/nar/18.18.5550;
RA   Kolyada A.Y.;
RT   "Sequence of a human liver cytochrome P-450 cDNA clone.";
RL   Nucleic Acids Res. 18:5550-5550(1990).
RN   [14]
RP   POLYMORPHISM.
RX   PubMed=15365880; DOI=10.1007/s10038-004-0188-6;
RA   Ishikawa C., Ozaki H., Nakajima T., Ishii T., Kanai S., Anjo S.,
RA   Shirai K., Inoue I.;
RT   "A frameshift variant of CYP2C8 was identified in a patient who
RT   suffered from rhabdomyolysis after administration of cerivastatin.";
RL   J. Hum. Genet. 49:582-585(2004).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 28-490.
RX   PubMed=14676196; DOI=10.1074/jbc.M312516200;
RA   Schoch G.A., Yano J.K., Wester M.R., Griffin K.J., Stout C.D.,
RA   Johnson E.F.;
RT   "Structure of human microsomal cytochrome P450 2C8. Evidence for a
RT   peripheral fatty acid binding site.";
RL   J. Biol. Chem. 279:9497-9503(2004).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.28 ANGSTROMS) OF 28-490 IN COMPLEX WITH
RP   INHIBITORS, AND SUBSTRATE-BINDING SITES.
RX   PubMed=18413310; DOI=10.1074/jbc.M802180200;
RA   Schoch G.A., Yano J.K., Sansen S., Dansette P.M., Stout C.D.,
RA   Johnson E.F.;
RT   "Determinants of cytochrome P450 2C8 substrate binding: structures of
RT   complexes with montelukast, troglitazone, felodipine, and 9-cis-
RT   retinoic acid.";
RL   J. Biol. Chem. 283:17227-17237(2008).
RN   [18]
RP   VARIANTS LYS-139; PHE-269 AND ARG-399.
RX   PubMed=11668219; DOI=10.1097/00008571-200110000-00006;
RA   Dai D., Zeldin D.C., Blaisdell J.A., Chanas B., Coulter S.J.,
RA   Ghanayem B.I., Goldstein J.A.;
RT   "Polymorphisms in human CYP2C8 decrease metabolism of the anticancer
RT   drug paclitaxel and arachidonic acid.";
RL   Pharmacogenetics 11:597-607(2001).
RN   [19]
RP   VARIANTS LYS-139; MET-264; PHE-269; SER-390 AND ARG-399.
RX   PubMed=12429347; DOI=10.1016/S0006-2952(02)01354-0;
RA   Bahadur N., Leathart J.B., Mutch E., Steimel-Crespi D., Dunn S.A.,
RA   Gilissen R., Houdt J.V., Hendrickx J., Mannens G., Bohets H.,
RA   Williams F.M., Armstrong M., Crespi C.L., Daly A.K.;
RT   "CYP2C8 polymorphisms in Caucasians and their relationship with
RT   paclitaxel 6alpha-hydroxylase activity in human liver microsomes.";
RL   Biochem. Pharmacol. 64:1579-1589(2002).
RN   [20]
RP   VARIANTS LYS-139; MET-264; PHE-269 AND ARG-399.
RX   PubMed=15469410; DOI=10.1517/14622416.5.7.895;
RA   Solus J.F., Arietta B.J., Harris J.R., Sexton D.P., Steward J.Q.,
RA   McMunn C., Ihrie P., Mehall J.M., Edwards T.L., Dawson E.P.;
RT   "Genetic variation in eleven phase I drug metabolism genes in an
RT   ethnically diverse population.";
RL   Pharmacogenomics 5:895-931(2004).
RN   [21]
RP   CHARACTERIZATION OF VARIANTS LYS-139; SER-171; GLY-186; MET-223;
RP   PRO-238; ARG-247; MET-264; PHE-269; ASN-383; ARG-399 AND VAL-461 DEL,
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=26427316; DOI=10.1016/j.dmpk.2015.07.003;
RA   Tsukada C., Saito T., Maekawa M., Mano N., Oda A., Hirasawa N.,
RA   Hiratsuka M.;
RT   "Functional characterization of 12 allelic variants of CYP2C8 by
RT   assessment of paclitaxel 6alpha-hydroxylation and amodiaquine N-
RT   deethylation.";
RL   Drug Metab. Pharmacokinet. 30:366-373(2015).
CC   -!- FUNCTION: Cytochromes P450 are a group of heme-thiolate
CC       monooxygenases. In liver microsomes, this enzyme is involved in an
CC       NADPH-dependent electron transport pathway. It oxidizes a variety
CC       of structurally unrelated compounds, including steroids, fatty
CC       acids, and xenobiotics. In the epoxidation of arachidonic acid it
CC       generates only 14,15- and 11,12-cis-epoxyeicosatrienoic acids. It
CC       is the principal enzyme responsible for the metabolism the anti-
CC       cancer drug paclitaxel (taxol). {ECO:0000269|PubMed:26427316,
CC       ECO:0000269|PubMed:7574697}.
CC   -!- CATALYTIC ACTIVITY: RH + [reduced NADPH--hemoprotein reductase] +
CC       O(2) = ROH + [oxidized NADPH--hemoprotein reductase] + H(2)O.
CC       {ECO:0000269|PubMed:7574697}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=7.18 uM for paclitaxel {ECO:0000269|PubMed:26427316};
CC         KM=1.35 uM for amodiaquine {ECO:0000269|PubMed:26427316};
CC         Vmax=2.18 pmol/min/pmol enzyme with paclitaxel as substrate
CC         {ECO:0000269|PubMed:26427316};
CC         Vmax=11.30 pmol/min/pmol enzyme with amodiaquine as substrate
CC         {ECO:0000269|PubMed:26427316};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral
CC       membrane protein. Microsome membrane; Peripheral membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P10632-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P10632-2; Sequence=VSP_043306, VSP_043307;
CC         Note=No experimental confirmation available.;
CC   -!- INDUCTION: By phenobarbital.
CC   -!- POLYMORPHISM: Several alleles are found in the human population,
CC       contributing to interindividual variations in the therapeutic
CC       efficacy and toxicity of a myriad of drugs such as paclitaxel or
CC       amodiaquine. The allele shown here is CYP2C8*1 (PubMed:26427316).
CC       CYP2C8 genetic variations may be associated with adverse effects
CC       of cerivastatin including acute rhabdomyolysis [MIM:601129].
CC       {ECO:0000269|PubMed:26427316}.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -!- CAUTION: Alternative splicing has been shown to occur but the
CC       shorter forms are believed to be non-functional. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Cytochrome P450 Allele Nomenclature Committee;
CC       Note=CYP2C8 alleles;
CC       URL="http://www.cypalleles.ki.se/cyp2c8.htm";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cyp2c8/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M17397; AAA35739.1; -; mRNA.
DR   EMBL; M17398; AAA35740.1; -; mRNA.
DR   EMBL; Y00498; CAA68550.1; -; mRNA.
DR   EMBL; AK292753; BAF85442.1; -; mRNA.
DR   EMBL; AK293328; BAH11492.1; -; mRNA.
DR   EMBL; AK315823; BAF98714.1; -; mRNA.
DR   EMBL; AY514490; AAR89907.1; -; Genomic_DNA.
DR   EMBL; AL359672; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW50018.1; -; Genomic_DNA.
DR   EMBL; BC020596; AAH20596.1; -; mRNA.
DR   EMBL; X54807; CAA38578.1; -; Genomic_DNA.
DR   EMBL; M21941; AAA52160.1; -; mRNA.
DR   EMBL; M21942; AAA52161.1; -; mRNA.
DR   EMBL; X51535; CAA35915.1; -; mRNA.
DR   CCDS; CCDS55721.1; -. [P10632-2]
DR   CCDS; CCDS7438.1; -. [P10632-1]
DR   PIR; A29782; A29782.
DR   RefSeq; NP_000761.3; NM_000770.3. [P10632-1]
DR   RefSeq; NP_001185782.1; NM_001198853.1.
DR   RefSeq; NP_001185783.1; NM_001198854.1. [P10632-2]
DR   RefSeq; NP_001185784.1; NM_001198855.1.
DR   UniGene; Hs.709188; -.
DR   PDB; 1PQ2; X-ray; 2.70 A; A/B=19-490.
DR   PDB; 2NNH; X-ray; 2.60 A; A/B=28-490.
DR   PDB; 2NNI; X-ray; 2.80 A; A=28-490.
DR   PDB; 2NNJ; X-ray; 2.28 A; A=28-490.
DR   PDB; 2VN0; X-ray; 2.70 A; A=28-490.
DR   PDBsum; 1PQ2; -.
DR   PDBsum; 2NNH; -.
DR   PDBsum; 2NNI; -.
DR   PDBsum; 2NNJ; -.
DR   PDBsum; 2VN0; -.
DR   ProteinModelPortal; P10632; -.
DR   SMR; P10632; -.
DR   BioGrid; 107936; 15.
DR   IntAct; P10632; 10.
DR   STRING; 9606.ENSP00000360317; -.
DR   BindingDB; P10632; -.
DR   ChEMBL; CHEMBL3721; -.
DR   DrugBank; DB05812; Abiraterone.
DR   DrugBank; DB00316; Acetaminophen.
DR   DrugBank; DB00945; Acetylsalicylic acid.
DR   DrugBank; DB00918; Almotriptan.
DR   DrugBank; DB01424; Aminophenazone.
DR   DrugBank; DB01118; Amiodarone.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB00381; Amlodipine.
DR   DrugBank; DB00613; Amodiaquine.
DR   DrugBank; DB00701; Amprenavir.
DR   DrugBank; DB01435; Antipyrine.
DR   DrugBank; DB06605; Apixaban.
DR   DrugBank; DB01076; Atorvastatin.
DR   DrugBank; DB00972; Azelastine.
DR   DrugBank; DB06770; Benzyl alcohol.
DR   DrugBank; DB05229; Beraprost.
DR   DrugBank; DB01393; Bezafibrate.
DR   DrugBank; DB00835; Brompheniramine.
DR   DrugBank; DB00921; Buprenorphine.
DR   DrugBank; DB01156; Bupropion.
DR   DrugBank; DB06772; Cabazitaxel.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB00796; Candesartan.
DR   DrugBank; DB00564; Carbamazepine.
DR   DrugBank; DB00748; Carbinoxamine.
DR   DrugBank; DB00482; Celecoxib.
DR   DrugBank; DB00439; Cerivastatin.
DR   DrugBank; DB00446; Chloramphenicol.
DR   DrugBank; DB00608; Chloroquine.
DR   DrugBank; DB00169; Cholecalciferol.
DR   DrugBank; DB00501; Cimetidine.
DR   DrugBank; DB00604; Cisapride.
DR   DrugBank; DB00758; Clopidogrel.
DR   DrugBank; DB00257; Clotrimazole.
DR   DrugBank; DB00363; Clozapine.
DR   DrugBank; DB00907; Cocaine.
DR   DrugBank; DB01394; Colchicine.
DR   DrugBank; DB05219; Crisaborole.
DR   DrugBank; DB00531; Cyclophosphamide.
DR   DrugBank; DB00091; Cyclosporine.
DR   DrugBank; DB08912; Dabrafenib.
DR   DrugBank; DB00250; Dapsone.
DR   DrugBank; DB09183; Dasabuvir.
DR   DrugBank; DB00705; Delavirdine.
DR   DrugBank; DB01234; Dexamethasone.
DR   DrugBank; DB00514; Dextromethorphan.
DR   DrugBank; DB00647; Dextropropoxyphene.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00586; Diclofenac.
DR   DrugBank; DB00255; Diethylstilbestrol.
DR   DrugBank; DB00343; Diltiazem.
DR   DrugBank; DB01184; Domperidone.
DR   DrugBank; DB00625; Efavirenz.
DR   DrugBank; DB06210; Eltrombopag.
DR   DrugBank; DB08899; Enzalutamide.
DR   DrugBank; DB00530; Erlotinib.
DR   DrugBank; DB00783; Estradiol.
DR   DrugBank; DB00402; Eszopiclone.
DR   DrugBank; DB00977; Ethinyl Estradiol.
DR   DrugBank; DB00773; Etoposide.
DR   DrugBank; DB01023; Felodipine.
DR   DrugBank; DB01039; Fenofibrate.
DR   DrugBank; DB00544; Fluorouracil.
DR   DrugBank; DB01095; Fluvastatin.
DR   DrugBank; DB01320; Fosphenytoin.
DR   DrugBank; DB01241; Gemfibrozil.
DR   DrugBank; DB01218; Halofantrine.
DR   DrugBank; DB00741; Hydrocortisone.
DR   DrugBank; DB01050; Ibuprofen.
DR   DrugBank; DB09054; Idelalisib.
DR   DrugBank; DB01181; Ifosfamide.
DR   DrugBank; DB01029; Irbesartan.
DR   DrugBank; DB00951; Isoniazid.
DR   DrugBank; DB09570; Ixazomib.
DR   DrugBank; DB01221; Ketamine.
DR   DrugBank; DB06738; Ketobemidone.
DR   DrugBank; DB01026; Ketoconazole.
DR   DrugBank; DB01009; Ketoprofen.
DR   DrugBank; DB00448; Lansoprazole.
DR   DrugBank; DB01259; Lapatinib.
DR   DrugBank; DB08918; Levomilnacipran.
DR   DrugBank; DB00451; Levothyroxine.
DR   DrugBank; DB04725; Licofelone.
DR   DrugBank; DB00281; Lidocaine.
DR   DrugBank; DB01583; Liotrix.
DR   DrugBank; DB00836; Loperamide.
DR   DrugBank; DB01601; Lopinavir.
DR   DrugBank; DB00455; Loratadine.
DR   DrugBank; DB00678; Losartan.
DR   DrugBank; DB00227; Lovastatin.
DR   DrugBank; DB09280; Lumacaftor.
DR   DrugBank; DB00603; Medroxyprogesterone acetate.
DR   DrugBank; DB00784; Mefenamic acid.
DR   DrugBank; DB00814; Meloxicam.
DR   DrugBank; DB00532; Mephenytoin.
DR   DrugBank; DB00333; Methadone.
DR   DrugBank; DB00916; Metronidazole.
DR   DrugBank; DB00370; Mirtazapine.
DR   DrugBank; DB00764; Mometasone.
DR   DrugBank; DB00471; Montelukast.
DR   DrugBank; DB00295; Morphine.
DR   DrugBank; DB00688; Mycophenolate mofetil.
DR   DrugBank; DB01183; Naloxone.
DR   DrugBank; DB00788; Naproxen.
DR   DrugBank; DB00622; Nicardipine.
DR   DrugBank; DB00184; Nicotine.
DR   DrugBank; DB01115; Nifedipine.
DR   DrugBank; DB04868; Nilotinib.
DR   DrugBank; DB00665; Nilutamide.
DR   DrugBank; DB06712; Nilvadipine.
DR   DrugBank; DB09080; Olodaterol.
DR   DrugBank; DB09296; Ombitasvir.
DR   DrugBank; DB00338; Omeprazole.
DR   DrugBank; DB01062; Oxybutynin.
DR   DrugBank; DB01229; Paclitaxel.
DR   DrugBank; DB03796; Palmitic Acid.
DR   DrugBank; DB00617; Paramethadione.
DR   DrugBank; DB00715; Paroxetine.
DR   DrugBank; DB06589; Pazopanib.
DR   DrugBank; DB00738; Pentamidine.
DR   DrugBank; DB00850; Perphenazine.
DR   DrugBank; DB00780; Phenelzine.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB00946; Phenprocoumon.
DR   DrugBank; DB00252; Phenytoin.
DR   DrugBank; DB01132; Pioglitazone.
DR   DrugBank; DB00554; Piroxicam.
DR   DrugBank; DB08860; Pitavastatin.
DR   DrugBank; DB08901; Ponatinib.
DR   DrugBank; DB00175; Pravastatin.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB01032; Probenecid.
DR   DrugBank; DB00396; Progesterone.
DR   DrugBank; DB01182; Propafenone.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB09396; Propoxyphene napsylate.
DR   DrugBank; DB00205; Pyrimethamine.
DR   DrugBank; DB04216; Quercetin.
DR   DrugBank; DB00908; Quinidine.
DR   DrugBank; DB00468; Quinine.
DR   DrugBank; DB01129; Rabeprazole.
DR   DrugBank; DB00481; Raloxifene.
DR   DrugBank; DB08896; Regorafenib.
DR   DrugBank; DB00912; Repaglinide.
DR   DrugBank; DB01045; Rifampicin.
DR   DrugBank; DB01201; Rifapentine.
DR   DrugBank; DB08931; Riociguat.
DR   DrugBank; DB00503; Ritonavir.
DR   DrugBank; DB00533; Rofecoxib.
DR   DrugBank; DB00412; Rosiglitazone.
DR   DrugBank; DB01698; Rutin.
DR   DrugBank; DB00938; Salmeterol.
DR   DrugBank; DB01232; Saquinavir.
DR   DrugBank; DB00418; Secobarbital.
DR   DrugBank; DB01037; Selegiline.
DR   DrugBank; DB11362; Selexipag.
DR   DrugBank; DB00641; Simvastatin.
DR   DrugBank; DB01261; Sitagliptin.
DR   DrugBank; DB00398; Sorafenib.
DR   DrugBank; DB00421; Spironolactone.
DR   DrugBank; DB09118; Stiripentol.
DR   DrugBank; DB00359; Sulfadiazine.
DR   DrugBank; DB01015; Sulfamethoxazole.
DR   DrugBank; DB06729; Sulfaphenazole.
DR   DrugBank; DB01138; Sulfinpyrazone.
DR   DrugBank; DB00675; Tamoxifen.
DR   DrugBank; DB00799; Tazarotene.
DR   DrugBank; DB01079; Tegaserod.
DR   DrugBank; DB00231; Temazepam.
DR   DrugBank; DB00857; Terbinafine.
DR   DrugBank; DB00342; Terfenadine.
DR   DrugBank; DB08880; Teriflunomide.
DR   DrugBank; DB00624; Testosterone.
DR   DrugBank; DB00277; Theophylline.
DR   DrugBank; DB00679; Thioridazine.
DR   DrugBank; DB00208; Ticlopidine.
DR   DrugBank; DB01007; Tioconazole.
DR   DrugBank; DB01124; Tolbutamide.
DR   DrugBank; DB00214; Torasemide.
DR   DrugBank; DB08911; Trametinib.
DR   DrugBank; DB00755; Tretinoin.
DR   DrugBank; DB00897; Triazolam.
DR   DrugBank; DB00347; Trimethadione.
DR   DrugBank; DB00440; Trimethoprim.
DR   DrugBank; DB00197; Troglitazone.
DR   DrugBank; DB01361; Troleandomycin.
DR   DrugBank; DB00313; Valproic Acid.
DR   DrugBank; DB00661; Verapamil.
DR   DrugBank; DB08828; Vismodegib.
DR   DrugBank; DB09068; Vortioxetine.
DR   DrugBank; DB00682; Warfarin.
DR   DrugBank; DB00549; Zafirlukast.
DR   DrugBank; DB00495; Zidovudine.
DR   DrugBank; DB01198; Zopiclone.
DR   GuidetoPHARMACOLOGY; 1325; -.
DR   SwissLipids; SLP:000001548; -.
DR   SwissLipids; SLP:000001616; -. [P10632-1]
DR   iPTMnet; P10632; -.
DR   PhosphoSitePlus; P10632; -.
DR   BioMuta; CYP2C8; -.
DR   DMDM; 117225; -.
DR   PaxDb; P10632; -.
DR   PeptideAtlas; P10632; -.
DR   PRIDE; P10632; -.
DR   DNASU; 1558; -.
DR   Ensembl; ENST00000371270; ENSP00000360317; ENSG00000138115. [P10632-1]
DR   Ensembl; ENST00000535898; ENSP00000445062; ENSG00000138115. [P10632-2]
DR   GeneID; 1558; -.
DR   KEGG; hsa:1558; -.
DR   UCSC; uc001kkb.4; human. [P10632-1]
DR   CTD; 1558; -.
DR   DisGeNET; 1558; -.
DR   EuPathDB; HostDB:ENSG00000138115.13; -.
DR   GeneCards; CYP2C8; -.
DR   HGNC; HGNC:2622; CYP2C8.
DR   HPA; HPA013547; -.
DR   HPA; HPA013970; -.
DR   HPA; HPA015066; -.
DR   MalaCards; CYP2C8; -.
DR   MIM; 601129; gene+phenotype.
DR   neXtProt; NX_P10632; -.
DR   OpenTargets; ENSG00000138115; -.
DR   PharmGKB; PA125; -.
DR   eggNOG; KOG0156; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00880000137861; -.
DR   HOGENOM; HOG000036992; -.
DR   HOVERGEN; HBG015789; -.
DR   InParanoid; P10632; -.
DR   KO; K17718; -.
DR   OMA; VIRSITF; -.
DR   OrthoDB; EOG091G0BT8; -.
DR   PhylomeDB; P10632; -.
DR   TreeFam; TF352043; -.
DR   BRENDA; 1.14.14.1; 2681.
DR   Reactome; R-HSA-211981; Xenobiotics.
DR   Reactome; R-HSA-211999; CYP2E1 reactions.
DR   Reactome; R-HSA-2142670; Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET).
DR   Reactome; R-HSA-2142816; Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE).
DR   SABIO-RK; P10632; -.
DR   ChiTaRS; CYP2C8; human.
DR   EvolutionaryTrace; P10632; -.
DR   GeneWiki; CYP2C8; -.
DR   GenomeRNAi; 1558; -.
DR   PRO; PR:P10632; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000138115; -.
DR   CleanEx; HS_CYP2C8; -.
DR   ExpressionAtlas; P10632; baseline and differential.
DR   Genevisible; P10632; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008392; F:arachidonic acid epoxygenase activity; IBA:GO_Central.
DR   GO; GO:0070330; F:aromatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0034875; F:caffeine oxidase activity; IDA:BHF-UCL.
DR   GO; GO:0101020; F:estrogen 16-alpha-hydroxylase activity; IDA:BHF-UCL.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; IDA:BHF-UCL.
DR   GO; GO:0019825; F:oxygen binding; TAS:Reactome.
DR   GO; GO:0017144; P:drug metabolic process; IDA:BHF-UCL.
DR   GO; GO:0019373; P:epoxygenase P450 pathway; IBA:GO_Central.
DR   GO; GO:0042738; P:exogenous drug catabolic process; IDA:BHF-UCL.
DR   GO; GO:0002933; P:lipid hydroxylation; IDA:BHF-UCL.
DR   GO; GO:0097267; P:omega-hydroxylase P450 pathway; TAS:Reactome.
DR   GO; GO:0006082; P:organic acid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL.
DR   GO; GO:0070989; P:oxidative demethylation; IDA:BHF-UCL.
DR   GO; GO:0008202; P:steroid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   Gene3D; 1.10.630.10; -; 1.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   InterPro; IPR036396; Cyt_P450_sf.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Endoplasmic reticulum; Heme; Iron;
KW   Membrane; Metal-binding; Microsome; Monooxygenase; Oxidoreductase;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    490       Cytochrome P450 2C8.
FT                                /FTId=PRO_0000051699.
FT   METAL       435    435       Iron (heme axial ligand).
FT   BINDING     100    100       Substrate.
FT   BINDING     204    204       Substrate.
FT   BINDING     241    241       Substrate.
FT   MOD_RES     100    100       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1      8       MEPFVVLV -> MFLQPIAK (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043306.
FT   VAR_SEQ       9    110       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043307.
FT   VARIANT     139    139       R -> K (in allele CYP2C8*3; reduces
FT                                enzymatic activity with paclitaxel as
FT                                substrate; decreases intrinsic clearance
FT                                of paclitaxel; reduces enzymatic activity
FT                                with amodiaquine as substrate;
FT                                dbSNP:rs11572080).
FT                                {ECO:0000269|PubMed:11668219,
FT                                ECO:0000269|PubMed:12429347,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:26427316,
FT                                ECO:0000269|PubMed:2729895,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_012238.
FT   VARIANT     154    154       E -> D. {ECO:0000269|PubMed:3196692}.
FT                                /FTId=VAR_001250.
FT   VARIANT     171    171       G -> S (in allele CYP2C8*6; no effect on
FT                                affinity or enzymatic activity with
FT                                paclitaxel as substrate; decreases
FT                                affinity for amodiaquine; reduces
FT                                enzymatic activity with amodiaquine as
FT                                substrate; decreases intrinsic clearance
FT                                of amodiaquine; dbSNP:rs142886225).
FT                                {ECO:0000269|PubMed:26427316}.
FT                                /FTId=VAR_075541.
FT   VARIANT     186    186       R -> G (in allele CYP2C8*8; increases
FT                                affinity for paclitaxel; reduces
FT                                enzymatic activity with paclitaxel as
FT                                substrate; decreases intrinsic clearance
FT                                of paclitaxel; reduces enzymatic activity
FT                                with amodiaquine as substrate; decreases
FT                                intrinsic clearance of amodiaquine;
FT                                dbSNP:rs72558195).
FT                                {ECO:0000269|PubMed:26427316}.
FT                                /FTId=VAR_075542.
FT   VARIANT     193    193       N -> K. {ECO:0000269|PubMed:3196692}.
FT                                /FTId=VAR_001251.
FT   VARIANT     223    223       I -> M (in allele CYP2C8*13; reduces
FT                                enzymatic activity with paclitaxel as
FT                                substrate; decreases intrinsic clearance
FT                                of paclitaxel; reduces enzymatic activity
FT                                with amodiaquine as substrate; decreases
FT                                intrinsic clearance of amodiaquine).
FT                                {ECO:0000269|PubMed:26427316}.
FT                                /FTId=VAR_075543.
FT   VARIANT     238    238       A -> P (in allele CYP2C8*14; reduces
FT                                enzymatic activity with paclitaxel as
FT                                substrate; decreases intrinsic clearance
FT                                of paclitaxel; dbSNP:rs188934928).
FT                                {ECO:0000269|PubMed:26427316}.
FT                                /FTId=VAR_075544.
FT   VARIANT     244    244       I -> V (in dbSNP:rs11572102).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_018958.
FT   VARIANT     247    247       K -> R (in allele CYP2C8*9; increases
FT                                enzymatic activity with paclitaxel as
FT                                substrate; reduces enzymatic activity
FT                                with amodiaquine as substrate; decreases
FT                                intrinsic clearance of amodiaquine;
FT                                dbSNP:rs769460274).
FT                                {ECO:0000269|PubMed:26427316}.
FT                                /FTId=VAR_075545.
FT   VARIANT     249    249       K -> R. {ECO:0000269|PubMed:3196692}.
FT                                /FTId=VAR_001252.
FT   VARIANT     264    264       I -> M (in allele CYP2C8*4; reduces
FT                                enzymatic activity with paclitaxel as
FT                                substrate; decreases affinity for
FT                                amodiaquine; dbSNP:rs1058930).
FT                                {ECO:0000269|PubMed:12429347,
FT                                ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:2009263,
FT                                ECO:0000269|PubMed:26427316,
FT                                ECO:0000269|PubMed:3500169,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_011754.
FT   VARIANT     269    269       I -> F (in allele CYP2C8*2; only found in
FT                                African-Americans; increases intrinsic
FT                                clearance of paclitaxel; decreases
FT                                affinity for amodiaquine; increases
FT                                enzymatic activity with amodiaquine as
FT                                substrate; dbSNP:rs11572103).
FT                                {ECO:0000269|PubMed:11668219,
FT                                ECO:0000269|PubMed:12429347,
FT                                ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:26427316,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_012239.
FT   VARIANT     383    383       K -> N (in allele CYP2C8*10; reduces
FT                                enzymatic activity with paclitaxel as
FT                                substrate; reduces enzymatic activity
FT                                with amodiaquine as substrate; decreases
FT                                intrinsic clearance of amodiaquine).
FT                                {ECO:0000269|PubMed:26427316}.
FT                                /FTId=VAR_075546.
FT   VARIANT     390    390       L -> S (in dbSNP:rs72558194).
FT                                {ECO:0000269|PubMed:12429347}.
FT                                /FTId=VAR_016947.
FT   VARIANT     399    399       K -> R (in allele CYP2C8*3; reduces
FT                                enzymatic activity with paclitaxel as
FT                                substrate; decreases intrinsic clearance
FT                                of paclitaxel; reduces enzymatic activity
FT                                with amodiaquine as substrate;
FT                                dbSNP:rs10509681).
FT                                {ECO:0000269|PubMed:11668219,
FT                                ECO:0000269|PubMed:12429347,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:2216732,
FT                                ECO:0000269|PubMed:26427316,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_012240.
FT   VARIANT     411    411       H -> L. {ECO:0000269|PubMed:3196692,
FT                                ECO:0000269|PubMed:7574697}.
FT                                /FTId=VAR_001253.
FT   VARIANT     461    461       Missing (in allele CYP2C8*12; increases
FT                                enzymatic activity with paclitaxel as
FT                                substrate; reduces enzymatic activity
FT                                with amodiaquine as substrate; decreases
FT                                intrinsic clearance of amodiaquine).
FT                                {ECO:0000269|PubMed:26427316}.
FT                                /FTId=VAR_075547.
FT   CONFLICT     54     54       F -> L (in Ref. 12; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT     67     67       V -> L (in Ref. 12; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT     76     76       V -> C (in Ref. 12; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT     82     82       A -> S (in Ref. 8; AAH20596).
FT                                {ECO:0000305}.
FT   CONFLICT    130    130       T -> N (in Ref. 1; AAA35739/AAA35740 and
FT                                3; no nucleotide entry). {ECO:0000305}.
FT   CONFLICT    209    209       N -> S (in Ref. 12; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    384    393       GTTIMALLTS -> SFDNKIMLAA (in Ref. 1;
FT                                AAA35740). {ECO:0000305}.
FT   CONFLICT    386    386       T -> A (in Ref. 4; BAF85442).
FT                                {ECO:0000305}.
FT   TURN         37     39       {ECO:0000244|PDB:2NNJ}.
FT   HELIX        42     44       {ECO:0000244|PDB:2NNJ}.
FT   STRAND       47     49       {ECO:0000244|PDB:1PQ2}.
FT   HELIX        50     61       {ECO:0000244|PDB:2NNJ}.
FT   STRAND       63     69       {ECO:0000244|PDB:2NNJ}.
FT   STRAND       72     77       {ECO:0000244|PDB:2NNJ}.
FT   HELIX        80     87       {ECO:0000244|PDB:2NNJ}.
FT   TURN         88     94       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       101    107       {ECO:0000244|PDB:2NNJ}.
FT   TURN        111    113       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       117    130       {ECO:0000244|PDB:2NNJ}.
FT   TURN        133    136       {ECO:0000244|PDB:2NNJ}.
FT   STRAND      137    139       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       141    157       {ECO:0000244|PDB:2NNJ}.
FT   TURN        158    161       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       167    182       {ECO:0000244|PDB:2NNJ}.
FT   STRAND      183    185       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       192    208       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       212    218       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       220    225       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       227    252       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       263    273       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       284    298       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       300    315       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       317    330       {ECO:0000244|PDB:2NNJ}.
FT   STRAND      333    335       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       339    344       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       346    359       {ECO:0000244|PDB:2NNJ}.
FT   STRAND      374    376       {ECO:0000244|PDB:2NNJ}.
FT   STRAND      379    381       {ECO:0000244|PDB:2NNJ}.
FT   STRAND      386    389       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       391    395       {ECO:0000244|PDB:2NNJ}.
FT   TURN        398    400       {ECO:0000244|PDB:2NNJ}.
FT   STRAND      401    403       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       409    412       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       431    433       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       438    455       {ECO:0000244|PDB:2NNJ}.
FT   STRAND      456    459       {ECO:0000244|PDB:2NNJ}.
FT   HELIX       464    466       {ECO:0000244|PDB:2NNJ}.
FT   STRAND      472    479       {ECO:0000244|PDB:2NNJ}.
FT   STRAND      485    489       {ECO:0000244|PDB:2NNJ}.
SQ   SEQUENCE   490 AA;  55825 MW;  E920EB2084F477E1 CRC64;
     MEPFVVLVLC LSFMLLFSLW RQSCRRRKLP PGPTPLPIIG NMLQIDVKDI CKSFTNFSKV
     YGPVFTVYFG MNPIVVFHGY EAVKEALIDN GEEFSGRGNS PISQRITKGL GIISSNGKRW
     KEIRRFSLTT LRNFGMGKRS IEDRVQEEAH CLVEELRKTK ASPCDPTFIL GCAPCNVICS
     VVFQKRFDYK DQNFLTLMKR FNENFRILNS PWIQVCNNFP LLIDCFPGTH NKVLKNVALT
     RSYIREKVKE HQASLDVNNP RDFIDCFLIK MEQEKDNQKS EFNIENLVGT VADLFVAGTE
     TTSTTLRYGL LLLLKHPEVT AKVQEEIDHV IGRHRSPCMQ DRSHMPYTDA VVHEIQRYSD
     LVPTGVPHAV TTDTKFRNYL IPKGTTIMAL LTSVLHDDKE FPNPNIFDPG HFLDKNGNFK
     KSDYFMPFSA GKRICAGEGL ARMELFLFLT TILQNFNLKS VDDLKNLNTT AVTKGIVSLP
     PSYQICFIPV
//
ID   DC122_HUMAN             Reviewed;         463 AA.
AC   Q5VW00; B2RN42;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 1.
DT   22-NOV-2017, entry version 121.
DE   RecName: Full=DDB1- and CUL4-associated factor 12-like protein 2;
DE   AltName: Full=WD repeat-containing protein 40C;
GN   Name=DCAF12L2; Synonyms=WDR40C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- SIMILARITY: Belongs to the WD repeat DCAF12 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL445072; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471107; EAX11842.1; -; Genomic_DNA.
DR   EMBL; BC136673; AAI36674.1; -; mRNA.
DR   EMBL; BC136674; AAI36675.1; -; mRNA.
DR   CCDS; CCDS43991.1; -.
DR   RefSeq; NP_001013650.1; NM_001013628.2.
DR   UniGene; Hs.181867; -.
DR   ProteinModelPortal; Q5VW00; -.
DR   BioGrid; 131079; 11.
DR   IntAct; Q5VW00; 1.
DR   STRING; 9606.ENSP00000353128; -.
DR   iPTMnet; Q5VW00; -.
DR   PhosphoSitePlus; Q5VW00; -.
DR   BioMuta; DCAF12L2; -.
DR   DMDM; 74756914; -.
DR   MaxQB; Q5VW00; -.
DR   PaxDb; Q5VW00; -.
DR   PeptideAtlas; Q5VW00; -.
DR   PRIDE; Q5VW00; -.
DR   Ensembl; ENST00000360028; ENSP00000353128; ENSG00000198354.
DR   GeneID; 340578; -.
DR   KEGG; hsa:340578; -.
DR   UCSC; uc004euk.3; human.
DR   CTD; 340578; -.
DR   EuPathDB; HostDB:ENSG00000198354.5; -.
DR   GeneCards; DCAF12L2; -.
DR   HGNC; HGNC:32950; DCAF12L2.
DR   HPA; HPA044737; -.
DR   HPA; HPA048981; -.
DR   HPA; HPA053138; -.
DR   neXtProt; NX_Q5VW00; -.
DR   OpenTargets; ENSG00000198354; -.
DR   PharmGKB; PA165756531; -.
DR   eggNOG; ENOG410IGRG; Eukaryota.
DR   eggNOG; ENOG410XTH6; LUCA.
DR   GeneTree; ENSGT00390000001132; -.
DR   HOGENOM; HOG000047356; -.
DR   HOVERGEN; HBG055605; -.
DR   InParanoid; Q5VW00; -.
DR   OMA; IGEFPNA; -.
DR   OrthoDB; EOG091G05P2; -.
DR   PhylomeDB; Q5VW00; -.
DR   TreeFam; TF323731; -.
DR   SignaLink; Q5VW00; -.
DR   GenomeRNAi; 340578; -.
DR   PRO; PR:Q5VW00; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000198354; -.
DR   CleanEx; HS_WDR40C; -.
DR   Gene3D; 2.130.10.10; -; 2.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   Pfam; PF00400; WD40; 1.
DR   SMART; SM00320; WD40; 4.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 1.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Polymorphism; Reference proteome; Repeat;
KW   WD repeat.
FT   CHAIN         1    463       DDB1- and CUL4-associated factor 12-like
FT                                protein 2.
FT                                /FTId=PRO_0000306850.
FT   REPEAT       89    137       WD 1.
FT   REPEAT      138    184       WD 2.
FT   REPEAT      185    252       WD 3.
FT   REPEAT      253    297       WD 4.
FT   REPEAT      298    341       WD 5.
FT   REPEAT      342    401       WD 6.
FT   REPEAT      402    445       WD 7.
FT   VARIANT     147    147       H -> Q (in dbSNP:rs10126452).
FT                                /FTId=VAR_062104.
SQ   SEQUENCE   463 AA;  50803 MW;  94B41809F2243CD7 CRC64;
     MAQQQTGSRK RKAPAVEAGA GSSSSQGLAA ADGEGPLLPK KQKRPATRRR LVHYLKGREV
     GARGPAGLQG FEGELRGYAV QRLPELLTER QLDLGTLNKV FASQWLNARQ VVCGTKCNTL
     FVVDVQSGHI TRIPLMRDKE AGLAQAHQGC GIHAIELNPS KTLLATGGEN PNSLAIYQLP
     TLDPLCLGDR HGHKDWIFAV AWLSDTVAVS GSRDGTVALW RMDPDMFNGS IAWHSEVGLP
     VYAHIRPRDV EAIPRASTNP SNRKVRALAF SGKNQELGAV SLDGYFHLWK ARSTLSRLLS
     IRLPYCRENV CLTYCDELSL YAVGSQSHVS FLDPRQRQQN IRPLCSREGG TGVRSLSFYQ
     HIITVGTGHG SLLFYDIRAQ KFLEERASSS LDSMPGPAGR KLKLACGRGW LNQDDVWVNY
     FGGMGEFPNA LYTHCYNWPE MKLFVAGGPL PSGLHGNYAG LWS
//
ID   DCC_HUMAN               Reviewed;        1447 AA.
AC   P43146;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   28-FEB-2018, entry version 179.
DE   RecName: Full=Netrin receptor DCC;
DE   AltName: Full=Colorectal cancer suppressor;
DE   AltName: Full=Immunoglobulin superfamily DCC subclass member 1;
DE   AltName: Full=Tumor suppressor protein DCC;
DE   Flags: Precursor;
GN   Name=DCC; Synonyms=IGDCC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT LEU-23.
RX   PubMed=7926722; DOI=10.1101/gad.8.10.1174;
RA   Hedrick L., Cho K.R., Fearon E.R., Wu T.-C., Kinzler K.W.,
RA   Vogelstein B.;
RT   "The DCC gene product in cellular differentiation and colorectal
RT   tumorigenesis.";
RL   Genes Dev. 8:1174-1183(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 1-750, AND VARIANT LEU-23.
RX   PubMed=2294591; DOI=10.1126/science.2294591;
RA   Fearon E.R., Cho K.R., Nigro J.M., Kern S.E., Simons J.W.,
RA   Ruppert J.M., Hamilton S.R., Preisinger A.C., Thomas G., Kinzler K.W.,
RA   Vogelstein B.;
RT   "Identification of a chromosome 18q gene that is altered in colorectal
RT   cancers.";
RL   Science 247:49-56(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 107-472.
RX   PubMed=1991322; DOI=10.1016/0092-8674(91)90244-S;
RA   Nigro J.M., Cho K.R., Fearon E.R., Kern S.E., Ruppert J.M.,
RA   Oliner J.D., Kinzler K.W., Vogelstein B.;
RT   "Scrambled exons.";
RL   Cell 64:607-613(1991).
RN   [5]
RP   GENE STRUCTURE, AND VARIANT HIS-1375.
RX   PubMed=8188295; DOI=10.1006/geno.1994.1102;
RA   Cho K.R., Oliner J.D., Simons J.W., Hedrick L., Fearon E.R.,
RA   Preisinger A.C., Hedge P., Silverman G.A., Vogelstein B.;
RT   "The DCC gene: structural analysis and mutations in colorectal
RT   carcinomas.";
RL   Genomics 19:525-531(1994).
RN   [6]
RP   FUNCTION.
RX   PubMed=8861902; DOI=10.1016/S0092-8674(00)81336-7;
RA   Keino-Masu K., Masu M., Hinck L., Leonardo E.D., Chan S.S.-Y.,
RA   Culotti J.G., Tessier-Lavigne M.;
RT   "Deleted in colorectal cancer (DCC) encodes a netrin receptor.";
RL   Cell 87:175-185(1996).
RN   [7]
RP   INTERACTION WITH SIAH1 AND SIAH2, AND DEGRADATION.
RX   PubMed=9334332; DOI=10.1101/gad.11.20.2701;
RA   Hu G., Zhang S., Vidal M., Baer J.L., Xu T., Fearon E.R.;
RT   "Mammalian homologs of seven in absentia regulate DCC via the
RT   ubiquitin-proteasome pathway.";
RL   Genes Dev. 11:2701-2714(1997).
RN   [8]
RP   INVOLVEMENT IN MRMV1.
RX   PubMed=20431009; DOI=10.1126/science.1186463;
RA   Srour M., Riviere J.B., Pham J.M., Dube M.P., Girard S., Morin S.,
RA   Dion P.A., Asselin G., Rochefort D., Hince P., Diab S.,
RA   Sharafaddinzadeh N., Chouinard S., Theoret H., Charron F.,
RA   Rouleau G.A.;
RT   "Mutations in DCC cause congenital mirror movements.";
RL   Science 328:592-592(2010).
RN   [9]
RP   INVOLVEMENT IN MRMV1, AND VARIANTS MRMV1 275-ARG--PHE-1447 DEL;
RP   PRO-597; LEU-743; MET-754; GLY-793; GLU-805; THR-893; VAL-1217 AND
RP   THR-1250.
RX   PubMed=28250454; DOI=10.1038/ng.3794;
RA   Marsh A.P., Heron D., Edwards T.J., Quartier A., Galea C., Nava C.,
RA   Rastetter A., Moutard M.L., Anderson V., Bitoun P., Bunt J.,
RA   Faudet A., Garel C., Gillies G., Gobius I., Guegan J., Heide S.,
RA   Keren B., Lesne F., Lukic V., Mandelstam S.A., McGillivray G.,
RA   McIlroy A., Meneret A., Mignot C., Morcom L.R., Odent S., Paolino A.,
RA   Pope K., Riant F., Robinson G.A., Spencer-Smith M., Srour M.,
RA   Stephenson S.E., Tankard R., Trouillard O., Welniarz Q., Wood A.,
RA   Brice A., Rouleau G., Attie-Bitach T., Delatycki M.B., Mandel J.L.,
RA   Amor D.J., Roze E., Piton A., Bahlo M., Billette de Villemeur T.,
RA   Sherr E.H., Leventer R.J., Richards L.J., Lockhart P.J., Depienne C.;
RT   "Mutations in DCC cause isolated agenesis of the corpus callosum with
RT   incomplete penetrance.";
RL   Nat. Genet. 49:511-514(2017).
RN   [10]
RP   STRUCTURE BY NMR OF 419-1047.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the fibronectin type III domains of human
RT   netrin receptor DCC.";
RL   Submitted (MAR-2008) to the PDB data bank.
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 1390-1447 IN COMPLEX WITH
RP   MYO10, INTERACTION WITH MYO10, AND MUTAGENESIS OF LEU-1432;
RP   1435-LEU-MET-1436 AND LEU-1439.
RX   PubMed=21642953; DOI=10.1038/emboj.2011.177;
RA   Hirano Y., Hatano T., Takahashi A., Toriyama M., Inagaki N.,
RA   Hakoshima T.;
RT   "Structural basis of cargo recognition by the myosin-X MyTH4-FERM
RT   domain.";
RL   EMBO J. 30:2734-2747(2011).
RN   [12]
RP   VARIANTS THR-168 AND GLY-201, AND ROLE IN METASTATIC TUMOR
RP   DISSEMINATION.
RX   PubMed=8187090;
RA   Miyake S., Nagai K., Yoshino K., Oto M., Endo M., Yuasa Y.;
RT   "Point mutations and allelic deletion of tumor suppressor gene DCC in
RT   human esophageal squamous cell carcinomas and their relation to
RT   metastasis.";
RL   Cancer Res. 54:3007-3010(1994).
RN   [13]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-1039.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [14]
RP   VARIANT HGPPS2 LYS-691, AND INVOLVEMENT IN HGPPS2.
RX   PubMed=28250456; DOI=10.1038/ng.3804;
RA   Jamuar S.S., Schmitz-Abe K., D'Gama A.M., Drottar M., Chan W.M.,
RA   Peeva M., Servattalab S., Lam A.N., Delgado M.R., Clegg N.J.,
RA   Zayed Z.A., Dogar M.A., Alorainy I.A., Jamea A.A., Abu-Amero K.,
RA   Griebel M., Ward W., Lein E.S., Markianos K., Barkovich A.J.,
RA   Robson C.D., Grant P.E., Bosley T.M., Engle E.C., Walsh C.A., Yu T.W.;
RT   "Biallelic mutations in human DCC cause developmental split-brain
RT   syndrome.";
RL   Nat. Genet. 49:606-612(2017).
CC   -!- FUNCTION: Receptor for netrin required for axon guidance. Mediates
CC       axon attraction of neuronal growth cones in the developing nervous
CC       system upon ligand binding. Its association with UNC5 proteins may
CC       trigger signaling for axon repulsion. It also acts as a dependence
CC       receptor required for apoptosis induction when not associated with
CC       netrin ligand. Implicated as a tumor suppressor gene.
CC       {ECO:0000269|PubMed:8187090, ECO:0000269|PubMed:8861902}.
CC   -!- SUBUNIT: Interacts with the cytoplasmic part of UNC5A, UNC5B,
CC       UNC5C and probably UNC5D. Interacts with DSCAM. Interacts with
CC       PTK2/FAK1 and MAPK1. Interacts with NTN1 (By similarity).
CC       Interacts with MYO10. Interacts with CBLN4; this interaction can
CC       be competed by NTN1 (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P55211:CASP9; NbExp=2; IntAct=EBI-1222919, EBI-516799;
CC       P56270:MAZ; NbExp=4; IntAct=EBI-1222919, EBI-1809742;
CC       Q9HD67:MYO10; NbExp=7; IntAct=EBI-1222919, EBI-307061;
CC       O95631:NTN1; NbExp=4; IntAct=EBI-1222919, EBI-2678626;
CC       P46779:RPL28; NbExp=3; IntAct=EBI-1222919, EBI-366357;
CC       P46777:RPL5; NbExp=7; IntAct=EBI-1222919, EBI-358018;
CC       P62266:RPS23; NbExp=2; IntAct=EBI-1222919, EBI-353072;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Found in axons of the central and peripheral
CC       nervous system and in differentiated cell types of the intestine.
CC       Not expressed in colorectal tumor cells that lost their capacity
CC       to differentiate into mucus producing cells.
CC       {ECO:0000269|PubMed:7926722}.
CC   -!- PTM: Ubiquitinated; mediated by SIAH1 or SIAH2 and leading to its
CC       subsequent proteasomal degradation. {ECO:0000305}.
CC   -!- DISEASE: Mirror movements 1 (MRMV1) [MIM:157600]: A disorder
CC       characterized by contralateral involuntary movements that mirror
CC       voluntary ones. While mirror movements are occasionally found in
CC       young children, persistence beyond the age of 10 is abnormal.
CC       Mirror movements occur more commonly in the upper extremities.
CC       Some MRMV1 patients have agenesis of the corpus callosum.
CC       {ECO:0000269|PubMed:20431009, ECO:0000269|PubMed:28250454}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Gaze palsy, familial horizontal, with progressive
CC       scoliosis, 2 (HGPPS2) [MIM:617542]: An autosomal recessive
CC       neurologic disorder characterized by global developmental delay,
CC       delayed walking, intellectual disability, horizontal gaze palsy,
CC       and childhood-onset progressive scoliosis.
CC       {ECO:0000269|PubMed:28250456}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Inactivation of DCC due to allelic deletion and/or
CC       point mutations is related to lymphatic and hematogenous
CC       metastatic tumor dissemination.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. DCC family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA52175.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=AAA52177.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAA52179.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAA52180.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/DCCID331ch18q21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X76132; CAA53735.1; -; mRNA.
DR   EMBL; AC011155; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016383; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC019239; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC021486; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC027248; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC078999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090660; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC100777; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC103949; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC110591; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC116002; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M32292; AAA35751.1; -; mRNA.
DR   EMBL; M32286; AAA52174.1; -; Genomic_DNA.
DR   EMBL; M32288; AAA52175.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; M32290; AAA52176.1; -; Genomic_DNA.
DR   EMBL; M63696; AAA52177.1; ALT_INIT; Genomic_DNA.
DR   EMBL; M63700; AAA52178.1; -; Genomic_DNA.
DR   EMBL; M63702; AAA52179.1; ALT_INIT; Genomic_DNA.
DR   EMBL; M63718; AAA52180.1; ALT_INIT; Genomic_DNA.
DR   EMBL; M63698; AAA52181.1; -; Genomic_DNA.
DR   CCDS; CCDS11952.1; -.
DR   PIR; A54100; A54100.
DR   RefSeq; NP_005206.2; NM_005215.3.
DR   UniGene; Hs.162025; -.
DR   PDB; 2ED7; NMR; -; A=419-524.
DR   PDB; 2ED8; NMR; -; A=528-620.
DR   PDB; 2ED9; NMR; -; A=602-718.
DR   PDB; 2EDB; NMR; -; A=716-818.
DR   PDB; 2EDD; NMR; -; A=833-942.
DR   PDB; 2EDE; NMR; -; A=944-1044.
DR   PDB; 3AU4; X-ray; 1.90 A; B=1390-1447.
DR   PDB; 4URT; X-ray; 3.10 A; B=844-1043.
DR   PDB; 5X83; X-ray; 3.00 A; A/C=721-815, B/D=844-1043.
DR   PDBsum; 2ED7; -.
DR   PDBsum; 2ED8; -.
DR   PDBsum; 2ED9; -.
DR   PDBsum; 2EDB; -.
DR   PDBsum; 2EDD; -.
DR   PDBsum; 2EDE; -.
DR   PDBsum; 3AU4; -.
DR   PDBsum; 4URT; -.
DR   PDBsum; 5X83; -.
DR   ProteinModelPortal; P43146; -.
DR   SMR; P43146; -.
DR   BioGrid; 107998; 39.
DR   DIP; DIP-38423N; -.
DR   ELM; P43146; -.
DR   IntAct; P43146; 44.
DR   MINT; P43146; -.
DR   STRING; 9606.ENSP00000389140; -.
DR   iPTMnet; P43146; -.
DR   PhosphoSitePlus; P43146; -.
DR   SwissPalm; P43146; -.
DR   BioMuta; DCC; -.
DR   DMDM; 296434474; -.
DR   MaxQB; P43146; -.
DR   PaxDb; P43146; -.
DR   PeptideAtlas; P43146; -.
DR   PRIDE; P43146; -.
DR   DNASU; 1630; -.
DR   Ensembl; ENST00000442544; ENSP00000389140; ENSG00000187323.
DR   GeneID; 1630; -.
DR   KEGG; hsa:1630; -.
DR   UCSC; uc002lfe.3; human.
DR   CTD; 1630; -.
DR   DisGeNET; 1630; -.
DR   EuPathDB; HostDB:ENSG00000187323.11; -.
DR   GeneCards; DCC; -.
DR   H-InvDB; HIX0039754; -.
DR   HGNC; HGNC:2701; DCC.
DR   HPA; HPA055376; -.
DR   HPA; HPA069552; -.
DR   MalaCards; DCC; -.
DR   MIM; 120470; gene.
DR   MIM; 157600; phenotype.
DR   MIM; 617542; phenotype.
DR   neXtProt; NX_P43146; -.
DR   OpenTargets; ENSG00000187323; -.
DR   Orphanet; 238722; Familial congenital mirror movements.
DR   PharmGKB; PA27170; -.
DR   eggNOG; KOG4221; Eukaryota.
DR   eggNOG; ENOG410Z913; LUCA.
DR   GeneTree; ENSGT00910000144009; -.
DR   HOGENOM; HOG000230686; -.
DR   HOVERGEN; HBG005455; -.
DR   InParanoid; P43146; -.
DR   KO; K06765; -.
DR   OMA; WGPGESS; -.
DR   OrthoDB; EOG091G098C; -.
DR   PhylomeDB; P43146; -.
DR   TreeFam; TF321506; -.
DR   Reactome; R-HSA-373752; Netrin-1 signaling.
DR   Reactome; R-HSA-376172; DSCAM interactions.
DR   Reactome; R-HSA-418885; DCC mediated attractive signaling.
DR   Reactome; R-HSA-418886; Netrin mediated repulsion signals.
DR   Reactome; R-HSA-418889; Ligand-independent caspase activation via DCC.
DR   Reactome; R-HSA-418890; Role of second messengers in netrin-1 signaling.
DR   Reactome; R-HSA-428542; Regulation of commissural axon pathfinding by SLIT and ROBO.
DR   SIGNOR; P43146; -.
DR   ChiTaRS; DCC; human.
DR   EvolutionaryTrace; P43146; -.
DR   GeneWiki; Deleted_in_Colorectal_Cancer; -.
DR   GenomeRNAi; 1630; -.
DR   PRO; PR:P43146; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000187323; -.
DR   CleanEx; HS_DCC; -.
DR   ExpressionAtlas; P43146; baseline and differential.
DR   Genevisible; P43146; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005042; F:netrin receptor activity; IEA:InterPro.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc.
DR   GO; GO:0033564; P:anterior/posterior axon guidance; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; TAS:ProtInc.
DR   GO; GO:0007411; P:axon guidance; TAS:Reactome.
DR   GO; GO:0007409; P:axonogenesis; TAS:ProtInc.
DR   GO; GO:0033563; P:dorsal/ventral axon guidance; IEA:Ensembl.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; TAS:Reactome.
DR   GO; GO:0048671; P:negative regulation of collateral sprouting; TAS:BHF-UCL.
DR   GO; GO:2000171; P:negative regulation of dendrite development; TAS:BHF-UCL.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; TAS:BHF-UCL.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:1901214; P:regulation of neuron death; IMP:UniProtKB.
DR   GO; GO:0021965; P:spinal cord ventral commissure morphogenesis; IEA:Ensembl.
DR   CDD; cd00063; FN3; 6.
DR   Gene3D; 2.60.40.10; -; 10.
DR   InterPro; IPR033012; DCC.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR010560; Neogenin_C.
DR   PANTHER; PTHR44146:SF3; PTHR44146:SF3; 1.
DR   Pfam; PF00041; fn3; 6.
DR   Pfam; PF07679; I-set; 3.
DR   Pfam; PF06583; Neogenin_C; 1.
DR   SMART; SM00060; FN3; 6.
DR   SMART; SM00409; IG; 5.
DR   SMART; SM00408; IGc2; 4.
DR   SUPFAM; SSF48726; SSF48726; 4.
DR   SUPFAM; SSF49265; SSF49265; 4.
DR   PROSITE; PS50853; FN3; 6.
DR   PROSITE; PS50835; IG_LIKE; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; Complete proteome; Developmental protein;
KW   Disease mutation; Disulfide bond; Glycoprotein; Immunoglobulin domain;
KW   Membrane; Mental retardation; Phosphoprotein; Polymorphism; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix; Tumor suppressor; Ubl conjugation.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26   1447       Netrin receptor DCC.
FT                                /FTId=PRO_0000014744.
FT   TOPO_DOM     26   1097       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1098   1122       Helical. {ECO:0000255}.
FT   TOPO_DOM   1123   1447       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       26    135       Ig-like C2-type 1.
FT   DOMAIN      139    229       Ig-like C2-type 2.
FT   DOMAIN      234    326       Ig-like C2-type 3.
FT   DOMAIN      331    416       Ig-like C2-type 4.
FT   DOMAIN      431    524       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      530    620       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      625    718       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      728    821       Fibronectin type-III 4.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      846    942       Fibronectin type-III 5.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      947   1044       Fibronectin type-III 6.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   REGION     1432   1439       Interaction with MYO10.
FT                                {ECO:0000269|PubMed:21642953}.
FT   MOD_RES    1178   1178       Phosphoserine; by MAPK1.
FT                                {ECO:0000250|UniProtKB:Q63155}.
FT   MOD_RES    1187   1187       Phosphothreonine; by MAPK1.
FT                                {ECO:0000250|UniProtKB:Q63155}.
FT   MOD_RES    1267   1267       Phosphoserine; by MAPK1.
FT                                {ECO:0000250|UniProtKB:Q63155}.
FT   CARBOHYD     94     94       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    299    299       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    318    318       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    478    478       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    628    628       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    702    702       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     61    117       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    161    212       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    261    310       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    352    400       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VARIANT      23     23       F -> L (in dbSNP:rs9951523).
FT                                {ECO:0000269|PubMed:2294591,
FT                                ECO:0000269|PubMed:7926722}.
FT                                /FTId=VAR_060257.
FT   VARIANT     168    168       M -> T (in a esophageal carcinoma;
FT                                dbSNP:rs121912967).
FT                                {ECO:0000269|PubMed:8187090}.
FT                                /FTId=VAR_003909.
FT   VARIANT     201    201       R -> G (in dbSNP:rs2229080).
FT                                {ECO:0000269|PubMed:8187090}.
FT                                /FTId=VAR_003910.
FT   VARIANT     275   1447       Missing (in MRMV1).
FT                                {ECO:0000269|PubMed:28250454}.
FT                                /FTId=VAR_079145.
FT   VARIANT     597    597       R -> P (in MRMV1; unknown pathological
FT                                significance; dbSNP:rs1057519056).
FT                                {ECO:0000269|PubMed:28250454}.
FT                                /FTId=VAR_079146.
FT   VARIANT     679    679       L -> R (in dbSNP:rs2271042).
FT                                /FTId=VAR_060258.
FT   VARIANT     691    691       Q -> K (in HGPPS2; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:28250456}.
FT                                /FTId=VAR_079287.
FT   VARIANT     743    743       M -> L (in MRMV1; unknown pathological
FT                                significance; dbSNP:rs199651452).
FT                                {ECO:0000269|PubMed:28250454}.
FT                                /FTId=VAR_079147.
FT   VARIANT     754    754       V -> M (in MRMV1; unknown pathological
FT                                significance; dbSNP:rs775565634).
FT                                {ECO:0000269|PubMed:28250454}.
FT                                /FTId=VAR_079148.
FT   VARIANT     759    759       I -> M (in dbSNP:rs2278339).
FT                                /FTId=VAR_056043.
FT   VARIANT     793    793       V -> G (in MRMV1; dbSNP:rs1057519054).
FT                                {ECO:0000269|PubMed:28250454}.
FT                                /FTId=VAR_079149.
FT   VARIANT     805    805       G -> E (in MRMV1; dbSNP:rs1057519055).
FT                                {ECO:0000269|PubMed:28250454}.
FT                                /FTId=VAR_079150.
FT   VARIANT     893    893       A -> T (in MRMV1; unknown pathological
FT                                significance; dbSNP:rs1057519057).
FT                                {ECO:0000269|PubMed:28250454}.
FT                                /FTId=VAR_079151.
FT   VARIANT    1017   1017       M -> V (in dbSNP:rs984274).
FT                                /FTId=VAR_024495.
FT   VARIANT    1039   1039       F -> S (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035511.
FT   VARIANT    1191   1191       H -> L (in dbSNP:rs2270950).
FT                                /FTId=VAR_060259.
FT   VARIANT    1217   1217       M -> V (in MRMV1; unknown pathological
FT                                significance; dbSNP:rs1039528164).
FT                                {ECO:0000269|PubMed:28250454}.
FT                                /FTId=VAR_079152.
FT   VARIANT    1250   1250       A -> T (in MRMV1; unknown pathological
FT                                significance; dbSNP:rs748112308).
FT                                {ECO:0000269|PubMed:28250454}.
FT                                /FTId=VAR_079153.
FT   VARIANT    1375   1375       P -> H (in a colorectal carcinoma;
FT                                dbSNP:rs387906555).
FT                                {ECO:0000269|PubMed:8188295}.
FT                                /FTId=VAR_003911.
FT   MUTAGEN    1432   1432       L->S: Abolishes interaction with MYO10.
FT                                {ECO:0000269|PubMed:21642953}.
FT   MUTAGEN    1435   1436       LM->SS: Abolishes interaction with MYO10.
FT                                {ECO:0000269|PubMed:21642953}.
FT   MUTAGEN    1439   1439       L->S: Abolishes interaction with MYO10.
FT                                {ECO:0000269|PubMed:21642953}.
FT   CONFLICT    951    951       L -> F (in Ref. 1; CAA53735).
FT                                {ECO:0000305}.
FT   STRAND      425    428       {ECO:0000244|PDB:2ED7}.
FT   STRAND      436    440       {ECO:0000244|PDB:2ED7}.
FT   STRAND      445    448       {ECO:0000244|PDB:2ED7}.
FT   STRAND      459    470       {ECO:0000244|PDB:2ED7}.
FT   STRAND      475    478       {ECO:0000244|PDB:2ED7}.
FT   STRAND      486    489       {ECO:0000244|PDB:2ED7}.
FT   STRAND      494    500       {ECO:0000244|PDB:2ED7}.
FT   STRAND      503    508       {ECO:0000244|PDB:2ED7}.
FT   STRAND      517    520       {ECO:0000244|PDB:2ED7}.
FT   STRAND      532    537       {ECO:0000244|PDB:2ED8}.
FT   STRAND      543    549       {ECO:0000244|PDB:2ED8}.
FT   STRAND      560    567       {ECO:0000244|PDB:2ED8}.
FT   TURN        568    570       {ECO:0000244|PDB:2ED8}.
FT   STRAND      573    578       {ECO:0000244|PDB:2ED8}.
FT   STRAND      583    587       {ECO:0000244|PDB:2ED8}.
FT   STRAND      593    601       {ECO:0000244|PDB:2ED8}.
FT   STRAND      606    609       {ECO:0000244|PDB:2ED8}.
FT   STRAND      613    616       {ECO:0000244|PDB:2ED8}.
FT   STRAND      631    635       {ECO:0000244|PDB:2ED9}.
FT   STRAND      638    642       {ECO:0000244|PDB:2ED9}.
FT   TURN        648    650       {ECO:0000244|PDB:2ED9}.
FT   STRAND      657    668       {ECO:0000244|PDB:2ED9}.
FT   STRAND      671    674       {ECO:0000244|PDB:2ED9}.
FT   STRAND      679    684       {ECO:0000244|PDB:2ED9}.
FT   STRAND      691    694       {ECO:0000244|PDB:2ED9}.
FT   STRAND      696    699       {ECO:0000244|PDB:2ED9}.
FT   STRAND      711    714       {ECO:0000244|PDB:2ED9}.
FT   STRAND      716    719       {ECO:0000244|PDB:2EDB}.
FT   STRAND      730    736       {ECO:0000244|PDB:5X83}.
FT   STRAND      741    746       {ECO:0000244|PDB:5X83}.
FT   STRAND      751    753       {ECO:0000244|PDB:5X83}.
FT   STRAND      757    765       {ECO:0000244|PDB:5X83}.
FT   STRAND      769    775       {ECO:0000244|PDB:5X83}.
FT   STRAND      780    783       {ECO:0000244|PDB:5X83}.
FT   STRAND      791    800       {ECO:0000244|PDB:5X83}.
FT   STRAND      808    813       {ECO:0000244|PDB:5X83}.
FT   STRAND      848    854       {ECO:0000244|PDB:5X83}.
FT   STRAND      856    858       {ECO:0000244|PDB:5X83}.
FT   STRAND      860    865       {ECO:0000244|PDB:5X83}.
FT   STRAND      867    869       {ECO:0000244|PDB:2EDD}.
FT   STRAND      880    891       {ECO:0000244|PDB:5X83}.
FT   STRAND      896    907       {ECO:0000244|PDB:5X83}.
FT   STRAND      915    924       {ECO:0000244|PDB:5X83}.
FT   STRAND      927    929       {ECO:0000244|PDB:5X83}.
FT   STRAND      935    938       {ECO:0000244|PDB:5X83}.
FT   STRAND      949    955       {ECO:0000244|PDB:5X83}.
FT   STRAND      963    968       {ECO:0000244|PDB:5X83}.
FT   STRAND      977    986       {ECO:0000244|PDB:5X83}.
FT   STRAND      988    990       {ECO:0000244|PDB:5X83}.
FT   HELIX       992    994       {ECO:0000244|PDB:5X83}.
FT   STRAND      995   1001       {ECO:0000244|PDB:5X83}.
FT   STRAND     1006   1009       {ECO:0000244|PDB:5X83}.
FT   STRAND     1017   1026       {ECO:0000244|PDB:5X83}.
FT   STRAND     1037   1040       {ECO:0000244|PDB:5X83}.
FT   HELIX      1415   1421       {ECO:0000244|PDB:3AU4}.
FT   HELIX      1425   1443       {ECO:0000244|PDB:3AU4}.
SQ   SEQUENCE   1447 AA;  158457 MW;  BC17EA0E93DE8768 CRC64;
     MENSLRCVWV PKLAFVLFGA SLFSAHLQVT GFQIKAFTAL RFLSEPSDAV TMRGGNVLLD
     CSAESDRGVP VIKWKKDGIH LALGMDERKQ QLSNGSLLIQ NILHSRHHKP DEGLYQCEAS
     LGDSGSIISR TAKVAVAGPL RFLSQTESVT AFMGDTVLLK CEVIGEPMPT IHWQKNQQDL
     TPIPGDSRVV VLPSGALQIS RLQPGDIGIY RCSARNPASS RTGNEAEVRI LSDPGLHRQL
     YFLQRPSNVV AIEGKDAVLE CCVSGYPPPS FTWLRGEEVI QLRSKKYSLL GGSNLLISNV
     TDDDSGMYTC VVTYKNENIS ASAELTVLVP PWFLNHPSNL YAYESMDIEF ECTVSGKPVP
     TVNWMKNGDV VIPSDYFQIV GGSNLRILGV VKSDEGFYQC VAENEAGNAQ TSAQLIVPKP
     AIPSSSVLPS APRDVVPVLV SSRFVRLSWR PPAEAKGNIQ TFTVFFSREG DNRERALNTT
     QPGSLQLTVG NLKPEAMYTF RVVAYNEWGP GESSQPIKVA TQPELQVPGP VENLQAVSTS
     PTSILITWEP PAYANGPVQG YRLFCTEVST GKEQNIEVDG LSYKLEGLKK FTEYSLRFLA
     YNRYGPGVST DDITVVTLSD VPSAPPQNVS LEVVNSRSIK VSWLPPPSGT QNGFITGYKI
     RHRKTTRRGE METLEPNNLW YLFTGLEKGS QYSFQVSAMT VNGTGPPSNW YTAETPENDL
     DESQVPDQPS SLHVRPQTNC IIMSWTPPLN PNIVVRGYII GYGVGSPYAE TVRVDSKQRY
     YSIERLESSS HYVISLKAFN NAGEGVPLYE SATTRSITDP TDPVDYYPLL DDFPTSVPDL
     STPMLPPVGV QAVALTHDAV RVSWADNSVP KNQKTSEVRL YTVRWRTSFS ASAKYKSEDT
     TSLSYTATGL KPNTMYEFSV MVTKNRRSST WSMTAHATTY EAAPTSAPKD LTVITREGKP
     RAVIVSWQPP LEANGKITAY ILFYTLDKNI PIDDWIMETI SGDRLTHQIM DLNLDTMYYF
     RIQARNSKGV GPLSDPILFR TLKVEHPDKM ANDQGRHGDG GYWPVDTNLI DRSTLNEPPI
     GQMHPPHGSV TPQKNSNLLV IIVVTVGVIT VLVVVIVAVI CTRRSSAQQR KKRATHSAGK
     RKGSQKDLRP PDLWIHHEEM EMKNIEKPSG TDPAGRDSPI QSCQDLTPVS HSQSETQLGS
     KSTSHSGQDT EEAGSSMSTL ERSLAARRAP RAKLMIPMDA QSNNPAVVSA IPVPTLESAQ
     YPGILPSPTC GYPHPQFTLR PVPFPTLSVD RGFGAGRSQS VSEGPTTQQP PMLPPSQPEH
     SSSEEAPSRT IPTACVRPTH PLRSFANPLL PPPMSAIEPK VPYTPLLSQP GPTLPKTHVK
     TASLGLAGKA RSPLLPVSVP TAPEVSEESH KPTEDSANVY EQDDLSEQMA SLEGLMKQLN
     AITGSAF
//
ID   Q49AK4_HUMAN            Unreviewed;       772 AA.
AC   Q49AK4;
DT   13-SEP-2005, integrated into UniProtKB/TrEMBL.
DT   13-SEP-2005, sequence version 1.
DT   31-JAN-2018, entry version 78.
DE   SubName: Full=DCC protein {ECO:0000313|EMBL:AAH36524.1};
DE   Flags: Fragment;
GN   Name=DCC {ECO:0000313|EMBL:AAH36524.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH36524.1};
RN   [1] {ECO:0000313|EMBL:AAH36524.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis {ECO:0000313|EMBL:AAH36524.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC036524; AAH36524.1; -; mRNA.
DR   RefSeq; NP_005206.2; NM_005215.3.
DR   UniGene; Hs.162025; -.
DR   ProteinModelPortal; Q49AK4; -.
DR   PeptideAtlas; Q49AK4; -.
DR   PRIDE; Q49AK4; -.
DR   DNASU; 1630; -.
DR   GeneID; 1630; -.
DR   KEGG; hsa:1630; -.
DR   CTD; 1630; -.
DR   PharmGKB; PA27170; -.
DR   eggNOG; KOG4221; Eukaryota.
DR   eggNOG; ENOG410Z913; LUCA.
DR   HOVERGEN; HBG005455; -.
DR   KO; K06765; -.
DR   ChiTaRS; DCC; human.
DR   GenomeRNAi; 1630; -.
DR   Genevisible; Q49AK4; HS.
DR   GO; GO:0005042; F:netrin receptor activity; IEA:InterPro.
DR   GO; GO:0006915; P:apoptotic process; IEA:InterPro.
DR   GO; GO:0007411; P:axon guidance; IEA:InterPro.
DR   CDD; cd00063; FN3; 4.
DR   Gene3D; 2.60.40.10; -; 8.
DR   InterPro; IPR033012; DCC.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   PANTHER; PTHR44146:SF3; PTHR44146:SF3; 1.
DR   Pfam; PF00041; fn3; 4.
DR   Pfam; PF07679; I-set; 3.
DR   SMART; SM00060; FN3; 4.
DR   SMART; SM00409; IG; 4.
DR   SMART; SM00408; IGc2; 4.
DR   SUPFAM; SSF48726; SSF48726; 4.
DR   SUPFAM; SSF49265; SSF49265; 3.
DR   PROSITE; PS50853; FN3; 4.
DR   PROSITE; PS50835; IG_LIKE; 4.
PE   2: Evidence at transcript level;
KW   Repeat {ECO:0000256|SAAS:SAAS00923712}.
FT   DOMAIN        1     69       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN       73    163       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      168    260       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      265    350       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      365    458       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      464    554       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      559    652       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      662    755       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAH36524.1}.
SQ   SEQUENCE   772 AA;  84992 MW;  E444052269F016DC CRC64;
     SGVPVIKWKK DGIHLALGMD ERKQQLSNGS LLIQNILHSR HHKPDEGLYQ CEASLGDSGS
     IISRTAKVAV AGPLRFLSQT ESVTAFMGDT VLLKCEVIGE PMPTIHWQKN QQDLTPIPGD
     SRVVVLPSGA LQISRLQPGD IGIYRCSARN PASSRTGNEA EVRILSDPGL HRQLYFLQRP
     SNVVAIEGKD AVLEGCVSGY PPPSFTWLRG EEVIQLRSKK YSLLGGSNLL ISNVTDDDSG
     MYTCVVTYKN ENISASAELT VLVPPWFLNH PSNLYAYESM DIEFECTVSG KPVPTVNWMK
     NGDVVIPSDY FQIVGGSNLR ILGVVKSDEG FYQCVAENEA GNAQTSAQLI VPKPAIPSSS
     VLPSAPRDVV PVLVSSRFVR LSWRPPAEAK GNIQTFTVFF SREGDNRERA LNTTQPGSLQ
     LTVGNLKPEA MYTFRVVAYN EWGPGESSQP IKVATQPELQ VPGPVENLQA VSTSPTSILI
     TWEPPAYANG PVQGYRLFCT EVSTGKEQNI EVDGLSYKLE GLKKFTEYSL RFLAYNRYGP
     GVSTDDITVV TLSDVPSAPP QNVSLEVVNS RSIKVSWLPP PSGTQNGFIT GYKIRHRKTT
     RRGEMETLEP NNLWYLFTGL EKGSQYSFQV SAMTVNGTGP PSNWYTAETP ENDLDESQVP
     DQPSSLHVRP QTNCIIMSWT PPLNPNIVVR GYIIGYGVGS PYAETVRVDS KQRYYSIERL
     ESSSHYVISL KAFNNAGEGV PLYESATTRS ITVRRHNISK LHSNRPQTKH NV
//
ID   ECT2L_HUMAN             Reviewed;         904 AA.
AC   Q008S8; B2RUV6; Q5JWK2; Q5JWK3; Q5JWK4;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   20-MAY-2008, sequence version 2.
DT   28-MAR-2018, entry version 95.
DE   RecName: Full=Epithelial cell-transforming sequence 2 oncogene-like;
DE   AltName: Full=Lung-specific F-box and DH domain-containing protein;
DE   AltName: Full=Putative guanine nucleotide exchange factor LFDH;
GN   Name=ECT2L; Synonyms=C6orf91, LFDH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 8-904.
RA   Corcoran M.M., Cepeda D., Akhondi S., Spruck C., Sangfelt O.;
RT   "Identification and characterization of the gene for human lung
RT   specific F-box and DH domain containing protein (LFDH).";
RL   Submitted (AUG-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: May act as a guanine nucleotide exchange factor (GEF).
CC       {ECO:0000250}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=ABI98401.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL121834; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC146884; AAI46885.1; -; mRNA.
DR   EMBL; DQ904331; ABI98401.1; ALT_INIT; mRNA.
DR   CCDS; CCDS43508.1; -.
DR   RefSeq; NP_001071174.1; NM_001077706.2.
DR   RefSeq; NP_001181966.1; NM_001195037.2.
DR   UniGene; Hs.660603; -.
DR   ProteinModelPortal; Q008S8; -.
DR   SMR; Q008S8; -.
DR   BioGrid; 131369; 3.
DR   STRING; 9606.ENSP00000356655; -.
DR   iPTMnet; Q008S8; -.
DR   PhosphoSitePlus; Q008S8; -.
DR   BioMuta; ECT2L; -.
DR   DMDM; 189046616; -.
DR   PaxDb; Q008S8; -.
DR   PeptideAtlas; Q008S8; -.
DR   PRIDE; Q008S8; -.
DR   Ensembl; ENST00000367682; ENSP00000356655; ENSG00000203734.
DR   Ensembl; ENST00000423192; ENSP00000387388; ENSG00000203734.
DR   Ensembl; ENST00000541398; ENSP00000442307; ENSG00000203734.
DR   GeneID; 345930; -.
DR   KEGG; hsa:345930; -.
DR   UCSC; uc003qif.2; human.
DR   CTD; 345930; -.
DR   DisGeNET; 345930; -.
DR   EuPathDB; HostDB:ENSG00000203734.11; -.
DR   GeneCards; ECT2L; -.
DR   HGNC; HGNC:21118; ECT2L.
DR   HPA; HPA035488; -.
DR   neXtProt; NX_Q008S8; -.
DR   OpenTargets; ENSG00000203734; -.
DR   PharmGKB; PA134893289; -.
DR   eggNOG; ENOG410IRSS; Eukaryota.
DR   eggNOG; ENOG4110R79; LUCA.
DR   GeneTree; ENSGT00530000063689; -.
DR   HOGENOM; HOG000067954; -.
DR   InParanoid; Q008S8; -.
DR   OMA; PPWVSGT; -.
DR   OrthoDB; EOG091G018T; -.
DR   PhylomeDB; Q008S8; -.
DR   TreeFam; TF343796; -.
DR   ChiTaRS; ECT2L; human.
DR   GeneWiki; ECT2L; -.
DR   GenomeRNAi; 345930; -.
DR   PRO; PR:Q008S8; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000203734; -.
DR   ExpressionAtlas; Q008S8; baseline and differential.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IEA:InterPro.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR025592; DUF4347.
DR   InterPro; IPR036047; F-box-like_dom_sf.
DR   InterPro; IPR001810; F-box_dom.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   Pfam; PF14252; DUF4347; 1.
DR   Pfam; PF12937; F-box-like; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF81383; SSF81383; 1.
DR   PROSITE; PS50010; DH_2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Guanine-nucleotide releasing factor; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    904       Epithelial cell-transforming sequence 2
FT                                oncogene-like.
FT                                /FTId=PRO_0000336075.
FT   DOMAIN       75    121       F-box.
FT   DOMAIN      566    754       DH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00062}.
FT   VARIANT     483    483       Q -> H (in dbSNP:rs12198781).
FT                                /FTId=VAR_051984.
FT   VARIANT     527    527       E -> K (in dbSNP:rs1529151).
FT                                /FTId=VAR_043482.
FT   VARIANT     594    594       A -> T (in dbSNP:rs11968285).
FT                                /FTId=VAR_043483.
FT   CONFLICT     60     60       R -> S (in Ref. 3; ABI98401).
FT                                {ECO:0000305}.
FT   CONFLICT     64     64       D -> E (in Ref. 3; ABI98401).
FT                                {ECO:0000305}.
FT   CONFLICT    472    472       R -> K (in Ref. 3; ABI98401).
FT                                {ECO:0000305}.
FT   CONFLICT    641    641       G -> D (in Ref. 3; ABI98401).
FT                                {ECO:0000305}.
SQ   SEQUENCE   904 AA;  104880 MW;  CF4AD8C84D94E983 CRC64;
     MESFHTRFSA WTPFSNKSLN RQLFQERVAL ISHWFDLWTN KQRQEFLFAI FLRCTKSQLR
     FVQDWFSERM QVAKVDFSTV LPRFISLYIF SFLSPKDLCA AAQVSWPWKF LTEQDCLWMP
     KCVKFGWFLP YTPTDNEYGA WKRHYIACVS HLDWLTPREA AATYGTLNEP KTEDEELLER
     QREKCLRKRI WEKIALRKKE LFKVRPPWVS GTCCSSVLKP RCQPRLSQTV RERVGLHEAL
     EKQLVLTSLE TLPKRSNISG SHSYPLLSKK NWHGVHKNDD RSSYALRPHF MLISSRIPAY
     EMVMESVKAG VVSVVYEHSV TLESLLYLIE KALDGQKAQS IGIFSDGDSR EINLLQGYKI
     GVKNLLRPEV RDFWEKLGSY VATEEEGGHV DFFVPLGASE AGIEVLSQLS QLTGTFFTAP
     TGIATGSYQH ILSDWLGSQW GKAPSSIYFC ESKLQTWSSF TDFLEETLKT VRKQLYPFFK
     ELQKSISGRM IGQFMFDTMG MTNILNNQDT AQALADGLME LSKEDSERNV VEDNSWDTKS
     RLSKNDLNFE ALINLERILQ KDSAEKRARV VRELLQSERK YVQILEIVRD VYVAPLKAAL
     SSNRAILSAA NIQIIFCDIL QILSLNRQFL DNLRDRLQEW GPAHCVGEIV TKFGSQLNTY
     TNFFNNYPVI LKTIEKCREM IPAFRTFLKR HDKTIVTKML SLPELLLYPS RRFEEYLNLL
     YAVRLHTPAE HVDRGDLTTA IDQIKKYKGY IDQMKQNITM KDHLSDIQRI IWGCPTLSEV
     NRYLIRVQDV AQLHCCDEEI SFSLRLYEHI HDLSLFLFND ALLVSSRGTS HTPFERTSKT
     TYQFIASVAL HRLLIENIPD SKYVKNAFIL QGPKYKWICA TEIEDDKFLW LSVLRNAIKS
     SMEK
//
ID   IF1AX_HUMAN             Reviewed;         144 AA.
AC   P47813; B2R5U5; Q0VGC2; Q5JPS5; Q5JPS6;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   28-MAR-2018, entry version 172.
DE   RecName: Full=Eukaryotic translation initiation factor 1A, X-chromosomal;
DE            Short=eIF-1A X isoform;
DE   AltName: Full=Eukaryotic translation initiation factor 4C;
DE            Short=eIF-4C;
GN   Name=EIF1AX; Synonyms=EIF1A, EIF4C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8106356;
RA   Dever T.E., Wei C.-L., Benkowski L.A., Browning K., Merrick W.C.,
RA   Hershey J.W.B.;
RT   "Determination of the amino acid sequence of rabbit, human, and wheat
RT   germ protein synthesis factor eIF-4C by cloning and chemical
RT   sequencing.";
RL   J. Biol. Chem. 269:3212-3218(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Hypothalamus, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   STRUCTURE BY NMR.
RX   PubMed=10678173; DOI=10.1016/S1097-2765(00)80407-4;
RA   Battiste J.L., Pestova T.V., Hellen C.U., Wagner G.;
RT   "The eIF1A solution structure reveals a large RNA-binding surface
RT   important for scanning function.";
RL   Mol. Cell 5:109-119(2000).
CC   -!- FUNCTION: Seems to be required for maximal rate of protein
CC       biosynthesis. Enhances ribosome dissociation into subunits and
CC       stabilizes the binding of the initiator Met-tRNA(I) to 40 S
CC       ribosomal subunits.
CC   -!- INTERACTION:
CC       Q14152:EIF3A; NbExp=2; IntAct=EBI-1045377, EBI-366617;
CC       Q99613:EIF3C; NbExp=2; IntAct=EBI-1045377, EBI-353741;
CC       P55010:EIF5; NbExp=2; IntAct=EBI-1045377, EBI-286450;
CC       O94829:IPO13; NbExp=14; IntAct=EBI-1045377, EBI-747310;
CC   -!- SIMILARITY: Belongs to the eIF-1A family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAI40551.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L18960; AAA19812.1; -; mRNA.
DR   EMBL; AK312320; BAG35242.1; -; mRNA.
DR   EMBL; BT007064; AAP35727.1; -; mRNA.
DR   EMBL; AL732366; CAI40550.1; -; Genomic_DNA.
DR   EMBL; AL732366; CAI40551.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC000793; AAH00793.1; -; mRNA.
DR   EMBL; BC067851; AAH67851.1; -; mRNA.
DR   CCDS; CCDS14196.1; -.
DR   PIR; C53045; C53045.
DR   RefSeq; NP_001403.1; NM_001412.3.
DR   RefSeq; XP_016855198.1; XM_016999709.1.
DR   UniGene; Hs.522590; -.
DR   PDB; 1D7Q; NMR; -; A=2-144.
DR   PDB; 3ZJY; X-ray; 3.60 A; C=1-112.
DR   PDB; 4KZY; X-ray; 7.01 A; n=1-144.
DR   PDB; 4KZZ; X-ray; 7.03 A; n=1-144.
DR   PDBsum; 1D7Q; -.
DR   PDBsum; 3ZJY; -.
DR   PDBsum; 4KZY; -.
DR   PDBsum; 4KZZ; -.
DR   DisProt; DP00903; -.
DR   ProteinModelPortal; P47813; -.
DR   SMR; P47813; -.
DR   BioGrid; 108284; 41.
DR   CORUM; P47813; -.
DR   DIP; DIP-40995N; -.
DR   IntAct; P47813; 17.
DR   MINT; P47813; -.
DR   STRING; 9606.ENSP00000368927; -.
DR   iPTMnet; P47813; -.
DR   PhosphoSitePlus; P47813; -.
DR   BioMuta; EIF1AX; -.
DR   DMDM; 1352425; -.
DR   EPD; P47813; -.
DR   MaxQB; P47813; -.
DR   PaxDb; P47813; -.
DR   PeptideAtlas; P47813; -.
DR   PRIDE; P47813; -.
DR   TopDownProteomics; P47813; -.
DR   DNASU; 1964; -.
DR   Ensembl; ENST00000379607; ENSP00000368927; ENSG00000173674.
DR   GeneID; 107984923; -.
DR   GeneID; 1964; -.
DR   KEGG; hsa:107984923; -.
DR   KEGG; hsa:1964; -.
DR   UCSC; uc004czt.4; human.
DR   CTD; 1964; -.
DR   DisGeNET; 1964; -.
DR   EuPathDB; HostDB:ENSG00000173674.10; -.
DR   GeneCards; EIF1AX; -.
DR   H-InvDB; HIX0028844; -.
DR   HGNC; HGNC:3250; EIF1AX.
DR   HPA; HPA002561; -.
DR   MalaCards; EIF1AX; -.
DR   MIM; 300186; gene.
DR   neXtProt; NX_P47813; -.
DR   OpenTargets; ENSG00000173674; -.
DR   PharmGKB; PA27684; -.
DR   eggNOG; KOG3403; Eukaryota.
DR   eggNOG; COG0361; LUCA.
DR   GeneTree; ENSGT00390000008256; -.
DR   HOGENOM; HOG000223675; -.
DR   HOVERGEN; HBG001131; -.
DR   InParanoid; P47813; -.
DR   KO; K03236; -.
DR   OMA; LGGNHVR; -.
DR   OrthoDB; EOG091G195V; -.
DR   PhylomeDB; P47813; -.
DR   TreeFam; TF350394; -.
DR   Reactome; R-HSA-156827; L13a-mediated translational silencing of Ceruloplasmin expression.
DR   Reactome; R-HSA-72649; Translation initiation complex formation.
DR   Reactome; R-HSA-72689; Formation of a pool of free 40S subunits.
DR   Reactome; R-HSA-72695; Formation of the ternary complex, and subsequently, the 43S complex.
DR   Reactome; R-HSA-72702; Ribosomal scanning and start codon recognition.
DR   Reactome; R-HSA-72706; GTP hydrolysis and joining of the 60S ribosomal subunit.
DR   ChiTaRS; EIF1AX; human.
DR   EvolutionaryTrace; P47813; -.
DR   GeneWiki; EIF1AX; -.
DR   GenomeRNAi; 1964; -.
DR   PRO; PR:P47813; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000173674; -.
DR   CleanEx; HS_EIF1AX; -.
DR   ExpressionAtlas; P47813; baseline and differential.
DR   Genevisible; P47813; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0008135; F:translation factor activity, RNA binding; TAS:ProtInc.
DR   GO; GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0006413; P:translational initiation; TAS:Reactome.
DR   CDD; cd05793; S1_IF1A; 1.
DR   HAMAP; MF_00216; aIF_1A; 1.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR006196; RNA-binding_domain_S1_IF1.
DR   InterPro; IPR001253; TIF_eIF-1A.
DR   InterPro; IPR018104; TIF_eIF-1A_CS.
DR   PANTHER; PTHR21668; PTHR21668; 1.
DR   Pfam; PF01176; eIF-1a; 1.
DR   ProDom; PD005579; TIF_eIF-1A; 1.
DR   SMART; SM00652; eIF1a; 1.
DR   SUPFAM; SSF50249; SSF50249; 1.
DR   TIGRFAMs; TIGR00523; eIF-1A; 1.
DR   PROSITE; PS01262; IF1A; 1.
DR   PROSITE; PS50832; S1_IF1_TYPE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Initiation factor;
KW   Protein biosynthesis; Reference proteome; RNA-binding.
FT   CHAIN         1    144       Eukaryotic translation initiation factor
FT                                1A, X-chromosomal.
FT                                /FTId=PRO_0000145101.
FT   DOMAIN       22     96       S1-like.
FT   STRAND        7     12       {ECO:0000244|PDB:1D7Q}.
FT   STRAND       33     41       {ECO:0000244|PDB:1D7Q}.
FT   STRAND       43     51       {ECO:0000244|PDB:1D7Q}.
FT   TURN         52     54       {ECO:0000244|PDB:1D7Q}.
FT   STRAND       55     60       {ECO:0000244|PDB:1D7Q}.
FT   HELIX        64     67       {ECO:0000244|PDB:1D7Q}.
FT   STRAND       76     80       {ECO:0000244|PDB:1D7Q}.
FT   STRAND       82     87       {ECO:0000244|PDB:1D7Q}.
FT   STRAND       90     95       {ECO:0000244|PDB:1D7Q}.
FT   TURN         97     99       {ECO:0000244|PDB:1D7Q}.
FT   HELIX       100    106       {ECO:0000244|PDB:1D7Q}.
FT   STRAND      120    122       {ECO:0000244|PDB:1D7Q}.
SQ   SEQUENCE   144 AA;  16460 MW;  1C4209855B21BFD4 CRC64;
     MPKNKGKGGK NRRRGKNENE SEKRELVFKE DGQEYAQVIK MLGNGRLEAM CFDGVKRLCH
     IRGKLRKKVW INTSDIILVG LRDYQDNKAD VILKYNADEA RSLKAYGELP EHAKINETDT
     FGPGDDDEIQ FDDIGDDDED IDDI
//
ID   A0A140VJJ0_HUMAN        Unreviewed;       983 AA.
AC   A0A140VJJ0;
DT   08-JUN-2016, integrated into UniProtKB/TrEMBL.
DT   08-JUN-2016, sequence version 1.
DT   28-FEB-2018, entry version 16.
DE   SubName: Full=EPH receptor A3 {ECO:0000313|EMBL:EAW68857.1};
DE   SubName: Full=Testicular tissue protein Li 64 {ECO:0000313|EMBL:AEE60977.1};
GN   Name=EPHA3 {ECO:0000313|EMBL:EAW68857.1};
GN   ORFNames=hCG_33008 {ECO:0000313|EMBL:EAW68857.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEE60977.1};
RN   [1] {ECO:0000313|EMBL:EAW68857.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW68857.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:AEE60977.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human testis protein.";
RL   Submitted (MAR-2010) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000256|SAAS:SAAS00701269}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. {ECO:0000256|SAAS:SAAS00941529}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HM005377; AEE60977.1; -; mRNA.
DR   EMBL; CH471110; EAW68857.1; -; Genomic_DNA.
DR   RefSeq; NP_005224.2; NM_005233.5.
DR   UniGene; Hs.123642; -.
DR   SMR; A0A140VJJ0; -.
DR   GeneID; 2042; -.
DR   KEGG; hsa:2042; -.
DR   CTD; 2042; -.
DR   KO; K05104; -.
DR   OMA; SSCDTIA; -.
DR   ChiTaRS; EPHA3; human.
DR   ExpressionAtlas; A0A140VJJ0; baseline and differential.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005003; F:ephrin receptor activity; IEA:InterPro.
DR   CDD; cd10481; EphR_LBD_A3; 1.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 2.60.120.260; -; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR027936; Eph_TM.
DR   InterPro; IPR034266; EphA3_rcpt_lig-bd.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016257; Tyr_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_kinase_rcpt_V_CS.
DR   Pfam; PF14575; EphA2_TM; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF07699; Ephrin_rec_like; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF07647; SAM_2; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM01411; Ephrin_rec_like; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS51550; EPH_LBD; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|PIRSR:PIRSR000666-2,
KW   ECO:0000256|SAAS:SAAS00708816};
KW   Kinase {ECO:0000256|SAAS:SAAS00582553};
KW   Membrane {ECO:0000256|SAAS:SAAS00602683, ECO:0000256|SAM:Phobius};
KW   Nucleotide-binding {ECO:0000256|PIRSR:PIRSR000666-2,
KW   ECO:0000256|SAAS:SAAS00708816};
KW   Receptor {ECO:0000256|SAAS:SAAS00600436, ECO:0000313|EMBL:EAW68857.1};
KW   Repeat {ECO:0000256|SAAS:SAAS00786331};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transferase {ECO:0000256|SAAS:SAAS00582553};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00602683,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00602683,
KW   ECO:0000256|SAM:Phobius};
KW   Tyrosine-protein kinase {ECO:0000256|SAAS:SAAS00582553}.
FT   SIGNAL        1     20       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        21    983       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5010061075.
FT   TRANSMEM    542    564       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       29    207       Eph LBD. {ECO:0000259|PROSITE:PS51550}.
FT   DOMAIN      325    435       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      436    531       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      621    882       Protein kinase.
FT                                {ECO:0000259|PROSITE:PS50011}.
FT   DOMAIN      911    975       SAM. {ECO:0000259|PROSITE:PS50105}.
FT   NP_BIND     627    635       ATP. {ECO:0000256|PIRSR:PIRSR000666-2}.
FT   ACT_SITE    746    746       Proton acceptor.
FT                                {ECO:0000256|PIRSR:PIRSR000666-1}.
FT   BINDING     653    653       ATP. {ECO:0000256|PIRSR:PIRSR000666-2}.
SQ   SEQUENCE   983 AA;  110131 MW;  BE04DBF958245424 CRC64;
     MDCQLSILLL LSCSVLDSFG ELIPQPSNEV NLLDSKTIQG ELGWISYPSH GWEEISGVDE
     HYTPIRTYQV CNVMDHSQNN WLRTNWVPRN SAQKIYVELK FTLRDCNSIP LVLGTCKETF
     NLYYMESDDD HGVKFREHQF TKIDTIAADE SFTQMDLGDR ILKLNTEIRE VGPVNKKGFY
     LAFQDVGACV ALVSVRVYFK KCPFTVKNLA MFPDTVPMDS QSLVEVRGSC VNNSKEEDPP
     RMYCSTEGEW LVPIGKCSCN AGYEERGFMC QACRPGFYKA LDGNMKCAKC PPHSSTQEDG
     SMNCRCENNY FRADKDPPSM ACTRPPSSPR NVISNINETS VILDWSWPLD TGGRKDVTFN
     IICKKCGWNI KQCEPCSPNV RFLPRQFGLT NTTVTVTDLL AHTNYTFEID AVNGVSELSS
     PPRQFAAVSI TTNQAAPSPV LTIKKDRTSR NSISLSWQEP EHPNGIILDY EVKYYEKQEQ
     ETSYTILRAR GTNVTISSLK PDTIYVFQIR ARTAAGYGTN SRKFEFETSP DSFSISGESS
     QVVMIAISAA VAIILLTVVI YVLIGRFCGY KSKHGADEKR LHFGNGHLKL PGLRTYVDPH
     TYEDPTQAVH EFAKELDATN ISIDKVVGAG EFGEVCSGRL KLPSKKEISV AIKTLKVGYT
     EKQRRDFLGE ASIMGQFDHP NIIRLEGVVT KSKPVMIVTE YMENGSLDSF LRKHDAQFTV
     IQLVGMLRGI ASGMKYLSDM GYVHRDLAAR NILINSNLVC KVSDFGLSRV LEDDPEAAYT
     TRGGKIPIRW TSPEAIAYRK FTSASDVWSY GIVLWEVMSY GERPYWEMSN QDVIKAVDEG
     YRLPPPMDCP AALYQLMLDC WQKDRNNRPK FEQIVSILDK LIRNPGSLKI ITSAAARPSN
     LLLDQSNVDI TTFRTTGDWL NGVWTAHCKE IFTGVEYSSC DTIAKISTDD MKKVGVTVVG
     PQKKIISSIK ALETQSKNGP VPV
//
ID   C9JXA2_HUMAN            Unreviewed;       918 AA.
AC   C9JXA2;
DT   03-NOV-2009, integrated into UniProtKB/TrEMBL.
DT   03-NOV-2009, sequence version 1.
DT   28-MAR-2018, entry version 79.
DE   SubName: Full=Ephrin type-A receptor 3 {ECO:0000313|Ensembl:ENSP00000419190};
GN   Name=EPHA3 {ECO:0000313|Ensembl:ENSP00000419190};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000419190, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000419190}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3] {ECO:0000313|Ensembl:ENSP00000419190}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000256|SAAS:SAAS00701269}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. {ECO:0000256|SAAS:SAAS00941529}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC107028; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC109129; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138973; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF457654; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_005264773.1; XM_005264716.2.
DR   UniGene; Hs.123642; -.
DR   ProteinModelPortal; C9JXA2; -.
DR   MaxQB; C9JXA2; -.
DR   PeptideAtlas; C9JXA2; -.
DR   PRIDE; C9JXA2; -.
DR   Ensembl; ENST00000494014; ENSP00000419190; ENSG00000044524.
DR   GeneID; 2042; -.
DR   UCSC; uc062lst.1; human.
DR   CTD; 2042; -.
DR   EuPathDB; HostDB:ENSG00000044524.10; -.
DR   HGNC; HGNC:3387; EPHA3.
DR   OpenTargets; ENSG00000044524; -.
DR   eggNOG; KOG0196; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000118975; -.
DR   HOGENOM; HOG000233856; -.
DR   ChiTaRS; EPHA3; human.
DR   GenomeRNAi; 2042; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000044524; -.
DR   ExpressionAtlas; C9JXA2; baseline and differential.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005003; F:ephrin receptor activity; IEA:InterPro.
DR   CDD; cd10481; EphR_LBD_A3; 1.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 2.60.120.260; -; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR027936; Eph_TM.
DR   InterPro; IPR034266; EphA3_rcpt_lig-bd.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016257; Tyr_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_kinase_rcpt_V_CS.
DR   Pfam; PF14575; EphA2_TM; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF07699; Ephrin_rec_like; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM01411; Ephrin_rec_like; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS51550; EPH_LBD; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
PE   1: Evidence at protein level;
KW   ATP-binding {ECO:0000256|PIRSR:PIRSR000666-2,
KW   ECO:0000256|SAAS:SAAS00708816};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Kinase {ECO:0000256|SAAS:SAAS00582553};
KW   Membrane {ECO:0000256|SAAS:SAAS00602683, ECO:0000256|SAM:Phobius};
KW   Nucleotide-binding {ECO:0000256|PIRSR:PIRSR000666-2,
KW   ECO:0000256|SAAS:SAAS00708816};
KW   Proteomics identification {ECO:0000213|MaxQB:C9JXA2,
KW   ECO:0000213|PeptideAtlas:C9JXA2};
KW   Receptor {ECO:0000256|SAAS:SAAS00600436};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|SAAS:SAAS00786331};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transferase {ECO:0000256|SAAS:SAAS00582553};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00602683,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00602683,
KW   ECO:0000256|SAM:Phobius};
KW   Tyrosine-protein kinase {ECO:0000256|SAAS:SAAS00582553}.
FT   SIGNAL        1     20       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        21    918       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002997907.
FT   TRANSMEM    542    564       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       29    207       Eph LBD. {ECO:0000259|PROSITE:PS51550}.
FT   DOMAIN      325    435       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      436    531       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      621    882       Protein kinase.
FT                                {ECO:0000259|PROSITE:PS50011}.
FT   NP_BIND     627    635       ATP. {ECO:0000256|PIRSR:PIRSR000666-2}.
FT   ACT_SITE    746    746       Proton acceptor.
FT                                {ECO:0000256|PIRSR:PIRSR000666-1}.
FT   BINDING     653    653       ATP. {ECO:0000256|PIRSR:PIRSR000666-2}.
SQ   SEQUENCE   918 AA;  103142 MW;  1060205871355682 CRC64;
     MDCQLSILLL LSCSVLDSFG ELIPQPSNEV NLLDSKTIQG ELGWISYPSH GWEEISGVDE
     HYTPIRTYQV CNVMDHSQNN WLRTNWVPRN SAQKIYVELK FTLRDCNSIP LVLGTCKETF
     NLYYMESDDD HGVKFREHQF TKIDTIAADE SFTQMDLGDR ILKLNTEIRE VGPVNKKGFY
     LAFQDVGACV ALVSVRVYFK KCPFTVKNLA MFPDTVPMDS QSLVEVRGSC VNNSKEEDPP
     RMYCSTEGEW LVPIGKCSCN AGYEERGFMC QACRPGFYKA LDGNMKCAKC PPHSSTQEDG
     SMNCRCENNY FRADKDPPSM ACTRPPSSPR NVISNINETS VILDWSWPLD TGGRKDVTFN
     IICKKCGWNI KQCEPCSPNV RFLPRQFGLT NTTVTVTDLL AHTNYTFEID AVNGVSELSS
     PPRQFAAVSI TTNQAAPSPV LTIKKDRTSR NSISLSWQEP EHPNGIILDY EVKYYEKQEQ
     ETSYTILRAR GTNVTISSLK PDTIYVFQIR ARTAAGYGTN SRKFEFETSP DSFSISGESS
     QVVMIAISAA VAIILLTVVI YVLIGRFCGY KSKHGADEKR LHFGNGHLKL PGLRTYVDPH
     TYEDPTQAVH EFAKELDATN ISIDKVVGAG EFGEVCSGRL KLPSKKEISV AIKTLKVGYT
     EKQRRDFLGE ASIMGQFDHP NIIRLEGVVT KSKPVMIVTE YMENGSLDSF LRKHDAQFTV
     IQLVGMLRGI ASGMKYLSDM GYVHRDLAAR NILINSNLVC KVSDFGLSRV LEDDPEAAYT
     TRGGKIPIRW TSPEAIAYRK FTSASDVWSY GIVLWEVMSY GERPYWEMSN QDVIKAVDEG
     YRLPPPMDCP AALYQLMLDC WQKDRNNRPK FEQIVSILDK LIRNPGSLKI ITSAAARPSN
     LLLDQSNVDI TTFRTTVT
//
ID   EPHA3_HUMAN             Reviewed;         983 AA.
AC   P29320; Q9H2V3; Q9H2V4;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   28-FEB-2018, entry version 195.
DE   RecName: Full=Ephrin type-A receptor 3;
DE            EC=2.7.10.1;
DE   AltName: Full=EPH-like kinase 4;
DE            Short=EK4;
DE            Short=hEK4;
DE   AltName: Full=HEK;
DE            Short=Human embryo kinase;
DE   AltName: Full=Tyrosine-protein kinase TYRO4;
DE   AltName: Full=Tyrosine-protein kinase receptor ETK1;
DE            Short=Eph-like tyrosine kinase 1;
DE   Flags: Precursor;
GN   Name=EPHA3; Synonyms=ETK, ETK1, HEK, TYRO4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ARG-924.
RX   PubMed=1311845; DOI=10.1073/pnas.89.5.1611;
RA   Wicks I.P., Wilkinson D., Salvaris E., Boyd A.W.;
RT   "Molecular cloning of HEK, the gene encoding a receptor tyrosine
RT   kinase expressed by human lymphoid tumor cell lines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:1611-1615(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Melanoma;
RX   PubMed=10987298;
RA   Chiari R., Hames G., Stroobant V., Texier C., Maillere B., Boon T.,
RA   Coulie P.G.;
RT   "Identification of a tumor-specific shared antigen derived from an Eph
RT   receptor and presented to CD4 T cells on HLA class II molecules.";
RL   Cancer Res. 60:4855-4863(2000).
RN   [3]
RP   PROTEIN SEQUENCE OF 21-29 AND 840-860, AND CHARACTERIZATION.
RX   PubMed=1737782;
RA   Boyd A.W., Ward L.D., Wicks I.P., Simpson R.J., Salvaris E., Wilks A.,
RA   Welch K., Loudovaris M., Rockman S., Busmanis I.;
RT   "Isolation and characterization of a novel receptor-type protein
RT   tyrosine kinase (hek) from a human pre-B cell line.";
RL   J. Biol. Chem. 267:3262-3267(1992).
RN   [4]
RP   NOMENCLATURE.
RX   PubMed=9267020;
RG   Eph nomenclature committee;
RT   "Unified nomenclature for Eph family receptors and their ligands, the
RT   ephrins.";
RL   Cell 90:403-404(1997).
RN   [5]
RP   FUNCTION IN CELL-CELL ADHESION, EFNA5-BINDING, SUBCELLULAR LOCATION
RP   (ISOFORM 1), INTERACTION WITH CRK, AND PHOSPHORYLATION AT TYR-596;
RP   TYR-602 AND TYR-779.
RX   PubMed=11870224;
RA   Lawrenson I.D., Wimmer-Kleikamp S.H., Lock P., Schoenwaelder S.M.,
RA   Down M., Boyd A.W., Alewood P.F., Lackmann M.;
RT   "Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-
RT   expressing 293T and melanoma cells by CrkII and Rho-mediated
RT   signalling.";
RL   J. Cell Sci. 115:1059-1072(2002).
RN   [6]
RP   INVOLVEMENT IN CRC.
RX   PubMed=12738854; DOI=10.1126/science.1082596;
RA   Bardelli A., Parsons D.W., Silliman N., Ptak J., Szabo S., Saha S.,
RA   Markowitz S., Willson J.K., Parmigiani G., Kinzler K.W.,
RA   Vogelstein B., Velculescu V.E.;
RT   "Mutational analysis of the tyrosine kinome in colorectal cancers.";
RL   Science 300:949-949(2003).
RN   [7]
RP   EPHRIN LIGAND-BINDING, OLIGOMERIZATION, MUTAGENESIS OF VAL-133 AND
RP   PHE-152, AND INTERACTION WITH CRK.
RX   PubMed=14660665; DOI=10.1074/jbc.M309326200;
RA   Smith F.M., Vearing C., Lackmann M., Treutlein H., Himanen J.,
RA   Chen K., Saul A., Nikolov D., Boyd A.W.;
RT   "Dissecting the EphA3/Ephrin-A5 interactions using a novel functional
RT   mutagenesis screen.";
RL   J. Biol. Chem. 279:9522-9531(2004).
RN   [8]
RP   IDENTIFICATION IN A COMPLEX WITH ADAM10 AND EFNA5.
RX   PubMed=16239146; DOI=10.1016/j.cell.2005.08.014;
RA   Janes P.W., Saha N., Barton W.A., Kolev M.V., Wimmer-Kleikamp S.H.,
RA   Nievergall E., Blobel C.P., Himanen J.P., Lackmann M., Nikolov D.B.;
RT   "Adam meets Eph: an ADAM substrate recognition module acts as a
RT   molecular switch for ephrin cleavage in trans.";
RL   Cell 123:291-304(2005).
RN   [9]
RP   EFNA5 LIGAND-BINDING.
RX   PubMed=15901737; DOI=10.1074/jbc.M504972200;
RA   Day B., To C., Himanen J.P., Smith F.M., Nikolov D.B., Boyd A.W.,
RA   Lackmann M.;
RT   "Three distinct molecular surfaces in ephrin-A5 are essential for a
RT   functional interaction with EphA3.";
RL   J. Biol. Chem. 280:26526-26532(2005).
RN   [10]
RP   INTERACTION WITH PTPN1, PHOSPHORYLATION, DEPHOSPHORYLATION BY PTPN1,
RP   AND SUBCELLULAR LOCATION (ISOFORM 2).
RX   PubMed=21135139; DOI=10.1083/jcb.201005035;
RA   Nievergall E., Janes P.W., Stegmayer C., Vail M.E., Haj F.G.,
RA   Teng S.W., Neel B.G., Bastiaens P.I., Lackmann M.;
RT   "PTP1B regulates Eph receptor function and trafficking.";
RL   J. Cell Biol. 191:1189-1203(2010).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.07 ANGSTROMS) OF 577-947 IN COMPLEX WITH ATP
RP   ANALOG, IDENTIFICATION BY MASS SPECTROMETRY, PHOSPHORYLATION AT
RP   TYR-596; TYR-602 AND TYR-701, AND MUTAGENESIS OF TYR-596; TYR-602;
RP   TYR-742 AND SER-768.
RX   PubMed=18547520; DOI=10.1016/j.str.2008.03.008;
RA   Davis T.L., Walker J.R., Loppnau P., Butler-Cole C.,
RA   Allali-Hassani A., Dhe-Paganon S.;
RT   "Autoregulation by the juxtamembrane region of the human ephrin
RT   receptor tyrosine kinase A3 (EphA3).";
RL   Structure 16:873-884(2008).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-37; SER-85; LEU-621 AND ASN-806.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [13]
RP   VARIANTS LYS-660 AND MET-933.
RX   PubMed=16941478; DOI=10.1002/humu.9452;
RA   Wood L.D., Calhoun E.S., Silliman N., Ptak J., Szabo S., Powell S.M.,
RA   Riggins G.J., Wang T.L., Yan H., Gazdar A., Kern S.E., Pennacchio L.,
RA   Kinzler K.W., Vogelstein B., Velculescu V.E.;
RT   "Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers.";
RL   Hum. Mutat. 27:1060-1061(2006).
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] TYR-229; PHE-449; LEU-518; VAL-564;
RP   SER-568; PRO-590; GLU-766; GLY-777; HIS-914 AND ARG-924.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [15]
RP   VARIANT ASN-207.
RX   PubMed=20838624; DOI=10.1371/journal.pone.0012653;
RA   Corbo V., Ritelli R., Barbi S., Funel N., Campani D., Bardelli A.,
RA   Scarpa A.;
RT   "Mutational profiling of kinases in human tumours of pancreatic origin
RT   identifies candidate cancer genes in ductal and ampulla of vater
RT   carcinomas.";
RL   PLoS ONE 5:E12653-E12653(2010).
CC   -!- FUNCTION: Receptor tyrosine kinase which binds promiscuously
CC       membrane-bound ephrin family ligands residing on adjacent cells,
CC       leading to contact-dependent bidirectional signaling into
CC       neighboring cells. The signaling pathway downstream of the
CC       receptor is referred to as forward signaling while the signaling
CC       pathway downstream of the ephrin ligand is referred to as reverse
CC       signaling. Highly promiscuous for ephrin-A ligands it binds
CC       preferentially EFNA5. Upon activation by EFNA5 regulates cell-cell
CC       adhesion, cytoskeletal organization and cell migration. Plays a
CC       role in cardiac cells migration and differentiation and regulates
CC       the formation of the atrioventricular canal and septum during
CC       development probably through activation by EFNA1. Involved in the
CC       retinotectal mapping of neurons. May also control the segregation
CC       but not the guidance of motor and sensory axons during
CC       neuromuscular circuit development. {ECO:0000269|PubMed:11870224}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028}.
CC   -!- SUBUNIT: Heterotetramer upon binding of the ligand. The
CC       heterotetramer is composed of an ephrin dimer and a receptor
CC       dimer. Oligomerization is probably required to induce biological
CC       responses. Forms a ternary EFNA5-EPHA3-ADAM10 complex mediating
CC       EFNA5 extracellular domain shedding by ADAM10 which regulates the
CC       EFNA5-EPHA3 complex internalization and function. Interacts with
CC       NCK1 (via SH2 domain); mediates EFNA5-EPHA3 signaling (By
CC       similarity). Interacts (phosphorylated) with PTPN1;
CC       dephosphorylates EPHA3 and may regulate its trafficking and
CC       function. Interacts (phosphorylated) with CRK; mediates EFNA5-
CC       EPHA3 signaling through RHOA GTPase activation. {ECO:0000250,
CC       ECO:0000269|PubMed:11870224, ECO:0000269|PubMed:14660665,
CC       ECO:0000269|PubMed:16239146, ECO:0000269|PubMed:18547520,
CC       ECO:0000269|PubMed:21135139}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane
CC       {ECO:0000269|PubMed:11870224}; Single-pass type I membrane protein
CC       {ECO:0000255}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Secreted
CC       {ECO:0000269|PubMed:21135139}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P29320-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P29320-2; Sequence=VSP_002995, VSP_002996;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highest level in placenta.
CC   -!- PTM: Autophosphorylates upon activation by EFNA5. Phosphorylation
CC       on Tyr-602 mediates interaction with NCK1. Dephosphorylated by
CC       PTPN1. {ECO:0000269|PubMed:11870224, ECO:0000269|PubMed:18547520,
CC       ECO:0000269|PubMed:21135139}.
CC   -!- DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease
CC       characterized by malignant lesions arising from the inner wall of
CC       the large intestine (the colon) and the rectum. Genetic
CC       alterations are often associated with progression from
CC       premalignant lesion (adenoma) to invasive adenocarcinoma. Risk
CC       factors for cancer of the colon and rectum include colon polyps,
CC       long-standing ulcerative colitis, and genetic family history.
CC       {ECO:0000269|PubMed:12738854}. Note=The gene represented in this
CC       entry may be involved in disease pathogenesis.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/EPHA3ID40463ch3p11.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M83941; AAA58633.1; -; mRNA.
DR   EMBL; AF213459; AAG43576.1; -; mRNA.
DR   EMBL; AF213460; AAG43577.1; -; mRNA.
DR   CCDS; CCDS2922.1; -. [P29320-1]
DR   CCDS; CCDS46875.1; -. [P29320-2]
DR   PIR; A38224; A38224.
DR   RefSeq; NP_005224.2; NM_005233.5. [P29320-1]
DR   RefSeq; NP_872585.1; NM_182644.2. [P29320-2]
DR   UniGene; Hs.123642; -.
DR   PDB; 2GSF; X-ray; 1.77 A; A=577-947.
DR   PDB; 2QO2; X-ray; 1.60 A; A=577-947.
DR   PDB; 2QO7; X-ray; 1.60 A; A=577-947.
DR   PDB; 2QO9; X-ray; 1.55 A; A=577-947.
DR   PDB; 2QOB; X-ray; 1.65 A; A=609-947.
DR   PDB; 2QOC; X-ray; 1.25 A; A=609-947.
DR   PDB; 2QOD; X-ray; 1.15 A; A=577-947.
DR   PDB; 2QOF; X-ray; 1.20 A; A=577-947.
DR   PDB; 2QOI; X-ray; 1.25 A; A=577-947.
DR   PDB; 2QOK; X-ray; 1.20 A; A=577-947.
DR   PDB; 2QOL; X-ray; 1.07 A; A=577-947.
DR   PDB; 2QON; X-ray; 1.79 A; A=577-947.
DR   PDB; 2QOO; X-ray; 1.25 A; A=577-947.
DR   PDB; 2QOQ; X-ray; 1.60 A; A=577-947.
DR   PDB; 3DZQ; X-ray; 1.75 A; A=609-947.
DR   PDB; 3FXX; X-ray; 1.70 A; A=577-947.
DR   PDB; 3FY2; X-ray; 1.80 A; A=577-947.
DR   PDB; 4G2F; X-ray; 1.70 A; A=609-947.
DR   PDB; 4GK2; X-ray; 2.20 A; A=609-947.
DR   PDB; 4GK3; X-ray; 1.90 A; A=609-947.
DR   PDB; 4GK4; X-ray; 2.10 A; A=609-947.
DR   PDB; 4L0P; X-ray; 2.26 A; A=29-201.
DR   PDB; 4P4C; X-ray; 1.60 A; A=609-947.
DR   PDB; 4P5Q; X-ray; 1.35 A; A=606-947.
DR   PDB; 4P5Z; X-ray; 2.00 A; A=606-947.
DR   PDB; 4TWN; X-ray; 1.71 A; A=609-947.
DR   PDB; 4TWO; X-ray; 2.05 A; A=609-947.
DR   PDBsum; 2GSF; -.
DR   PDBsum; 2QO2; -.
DR   PDBsum; 2QO7; -.
DR   PDBsum; 2QO9; -.
DR   PDBsum; 2QOB; -.
DR   PDBsum; 2QOC; -.
DR   PDBsum; 2QOD; -.
DR   PDBsum; 2QOF; -.
DR   PDBsum; 2QOI; -.
DR   PDBsum; 2QOK; -.
DR   PDBsum; 2QOL; -.
DR   PDBsum; 2QON; -.
DR   PDBsum; 2QOO; -.
DR   PDBsum; 2QOQ; -.
DR   PDBsum; 3DZQ; -.
DR   PDBsum; 3FXX; -.
DR   PDBsum; 3FY2; -.
DR   PDBsum; 4G2F; -.
DR   PDBsum; 4GK2; -.
DR   PDBsum; 4GK3; -.
DR   PDBsum; 4GK4; -.
DR   PDBsum; 4L0P; -.
DR   PDBsum; 4P4C; -.
DR   PDBsum; 4P5Q; -.
DR   PDBsum; 4P5Z; -.
DR   PDBsum; 4TWN; -.
DR   PDBsum; 4TWO; -.
DR   ProteinModelPortal; P29320; -.
DR   SMR; P29320; -.
DR   BioGrid; 108356; 28.
DR   DIP; DIP-40307N; -.
DR   IntAct; P29320; 9.
DR   MINT; P29320; -.
DR   STRING; 9606.ENSP00000337451; -.
DR   BindingDB; P29320; -.
DR   ChEMBL; CHEMBL4954; -.
DR   GuidetoPHARMACOLOGY; 1823; -.
DR   iPTMnet; P29320; -.
DR   PhosphoSitePlus; P29320; -.
DR   BioMuta; EPHA3; -.
DR   DMDM; 116241351; -.
DR   MaxQB; P29320; -.
DR   PaxDb; P29320; -.
DR   PeptideAtlas; P29320; -.
DR   PRIDE; P29320; -.
DR   DNASU; 2042; -.
DR   Ensembl; ENST00000336596; ENSP00000337451; ENSG00000044524. [P29320-1]
DR   Ensembl; ENST00000452448; ENSP00000399926; ENSG00000044524. [P29320-2]
DR   GeneID; 2042; -.
DR   KEGG; hsa:2042; -.
DR   UCSC; uc003dqx.2; human. [P29320-1]
DR   CTD; 2042; -.
DR   DisGeNET; 2042; -.
DR   EuPathDB; HostDB:ENSG00000044524.10; -.
DR   GeneCards; EPHA3; -.
DR   HGNC; HGNC:3387; EPHA3.
DR   HPA; CAB010462; -.
DR   MIM; 114500; phenotype.
DR   MIM; 179611; gene.
DR   neXtProt; NX_P29320; -.
DR   OpenTargets; ENSG00000044524; -.
DR   PharmGKB; PA27819; -.
DR   eggNOG; KOG0196; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000118975; -.
DR   HOGENOM; HOG000233856; -.
DR   HOVERGEN; HBG062180; -.
DR   InParanoid; P29320; -.
DR   KO; K05104; -.
DR   OMA; SSCDTIA; -.
DR   OrthoDB; EOG091G00W0; -.
DR   PhylomeDB; P29320; -.
DR   TreeFam; TF315608; -.
DR   BRENDA; 2.7.10.1; 2681.
DR   Reactome; R-HSA-2682334; EPH-Ephrin signaling.
DR   Reactome; R-HSA-3928663; EPHA-mediated growth cone collapse.
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   SignaLink; P29320; -.
DR   SIGNOR; P29320; -.
DR   ChiTaRS; EPHA3; human.
DR   EvolutionaryTrace; P29320; -.
DR   GeneWiki; EPH_receptor_A3; -.
DR   GenomeRNAi; 2042; -.
DR   PRO; PR:P29320; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000044524; -.
DR   CleanEx; HS_EPHA3; -.
DR   ExpressionAtlas; P29320; baseline and differential.
DR   Genevisible; P29320; HS.
DR   GO; GO:0005769; C:early endosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005004; F:GPI-linked ephrin receptor activity; IDA:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0016477; P:cell migration; ISS:UniProtKB.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IMP:BHF-UCL.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0097156; P:fasciculation of motor neuron axon; ISS:UniProtKB.
DR   GO; GO:0097155; P:fasciculation of sensory neuron axon; ISS:UniProtKB.
DR   GO; GO:0045806; P:negative regulation of endocytosis; IDA:UniProtKB.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IMP:BHF-UCL.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; IDA:UniProtKB.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; IDA:UniProtKB.
DR   GO; GO:0010717; P:regulation of epithelial to mesenchymal transition; ISS:UniProtKB.
DR   GO; GO:0051893; P:regulation of focal adhesion assembly; IDA:UniProtKB.
DR   GO; GO:0043087; P:regulation of GTPase activity; IDA:UniProtKB.
DR   GO; GO:0070507; P:regulation of microtubule cytoskeleton organization; IDA:UniProtKB.
DR   CDD; cd10481; EphR_LBD_A3; 1.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 2.60.120.260; -; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR027936; Eph_TM.
DR   InterPro; IPR034266; EphA3_rcpt_lig-bd.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016257; Tyr_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_kinase_rcpt_V_CS.
DR   Pfam; PF14575; EphA2_TM; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF07699; Ephrin_rec_like; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF07647; SAM_2; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM01411; Ephrin_rec_like; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS51550; EPH_LBD; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell adhesion;
KW   Cell membrane; Complete proteome; Direct protein sequencing;
KW   Glycoprotein; Kinase; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Receptor; Reference proteome; Repeat; Secreted; Signal;
KW   Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase.
FT   SIGNAL        1     20       {ECO:0000269|PubMed:1737782}.
FT   CHAIN        21    983       Ephrin type-A receptor 3.
FT                                /FTId=PRO_0000016802.
FT   TOPO_DOM     21    541       Extracellular. {ECO:0000255}.
FT   TRANSMEM    542    565       Helical. {ECO:0000255}.
FT   TOPO_DOM    566    983       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       29    207       Eph LBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00883}.
FT   DOMAIN      325    435       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      436    531       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      621    882       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      911    975       SAM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00184}.
FT   NP_BIND     628    633       ATP.
FT   NP_BIND     700    706       ATP.
FT   NP_BIND     750    751       ATP.
FT   MOTIF       981    983       PDZ-binding. {ECO:0000255}.
FT   COMPBIAS    189    322       Cys-rich.
FT   ACT_SITE    746    746       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     653    653       ATP.
FT   MOD_RES     596    596       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:11870224,
FT                                ECO:0000269|PubMed:18547520}.
FT   MOD_RES     602    602       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:11870224,
FT                                ECO:0000269|PubMed:18547520}.
FT   MOD_RES     701    701       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:18547520}.
FT   MOD_RES     779    779       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:11870224}.
FT   MOD_RES     937    937       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P29319}.
FT   CARBOHYD    232    232       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    337    337       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    391    391       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    404    404       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    493    493       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     532    539       SFSISGES -> CMYYFNAV (in isoform 2).
FT                                {ECO:0000303|PubMed:10987298}.
FT                                /FTId=VSP_002995.
FT   VAR_SEQ     540    983       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10987298}.
FT                                /FTId=VSP_002996.
FT   VARIANT      37     37       T -> K (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036086.
FT   VARIANT      85     85       N -> S (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036087.
FT   VARIANT     207    207       K -> N (in a pancreatic ductal
FT                                adenocarcinoma sample; somatic mutation;
FT                                dbSNP:rs200567888).
FT                                {ECO:0000269|PubMed:20838624}.
FT                                /FTId=VAR_068853.
FT   VARIANT     229    229       S -> Y (in a lung large cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042126.
FT   VARIANT     449    449       S -> F (in a lung neuroendocrine
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042127.
FT   VARIANT     518    518       G -> L (in a lung squamous cell carcinoma
FT                                sample; somatic mutation; requires 2
FT                                nucleotide substitutions).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042128.
FT   VARIANT     564    564       I -> V (in dbSNP:rs55712516).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042129.
FT   VARIANT     568    568       C -> S (in dbSNP:rs56077781).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042130.
FT   VARIANT     590    590       L -> P (in dbSNP:rs56081642).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042131.
FT   VARIANT     621    621       I -> L (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036088.
FT   VARIANT     660    660       T -> K (in a lung carcinoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16941478}.
FT                                /FTId=VAR_065831.
FT   VARIANT     766    766       G -> E (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042132.
FT   VARIANT     777    777       A -> G (in dbSNP:rs34437982).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042133.
FT   VARIANT     806    806       D -> N (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036089.
FT   VARIANT     914    914       R -> H (in dbSNP:rs17801309).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_027919.
FT   VARIANT     924    924       W -> R (in dbSNP:rs35124509).
FT                                {ECO:0000269|PubMed:1311845,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042134.
FT   VARIANT     933    933       T -> M (in a lung carcinoma sample;
FT                                somatic mutation; dbSNP:rs372594677).
FT                                {ECO:0000269|PubMed:16941478}.
FT                                /FTId=VAR_065832.
FT   MUTAGEN     133    133       V->E: Loss of EFNA5-binding ability and
FT                                function. {ECO:0000269|PubMed:14660665}.
FT   MUTAGEN     152    152       F->L: Loss of EFNA5-binding ability and
FT                                function. {ECO:0000269|PubMed:14660665}.
FT   MUTAGEN     596    596       Y->F: 10-fold suppression of kinase
FT                                activity; when associated with F-602.
FT                                Full kinase activity; when associated
FT                                with F-602 and F-742. Full kinase
FT                                activity; when associated with F-602 and
FT                                A-768. {ECO:0000269|PubMed:18547520}.
FT   MUTAGEN     602    602       Y->F: 10-fold suppression of kinase
FT                                activity; when associated with F-596.
FT                                Full kinase activity; when associated
FT                                with F-596 and F-742. Full kinase
FT                                activity; when associated with F-596 and
FT                                A-768. {ECO:0000269|PubMed:18547520}.
FT   MUTAGEN     742    742       Y->F: Full kinase activity; when
FT                                associated with F-596 and F-602.
FT                                {ECO:0000269|PubMed:18547520}.
FT   MUTAGEN     768    768       S->A: Full kinase activity; when
FT                                associated with F-596 and F-602.
FT                                {ECO:0000269|PubMed:18547520}.
FT   CONFLICT    911    911       T -> S (in Ref. 1; AAA58633).
FT                                {ECO:0000305}.
FT   STRAND       29     34       {ECO:0000244|PDB:4L0P}.
FT   TURN         38     41       {ECO:0000244|PDB:4L0P}.
FT   STRAND       45     48       {ECO:0000244|PDB:4L0P}.
FT   STRAND       51     58       {ECO:0000244|PDB:4L0P}.
FT   STRAND       64     71       {ECO:0000244|PDB:4L0P}.
FT   STRAND       75     77       {ECO:0000244|PDB:4L0P}.
FT   STRAND       80     83       {ECO:0000244|PDB:4L0P}.
FT   STRAND       96    104       {ECO:0000244|PDB:4L0P}.
FT   HELIX       106    108       {ECO:0000244|PDB:4L0P}.
FT   STRAND      117    128       {ECO:0000244|PDB:4L0P}.
FT   STRAND      130    132       {ECO:0000244|PDB:4L0P}.
FT   HELIX       137    139       {ECO:0000244|PDB:4L0P}.
FT   STRAND      141    147       {ECO:0000244|PDB:4L0P}.
FT   HELIX       154    159       {ECO:0000244|PDB:4L0P}.
FT   STRAND      165    170       {ECO:0000244|PDB:4L0P}.
FT   STRAND      176    200       {ECO:0000244|PDB:4L0P}.
FT   TURN        610    612       {ECO:0000244|PDB:2QOL}.
FT   HELIX       618    620       {ECO:0000244|PDB:2QOL}.
FT   STRAND      621    629       {ECO:0000244|PDB:2QOL}.
FT   STRAND      631    641       {ECO:0000244|PDB:2QOL}.
FT   STRAND      647    654       {ECO:0000244|PDB:2QOL}.
FT   HELIX       661    674       {ECO:0000244|PDB:2QOL}.
FT   STRAND      685    689       {ECO:0000244|PDB:2QOL}.
FT   STRAND      691    694       {ECO:0000244|PDB:2QOL}.
FT   STRAND      696    700       {ECO:0000244|PDB:2QOL}.
FT   HELIX       707    712       {ECO:0000244|PDB:2QOL}.
FT   TURN        713    716       {ECO:0000244|PDB:2QOL}.
FT   HELIX       720    739       {ECO:0000244|PDB:2QOL}.
FT   HELIX       749    751       {ECO:0000244|PDB:2QOL}.
FT   STRAND      752    754       {ECO:0000244|PDB:2QOL}.
FT   STRAND      760    762       {ECO:0000244|PDB:2QOL}.
FT   HELIX       765    768       {ECO:0000244|PDB:4TWN}.
FT   HELIX       788    790       {ECO:0000244|PDB:2QOD}.
FT   HELIX       793    798       {ECO:0000244|PDB:2QOL}.
FT   HELIX       803    818       {ECO:0000244|PDB:2QOL}.
FT   TURN        819    821       {ECO:0000244|PDB:2QO9}.
FT   TURN        824    827       {ECO:0000244|PDB:2QOL}.
FT   HELIX       830    838       {ECO:0000244|PDB:2QOL}.
FT   HELIX       851    860       {ECO:0000244|PDB:2QOL}.
FT   HELIX       865    867       {ECO:0000244|PDB:2QOL}.
FT   HELIX       871    883       {ECO:0000244|PDB:2QOL}.
FT   HELIX       885    889       {ECO:0000244|PDB:2QOL}.
FT   STRAND      890    892       {ECO:0000244|PDB:4G2F}.
FT   STRAND      898    903       {ECO:0000244|PDB:2QOC}.
SQ   SEQUENCE   983 AA;  110131 MW;  BE04DBF958245424 CRC64;
     MDCQLSILLL LSCSVLDSFG ELIPQPSNEV NLLDSKTIQG ELGWISYPSH GWEEISGVDE
     HYTPIRTYQV CNVMDHSQNN WLRTNWVPRN SAQKIYVELK FTLRDCNSIP LVLGTCKETF
     NLYYMESDDD HGVKFREHQF TKIDTIAADE SFTQMDLGDR ILKLNTEIRE VGPVNKKGFY
     LAFQDVGACV ALVSVRVYFK KCPFTVKNLA MFPDTVPMDS QSLVEVRGSC VNNSKEEDPP
     RMYCSTEGEW LVPIGKCSCN AGYEERGFMC QACRPGFYKA LDGNMKCAKC PPHSSTQEDG
     SMNCRCENNY FRADKDPPSM ACTRPPSSPR NVISNINETS VILDWSWPLD TGGRKDVTFN
     IICKKCGWNI KQCEPCSPNV RFLPRQFGLT NTTVTVTDLL AHTNYTFEID AVNGVSELSS
     PPRQFAAVSI TTNQAAPSPV LTIKKDRTSR NSISLSWQEP EHPNGIILDY EVKYYEKQEQ
     ETSYTILRAR GTNVTISSLK PDTIYVFQIR ARTAAGYGTN SRKFEFETSP DSFSISGESS
     QVVMIAISAA VAIILLTVVI YVLIGRFCGY KSKHGADEKR LHFGNGHLKL PGLRTYVDPH
     TYEDPTQAVH EFAKELDATN ISIDKVVGAG EFGEVCSGRL KLPSKKEISV AIKTLKVGYT
     EKQRRDFLGE ASIMGQFDHP NIIRLEGVVT KSKPVMIVTE YMENGSLDSF LRKHDAQFTV
     IQLVGMLRGI ASGMKYLSDM GYVHRDLAAR NILINSNLVC KVSDFGLSRV LEDDPEAAYT
     TRGGKIPIRW TSPEAIAYRK FTSASDVWSY GIVLWEVMSY GERPYWEMSN QDVIKAVDEG
     YRLPPPMDCP AALYQLMLDC WQKDRNNRPK FEQIVSILDK LIRNPGSLKI ITSAAARPSN
     LLLDQSNVDI TTFRTTGDWL NGVWTAHCKE IFTGVEYSSC DTIAKISTDD MKKVGVTVVG
     PQKKIISSIK ALETQSKNGP VPV
//
ID   Q6P4R6_HUMAN            Unreviewed;       983 AA.
AC   Q6P4R6;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   28-FEB-2018, entry version 129.
DE   SubName: Full=EPH receptor A3 {ECO:0000313|EMBL:AAH63282.1};
GN   Name=EPHA3 {ECO:0000313|EMBL:AAH63282.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH63282.1};
RN   [1] {ECO:0000313|EMBL:AAH63282.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta {ECO:0000313|EMBL:AAH63282.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000256|SAAS:SAAS00701269}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. {ECO:0000256|SAAS:SAAS00941529}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC063282; AAH63282.1; -; mRNA.
DR   RefSeq; NP_005224.2; NM_005233.5.
DR   UniGene; Hs.123642; -.
DR   ProteinModelPortal; Q6P4R6; -.
DR   PeptideAtlas; Q6P4R6; -.
DR   DNASU; 2042; -.
DR   GeneID; 2042; -.
DR   KEGG; hsa:2042; -.
DR   CTD; 2042; -.
DR   PharmGKB; PA27819; -.
DR   eggNOG; KOG0196; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   HOVERGEN; HBG062180; -.
DR   KO; K05104; -.
DR   ChiTaRS; EPHA3; human.
DR   GenomeRNAi; 2042; -.
DR   Genevisible; Q6P4R6; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005003; F:ephrin receptor activity; IEA:InterPro.
DR   CDD; cd10481; EphR_LBD_A3; 1.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 2.60.120.260; -; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR027936; Eph_TM.
DR   InterPro; IPR034266; EphA3_rcpt_lig-bd.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016257; Tyr_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_kinase_rcpt_V_CS.
DR   Pfam; PF14575; EphA2_TM; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF07699; Ephrin_rec_like; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF07647; SAM_2; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM01411; Ephrin_rec_like; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS51550; EPH_LBD; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|PIRSR:PIRSR000666-2,
KW   ECO:0000256|SAAS:SAAS00708816};
KW   Kinase {ECO:0000256|SAAS:SAAS00582553};
KW   Membrane {ECO:0000256|SAAS:SAAS00602683, ECO:0000256|SAM:Phobius};
KW   Nucleotide-binding {ECO:0000256|PIRSR:PIRSR000666-2,
KW   ECO:0000256|SAAS:SAAS00708816};
KW   Receptor {ECO:0000256|SAAS:SAAS00600436, ECO:0000313|EMBL:AAH63282.1};
KW   Repeat {ECO:0000256|SAAS:SAAS00786331};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transferase {ECO:0000256|SAAS:SAAS00582553};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00602683,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00602683,
KW   ECO:0000256|SAM:Phobius};
KW   Tyrosine-protein kinase {ECO:0000256|SAAS:SAAS00582553}.
FT   SIGNAL        1     20       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        21    983       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004278260.
FT   TRANSMEM    542    564       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       29    207       Eph LBD. {ECO:0000259|PROSITE:PS51550}.
FT   DOMAIN      325    435       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      436    531       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      621    882       Protein kinase.
FT                                {ECO:0000259|PROSITE:PS50011}.
FT   DOMAIN      911    975       SAM. {ECO:0000259|PROSITE:PS50105}.
FT   NP_BIND     627    635       ATP. {ECO:0000256|PIRSR:PIRSR000666-2}.
FT   ACT_SITE    746    746       Proton acceptor.
FT                                {ECO:0000256|PIRSR:PIRSR000666-1}.
FT   BINDING     653    653       ATP. {ECO:0000256|PIRSR:PIRSR000666-2}.
SQ   SEQUENCE   983 AA;  110161 MW;  1EBDABFC59282527 CRC64;
     MDCQLSILLL LSCSVLDSFG ELIPQPSNEV NLLDSKTIQG ELGWISYPSH GWEEISGVDE
     HYTPIRTYQV CNVMDHSQNN WLRTNWVPRN SAQKIYVELK FTLRDCNSIP LVLGTCKETF
     NLYYMESDDD HGVKFREHQF TKIDTIAADE SFTQMDLGDR ILKLNTEIRE VGPVNKKGFY
     LAFQDVGACV ALVSVRVYFK KCPFTVKNLA MFPDTVPMDS QSLVEVRGSC VNNSKEEDPP
     RMYCSTEGEW LVPIGKCSCN AGYEERGFMC QACRPGFYKA LDGNMKCAKC PPHSSTQEDG
     SMNCRCENNY FRADKDPPSM ACTRPPSSPR NVISNINETS VILDWSWPLD TGGRKDVTFN
     IICKKCGWNI KQCEPCSPNV RFLPRQFGLT NTTVTVTDLL AHTNYTFEID AVNGVSELSS
     PPRQFAAVSI TTNQAAPSPV LTIKKDRTSR NSISLSWQEP EHPNGIILDY EVKYYEKQEQ
     ETSYTILRAR GTNVTISSLK PDTIYVFQIR ARTAAGYGTN SRKFEFETSP DSFSISGESS
     QVVMIAISAA VAIILLTVVI YVLIGRFCGY KSKHGADEKR LHFGNGHLKL PGLRTYVDPH
     TYEDPTQTVH EFAKELDATN ISIDKVVGAG EFGEVCSGRL KLPSKKEISV AIKTLKVGYT
     EKQRRDFLGE ASIMGQFDHP NIIRLEGVVT KSKPVMIVTE YMENGSLDSF LRKHDAQFTV
     IQLVGMLRGI ASGMKYLSDM GYVHRDLAAR NILINSNLVC KVSDFGLSRV LEDDPEAAYT
     TRGGKIPIRW TSPEAIAYRK FTSASDVWSY GIVLWEVMSY GERPYWEMSN QDVIKAVDEG
     YRLPPPMDCP AALYQLMLDC WQKDRNNRPK FEQIVSILDK LIRNPGSLKI ITSAAARPSN
     LLLDQSNVDI TTFRTTGDWL NGVWTAHCKE IFTGVEYSSC DTIAKISTDD MKKVGVTVVG
     PQKKIISSIK ALETQSKNGP VPV
//
ID   EPHA7_HUMAN             Reviewed;         998 AA.
AC   Q15375; A0AUX7; B2R8W1; B7ZLJ9; B7ZLK0; Q59G40; Q5VTU0; Q8N368;
AC   Q9H124;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 3.
DT   28-FEB-2018, entry version 191.
DE   RecName: Full=Ephrin type-A receptor 7;
DE            EC=2.7.10.1;
DE   AltName: Full=EPH homology kinase 3;
DE            Short=EHK-3;
DE   AltName: Full=EPH-like kinase 11;
DE            Short=EK11;
DE            Short=hEK11;
DE   Flags: Precursor;
GN   Name=EPHA7; Synonyms=EHK3, HEK11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=7898931;
RA   Fox G.M., Holst P.L., Chute H.T., Lindberg R.A., Janssen A.M.,
RA   Basu R., Welcher A.A.;
RT   "cDNA cloning and tissue distribution of five human EPH-like receptor
RT   protein-tyrosine kinases.";
RL   Oncogene 10:897-905(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2; 3 AND 4), AND
RP   VARIANT VAL-138.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NOMENCLATURE.
RX   PubMed=9267020;
RG   Eph nomenclature committee;
RT   "Unified nomenclature for Eph family receptors and their ligands, the
RT   ephrins.";
RL   Cell 90:403-404(1997).
RN   [8]
RP   FUNCTION IN MAP2K1; MAP2K2; MAPK1 AND MAPK3 PHOSPHORYLATION.
RX   PubMed=17726105; DOI=10.1073/pnas.0703211104;
RA   Nakanishi H., Nakamura T., Canaani E., Croce C.M.;
RT   "ALL1 fusion proteins induce deregulation of EphA7 and ERK
RT   phosphorylation in human acute leukemias.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:14442-14447(2007).
RN   [9]
RP   ALTERNATIVE SPLICING (ISOFORM 5).
RX   PubMed=20126984;
RA   Tsuboi M., Mori H., Bunai T., Kageyama S., Suzuki M., Okudela K.,
RA   Takamochi K., Ogawa H., Niwa H., Shinmura K., Sugimura H.;
RT   "Secreted form of EphA7 in lung cancer.";
RL   Int. J. Oncol. 36:635-640(2010).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 32-204.
RA   Walker J.R., Yermekbayeva L., Seitova A., Kania J., Bountra C.,
RA   Weigelt J., Arrowsmith C.H., Edwards A.M., Bochkarev A.,
RA   Dhe-Paganon S.;
RT   "Ephrin A7 ligand binding domain.";
RL   Submitted (JUN-2010) to the PDB data bank.
RN   [11]
RP   VARIANT [LARGE SCALE ANALYSIS] TRP-371.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-138; LYS-170; ARG-232; SER-278 AND
RP   SER-903.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor tyrosine kinase which binds promiscuously GPI-
CC       anchored ephrin-A family ligands residing on adjacent cells,
CC       leading to contact-dependent bidirectional signaling into
CC       neighboring cells. The signaling pathway downstream of the
CC       receptor is referred to as forward signaling while the signaling
CC       pathway downstream of the ephrin ligand is referred to as reverse
CC       signaling. Among GPI-anchored ephrin-A ligands, EFNA5 is a
CC       cognate/functional ligand for EPHA7 and their interaction
CC       regulates brain development modulating cell-cell adhesion and
CC       repulsion. Has a repellent activity on axons and is for instance
CC       involved in the guidance of corticothalamic axons and in the
CC       proper topographic mapping of retinal axons to the colliculus. May
CC       also regulate brain development through a caspase(CASP3)-dependent
CC       proapoptotic activity. Forward signaling may result in activation
CC       of components of the ERK signaling pathway including MAP2K1,
CC       MAP2K2, MAPK1 AND MAPK3 which are phosphorylated upon activation
CC       of EPHA7. {ECO:0000269|PubMed:17726105}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028}.
CC   -!- SUBUNIT: Heterotetramer upon binding of the ligand. The
CC       heterotetramer is composed of an ephrin dimer and a receptor
CC       dimer. Oligomerization is probably required to induce biological
CC       responses (By similarity). Interacts (via PDZ-binding motif) with
CC       GRIP1 and PICK1 (via PDZ domain) (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P52793:Efna1 (xeno); NbExp=2; IntAct=EBI-1383428, EBI-5241529;
CC       P29317:EPHA2; NbExp=3; IntAct=EBI-1383428, EBI-702104;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass
CC       type I membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=EPHA7-FL;
CC         IsoId=Q15375-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15375-2; Sequence=VSP_014382;
CC         Note=May be due to a competing donor splice site.;
CC       Name=3;
CC         IsoId=Q15375-3; Sequence=VSP_014380, VSP_014381;
CC         Note=No experimental confirmation available. Ref.6 (AAH27940)
CC         sequence is in conflict in position: 278:R->C. {ECO:0000305};
CC       Name=4;
CC         IsoId=Q15375-4; Sequence=VSP_041945;
CC         Note=No experimental confirmation available.;
CC       Name=5; Synonyms=EPHA7-S;
CC         IsoId=Q15375-5; Sequence=VSP_041943, VSP_041944;
CC         Note=Expressed in lung cancer cells, lacks the kinase domain and
CC         is most probably secreted.;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC   -!- PTM: Phosphorylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92506.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/EPHA7ID40466ch6q16.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L36642; AAA74243.1; -; mRNA.
DR   EMBL; AK313529; BAG36308.1; -; mRNA.
DR   EMBL; AB209269; BAD92506.1; ALT_INIT; mRNA.
DR   EMBL; AL121966; CAC19520.2; -; Genomic_DNA.
DR   EMBL; AL354857; CAH72780.1; -; Genomic_DNA.
DR   EMBL; AL121966; CAH72780.1; JOINED; Genomic_DNA.
DR   EMBL; AL591036; CAH72780.1; JOINED; Genomic_DNA.
DR   EMBL; AL591036; CAH73650.1; -; Genomic_DNA.
DR   EMBL; AL121966; CAH73650.1; JOINED; Genomic_DNA.
DR   EMBL; AL354857; CAH73650.1; JOINED; Genomic_DNA.
DR   EMBL; AL121966; CAI19722.1; -; Genomic_DNA.
DR   EMBL; AL354857; CAI19722.1; JOINED; Genomic_DNA.
DR   EMBL; AL591036; CAI19722.1; JOINED; Genomic_DNA.
DR   EMBL; CH471051; EAW48518.1; -; Genomic_DNA.
DR   EMBL; BC027940; AAH27940.1; -; mRNA.
DR   EMBL; BC126125; AAI26126.1; -; mRNA.
DR   EMBL; BC126151; AAI26152.1; -; mRNA.
DR   EMBL; BC143857; AAI43858.1; -; mRNA.
DR   EMBL; BC143858; AAI43859.1; -; mRNA.
DR   CCDS; CCDS5031.1; -. [Q15375-1]
DR   CCDS; CCDS75494.1; -. [Q15375-3]
DR   PIR; I58351; I58351.
DR   RefSeq; NP_001275558.1; NM_001288629.1. [Q15375-2]
DR   RefSeq; NP_001275559.1; NM_001288630.1. [Q15375-3]
DR   RefSeq; NP_004431.1; NM_004440.3. [Q15375-1]
DR   RefSeq; XP_005248726.1; XM_005248669.2. [Q15375-4]
DR   UniGene; Hs.73962; -.
DR   PDB; 2REI; X-ray; 1.60 A; A=590-899.
DR   PDB; 3DKO; X-ray; 2.00 A; A=590-899.
DR   PDB; 3H8M; X-ray; 2.10 A; A/B=919-990.
DR   PDB; 3NRU; X-ray; 2.30 A; A/B/C/D/E/F/G/H/I/J/K/L=32-204.
DR   PDBsum; 2REI; -.
DR   PDBsum; 3DKO; -.
DR   PDBsum; 3H8M; -.
DR   PDBsum; 3NRU; -.
DR   ProteinModelPortal; Q15375; -.
DR   SMR; Q15375; -.
DR   BioGrid; 108359; 54.
DR   IntAct; Q15375; 10.
DR   MINT; Q15375; -.
DR   STRING; 9606.ENSP00000358309; -.
DR   BindingDB; Q15375; -.
DR   ChEMBL; CHEMBL4602; -.
DR   DrugBank; DB07970; 5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide.
DR   GuidetoPHARMACOLOGY; 1827; -.
DR   iPTMnet; Q15375; -.
DR   PhosphoSitePlus; Q15375; -.
DR   SwissPalm; Q15375; -.
DR   BioMuta; EPHA7; -.
DR   DMDM; 146345416; -.
DR   MaxQB; Q15375; -.
DR   PaxDb; Q15375; -.
DR   PeptideAtlas; Q15375; -.
DR   PRIDE; Q15375; -.
DR   Ensembl; ENST00000369297; ENSP00000358303; ENSG00000135333. [Q15375-3]
DR   Ensembl; ENST00000369303; ENSP00000358309; ENSG00000135333. [Q15375-1]
DR   GeneID; 2045; -.
DR   KEGG; hsa:2045; -.
DR   UCSC; uc003poe.5; human. [Q15375-1]
DR   CTD; 2045; -.
DR   DisGeNET; 2045; -.
DR   EuPathDB; HostDB:ENSG00000135333.13; -.
DR   GeneCards; EPHA7; -.
DR   HGNC; HGNC:3390; EPHA7.
DR   HPA; CAB010496; -.
DR   MIM; 602190; gene.
DR   neXtProt; NX_Q15375; -.
DR   OpenTargets; ENSG00000135333; -.
DR   PharmGKB; PA27822; -.
DR   eggNOG; KOG0196; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000118975; -.
DR   HOVERGEN; HBG062180; -.
DR   InParanoid; Q15375; -.
DR   KO; K05108; -.
DR   OMA; TRHPSWI; -.
DR   OrthoDB; EOG091G00W0; -.
DR   PhylomeDB; Q15375; -.
DR   TreeFam; TF315608; -.
DR   BRENDA; 2.7.10.1; 2681.
DR   Reactome; R-HSA-2682334; EPH-Ephrin signaling.
DR   Reactome; R-HSA-3928663; EPHA-mediated growth cone collapse.
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   SignaLink; Q15375; -.
DR   SIGNOR; Q15375; -.
DR   ChiTaRS; EPHA7; human.
DR   EvolutionaryTrace; Q15375; -.
DR   GeneWiki; EPHA7; -.
DR   GenomeRNAi; 2045; -.
DR   PRO; PR:Q15375; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000135333; -.
DR   CleanEx; HS_EPHA7; -.
DR   Genevisible; Q15375; HS.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0031594; C:neuromuscular junction; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008046; F:axon guidance receptor activity; ISS:UniProtKB.
DR   GO; GO:0045499; F:chemorepellent activity; ISS:UniProtKB.
DR   GO; GO:0046875; F:ephrin receptor binding; IEA:Ensembl.
DR   GO; GO:0005004; F:GPI-linked ephrin receptor activity; ISS:UniProtKB.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; ISS:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0007420; P:brain development; ISS:UniProtKB.
DR   GO; GO:0048755; P:branching morphogenesis of a nerve; ISS:UniProtKB.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0050919; P:negative chemotaxis; ISS:UniProtKB.
DR   GO; GO:0048671; P:negative regulation of collateral sprouting; IEA:Ensembl.
DR   GO; GO:0051964; P:negative regulation of synapse assembly; IEA:Ensembl.
DR   GO; GO:0072178; P:nephric duct morphogenesis; IEA:Ensembl.
DR   GO; GO:0016310; P:phosphorylation; ISS:UniProtKB.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IEA:Ensembl.
DR   GO; GO:0022407; P:regulation of cell-cell adhesion; ISS:UniProtKB.
DR   GO; GO:0043281; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB.
DR   GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; IDA:UniProtKB.
DR   GO; GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0031952; P:regulation of protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0031290; P:retinal ganglion cell axon guidance; IEA:Ensembl.
DR   CDD; cd10485; EphR_LBD_A7; 1.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 2.60.120.260; -; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR027936; Eph_TM.
DR   InterPro; IPR034283; EphA7_rcpt_lig-bd.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016257; Tyr_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_kinase_rcpt_V_CS.
DR   Pfam; PF14575; EphA2_TM; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF07699; Ephrin_rec_like; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00536; SAM_1; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM01411; Ephrin_rec_like; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS51550; EPH_LBD; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; ATP-binding;
KW   Cell membrane; Complete proteome; Developmental protein; Glycoprotein;
KW   Kinase; Membrane; Neurogenesis; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Receptor; Reference proteome; Repeat; Signal;
KW   Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase.
FT   SIGNAL        1     27       {ECO:0000255}.
FT   CHAIN        28    998       Ephrin type-A receptor 7.
FT                                /FTId=PRO_0000016818.
FT   TOPO_DOM     28    555       Extracellular. {ECO:0000255}.
FT   TRANSMEM    556    576       Helical. {ECO:0000255}.
FT   TOPO_DOM    577    998       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       32    210       Eph LBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00883}.
FT   DOMAIN      331    441       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      442    537       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      633    894       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      923    987       SAM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00184}.
FT   NP_BIND     639    647       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF       996    998       PDZ-binding. {ECO:0000255}.
FT   COMPBIAS    192    328       Cys-rich.
FT   ACT_SITE    758    758       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     665    665       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     608    608       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000255}.
FT   MOD_RES     614    614       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000255}.
FT   MOD_RES     791    791       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000255}.
FT   MOD_RES     940    940       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000255}.
FT   CARBOHYD    343    343       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    410    410       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     278    279       PC -> RK (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_014380.
FT   VAR_SEQ     280    998       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_014381.
FT   VAR_SEQ     442    450       APSQVSGVM -> GMFCVYLH (in isoform 5).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_041943.
FT   VAR_SEQ     451    998       Missing (in isoform 5). {ECO:0000305}.
FT                                /FTId=VSP_041944.
FT   VAR_SEQ     540    544       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_014382.
FT   VAR_SEQ     600    604       FKFPG -> C (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_041945.
FT   VARIANT     138    138       I -> V (in dbSNP:rs2278107).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_022105.
FT   VARIANT     170    170       E -> K (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042150.
FT   VARIANT     232    232       G -> R (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042151.
FT   VARIANT     278    278       P -> S (in dbSNP:rs2278106).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_022106.
FT   VARIANT     371    371       R -> W (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs371089003).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036090.
FT   VARIANT     903    903       P -> S (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042152.
FT   STRAND       33     37       {ECO:0000244|PDB:3NRU}.
FT   STRAND       48     51       {ECO:0000244|PDB:3NRU}.
FT   STRAND       54     61       {ECO:0000244|PDB:3NRU}.
FT   STRAND       67     74       {ECO:0000244|PDB:3NRU}.
FT   STRAND       78     80       {ECO:0000244|PDB:3NRU}.
FT   STRAND       83     86       {ECO:0000244|PDB:3NRU}.
FT   STRAND       96    106       {ECO:0000244|PDB:3NRU}.
FT   TURN        109    111       {ECO:0000244|PDB:3NRU}.
FT   STRAND      121    132       {ECO:0000244|PDB:3NRU}.
FT   HELIX       140    142       {ECO:0000244|PDB:3NRU}.
FT   STRAND      144    150       {ECO:0000244|PDB:3NRU}.
FT   STRAND      168    174       {ECO:0000244|PDB:3NRU}.
FT   STRAND      178    190       {ECO:0000244|PDB:3NRU}.
FT   STRAND      192    202       {ECO:0000244|PDB:3NRU}.
FT   HELIX       611    613       {ECO:0000244|PDB:2REI}.
FT   STRAND      614    616       {ECO:0000244|PDB:2REI}.
FT   HELIX       617    624       {ECO:0000244|PDB:2REI}.
FT   HELIX       630    632       {ECO:0000244|PDB:2REI}.
FT   STRAND      633    641       {ECO:0000244|PDB:2REI}.
FT   STRAND      643    652       {ECO:0000244|PDB:2REI}.
FT   STRAND      655    657       {ECO:0000244|PDB:3DKO}.
FT   STRAND      660    666       {ECO:0000244|PDB:2REI}.
FT   HELIX       673    686       {ECO:0000244|PDB:2REI}.
FT   STRAND      697    701       {ECO:0000244|PDB:2REI}.
FT   STRAND      703    705       {ECO:0000244|PDB:2REI}.
FT   STRAND      708    712       {ECO:0000244|PDB:2REI}.
FT   HELIX       719    725       {ECO:0000244|PDB:2REI}.
FT   TURN        726    728       {ECO:0000244|PDB:2REI}.
FT   HELIX       732    751       {ECO:0000244|PDB:2REI}.
FT   HELIX       761    763       {ECO:0000244|PDB:2REI}.
FT   STRAND      764    766       {ECO:0000244|PDB:2REI}.
FT   STRAND      772    774       {ECO:0000244|PDB:2REI}.
FT   HELIX       800    802       {ECO:0000244|PDB:2REI}.
FT   HELIX       805    810       {ECO:0000244|PDB:2REI}.
FT   HELIX       815    830       {ECO:0000244|PDB:2REI}.
FT   TURN        836    839       {ECO:0000244|PDB:2REI}.
FT   HELIX       842    850       {ECO:0000244|PDB:2REI}.
FT   HELIX       863    872       {ECO:0000244|PDB:2REI}.
FT   HELIX       877    879       {ECO:0000244|PDB:2REI}.
FT   HELIX       883    895       {ECO:0000244|PDB:2REI}.
FT   HELIX       897    899       {ECO:0000244|PDB:2REI}.
FT   HELIX       928    934       {ECO:0000244|PDB:3H8M}.
FT   HELIX       938    940       {ECO:0000244|PDB:3H8M}.
FT   HELIX       941    946       {ECO:0000244|PDB:3H8M}.
FT   HELIX       952    956       {ECO:0000244|PDB:3H8M}.
FT   HELIX       960    965       {ECO:0000244|PDB:3H8M}.
FT   HELIX       971    988       {ECO:0000244|PDB:3H8M}.
SQ   SEQUENCE   998 AA;  112097 MW;  479B9CA0D2BB06EB CRC64;
     MVFQTRYPSW IILCYIWLLR FAHTGEAQAA KEVLLLDSKA QQTELEWISS PPNGWEEISG
     LDENYTPIRT YQVCQVMEPN QNNWLRTNWI SKGNAQRIFV ELKFTLRDCN SLPGVLGTCK
     ETFNLYYYET DYDTGRNIRE NLYVKIDTIA ADESFTQGDL GERKMKLNTE VREIGPLSKK
     GFYLAFQDVG ACIALVSVKV YYKKCWSIIE NLAIFPDTVT GSEFSSLVEV RGTCVSSAEE
     EAENAPRMHC SAEGEWLVPI GKCICKAGYQ QKGDTCEPCG RGFYKSSSQD LQCSRCPTHS
     FSDKEGSSRC ECEDGYYRAP SDPPYVACTR PPSAPQNLIF NINQTTVSLE WSPPADNGGR
     NDVTYRILCK RCSWEQGECV PCGSNIGYMP QQTGLEDNYV TVMDLLAHAN YTFEVEAVNG
     VSDLSRSQRL FAAVSITTGQ AAPSQVSGVM KERVLQRSVE LSWQEPEHPN GVITEYEIKY
     YEKDQRERTY STVKTKSTSA SINNLKPGTV YVFQIRAFTA AGYGNYSPRL DVATLEEATG
     KMFEATAVSS EQNPVIIIAV VAVAGTIILV FMVFGFIIGR RHCGYSKADQ EGDEELYFHF
     KFPGTKTYID PETYEDPNRA VHQFAKELDA SCIKIERVIG AGEFGEVCSG RLKLPGKRDV
     AVAIKTLKVG YTEKQRRDFL CEASIMGQFD HPNVVHLEGV VTRGKPVMIV IEFMENGALD
     AFLRKHDGQF TVIQLVGMLR GIAAGMRYLA DMGYVHRDLA ARNILVNSNL VCKVSDFGLS
     RVIEDDPEAV YTTTGGKIPV RWTAPEAIQY RKFTSASDVW SYGIVMWEVM SYGERPYWDM
     SNQDVIKAIE EGYRLPAPMD CPAGLHQLML DCWQKERAER PKFEQIVGIL DKMIRNPNSL
     KTPLGTCSRP ISPLLDQNTP DFTTFCSVGE WLQAIKMERY KDNFTAAGYN SLESVARMTI
     EDVMSLGITL VGHQKKIMSS IQTMRAQMLH LHGTGIQV
//
ID   F135B_HUMAN             Reviewed;        1406 AA.
AC   Q49AJ0; B5MDB3; O95879; Q2WGJ7; Q3KP46;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   15-JAN-2008, sequence version 2.
DT   28-MAR-2018, entry version 90.
DE   RecName: Full=Protein FAM135B;
GN   Name=FAM135B; Synonyms=C8orfK32;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RA   Shimizu N., Asakawa S., Shimizu A., Yamazaki S., Ishikawa S.K.;
RT   "Novel gene on human chromosome 8.";
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 756-1406 (ISOFORM 4), AND VARIANT
RP   VAL-477.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 691-1406 (ISOFORM 3).
RC   TISSUE=Brain;
RA   Mei G., Yu W., Gibbs R.A.;
RL   Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 801-1406 (ISOFORM 3).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q49AJ0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q49AJ0-2; Sequence=VSP_030232;
CC       Name=3;
CC         IsoId=Q49AJ0-3; Sequence=VSP_030233, VSP_030234;
CC       Name=4;
CC         IsoId=Q49AJ0-4; Sequence=VSP_030235, VSP_030236;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the FAM135 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB196635; BAE53437.1; -; mRNA.
DR   EMBL; AC068467; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC087711; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC103777; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC037288; AAH37288.1; -; mRNA.
DR   EMBL; BC106912; AAI06913.2; -; mRNA.
DR   EMBL; BC106913; AAI06914.2; -; mRNA.
DR   EMBL; AF131744; AAD20030.1; -; mRNA.
DR   EMBL; CR457147; CAG33428.1; -; mRNA.
DR   CCDS; CCDS6375.2; -. [Q49AJ0-1]
DR   RefSeq; NP_056996.2; NM_015912.3. [Q49AJ0-1]
DR   RefSeq; XP_011515366.1; XM_011517064.2. [Q49AJ0-1]
DR   RefSeq; XP_011515370.1; XM_011517068.2. [Q49AJ0-2]
DR   RefSeq; XP_016868959.1; XM_017013470.1. [Q49AJ0-1]
DR   UniGene; Hs.126024; -.
DR   UniGene; Hs.662285; -.
DR   ProteinModelPortal; Q49AJ0; -.
DR   SMR; Q49AJ0; -.
DR   BioGrid; 119251; 2.
DR   IntAct; Q49AJ0; 2.
DR   STRING; 9606.ENSP00000378710; -.
DR   ESTHER; human-FAM135B; Duf_676.
DR   iPTMnet; Q49AJ0; -.
DR   PhosphoSitePlus; Q49AJ0; -.
DR   BioMuta; FAM135B; -.
DR   DMDM; 166233528; -.
DR   PaxDb; Q49AJ0; -.
DR   PeptideAtlas; Q49AJ0; -.
DR   PRIDE; Q49AJ0; -.
DR   Ensembl; ENST00000276737; ENSP00000276737; ENSG00000147724. [Q49AJ0-3]
DR   Ensembl; ENST00000395297; ENSP00000378710; ENSG00000147724. [Q49AJ0-1]
DR   GeneID; 51059; -.
DR   KEGG; hsa:51059; -.
DR   UCSC; uc003yuy.3; human. [Q49AJ0-1]
DR   CTD; 51059; -.
DR   DisGeNET; 51059; -.
DR   EuPathDB; HostDB:ENSG00000147724.11; -.
DR   GeneCards; FAM135B; -.
DR   HGNC; HGNC:28029; FAM135B.
DR   HPA; HPA023911; -.
DR   HPA; HPA023950; -.
DR   HPA; HPA024815; -.
DR   neXtProt; NX_Q49AJ0; -.
DR   OpenTargets; ENSG00000147724; -.
DR   PharmGKB; PA162386277; -.
DR   eggNOG; KOG2205; Eukaryota.
DR   eggNOG; ENOG410XQFK; LUCA.
DR   GeneTree; ENSGT00390000007885; -.
DR   HOGENOM; HOG000082668; -.
DR   HOVERGEN; HBG107866; -.
DR   InParanoid; Q49AJ0; -.
DR   OMA; RYVDCPA; -.
DR   OrthoDB; EOG091G0KFW; -.
DR   PhylomeDB; Q49AJ0; -.
DR   TreeFam; TF314837; -.
DR   GeneWiki; FAM135B; -.
DR   GenomeRNAi; 51059; -.
DR   PRO; PR:Q49AJ0; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000147724; -.
DR   CleanEx; HS_FAM135B; -.
DR   ExpressionAtlas; Q49AJ0; baseline and differential.
DR   Genevisible; Q49AJ0; HS.
DR   GO; GO:0052689; F:carboxylic ester hydrolase activity; IBA:GO_Central.
DR   GO; GO:0044255; P:cellular lipid metabolic process; IBA:GO_Central.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR022122; DUF3657.
DR   InterPro; IPR007751; DUF676_lipase-like.
DR   Pfam; PF12394; DUF3657; 1.
DR   Pfam; PF05057; DUF676; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1   1406       Protein FAM135B.
FT                                /FTId=PRO_0000314171.
FT   MOD_RES     777    777       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9DAI6}.
FT   MOD_RES     778    778       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9DAI6}.
FT   VAR_SEQ       1     99       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_030232.
FT   VAR_SEQ    1094   1141       SFYQAKEKFKKELKIEGFLYSDLTVLASDIPYFPPEEEEEN
FT                                LEDGIHL -> RGRGRKFGRWNSPGCLCPWPGWEQCRPPAG
FT                                KDFHRTGAPWRKTGLPNV (in isoform 3).
FT                                {ECO:0000303|Ref.1, ECO:0000303|Ref.4,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_030233.
FT   VAR_SEQ    1142   1406       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.1, ECO:0000303|Ref.4,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_030234.
FT   VAR_SEQ    1213   1213       S -> R (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_030235.
FT   VAR_SEQ    1214   1406       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_030236.
FT   VARIANT     477    477       I -> V (in dbSNP:rs7835830).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_053980.
FT   VARIANT     578    578       S -> N (in dbSNP:rs57534956).
FT                                /FTId=VAR_062218.
FT   VARIANT     846    846       D -> N (in dbSNP:rs2978180).
FT                                /FTId=VAR_053981.
FT   VARIANT    1142   1142       V -> I (in dbSNP:rs35765793).
FT                                /FTId=VAR_062219.
FT   CONFLICT    245    245       C -> W (in Ref. 3; AAH37288).
FT                                {ECO:0000305}.
FT   CONFLICT   1020   1020       F -> V (in Ref. 4; AAD20030).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1406 AA;  155770 MW;  E2C3831C53A6CA13 CRC64;
     MSEIQGTVEF SVELHKFYNV DLFQRGYYQI RVTLKVSSRI PHRLSASIAG QTESSSLHSA
     CVHDSTVHSR VFQILYRNEE VPINDAVVFR VHLLLGGERM EDALSEVDFQ LKVDLHFTDS
     EQQLRDVAGA PMVSSRTLGL HFHPRNGLHH QVPVMFDYFH LSVISVTVHA ALVALQQPLI
     SFTRPGRGSW LGKGGPDTGQ EQSIISLENL VFGAGYCKPT SSEGSFYITS ENCMQHAHKW
     HRDLCLLLLH AYRGLRLHFL VIMRDIPELP HTELEALAVE ETLSQLCSEL QMLNNPEKIA
     EQISKDLAWL TSHMMTLWTQ FLDTVTLHSQ VTTYLTQEHH TLRVRRFSEA FFYMEHQKLA
     VLTFQENLIQ THSQLSLDIR NSEYLTSMPP LPAECLDIDG DWNTLPVIFE DRYVDCPATG
     HNLSVYPNFD VPVTSPTIMN LKDKEDNCMV NSNLSFREDL VLSTIKPSQM DSDEEVIRCP
     EPGENVATQN HMDMCSESQV YISIGEFQNK AGVPEDECWT GQTSDAGTYP VADVDTSRRS
     PGPEDGQAPV LTYIDVKSSN KNPSRAEPLV AFNAQHESRS SRDKYGLDRT GLSKVVVGGS
     HQNAISSDKT TLHELSTLGK GIDQEGKMVL LSLKLTPSEP CDPLSSTLRE PLDIRSSLKD
     SHTEEQEELS VLSGVIKRSS SIISDSGIES EPSSVAWSEA RSRALELPSD REVLHPFVRR
     HALHRNSLEG GHTESNTSLP SGIQASLTSI SSLPFEEDER EVALTKLTKS VSAPHISSPE
     EAAEDADTKQ QDGGFAEPSD MHSKSQGSPG SCSQLCGDSG TDAGADHPLV EIVLDADNQQ
     GPGYIDIPKG KGKQFDAQGH CLPDGRTENT PGVETKGLNL KIPRVIALEN PRTRSLHRAL
     EETPKGMPKD LNVGQQALSN SGISEVEGLS QHQVPELSCT SAADAINRNS TGQQSQSGSP
     CIMDDTAFNR GVNAFPEAKH KAGTVCPTVT HSVHSQVLKN QELKAGTSIM GSHLTSAETF
     TLDSLKAVEV VNLSVSCTAT CLPFSSVPKE TPARAGFSSK QTLFPITHQP LGSFGVVSTH
     SSTLDEEVSE RMFSFYQAKE KFKKELKIEG FLYSDLTVLA SDIPYFPPEE EEENLEDGIH
     LVVCVHGLDG NSADLRLVKT FIELGLPGGK LDFLMSEKNQ MDTFADFDTM TDRLLDEIIQ
     HIQLYNLSIS RISFIGHSLG NIIIRSVLTR PRFRYYLNKL HTFLSLSGPH LGTLYNNSTL
     VSTGLWLMQK LKKSGSLLQL TFRDNADLRK CFLYQLSQKT GLQYFKNVVL VASPQDRYVP
     FHSARIEMCK TALKDRHTGP VYAEMINNLL GPLVEAKDCT LIRHNVFHAL PNTANTLIGR
     AAHIAVLDSE LFLEKFFLVA GLNYFK
//
ID   FA47C_HUMAN             Reviewed;        1035 AA.
AC   Q5HY64; Q6ZU46;
DT   02-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 1.
DT   25-OCT-2017, entry version 84.
DE   RecName: Full=Putative protein FAM47C;
GN   Name=FAM47C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 77-1035.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -!- SIMILARITY: Belongs to the FAM47 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC86381.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX842568; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK125992; BAC86381.1; ALT_INIT; mRNA.
DR   CCDS; CCDS35227.1; -.
DR   RefSeq; NP_001013758.1; NM_001013736.2.
DR   UniGene; Hs.535216; -.
DR   ProteinModelPortal; Q5HY64; -.
DR   iPTMnet; Q5HY64; -.
DR   PhosphoSitePlus; Q5HY64; -.
DR   BioMuta; FAM47C; -.
DR   DMDM; 74741513; -.
DR   PaxDb; Q5HY64; -.
DR   PeptideAtlas; Q5HY64; -.
DR   PRIDE; Q5HY64; -.
DR   Ensembl; ENST00000358047; ENSP00000367913; ENSG00000198173.
DR   GeneID; 442444; -.
DR   KEGG; hsa:442444; -.
DR   UCSC; uc004ddl.3; human.
DR   CTD; 442444; -.
DR   EuPathDB; HostDB:ENSG00000198173.4; -.
DR   GeneCards; FAM47C; -.
DR   HGNC; HGNC:25301; FAM47C.
DR   neXtProt; NX_Q5HY64; -.
DR   OpenTargets; ENSG00000198173; -.
DR   PharmGKB; PA145148924; -.
DR   eggNOG; ENOG410J8EG; Eukaryota.
DR   eggNOG; ENOG410XRKP; LUCA.
DR   GeneTree; ENSGT00400000022396; -.
DR   HOGENOM; HOG000112475; -.
DR   HOVERGEN; HBG076577; -.
DR   InParanoid; Q5HY64; -.
DR   OMA; SSTMECV; -.
DR   OrthoDB; EOG091G12OH; -.
DR   PhylomeDB; Q5HY64; -.
DR   TreeFam; TF340932; -.
DR   GenomeRNAi; 442444; -.
DR   PRO; PR:Q5HY64; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000198173; -.
DR   CleanEx; HS_FAM47C; -.
DR   Genevisible; Q5HY64; HS.
DR   InterPro; IPR032743; FAM47.
DR   InterPro; IPR026083; FAM47C/D.
DR   PANTHER; PTHR23213:SF203; PTHR23213:SF203; 6.
DR   Pfam; PF14642; FAM47; 13.
PE   2: Evidence at transcript level;
KW   Complete proteome; Polymorphism; Reference proteome.
FT   CHAIN         1   1035       Putative protein FAM47C.
FT                                /FTId=PRO_0000349311.
FT   VARIANT     924    924       N -> T (in dbSNP:rs1995914).
FT                                /FTId=VAR_046358.
FT   CONFLICT    275    275       P -> S (in Ref. 2; BAC86381).
FT                                {ECO:0000305}.
FT   CONFLICT    482    482       D -> N (in Ref. 2; BAC86381).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1035 AA;  115338 MW;  2752692CC5AC9DE7 CRC64;
     MGDQRPQDRP SSPGMDSTPW YCDKPPSKYF AKRKHRRLRF PPVDTQNWVF VTEGMDDFRY
     GCQSPEDTLV CRRDEFLLPK ISLRGPQADP KSRKKKLLKK AALFSKLSPA QPARKAFVEE
     VEAQLMTKHP LAMYPNLGED MPPDLLLQVL KPLDPERKLE DAGSCEGQEK TTDEPTEPGK
     YPCGEFSPRP PETRVSCLPP EPPKTPVSSL RPEPPETGVS HLRPQPPKTQ VSSLHLEPPE
     TGVSHLRPEP PKTQVSSLHL EPPETGVSHL YLEPPGTGVS HLCPEPPKTR VSHLHREPPE
     TGVPDLCLEP PKSRVSHLRP EPSETGVSHL HPEPPKTLVS SLHPEPPETG VSHLCPEPPE
     TRVSPLRQLP PEAGVSHLCP EPPKTRVPPL RPETPKNGVS PLFPEPPKTR ISNLRSEPPK
     IGVSHLCLEP PKTRGSHLRP EPPETGVSHL RPEPPKTRVS SLHLEPPETG VSHLCPEPPE
     KDVSHLRPEP PDTGVSHLCP EPPKTRVSHL RPEPSETGVS HLRPEPPKIL VSSLHQAPPE
     SSVSHLRPEP PETGVSHLRP EPPKTRMYSL RPEPPDTGVS HLCPEPPKTR VSSLPPEPPE
     TGVSHLCPEP PETRVSHLRP EPPETGVSHL RPEPPKTRMY SLRPEPPNTG VSHLCPEPPK
     TRVSSLPPEP PETGVSHLCP EPPETRVSHL RPEPPETGVS RLHPEPPKTR VSSLHAEPPE
     SRVSHLCPEP PETGVSHLRP EPPKPRVSSL RPEPLETRVS HLRPEPPETG VSHLHPELPK
     PRVSSLHLEP PKTRRVSSLR LEPPKTGRVS SLCPEPTKTG ASHLKELFQE GTSSTMECVS
     DSLQRRHTSR KLRDFKWAGD LGVNEESISS LFDFTPECRA TYQDQKNKKA NECSSGLKYS
     MELDEMDEVK FFSQEKDLDG KIQNAPNSHS AQHVKMGYGA WYLKPKLGKK LRSDEPLIDP
     KLVLEKPDEP DILDGLYGPI AFKDFILSKG YEMPGIIQRL FARRGWTYDS VKTPIQRAMQ
     VYKYKEDVTD ASEED
//
ID   FAT3_HUMAN              Reviewed;        4589 AA.
AC   Q8TDW7; B5MDB0; Q96AU6;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAR-2008, sequence version 2.
DT   28-MAR-2018, entry version 126.
DE   RecName: Full=Protocadherin Fat 3;
DE            Short=hFat3;
DE   AltName: Full=Cadherin family member 15;
DE   AltName: Full=FAT tumor suppressor homolog 3;
DE   Flags: Precursor;
GN   Name=FAT3; Synonyms=CDHF15, KIAA1989;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1026-4589 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3493-4589 (ISOFORM 1), AND VARIANT
RP   GLY-3812.
RC   TISSUE=Brain;
RX   PubMed=11811999; DOI=10.1006/bbrc.2002.6338;
RA   Mitsui K., Nakajima D., Ohara O., Nakayama M.;
RT   "Mammalian fat3: a large protein that contains multiple cadherin and
RT   EGF-like motifs.";
RL   Biochem. Biophys. Res. Commun. 290:1260-1266(2002).
RN   [4]
RP   IDENTIFICATION, AND TISSUE SPECIFICITY.
RX   PubMed=16865240;
RA   Katoh Y., Katoh M.;
RT   "Comparative integromics on FAT1, FAT2, FAT3 and FAT4.";
RL   Int. J. Mol. Med. 18:523-528(2006).
CC   -!- FUNCTION: May play a role in the interactions between neurites
CC       derived from specific subsets of neurons during development.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8TDW7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TDW7-2; Sequence=VSP_032327, VSP_032328;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q8TDW7-3; Sequence=VSP_040467;
CC         Note=Gene prediction based on similarity to rat ortholog and
CC         partial EST and cDNA data.;
CC   -!- TISSUE SPECIFICITY: Expressed in ES cells, primitive
CC       neuroectoderm, fetal brain, infant brain, adult neural tissues and
CC       prostate. {ECO:0000269|PubMed:16865240}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH16722.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP000722; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP000805; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP002514; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003171; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003718; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC016722; AAH16722.1; ALT_INIT; mRNA.
DR   EMBL; AB076400; BAB86868.1; -; mRNA.
DR   RefSeq; NP_001008781.2; NM_001008781.2. [Q8TDW7-3]
DR   RefSeq; XP_016872670.1; XM_017017181.1. [Q8TDW7-1]
DR   RefSeq; XP_016872672.1; XM_017017183.1. [Q8TDW7-3]
DR   UniGene; Hs.98523; -.
DR   ProteinModelPortal; Q8TDW7; -.
DR   SMR; Q8TDW7; -.
DR   BioGrid; 125669; 36.
DR   STRING; 9606.ENSP00000298047; -.
DR   iPTMnet; Q8TDW7; -.
DR   PhosphoSitePlus; Q8TDW7; -.
DR   BioMuta; FAT3; -.
DR   DMDM; 172045818; -.
DR   EPD; Q8TDW7; -.
DR   MaxQB; Q8TDW7; -.
DR   PaxDb; Q8TDW7; -.
DR   PeptideAtlas; Q8TDW7; -.
DR   PRIDE; Q8TDW7; -.
DR   Ensembl; ENST00000409404; ENSP00000387040; ENSG00000165323. [Q8TDW7-3]
DR   Ensembl; ENST00000634703; ENSP00000489369; ENSG00000282908. [Q8TDW7-3]
DR   GeneID; 120114; -.
DR   KEGG; hsa:120114; -.
DR   UCSC; uc001pdj.5; human. [Q8TDW7-1]
DR   CTD; 120114; -.
DR   DisGeNET; 120114; -.
DR   EuPathDB; HostDB:ENSG00000165323.15; -.
DR   GeneCards; FAT3; -.
DR   HGNC; HGNC:23112; FAT3.
DR   HPA; HPA026878; -.
DR   MIM; 612483; gene.
DR   neXtProt; NX_Q8TDW7; -.
DR   OpenTargets; ENSG00000165323; -.
DR   PharmGKB; PA134962612; -.
DR   eggNOG; KOG1219; Eukaryota.
DR   eggNOG; ENOG410XPEI; LUCA.
DR   GeneTree; ENSGT00760000118805; -.
DR   HOGENOM; HOG000046499; -.
DR   HOVERGEN; HBG005641; -.
DR   InParanoid; Q8TDW7; -.
DR   KO; K16506; -.
DR   OMA; DNGWMVT; -.
DR   OrthoDB; EOG091G00A0; -.
DR   PhylomeDB; Q8TDW7; -.
DR   TreeFam; TF316403; -.
DR   ChiTaRS; FAT3; human.
DR   GenomeRNAi; 120114; -.
DR   PRO; PR:Q8TDW7; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000165323; -.
DR   CleanEx; HS_FAT3; -.
DR   ExpressionAtlas; Q8TDW7; baseline and differential.
DR   Genevisible; Q8TDW7; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IEA:InterPro.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   InterPro; IPR002126; Cadherin.
DR   InterPro; IPR015919; Cadherin-like.
DR   InterPro; IPR020894; Cadherin_CS.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR001791; Laminin_G.
DR   Pfam; PF00028; Cadherin; 26.
DR   Pfam; PF02210; Laminin_G_2; 1.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 32.
DR   SMART; SM00181; EGF; 4.
DR   SMART; SM00179; EGF_CA; 3.
DR   SMART; SM00282; LamG; 1.
DR   SUPFAM; SSF49313; SSF49313; 34.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 1.
DR   PROSITE; PS00232; CADHERIN_1; 19.
DR   PROSITE; PS50268; CADHERIN_2; 32.
DR   PROSITE; PS00022; EGF_1; 3.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 4.
DR   PROSITE; PS01187; EGF_CA; 1.
DR   PROSITE; PS50025; LAM_G_DOMAIN; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calcium; Cell adhesion; Complete proteome;
KW   Developmental protein; Disulfide bond; EGF-like domain; Glycoprotein;
KW   Membrane; Methylation; Polymorphism; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     32       {ECO:0000255}.
FT   CHAIN        33   4589       Protocadherin Fat 3.
FT                                /FTId=PRO_0000324634.
FT   TOPO_DOM     33   4154       Extracellular. {ECO:0000255}.
FT   TRANSMEM   4155   4175       Helical. {ECO:0000255}.
FT   TOPO_DOM   4176   4589       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       44    158       Cadherin 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      159    266       Cadherin 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      264    375       Cadherin 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      377    472       Cadherin 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      473    578       Cadherin 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      579    681       Cadherin 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      727    831       Cadherin 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      832    936       Cadherin 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      937   1043       Cadherin 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     1044   1148       Cadherin 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     1149   1254       Cadherin 11. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     1255   1359       Cadherin 12. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     1363   1460       Cadherin 13. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     1461   1566       Cadherin 14. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     1567   1769       Cadherin 15. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     1770   1883       Cadherin 16. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     1884   1986       Cadherin 17. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     1983   2084       Cadherin 18. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     2085   2186       Cadherin 19. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     2187   2287       Cadherin 20. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     2288   2394       Cadherin 21. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     2395   2496       Cadherin 22. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     2497   2600       Cadherin 23. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     2601   2708       Cadherin 24. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     2709   2814       Cadherin 25. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     2815   2924       Cadherin 26. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     2925   3029       Cadherin 27. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     3030   3131       Cadherin 28. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     3132   3236       Cadherin 29. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     3237   3341       Cadherin 30. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     3342   3446       Cadherin 31. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     3447   3551       Cadherin 32. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     3552   3653       Cadherin 33. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     3795   3833       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     3835   4018       Laminin G-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00122}.
FT   DOMAIN     4021   4058       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     4060   4096       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     4098   4134       EGF-like 4; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   COMPBIAS   4438   4509       Pro-rich.
FT   MOD_RES    4542   4542       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q8BNA6}.
FT   CARBOHYD     49     49       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    342    342       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    482    482       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    563    563       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    668    668       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    800    800       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    880    880       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    899    899       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1007   1007       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1368   1368       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1430   1430       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1752   1752       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1945   1945       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1994   1994       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1997   1997       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2209   2209       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2293   2293       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2332   2332       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2468   2468       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3001   3001       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3202   3202       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3330   3330       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3450   3450       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3619   3619       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3742   3742       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3927   3927       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID   3799   3810       {ECO:0000250}.
FT   DISULFID   3804   3822       {ECO:0000250}.
FT   DISULFID   3824   3832       {ECO:0000250}.
FT   DISULFID   3985   4018       {ECO:0000250}.
FT   DISULFID   4025   4036       {ECO:0000250}.
FT   DISULFID   4030   4046       {ECO:0000250}.
FT   DISULFID   4048   4057       {ECO:0000250}.
FT   DISULFID   4064   4075       {ECO:0000250}.
FT   DISULFID   4069   4084       {ECO:0000250}.
FT   DISULFID   4086   4095       {ECO:0000250}.
FT   DISULFID   4102   4113       {ECO:0000250}.
FT   DISULFID   4107   4122       {ECO:0000250}.
FT   DISULFID   4124   4133       {ECO:0000250}.
FT   VAR_SEQ    1204   1260       LITTTSRKLDREQQAEHFLEVTVTDGGPSPKQSTIWVVVQV
FT                                LDENDNKPQFPEKVYQ -> SCSVAQAGMQWHDRSSLQSRT
FT                                PGFKGYPCLSLLSSWDYRHAPPCPATFLNS (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_032327.
FT   VAR_SEQ    1261   4589       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_032328.
FT   VAR_SEQ    4351   4382       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_040467.
FT   VARIANT     412    412       S -> F (in dbSNP:rs10830902).
FT                                /FTId=VAR_039851.
FT   VARIANT     462    462       I -> V (in dbSNP:rs16917409).
FT                                /FTId=VAR_039852.
FT   VARIANT    1167   1167       V -> G (in dbSNP:rs11821058).
FT                                /FTId=VAR_039853.
FT   VARIANT    1726   1726       Q -> R (in dbSNP:rs7949157).
FT                                /FTId=VAR_039854.
FT   VARIANT    2293   2293       N -> S (in dbSNP:rs16918105).
FT                                /FTId=VAR_039855.
FT   VARIANT    2622   2622       V -> F (in dbSNP:rs17615477).
FT                                /FTId=VAR_039856.
FT   VARIANT    2755   2755       I -> V (in dbSNP:rs3847531).
FT                                /FTId=VAR_039857.
FT   VARIANT    3518   3518       V -> L (in dbSNP:rs10765565).
FT                                /FTId=VAR_039858.
FT   VARIANT    3812   3812       S -> G (in dbSNP:rs4753069).
FT                                {ECO:0000269|PubMed:11811999}.
FT                                /FTId=VAR_039859.
SQ   SEQUENCE   4589 AA;  505523 MW;  C993CE7F08EC6BF9 CRC64;
     MDIIMGHCVG TRPPACCLIL LLFKLLATVS QGLPGTGPLG FHFTHSIYNA TVYENSAART
     YVNSQSRMGI TLIDLSWDIK YRIVSGDEEG FFKAEEVIIA DFCFLRIRTK GGNSAILNRE
     IQDNYLLIVK GSVRGEDLEA WTKVNIQVLD MNDLRPLFSP TTYSVTIAES TPLRTSVAQV
     TATDADIGSN GEFYYYFKNK VDLFSVHPTS GVISLSGRLN YDEKNRYDLE ILAVDRGMKL
     YGNNGVSSTA KLYVHIERIN EHAPTIHVVT HVPFSLEKEP TYAVVTVDDL DDGANGEIES
     VSIVAGDPLD QFFLAKEGKW LNEYKIKERK QIDWESFPYG YNLTLQAKDK GSPQKCSALK
     AVYIGNPTRD TVPIRFEKEV YDVSISEFSP PGVVVAIVKL SPEPIDVEYK LSPGEDAVYF
     KINPRSGLIV TARPLNTVKK EVYKLEVTNK EGDLKAQVTI SIEDANDHTP EFQQPLYDAY
     VNESVPVGTS VLTVSASDKD KGENGYITYS IASLNLLPFV INQFTGVIST TEELDFESSP
     EIYRFIVRAS DWGSPYRHES EVNVTIRIGN VNDNSPLFEK VACQGVISYD FPVGGHITAV
     SAIDIDELEL VKYKIISGNE LGFFYLNPDS GVLQLKKSLT NSGIKNGNFA LRITATDGEN
     LADPMSINIS VLHGKVSSKS FSCRETRVAQ KLAEKLLIKA KANGKLNLED GFLDFYSINR
     QGPYFDKSFP SDVAVKEDLP VGANILKIKA YDADSGFNGK VLFTISDGNT DSCFNIDMET
     GQLKVLMPMD REHTDLYLLN ITIYDLGNPQ KSSWRLLTIN VEDANDNSPV FIQDSYSVNI
     LESSGIGTEI IQVEARDKDL GSNGEVTYSV LTDTQQFAIN SSTGIVYVAD QLDRESKANY
     SLKIEARDKA ESGQQLFSVV TLKVFLDDVN DCSPAFIPSS YSVKVLEDLP VGTVIAWLET
     HDPDLGLGGQ VRYSLVNDYN GRFEIDKASG AIRLSKELDY EKQQFYNLTV RAKDKGRPVS
     LSSVSFVEVE VVDVNENLHT PYFPDFAVVG SVKENSRIGT SVLQVTARDE DSGRDGEIQY
     SIRDGSGLGR FSIDDESGVI TAADILDRET MGSYWLTVYA TDRGVVPLYS TIEVYIEVED
     VNDNAPLTSE PIYYPVVMEN SPKDVSVIQI QAEDPDSSSN EKLTYRITSG NPQNFFAINI
     KTGLITTTSR KLDREQQAEH FLEVTVTDGG PSPKQSTIWV VVQVLDENDN KPQFPEKVYQ
     IKLPERDRKK RGEPIYRAFA FDRDEGPNAE ISYSIVDGND DGKFFIDPKT GMVSSRKQFT
     AGSYDILTIK AVDNGRPQKS STARLHIEWI KKPPPSPIPL TFDEPFYNFT VMESDRVTEI
     VGVVSVQPAN TPLWFDIVGG NFDSAFDAEK GVGTIVIAKP LDAEQRSIYN MSVEVTDGTN
     VAVTQVFIKV LDNNDNGPEF SQPNYDVTIS EDVLPDTEIL QIEATDRDEK HKLSYTVHSS
     IDSISMRKFR IDPSTGVLYT AERLDHEAQD KHILNIMVRD QEFPYRRNLA RVIVNVEDAN
     DHSPYFTNPL YEASVFESAA LGSAVLQVTA LDKDKGENAE LIYTIEAGNT GNMFKIEPVL
     GIITICKEPD MTTMGQFVLS IKVTDQGSPP MSATAIVRIS VTMSDNSHPK FIHKDYQAEV
     NENVDIGTSV ILISAISQST LIYEVKDGDI NGIFTINPYS GVITTQKALD YERTSSYQLI
     IQATNMAGMA SNATVNIQIV DENDNAPVFL FSQYSGSLSE AAPINSIVRS LDNSPLVIRA
     TDADSNRNAL LVYQIVESTA KKFFTVDSST GAIRTIANLD HETIAHFHFH VHVRDSGSPQ
     LTAESPVEVN IEVTDVNDNP PVFTQAVFET ILLLPTYVGV EVLKVSATDP DSEVPPELTY
     SLMEGSLDHF LIDSNSGVLT IKNNNLSKDH YMLIVKVSDG KFYSTSMVTI MVKEAMDSGL
     HFTQSFYSTS ISENNTNITK VAIVNAVGNR LNEPLKYSIL NPGNKFKIKS TSGVIQTTGV
     PFDREEQELY ELVVEASREL DHLRVARVVV RVNIEDINDN SPVFVGLPYY AAVQVDAEPG
     TLIYQVTAID KDKGPNGEVT YVLQDDYGHF EINPNSGNVI LKEAFNSDLS NIEYGVTILA
     KDGGKPSLST SVELPITIVN KAMPVFDKPF YTASVNEDIR MNTPILSINA TSPEGQGIIY
     IIIDGDPFKQ FNIDFDTGVL KVVSPLDYEV TSAYKLTIRA SDALTGARAE VTVDLLVNDV
     NDNPPIFDQP TYNTTLSEAS LIGTPVLQVV SIDADSENNK MVHYQIVQDT YNSTDYFHID
     SSSGLILTAR MLDHELVQHC TLKVRSIDSG FPSLSSEVLV HIYISDVNDN PPVFNQLIYE
     SYVSELAPRG HFVTCVQASD ADSSDFDRLE YSILSGNDRT SFLMDSKSGV ITLSNHRKQR
     MEPLYSLNVS VSDGLFTSTA QVHIRVLGAN LYSPAFSQST YVAEVRENVA AGTKVIHVRA
     TDGDPGTYGQ ISYAIINDFA KDRFLIDSNG QVITTERLDR ENPLEGDVSI FVRALDGGGR
     TTFCTVRVIV VDENDNAPQF MTVEYRASVR ADVGRGHLVT QVQAIDPDDG ANSRITYSLY
     SEASVSVADL LEIDPDNGWM VTKGNFNQLK NTVLSFFVKA VDGGIPVKHS LIPVYIHVLP
     PETFLPSFTQ SQYSFTIAED TAIGSTVDTL RILPSQNVWF STVNGERPEN NKGGIFVIEQ
     ETGTIKLDKR LDRETSPAFH FKVAATIPLD KVDIVFTVDV DIKVLDLNDN KPVFETSSYD
     TIIMEGMPVG TKLTQVRAID MDWGANGQVT YSLHSDSQPE KVMEAFNIDS NTGWISTLKD
     LDHETDPTFT FSVVASDLGE AFSLSSTALV SVRVTDINDN APVFAQEVYR GNVKESDPPG
     EVVAVLSTWD RDTSDVNRQV SYHITGGNPR GRFALGLVQS EWKVYVKRPL DREEQDIYFL
     NITATDGLFV TQAMVEVSVS DVNDNSPVCD QVAYTALLPE DIPSNKIILK VSAKDADIGS
     NGYIRYSLYG SGNSEFFLDP ESGELKTLAL LDRERIPVYS LMAKATDGGG RFCQSNIHLI
     LEDVNDNPPV FSSDHYNTCV YENTATKALL TRVQAVDPDI GINRKVVYSL ADSAGGVFSI
     DSSSGIIILE QPLDREQQSS YNISVRATDQ SPGQSLSSLT TVTITVLDIN DNPPVFERRD
     YLVTVPEDTS PGTQVLAVFA TSKDIGTNAE ITYLIRSGNE QGKFKINPKT GGISVSEVLD
     YELCKRFYLV VEAKDGGTPA LSAVATVNIN LTDVNDNPPK FSQDVYSAVI SEDALVGDSV
     ILLIAEDVDS QPNGQIHFSI VNGDRDNEFT VDPVLGLVKV KKKLDRERVS GYSLLVQAVD
     SGIPAMSSTA TVNIDISDVN DNSPVFTPAN YTAVIQENKP VGTSILQLVV TDRDSFHNGP
     PFSFSILSGN EEEEFVLDPH GILRSAVVFQ HTESLEYVLC VQAKDSGKPQ QVSHTYIRVR
     VIEESTHKPT AIPLEIFIVT MEDDFPGGVI GKIHATDQDM YDVLTFALKS EQKSLFKVNS
     HDGKIIALGG LDSGKYVLNV SVSDGRFQVP IDVVVHVEQL VHEMLQNTVT IRFENVSPED
     FVGLHMHGFR RTLRNAVLTQ KQDSLRIISI QPVAGTNQLD MLFAVEMHSS EFYKPAYLIQ
     KLSNARRHLE NIMRISAILE KNCSGLDCQE QHCEQGLSLD SHALMTYSTA RISFVCPRFY
     RNVRCTCNGG LCPGSNDPCV EKPCPGDMQC VSYEASRRPF LCQCPPGKLG ECSGHTSLSF
     AGNSYIKYRL SENSKEEDFK LALRLRTLQS NGIIMYTRAN PCIILKIVDG KLWFQLDCGS
     GPGILGISGR AVNDGSWHSV FLELNRNFTS LSLDDSYVER RRAPLYFQTL STESSIYFGA
     LVQADNIRSL TDTRVTQVLS GFQGCLDSVI LNNNELPLQN KRSSFAEVVG LTELKLGCVL
     YPDACKRSPC QHGGSCTGLP SGGYQCTCLS QFTGRNCESE ITACFPNPCR NGGSCDPIGN
     TFICNCKAGL TGVTCEEDIN ECEREECENG GSCVNVFGSF LCNCTPGYVG QYCGLRPVVV
     PNIQAGHSYV GKEELIGIAV VLFVIFILVV LFIVFRKKVF RKNYSRNNIT LVQDPATAAL
     LNKSNGIPFR NLRGSGDGRN VYQEVGPPQV PVRPMAYTPC FQSDSRSNLD KIVDGLGGEH
     QEMTTFHPES PRILTARRGV VVCSVAPNLP AVSPCRSDCD SIRKNGWDAG TENKGVDDPG
     EVTCFAGSNK GSNSEVQSLS SFQSDSGDDN ASIVTVIQLV NNVVDTIENE VSVMDQGQNY
     NRAYHWDTSD WMPGARLSDI EEVPNYENQD GGSAHQGSTR ELESDYYLGG YDIDSEYPPP
     HEEEFLSQDQ LPPPLPEDFP DQYEALPPSQ PVSLASTLSP DCRRRPQFHP SQYLPPHPFP
     NETDLVGPPA SCEFSTFAVS MNQGTEPTGP ADSVSLSLHN SRGTSSSDVS ANCGFDDSEV
     AMSDYESVGE LSLASLHIPF VETQHQTQV
//
ID   A7YQ73_HUMAN            Unreviewed;       147 AA.
AC   A7YQ73;
DT   23-OCT-2007, integrated into UniProtKB/TrEMBL.
DT   23-OCT-2007, sequence version 1.
DT   28-FEB-2018, entry version 74.
DE   RecName: Full=Peptidylprolyl isomerase {ECO:0000256|PROSITE-ProRule:PRU00277};
DE            EC=5.2.1.8 {ECO:0000256|PROSITE-ProRule:PRU00277};
DE   Flags: Fragment;
GN   Name=FKBP9 {ECO:0000313|EMBL:AAH99918.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH99918.1};
RN   [1] {ECO:0000313|EMBL:AAH99918.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Breast {ECO:0000313|EMBL:AAH99918.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00448}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC099918; AAH99918.1; -; mRNA.
DR   RefSeq; NP_001271270.1; NM_001284341.1.
DR   RefSeq; NP_001271272.1; NM_001284343.1.
DR   RefSeq; NP_009201.2; NM_007270.4.
DR   UniGene; Hs.103934; -.
DR   PeptideAtlas; A7YQ73; -.
DR   PRIDE; A7YQ73; -.
DR   GeneID; 11328; -.
DR   KEGG; hsa:11328; -.
DR   CTD; 11328; -.
DR   PharmGKB; PA28166; -.
DR   eggNOG; KOG0549; Eukaryota.
DR   eggNOG; COG0545; LUCA.
DR   HOVERGEN; HBG051620; -.
DR   KO; K09575; -.
DR   ChiTaRS; FKBP9; human.
DR   GenomeRNAi; 11328; -.
DR   Genevisible; A7YQ73; HS.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR023566; PPIase_FKBP.
DR   InterPro; IPR001179; PPIase_FKBP_dom.
DR   PANTHER; PTHR10516; PTHR10516; 2.
DR   Pfam; PF13202; EF-hand_5; 1.
DR   Pfam; PF00254; FKBP_C; 1.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS50222; EF_HAND_2; 2.
DR   PROSITE; PS50059; FKBP_PPIASE; 1.
PE   2: Evidence at transcript level;
KW   Calcium {ECO:0000256|PROSITE-ProRule:PRU00448};
KW   Isomerase {ECO:0000256|PROSITE-ProRule:PRU00277};
KW   Rotamase {ECO:0000256|PROSITE-ProRule:PRU00277}.
FT   DOMAIN        1     54       PPIase FKBP-type.
FT                                {ECO:0000259|PROSITE:PS50059}.
FT   DOMAIN       65    100       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN      110    145       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   CA_BIND     123    134       {ECO:0000256|PROSITE-ProRule:PRU00448}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAH99918.1}.
SQ   SEQUENCE   147 AA;  16096 MW;  47C4BB81375C9B0F CRC64;
     QVVLGMDMGL REMCVGEKRT VIIPPHLGYG EAGVDGEVPG SAVLVFDIEL LELVAGLPEG
     YMFIWNGEVS PNLFEEIDKD GNGEVLLEEF SEYIHAQVAS GKGKLAPGFD AELIVKNMFT
     NQDRNGDGKV TAEEFKLKDQ EAKHDEL
//
ID   FKBP9_HUMAN             Reviewed;         570 AA.
AC   O95302; B3KY35; B7Z1G9; B7Z6H3; Q2M2A1; Q3MIR7; Q6IN76; Q6P2N1;
AC   Q96EX5; Q96IJ9;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   10-JAN-2006, sequence version 2.
DT   25-APR-2018, entry version 162.
DE   RecName: Full=Peptidyl-prolyl cis-trans isomerase FKBP9;
DE            Short=PPIase FKBP9;
DE            EC=5.2.1.8;
DE   AltName: Full=63 kDa FK506-binding protein;
DE            Short=63 kDa FKBP;
DE            Short=FKBP-63;
DE   AltName: Full=FK506-binding protein 9;
DE            Short=FKBP-9;
DE   AltName: Full=Rotamase;
DE   Flags: Precursor;
GN   Name=FKBP9; Synonyms=FKBP60, FKBP63;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney, Liver, Lung, and PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 54-570 (ISOFORM 1).
RX   PubMed=10524204; DOI=10.1016/S0167-4781(99)00080-9;
RA   Shadidy M., Caubit X., Olsen R., Seternes O.M., Moens U., Krauss S.;
RT   "Biochemical analysis of mouse FKBP60, a novel member of the FKBP
RT   family.";
RL   Biochim. Biophys. Acta 1446:295-307(1999).
RN   [5]
RP   GLYCOSYLATION AT ASN-174; ASN-286 AND ASN-397.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: PPIases accelerate the folding of proteins during
CC       protein synthesis.
CC   -!- CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline
CC       (omega=0).
CC   -!- ENZYME REGULATION: Inhibited by FK506. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000255|PROSITE-
CC       ProRule:PRU10138}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O95302-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95302-2; Sequence=VSP_054825;
CC       Name=3;
CC         IsoId=O95302-3; Sequence=VSP_054826;
CC   -!- PTM: Phosphorylated. {ECO:0000250}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK128597; BAG54697.1; -; mRNA.
DR   EMBL; AK293440; BAH11505.1; -; mRNA.
DR   EMBL; AK300328; BAH13259.1; -; mRNA.
DR   EMBL; AC083863; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007443; AAH07443.2; -; mRNA.
DR   EMBL; BC064418; AAH64418.1; -; mRNA.
DR   EMBL; BC072422; AAH72422.1; -; mRNA.
DR   EMBL; BC101723; AAI01724.1; -; mRNA.
DR   EMBL; BC112053; AAI12054.1; -; mRNA.
DR   EMBL; AF089745; AAC78853.1; -; mRNA.
DR   CCDS; CCDS5439.1; -. [O95302-1]
DR   CCDS; CCDS64622.1; -. [O95302-3]
DR   CCDS; CCDS64623.1; -. [O95302-2]
DR   RefSeq; NP_001271270.1; NM_001284341.1. [O95302-3]
DR   RefSeq; NP_001271272.1; NM_001284343.1. [O95302-2]
DR   RefSeq; NP_009201.2; NM_007270.4. [O95302-1]
DR   UniGene; Hs.103934; -.
DR   ProteinModelPortal; O95302; -.
DR   SMR; O95302; -.
DR   BioGrid; 116456; 39.
DR   IntAct; O95302; 4.
DR   MINT; O95302; -.
DR   STRING; 9606.ENSP00000242209; -.
DR   iPTMnet; O95302; -.
DR   PhosphoSitePlus; O95302; -.
DR   EPD; O95302; -.
DR   MaxQB; O95302; -.
DR   PaxDb; O95302; -.
DR   PeptideAtlas; O95302; -.
DR   PRIDE; O95302; -.
DR   Ensembl; ENST00000242209; ENSP00000242209; ENSG00000122642. [O95302-1]
DR   Ensembl; ENST00000490776; ENSP00000441317; ENSG00000122642. [O95302-2]
DR   Ensembl; ENST00000538336; ENSP00000439250; ENSG00000122642. [O95302-3]
DR   GeneID; 11328; -.
DR   KEGG; hsa:11328; -.
DR   UCSC; uc003tdh.5; human. [O95302-1]
DR   CTD; 11328; -.
DR   EuPathDB; HostDB:ENSG00000122642.10; -.
DR   GeneCards; FKBP9; -.
DR   H-InvDB; HIX0006586; -.
DR   H-InvDB; HIX0167892; -.
DR   HGNC; HGNC:3725; FKBP9.
DR   HPA; HPA012595; -.
DR   HPA; HPA055256; -.
DR   MIM; 616257; gene.
DR   neXtProt; NX_O95302; -.
DR   OpenTargets; ENSG00000122642; -.
DR   PharmGKB; PA28166; -.
DR   eggNOG; KOG0549; Eukaryota.
DR   eggNOG; COG0545; LUCA.
DR   GeneTree; ENSGT00530000062784; -.
DR   HOVERGEN; HBG051620; -.
DR   InParanoid; O95302; -.
DR   KO; K09575; -.
DR   OMA; EMIVKNM; -.
DR   OrthoDB; EOG091G02W1; -.
DR   PhylomeDB; O95302; -.
DR   TreeFam; TF105296; -.
DR   Reactome; R-HSA-390471; Association of TriC/CCT with target proteins during biosynthesis.
DR   ChiTaRS; FKBP9; human.
DR   GeneWiki; FKBP9; -.
DR   GenomeRNAi; 11328; -.
DR   PRO; PR:O95302; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000122642; -.
DR   CleanEx; HS_FKBP9; -.
DR   ExpressionAtlas; O95302; baseline and differential.
DR   Genevisible; O95302; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; ISS:UniProtKB.
DR   GO; GO:0005528; F:FK506 binding; IBA:GO_Central.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IBA:GO_Central.
DR   GO; GO:0061077; P:chaperone-mediated protein folding; IBA:GO_Central.
DR   GO; GO:0006457; P:protein folding; ISS:UniProtKB.
DR   CDD; cd00051; EFh; 1.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR023566; PPIase_FKBP.
DR   InterPro; IPR001179; PPIase_FKBP_dom.
DR   PANTHER; PTHR10516; PTHR10516; 7.
DR   Pfam; PF00254; FKBP_C; 4.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS50222; EF_HAND_2; 2.
DR   PROSITE; PS00014; ER_TARGET; 1.
DR   PROSITE; PS50059; FKBP_PPIASE; 4.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Complete proteome;
KW   Endoplasmic reticulum; Glycoprotein; Isomerase; Metal-binding;
KW   Phosphoprotein; Reference proteome; Repeat; Rotamase; Signal.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    570       Peptidyl-prolyl cis-trans isomerase
FT                                FKBP9.
FT                                /FTId=PRO_0000045760.
FT   DOMAIN       54    142       PPIase FKBP-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00277}.
FT   DOMAIN      166    254       PPIase FKBP-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00277}.
FT   DOMAIN      278    365       PPIase FKBP-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00277}.
FT   DOMAIN      389    477       PPIase FKBP-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00277}.
FT   DOMAIN      488    523       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      533    568       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     501    513       1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     546    557       2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   MOTIF       567    570       Prevents secretion from ER.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10138}.
FT   CARBOHYD    174    174       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519}.
FT   CARBOHYD    286    286       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519}.
FT   CARBOHYD    302    302       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    397    397       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519}.
FT   VAR_SEQ       1    234       MAFRGWRPPPPPLLLLLLWVTGQAAPVAGLGSDAELQIERR
FT                                FVPDECPRTVRSGDFVRYHYVGTFPDGQKFDSSYDRDSTFN
FT                                VFVGKGQLITGMDQALVGMCVNERRFVKIPPKLAYGNEGVS
FT                                GVIPPNSVLHFDVLLMDIWNSEDQVQIHTYFKPPSCPRTIQ
FT                                VSDFVRYHYNGTFLDGTLFDSSHNRMKTYDTYVGIGWLIPG
FT                                MDKGLLGMCVGEKRIITIPPFLAYGEDGD -> MA (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054825.
FT   VAR_SEQ      73     73       S -> SRYWDTAEDKADKSPCPQVRVGVNTSPSCRLKQKGV
FT                                GIYWKDLQFLVRVQNHGL (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054826.
SQ   SEQUENCE   570 AA;  63084 MW;  E1F44A2FA6E112F8 CRC64;
     MAFRGWRPPP PPLLLLLLWV TGQAAPVAGL GSDAELQIER RFVPDECPRT VRSGDFVRYH
     YVGTFPDGQK FDSSYDRDST FNVFVGKGQL ITGMDQALVG MCVNERRFVK IPPKLAYGNE
     GVSGVIPPNS VLHFDVLLMD IWNSEDQVQI HTYFKPPSCP RTIQVSDFVR YHYNGTFLDG
     TLFDSSHNRM KTYDTYVGIG WLIPGMDKGL LGMCVGEKRI ITIPPFLAYG EDGDGKDIPG
     QASLVFDVAL LDLHNPKDSI SIENKVVPEN CERISQSGDF LRYHYNGTLL DGTLFDSSYS
     RNRTFDTYIG QGYVIPGMDE GLLGVCIGEK RRIVVPPHLG YGEEGRGNIP GSAVLVFDIH
     VIDFHNPSDS ISITSHYKPP DCSVLSKKGD YLKYHYNASL LDGTLLDSTW NLGKTYNIVL
     GSGQVVLGMD MGLREMCVGE KRTVIIPPHL GYGEAGVDGE VPGSAVLVFD IELLELVAGL
     PEGYMFIWNG EVSPNLFEEI DKDGNGEVLL EEFSEYIHAQ VASGKGKLAP GFDAELIVKN
     MFTNQDRNGD GKVTAEEFKL KDQEAKHDEL
//
ID   FLNA_HUMAN              Reviewed;        2647 AA.
AC   P21333; E9KL45; Q5HY53; Q5HY55; Q8NF52;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   25-APR-2018, entry version 231.
DE   RecName: Full=Filamin-A;
DE            Short=FLN-A;
DE   AltName: Full=Actin-binding protein 280;
DE            Short=ABP-280;
DE   AltName: Full=Alpha-filamin;
DE   AltName: Full=Endothelial actin-binding protein;
DE   AltName: Full=Filamin-1;
DE   AltName: Full=Non-muscle filamin;
GN   Name=FLNA; Synonyms=FLN, FLN1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=2391361; DOI=10.1083/jcb.111.3.1089;
RA   Gorlin J.B., Yamin R., Egan S., Stewart M., Stossel T.P.,
RA   Kwiatkowski D.J., Hartwig J.H.;
RT   "Human endothelial actin-binding protein (ABP-280, nonmuscle filamin):
RT   a molecular leaf spring.";
RL   J. Cell Biol. 111:1089-1105(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8088819; DOI=10.1006/geno.1994.1226;
RA   Patrosso M.C., Repetto M., Villa A., Milanesi L., Frattini A.,
RA   Faranda S., Mancini M., Maestrini E., Toniolo D., Vezzoni P.;
RT   "The exon-intron organization of the human X-linked gene (FLN1)
RT   encoding actin-binding protein 280.";
RL   Genomics 21:71-76(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8733135; DOI=10.1093/hmg/5.5.659;
RA   Chen E.Y., Zollo M., Mazzarella R.A., Ciccodicola A., Chen C.-N.,
RA   Zuo L., Heiner C., Burough F.W., Ripetto M., Schlessinger D.,
RA   D'Urso M.;
RT   "Long-range sequence analysis in Xq28: thirteen known and six
RT   candidate genes in 219.4 kb of high GC DNA between the RCP/GCP and
RT   G6PD loci.";
RL   Hum. Mol. Genet. 5:659-668(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=20736409; DOI=10.1074/mcp.M110.001719;
RA   Li J., Liu F., Wang H., Liu X., Liu J., Li N., Wan F., Wang W.,
RA   Zhang C., Jin S., Liu J., Zhu P., Liu Y.;
RT   "Systematic mapping and functional analysis of a family of human
RT   epididymal secretory sperm-located proteins.";
RL   Mol. Cell. Proteomics 9:2517-2528(2010).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=21697133; DOI=10.1167/iovs.11-7479;
RA   Oshikawa M., Tsutsui C., Ikegami T., Fuchida Y., Matsubara M.,
RA   Toyama S., Usami R., Ohtoko K., Kato S.;
RT   "Full-length transcriptome analysis of human retina-derived cell lines
RT   ARPE-19 and Y79 using the vector-capping method.";
RL   Invest. Ophthalmol. Vis. Sci. 52:6662-6670(2011).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   PROTEIN SEQUENCE OF 2-24; 44-51; 64-87; 101-127; 172-190; 300-376;
RP   384-400; 428-437; 497-504; 581-593; 656-664; 685-700; 761-771;
RP   774-781; 829-837; 842-900; 907-916; 959-973; 983-994; 1020-1032;
RP   1165-1172; 1235-1294; 1297-1312; 1360-1399; 1440-1450; 1465-1486;
RP   1492-1532; 1539-1547; 1550-1592; 1622-1633; 1636-1644; 1726-1753;
RP   1801-1809; 1815-1831; 1892-1907; 1965-1993; 2015-2024; 2026-2049;
RP   2202-2215; 2243-2250; 2265-2289; 2311-2333; 2335-2361; 2396-2405;
RP   2521-2540; 2585-2598 AND 2613-2631, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT SER-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Platelet;
RA   Bienvenut W.V., Claeys D.;
RL   Submitted (NOV-2005) to UniProtKB.
RN   [10]
RP   PROTEIN SEQUENCE OF 25-54; 917-940; 1037-1050; 1754-1783 AND
RP   2148-2168.
RX   PubMed=2248958; DOI=10.1021/bi00492a019;
RA   Hock R.S., Davis G., Speicher D.W.;
RT   "Purification of human smooth muscle filamin and characterization of
RT   structural domains and functional sites.";
RL   Biochemistry 29:9441-9451(1990).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1658-1772.
RX   PubMed=7689010; DOI=10.1093/hmg/2.6.761;
RA   Maestrini E., Patrosso C., Mancini M., Rivella S., Rocchi M.,
RA   Repetto M., Villa A., Frattini A., Zoppe M., Vezzoni P., Toniolo D.;
RT   "Mapping of two genes encoding isoforms of the actin binding protein
RT   ABP-280, a dystrophin like protein, to Xq28 and to chromosome 7.";
RL   Hum. Mol. Genet. 2:761-766(1993).
RN   [12]
RP   SIMILARITY TO OTHER MEMBERS OF THE FAMILY.
RX   PubMed=11153914; DOI=10.1007/s004390000414;
RA   Chakarova C., Wehnert M.S., Uhl K., Sakthivel S., Vosberg H.-P.,
RA   van der Ven P.F.M., Fuerst D.O.;
RT   "Genomic structure and fine mapping of the two human filamin gene
RT   paralogues FLNB and FLNC and comparative analysis of the filamin gene
RT   family.";
RL   Hum. Genet. 107:597-611(2000).
RN   [13]
RP   INTERACTION WITH PSEN1 AND PSEN2.
RX   PubMed=9437013;
RA   Zhang W., Han S.W., McKeel D.W., Goate A., Wu J.Y.;
RT   "Interaction of presenilins with the filamin family of actin-binding
RT   proteins.";
RL   J. Neurosci. 18:914-922(1998).
RN   [14]
RP   INTERACTION WITH KCND2.
RX   PubMed=11102480;
RA   Petrecca K., Miller D.M., Shrier A.;
RT   "Localization and enhanced current density of the Kv4.2 potassium
RT   channel by interaction with the actin-binding protein filamin.";
RL   J. Neurosci. 20:8736-8744(2000).
RN   [15]
RP   INTERACTION WITH INPPL1.
RX   PubMed=11739414; DOI=10.1083/jcb.200104005;
RA   Dyson J.M., O'Malley C.J., Becanovic J., Munday A.D., Berndt M.C.,
RA   Coghill I.D., Nandurkar H.H., Ooms L.M., Mitchell C.A.;
RT   "The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2,
RT   binds filamin and regulates submembraneous actin.";
RL   J. Cell Biol. 155:1065-1079(2001).
RN   [16]
RP   INTERACTION WITH FLNB.
RX   PubMed=12393796; DOI=10.1093/hmg/11.23.2845;
RA   Sheen V.L., Feng Y., Graham D., Takafuta T., Shapiro S.S., Walsh C.A.;
RT   "Filamin A and filamin B are co-expressed within neurons during
RT   periods of neuronal migration and can physically interact.";
RL   Hum. Mol. Genet. 11:2845-2854(2002).
RN   [17]
RP   INTERACTION WITH MYOT AND MYOZ1.
RX   PubMed=16076904; DOI=10.1242/jcs.02484;
RA   Gontier Y., Taivainen A., Fontao L., Sonnenberg A., van der Flier A.,
RA   Carpen O., Faulkner G., Borradori L.;
RT   "The Z-disc proteins myotilin and FATZ-1 interact with each other and
RT   are connected to the sarcolemma via muscle-specific filamins.";
RL   J. Cell Sci. 118:3739-3749(2005).
RN   [18]
RP   REVIEW.
RX   PubMed=11336782; DOI=10.1016/S0167-4889(01)00072-6;
RA   van der Flier A., Sonnenberg A.;
RT   "Structural and functional aspects of filamins.";
RL   Biochim. Biophys. Acta 1538:99-117(2001).
RN   [19]
RP   REVIEW.
RX   PubMed=11252955; DOI=10.1038/35052082;
RA   Stossel T.P., Condeelis J., Cooley L., Hartwig J.H., Noegel A.,
RA   Schleicher M., Shapiro S.S.;
RT   "Filamins as integrators of cell mechanics and signalling.";
RL   Nat. Rev. Mol. Cell Biol. 2:138-145(2001).
RN   [20]
RP   INTERACTION WITH CEACAM1.
RX   PubMed=16291724; DOI=10.1242/jcs.02660;
RA   Klaile E., Mueller M.M., Kannicht C., Singer B.B., Lucka L.;
RT   "CEACAM1 functionally interacts with filamin A and exerts a dual role
RT   in the regulation of cell migration.";
RL   J. Cell Sci. 118:5513-5524(2005).
RN   [21]
RP   INTERACTION WITH FOXC1.
RX   PubMed=15684392; DOI=10.1128/MCB.25.4.1415-1424.2005;
RA   Berry F.B., O'Neill M.A., Coca-Prados M., Walter M.A.;
RT   "FOXC1 transcriptional regulatory activity is impaired by PBX1 in a
RT   filamin A-mediated manner.";
RL   Mol. Cell. Biol. 25:1415-1424(2005).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1089; SER-1459; SER-2152
RP   AND SER-2284, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [23]
RP   INVOLVEMENT IN PVNH1.
RX   PubMed=16299064; DOI=10.1136/jmg.2005.038505;
RA   Hehr U., Hehr A., Uyanik G., Phelan E., Winkler J., Reardon W.;
RT   "A filamin A splice mutation resulting in a syndrome of facial
RT   dysmorphism, periventricular nodular heterotopia, and severe
RT   constipation reminiscent of cerebro-fronto-facial syndrome.";
RL   J. Med. Genet. 43:541-544(2006).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084 AND SER-1459, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [25]
RP   INTERACTION WITH ARHGAP24.
RX   PubMed=16862148; DOI=10.1038/ncb1437;
RA   Ohta Y., Hartwig J.H., Stossel T.P.;
RT   "FilGAP, a Rho- and ROCK-regulated GAP for Rac binds filamin A to
RT   control actin remodelling.";
RL   Nat. Cell Biol. 8:803-814(2006).
RN   [26]
RP   INVOLVEMENT IN IPOX.
RX   PubMed=17357080; DOI=10.1086/513321;
RA   Gargiulo A., Auricchio R., Barone M.V., Cotugno G., Reardon W.,
RA   Milla P.J., Ballabio A., Ciccodicola A., Auricchio A.;
RT   "Filamin A is mutated in X-linked chronic idiopathic intestinal
RT   pseudo-obstruction with central nervous system involvement.";
RL   Am. J. Hum. Genet. 80:751-758(2007).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [28]
RP   INTERACTION WITH ECSCR.
RX   PubMed=18556573; DOI=10.1161/ATVBAHA.108.162511;
RA   Armstrong L.-J., Heath V.L., Sanderson S., Kaur S., Beesley J.F.J.,
RA   Herbert J.M.J., Legg J.A., Poulsom R., Bicknell R.;
RT   "ECSM2, an endothelial specific filamin a binding protein that
RT   mediates chemotaxis.";
RL   Arterioscler. Thromb. Vasc. Biol. 28:1640-1646(2008).
RN   [29]
RP   INTERACTION WITH FCGR1A.
RX   PubMed=18322202; DOI=10.4049/jimmunol.180.6.3938;
RA   Beekman J.M., van der Poel C.E., van der Linden J.A.,
RA   van den Berg D.L.C., van den Berghe P.V.E., van de Winkel J.G.J.,
RA   Leusen J.H.W.;
RT   "Filamin A stabilizes FcgammaRI surface expression and prevents its
RT   lysosomal routing.";
RL   J. Immunol. 180:3938-3945(2008).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1459, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084; SER-1459; SER-2152
RP   AND SER-2158, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1081, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084; SER-1338;
RP   SER-1459; SER-1533; SER-1630; SER-2053; SER-2152; SER-2327; SER-2414
RP   AND SER-2510, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [35]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [36]
RP   INTERACTION WITH GP1BA; ITGB7; ITGB2 AND FBLIM1.
RX   PubMed=19828450; DOI=10.1074/jbc.M109.060954;
RA   Ithychanda S.S., Hsu D., Li H., Yan L., Liu D.D., Liu D., Das M.,
RA   Plow E.F., Qin J.;
RT   "Identification and characterization of multiple similar ligand-
RT   binding repeats in filamin: implication on filamin-mediated receptor
RT   clustering and cross-talk.";
RL   J. Biol. Chem. 284:35113-35121(2009).
RN   [37]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [38]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-508; LYS-700; LYS-781;
RP   LYS-837; LYS-2607 AND LYS-2621, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [39]
RP   INTERACTION WITH SYK.
RX   PubMed=20713593; DOI=10.1084/jem.20100222;
RA   Falet H., Pollitt A.Y., Begonja A.J., Weber S.E., Duerschmied D.,
RA   Wagner D.D., Watson S.P., Hartwig J.H.;
RT   "A novel interaction between FlnA and Syk regulates platelet ITAM-
RT   mediated receptor signaling and function.";
RL   J. Exp. Med. 207:1967-1979(2010).
RN   [40]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1081; SER-1084;
RP   SER-1459; SER-1533; SER-1734; SER-2053; SER-2152; SER-2284; SER-2327;
RP   THR-2336 AND SER-2414, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [41]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [42]
RP   INTERACTION WITH ITGB7 AND FBLIM1, AND DOMAIN.
RX   PubMed=21524097; DOI=10.1021/bi2003229;
RA   Ithychanda S.S., Qin J.;
RT   "Evidence for multisite ligand binding and stretching of filamin by
RT   integrin and migfilin.";
RL   Biochemistry 50:4229-4231(2011).
RN   [43]
RP   INTERACTION WITH TAF1B AND MIS18BP1, AND CHARACTERIZATION OF VARIANTS
RP   ALA-1159; THR-1188 AND LEU-1199.
RX   PubMed=21228480; DOI=10.1271/bbb.100567;
RA   Qiu H., Nomiyama R., Moriguchi K., Fukada T., Sugimoto K.;
RT   "Identification of novel nuclear protein interactions with the N-
RT   terminal part of filamin A.";
RL   Biosci. Biotechnol. Biochem. 75:145-147(2011).
RN   [44]
RP   INVOLVEMENT IN MACROTHROMBOCYTOPENIA, AND VARIANT LYS-1803.
RX   PubMed=21960593; DOI=10.1182/blood-2011-07-365601;
RA   Nurden P., Debili N., Coupry I., Bryckaert M., Youlyouz-Marfak I.,
RA   Sole G., Pons A.C., Berrou E., Adam F., Kauskot A., Lamaziere J.M.,
RA   Rameau P., Fergelot P., Rooryck C., Cailley D., Arveiler B.,
RA   Lacombe D., Vainchenker W., Nurden A., Goizet C.;
RT   "Thrombocytopenia resulting from mutations in filamin A can be
RT   expressed as an isolated syndrome.";
RL   Blood 118:5928-5937(2011).
RN   [45]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-1081; SER-1084;
RP   SER-1459; SER-2152 AND SER-2327, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [46]
RP   FUNCTION IN CILIOGENESIS, AND INTERACTION WITH TMEM67 AND MKS1.
RX   PubMed=22121117; DOI=10.1093/hmg/ddr557;
RA   Adams M., Simms R.J., Abdelhamed Z., Dawe H.R., Szymanska K.,
RA   Logan C.V., Wheway G., Pitt E., Gull K., Knowles M.A., Blair E.,
RA   Cross S.H., Sayer J.A., Johnson C.A.;
RT   "A meckelin-filamin A interaction mediates ciliogenesis.";
RL   Hum. Mol. Genet. 21:1272-1286(2012).
RN   [47]
RP   INTERACTION WITH MICALL2.
RX   PubMed=23890175; DOI=10.1111/gtc.12078;
RA   Sakane A., Alamir Mahmoud Abdallah A., Nakano K., Honda K.,
RA   Kitamura T., Imoto I., Matsushita N., Sasaki T.;
RT   "Junctional Rab13-binding protein (JRAB) regulates cell spreading via
RT   filamins.";
RL   Genes Cells 18:810-822(2013).
RN   [48]
RP   INVOLVEMENT IN CSBSX.
RX   PubMed=23037936; DOI=10.1038/gim.2012.123;
RA   van der Werf C.S., Sribudiani Y., Verheij J.B., Carroll M.,
RA   O'Loughlin E., Chen C.H., Brooks A.S., Liszewski M.K., Atkinson J.P.,
RA   Hofstra R.M.;
RT   "Congenital short bowel syndrome as the presenting symptom in male
RT   patients with FLNA mutations.";
RL   Genet. Med. 15:310-313(2013).
RN   [49]
RP   UBIQUITINATION AT LYS-42; LYS-43 AND LYS-135, AND MUTAGENESIS OF
RP   LYS-42; LYS-43 AND LYS-135.
RX   PubMed=24052262; DOI=10.1074/jbc.M113.496604;
RA   Razinia Z., Baldassarre M., Cantelli G., Calderwood D.A.;
RT   "ASB2alpha, an E3 ubiquitin ligase specificity subunit, regulates cell
RT   spreading and triggers proteasomal degradation of filamins by
RT   targeting the filamin calponin homology 1 domain.";
RL   J. Biol. Chem. 288:32093-32105(2013).
RN   [50]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1081; SER-1084;
RP   SER-1301; SER-1459; SER-1533; SER-1630; SER-1835; SER-2128; SER-2152;
RP   SER-2158; SER-2284; SER-2327; THR-2336; SER-2338 AND SER-2510, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [51]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1055; SER-1081;
RP   SER-1459; SER-1734; SER-1967; SER-2152; SER-2158 AND SER-2163, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [52]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-299, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [53]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-299, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [54]
RP   INTERACTION WITH DRD3; MAS1; AGTR1 AND ADRA1D, AND PHOSPHORYLATION AT
RP   SER-2152.
RX   PubMed=26460884; DOI=10.1021/acs.biochem.5b00975;
RA   Tirupula K.C., Ithychanda S.S., Mohan M.L., Naga Prasad S.V., Qin J.,
RA   Karnik S.S.;
RT   "G Protein-Coupled Receptors Directly Bind Filamin A with High
RT   Affinity and Promote Filamin Phosphorylation.";
RL   Biochemistry 54:6673-6683(2015).
RN   [55]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-299, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [56]
RP   PHOSPHORYLATION AT SER-2152 AND THR-2336, REGULATION OF
RP   PHOSPHORYLATION AT SER-2152, INTERACTION WITH GP1BA, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=25666618; DOI=10.1074/jbc.M114.633446;
RA   Ithychanda S.S., Fang X., Mohan M.L., Zhu L., Tirupula K.C.,
RA   Naga Prasad S.V., Wang Y.X., Karnik S.S., Qin J.;
RT   "A mechanism of global shape-dependent recognition and phosphorylation
RT   of filamin by protein kinase A.";
RL   J. Biol. Chem. 290:8527-8538(2015).
RN   [57]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-299, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [58]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [59]
RP   UBIQUITINATION.
RX   PubMed=26766444; DOI=10.1016/j.devcel.2015.12.015;
RA   Scholz B., Korn C., Wojtarowicz J., Mogler C., Augustin I.,
RA   Boutros M., Niehrs C., Augustin H.G.;
RT   "Endothelial RSPO3 controls vascular stability and pruning through
RT   non-canonical WNT/Ca(2+)/NFAT signaling.";
RL   Dev. Cell 36:79-93(2016).
RN   [60]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-299, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [61]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 2045-2329, AND DOMAIN.
RX   PubMed=17690686; DOI=10.1038/sj.emboj.7601827;
RA   Lad Y., Kiema T., Jiang P., Pentikainen O.T., Coles C.H.,
RA   Campbell I.D., Calderwood D.A., Ylanne J.;
RT   "Structure of three tandem filamin domains reveals auto-inhibition of
RT   ligand binding.";
RL   EMBO J. 26:3993-4004(2007).
RN   [62]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 1-278, ACTIN-BINDING REGION,
RP   AND SUBUNIT.
RX   PubMed=19923718; DOI=10.1107/S0907444909037330;
RA   Ruskamo S., Ylanne J.;
RT   "Structure of the human filamin A actin-binding domain.";
RL   Acta Crystallogr. D 65:1217-1221(2009).
RN   [63]
RP   STRUCTURE BY NMR OF 1772-1956 AND 1954-2141.
RX   PubMed=19622754; DOI=10.1074/jbc.M109.019661;
RA   Heikkinen O.K., Ruskamo S., Konarev P.V., Svergun D.I., Iivanainen T.,
RA   Heikkinen S.M., Permi P., Koskela H., Kilpelainen I., Ylanne J.;
RT   "Atomic structures of two novel immunoglobulin-like domain pairs in
RT   the actin cross-linking protein filamin.";
RL   J. Biol. Chem. 284:25450-25458(2009).
RN   [64]
RP   VARIANT PVNH1 PHE-656, AND VARIANT THR-1764.
RX   PubMed=11532987; DOI=10.1093/hmg/10.17.1775;
RA   Sheen V.L., Dixon P.H., Fox J.W., Hong S.E., Kinton L., Sisodiya S.M.,
RA   Duncan J.S., Dubeau F., Scheffer I.E., Schachter S.C., Wilner A.,
RA   Henchy R., Crino P., Kamuro K., DiMario F., Berg M., Kuzniecky R.,
RA   Cole A.J., Bromfield E., Biber M., Schomer D., Wheless J., Silver K.,
RA   Mochida G.H., Berkovic S.F., Andermann F., Andermann E., Dobyns W.B.,
RA   Wood N.W., Walsh C.A.;
RT   "Mutations in the X-linked filamin 1 gene cause periventricular
RT   nodular heterotopia in males as well as in females.";
RL   Hum. Mol. Genet. 10:1775-1783(2001).
RN   [65]
RP   VARIANT MET-528.
RX   PubMed=12410386; DOI=10.1007/s00401-002-0594-9;
RA   Kakita A., Hayashi S., Moro F., Guerrini R., Ozawa T., Ono K.,
RA   Kameyama S., Walsh C.A., Takahashi H.;
RT   "Bilateral periventricular nodular heterotopia due to filamin 1 gene
RT   mutation: widespread glomeruloid microvascular anomaly and dysplastic
RT   cytoarchitecture in the cerebral cortex.";
RL   Acta Neuropathol. 104:649-657(2002).
RN   [66]
RP   VARIANT PVNH1 VAL-82.
RX   PubMed=11914408; DOI=10.1212/WNL.58.6.916;
RA   Moro F., Carrozzo R., Veggiotti P., Tortorella G., Toniolo D.,
RA   Volzone A., Guerrini R.;
RT   "Familial periventricular heterotopia: missense and distal truncating
RT   mutations of the FLN1 gene.";
RL   Neurology 58:916-921(2002).
RN   [67]
RP   VARIANTS OPD1 PHE-172; TRP-196 AND LEU-207, VARIANTS OPD2 PRO-170;
RP   GLY-196; SER-200; LYS-254; PRO-273; LYS-555 AND PHE-1645, VARIANTS
RP   FMD1 ALA-1159; LEU-1186 AND ILE-1620 DEL, VARIANTS MNS GLU-1184;
RP   THR-1188 AND LEU-1199, AND VARIANTS MET-429 AND THR-1764.
RX   PubMed=12612583; DOI=10.1038/ng1119;
RA   Robertson S.P., Twigg S.R.F., Sutherland-Smith A.J., Biancalana V.,
RA   Gorlin R.J., Horn D., Kenwrick S.J., Kim C.A., Morava E.,
RA   Newbury-Ecob R., Oerstavik K.H., Quarrell O.W.J., Schwartz C.E.,
RA   Shears D.J., Suri M., Kendrick-Jones J., Wilkie A.O.M.;
RT   "Localized mutations in the gene encoding the cytoskeletal protein
RT   filamin A cause diverse malformations in humans.";
RL   Nat. Genet. 33:487-491(2003).
RN   [68]
RP   VARIANTS PVNH1 VAL-102 AND PHE-149.
RX   PubMed=15249610; DOI=10.1212/01.WNL.0000132818.84827.4D;
RA   Guerrini R., Mei D., Sisodiya S.M., Sicca F., Harding B.,
RA   Takahashi Y., Dorn T., Yoshida A., Campistol J., Kraemer G., Moro F.,
RA   Dobyns W.B., Parrini E.;
RT   "Germline and mosaic mutations of FLN1 in men with periventricular
RT   heterotopia.";
RL   Neurology 63:51-56(2004).
RN   [69]
RP   VARIANT OTOPALATODIGITAL SPECTRUM DISORDER 1635-ARG--VAL-1637 DEL.
RX   PubMed=15654694; DOI=10.1002/ajmg.a.30484;
RA   Stefanova M., Meinecke P., Gal A., Bolz H.;
RT   "A novel 9 bp deletion in the filamin A gene causes an
RT   otopalatodigital-spectrum disorder with a variable, intermediate
RT   phenotype.";
RL   Am. J. Med. Genet. A 132:386-390(2005).
RN   [70]
RP   VARIANT OPD1 TYR-203.
RX   PubMed=15940695; DOI=10.1002/ajmg.a.30792;
RA   Hidalgo-Bravo A., Pompa-Mera E.N., Kofman-Alfaro S.,
RA   Gonzalez-Bonilla C.R., Zenteno J.C.;
RT   "A novel filamin A D203Y mutation in a female patient with
RT   otopalatodigital type 1 syndrome and extremely skewed X chromosome
RT   inactivation.";
RL   Am. J. Med. Genet. A 136:190-193(2005).
RN   [71]
RP   VARIANT PVNH1 GLY-39.
RX   PubMed=15668422; DOI=10.1212/01.WNL.0000149512.79621.DF;
RA   Sheen V.L., Jansen A., Chen M.H., Parrini E., Morgan T.,
RA   Ravenscroft R., Ganesh V., Underwood T., Wiley J., Leventer R.,
RA   Vaid R.R., Ruiz D.E., Hutchins G.M., Menasha J., Willner J., Geng Y.,
RA   Gripp K.W., Nicholson L., Berry-Kravis E., Bodell A., Apse K.,
RA   Hill R.S., Dubeau F., Andermann F., Barkovich J., Andermann E.,
RA   Shugart Y.Y., Thomas P., Viri M., Veggiotti P., Robertson S.,
RA   Guerrini R., Walsh C.A.;
RT   "Filamin A mutations cause periventricular heterotopia with Ehlers-
RT   Danlos syndrome.";
RL   Neurology 64:254-262(2005).
RN   [72]
RP   VARIANTS FMD1 LEU-1186 AND CYS-1728.
RX   PubMed=16596676; DOI=10.1002/ajmg.a.31213;
RA   Zenker M., Naehrlich L., Sticht H., Reis A., Horn D.;
RT   "Genotype-epigenotype-phenotype correlations in females with
RT   frontometaphyseal dysplasia.";
RL   Am. J. Med. Genet. A 140:1069-1073(2006).
RN   [73]
RP   VARIANT PVNH1 VAL-128.
RX   PubMed=15994863; DOI=10.1136/jmg.2004.029173;
RA   Gomez-Garre P., Seijo M., Gutierrez-Delicado E., Castro del Rio M.,
RA   de la Torre C., Gomez-Abad C., Morales-Corraliza J., Puig M.,
RA   Serratosa J.M.;
RT   "Ehlers-Danlos syndrome and periventricular nodular heterotopia in a
RT   Spanish family with a single FLNA mutation.";
RL   J. Med. Genet. 43:232-237(2006).
RN   [74]
RP   VARIANT OPD2 PHE-210.
RX   PubMed=17431908; DOI=10.1002/ajmg.a.31696;
RA   Marino-Enriquez A., Lapunzina P., Robertson S.P., Rodriguez J.I.;
RT   "Otopalatodigital syndrome type 2 in two siblings with a novel filamin
RT   A 629G>T mutation: clinical, pathological, and molecular findings.";
RL   Am. J. Med. Genet. A 143:1120-1125(2007).
RN   [75]
RP   VARIANT FGS2 LEU-1291.
RX   PubMed=17632775; DOI=10.1002/ajmg.a.31751;
RA   Unger S., Mainberger A., Spitz C., Baehr A., Zeschnigk C., Zabel B.,
RA   Superti-Furga A., Morris-Rosendahl D.J.;
RT   "Filamin A mutation is one cause of FG syndrome.";
RL   Am. J. Med. Genet. A 143:1876-1879(2007).
RN   [76]
RP   VARIANTS CVDX ARG-288; GLN-637 AND ASP-711.
RX   PubMed=17190868; DOI=10.1161/CIRCULATIONAHA.106.622621;
RA   Kyndt F., Gueffet J.P., Probst V., Jaafar P., Legendre A.,
RA   Le Bouffant F., Toquet C., Roy E., McGregor L., Lynch S.A.,
RA   Newbury-Ecob R., Tran V., Young I., Trochu J.N., Le Marec H.,
RA   Schott J.J.;
RT   "Mutations in the gene encoding filamin A as a cause for familial
RT   cardiac valvular dystrophy.";
RL   Circulation 115:40-49(2007).
RN   [77]
RP   VARIANT TOD 1724-VAL--THR-1739 DEL.
RX   PubMed=20598277; DOI=10.1016/j.ajhg.2010.06.008;
RA   Sun Y., Almomani R., Aten E., Celli J., van der Heijden J.,
RA   Venselaar H., Robertson S.P., Baroncini A., Franco B.,
RA   Basel-Vanagaite L., Horii E., Drut R., Ariyurek Y., den Dunnen J.T.,
RA   Breuning M.H.;
RT   "Terminal osseous dysplasia is caused by a single recurrent mutation
RT   in the FLNA gene.";
RL   Am. J. Hum. Genet. 87:146-153(2010).
RN   [78]
RP   VARIANT MET-528.
RX   PubMed=20844545; DOI=10.1038/jhg.2010.114;
RA   Kunishima S., Ito-Yamamura Y., Hayakawa A., Yamamoto T., Saito H.;
RT   "FLNA p.V528M substitution is neither associated with bilateral
RT   periventricular nodular heterotopia nor with macrothrombocytopenia.";
RL   J. Hum. Genet. 55:844-846(2010).
RN   [79]
RP   VARIANTS OPD2 SER-187 AND GLY-196, VARIANTS OPD1 LEU-207; THR-267;
RP   ASP-804 AND HIS-2391, VARIANTS FMD1 VAL-1142; LEU-1186 AND ARG-1840,
RP   AND VARIANTS MNS LEU-1163 AND THR-1188.
RX   PubMed=27193221; DOI=10.1038/jhg.2016.37;
RA   Moutton S., Fergelot P., Naudion S., Cordier M.P., Sole G.,
RA   Guerineau E., Hubert C., Rooryck C., Vuillaume M.L., Houcinat N.,
RA   Deforges J., Bouron J., Deves S., Le Merrer M., David A.,
RA   Genevieve D., Giuliano F., Journel H., Megarbane A., Faivre L.,
RA   Chassaing N., Francannet C., Sarrazin E., Stattin E.L., Vigneron J.,
RA   Leclair D., Abadie C., Sarda P., Baumann C., Delrue M.A., Arveiler B.,
RA   Lacombe D., Goizet C., Coupry I.;
RT   "Otopalatodigital spectrum disorders: refinement of the phenotypic and
RT   mutational spectrum.";
RL   J. Hum. Genet. 61:693-699(2016).
CC   -!- FUNCTION: Promotes orthogonal branching of actin filaments and
CC       links actin filaments to membrane glycoproteins. Anchors various
CC       transmembrane proteins to the actin cytoskeleton and serves as a
CC       scaffold for a wide range of cytoplasmic signaling proteins.
CC       Interaction with FLNA may allow neuroblast migration from the
CC       ventricular zone into the cortical plate. Tethers cell surface-
CC       localized furin, modulates its rate of internalization and directs
CC       its intracellular trafficking (By similarity). Involved in
CC       ciliogenesis. Plays a role in cell-cell contacts and adherens
CC       junctions during the development of blood vessels, heart and brain
CC       organs. Plays a role in platelets morphology through interaction
CC       with SYK that regulates ITAM- and ITAM-like-containing receptor
CC       signaling, resulting in by platelet cytoskeleton organization
CC       maintenance (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q8BTM8, ECO:0000269|PubMed:22121117}.
CC   -!- SUBUNIT: Homodimer. Interacts with PDLIM2 (By similarity).
CC       Interacts with RFLNA and RFLNB (By similarity). Interacts with
CC       FCGR1A, FLNB, FURIN, HSPB7, INPPL1, KCND2, MYOT, MYOZ1, ARHGAP24,
CC       PSEN1, PSEN2 and ECSCR. Interacts also with various other binding
CC       partners in addition to filamentous actin. Interacts (via N-
CC       terminus) with MIS18BP1 (via N-terminus). Interacts (via N-
CC       terminus) with TAF1B. Interacts with TMEM67 (via C-terminus) and
CC       MKS1. Interacts (via actin-binding domain) with MICALL2 (via CH
CC       domain). Interacts (via filamin repeat 5) with SYK; docks SYK to
CC       the plasma membrane (PubMed:20713593). Interacts (via filamin
CC       repeats 19 and 21) with DRD3; increased PKA-mediated
CC       phosphorylation at Ser-2152. Interacts (via filamin repeat 21)
CC       with MAS1, AGTR1 and ADRA1D; increases PKA-mediated
CC       phosphorylation of FLNA at Ser-2152 (PubMed:26460884). Interacts
CC       (via filamin repeats 4, 9, 12, 17, 19, 21, and 23) with GP1BA
CC       (high affinity), ITGB7, ITGB2 and FBLIM1 (PubMed:19828450,
CC       PubMed:21524097, PubMed:25666618). Interacts with CEACAM1 (via
CC       cytoplasmic domain); inhibits cell migration and cell scattering
CC       by interfering with the interaction between FLNA and RALA
CC       (PubMed:16291724). Interacts with FOXC1 (PubMed:15684392).
CC       {ECO:0000250, ECO:0000250|UniProtKB:Q8BTM8,
CC       ECO:0000269|PubMed:11102480, ECO:0000269|PubMed:11739414,
CC       ECO:0000269|PubMed:12393796, ECO:0000269|PubMed:15684392,
CC       ECO:0000269|PubMed:16076904, ECO:0000269|PubMed:16291724,
CC       ECO:0000269|PubMed:16862148, ECO:0000269|PubMed:18322202,
CC       ECO:0000269|PubMed:18556573, ECO:0000269|PubMed:19828450,
CC       ECO:0000269|PubMed:19923718, ECO:0000269|PubMed:20713593,
CC       ECO:0000269|PubMed:21228480, ECO:0000269|PubMed:21524097,
CC       ECO:0000269|PubMed:22121117, ECO:0000269|PubMed:23890175,
CC       ECO:0000269|PubMed:25666618, ECO:0000269|PubMed:26460884,
CC       ECO:0000269|PubMed:9437013}.
CC   -!- INTERACTION:
CC       Q9WMX2:- (xeno); NbExp=6; IntAct=EBI-350432, EBI-6863748;
CC       Q6UY14-3:ADAMTSL4; NbExp=3; IntAct=EBI-9641086, EBI-10173507;
CC       Q8N264:ARHGAP24; NbExp=6; IntAct=EBI-350432, EBI-988764;
CC       O95067:CCNB2; NbExp=8; IntAct=EBI-350432, EBI-375024;
CC       P46108:CRK; NbExp=3; IntAct=EBI-350432, EBI-886;
CC       P07148:FABP1; NbExp=3; IntAct=EBI-9641086, EBI-2115989;
CC       O75369:FLNB; NbExp=5; IntAct=EBI-350432, EBI-352089;
CC       Q12948:FOXC1; NbExp=8; IntAct=EBI-350432, EBI-1175253;
CC       P62993:GRB2; NbExp=2; IntAct=EBI-350432, EBI-401755;
CC       P08238:HSP90AB1; NbExp=3; IntAct=EBI-350432, EBI-352572;
CC       Q9UBY9:HSPB7; NbExp=9; IntAct=EBI-9641086, EBI-739361;
CC       P08514-1:ITGA2B; NbExp=3; IntAct=EBI-350432, EBI-15805658;
CC       P05556:ITGB1; NbExp=6; IntAct=EBI-350432, EBI-703066;
CC       P07228:ITGB1 (xeno); NbExp=2; IntAct=EBI-350432, EBI-5606437;
CC       P05106:ITGB3; NbExp=3; IntAct=EBI-350432, EBI-702847;
CC       P26010:ITGB7; NbExp=7; IntAct=EBI-350432, EBI-702932;
CC       P26010-1:ITGB7; NbExp=2; IntAct=EBI-350432, EBI-15944630;
CC       Q53G59:KLHL12; NbExp=5; IntAct=EBI-9641086, EBI-740929;
CC       Q8TCE9:LGALS14; NbExp=5; IntAct=EBI-9641086, EBI-10274069;
CC       Q99759:MAP3K3; NbExp=2; IntAct=EBI-350432, EBI-307281;
CC       O14786:NRP1; NbExp=2; IntAct=EBI-350432, EBI-1187100;
CC       P35372:OPRM1; NbExp=5; IntAct=EBI-350432, EBI-2624570;
CC       Q86SQ0:PHLDB2; NbExp=3; IntAct=EBI-350432, EBI-2798483;
CC       P49768:PSEN1; NbExp=2; IntAct=EBI-350432, EBI-297277;
CC       P49810:PSEN2; NbExp=2; IntAct=EBI-350432, EBI-2010251;
CC       Q04864:REL; NbExp=3; IntAct=EBI-9641086, EBI-307352;
CC       Q6ZTI6:RFLNA; NbExp=3; IntAct=EBI-9641086, EBI-10200920;
CC       P15884:TCF4; NbExp=3; IntAct=EBI-9641086, EBI-533224;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cell cortex. Cytoplasm,
CC       cytoskeleton.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P21333-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P21333-2; Sequence=VSP_035454;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DOMAIN: Comprised of a NH2-terminal actin-binding domain, 24
CC       immunoglobulin-like internally homologous repeats and two hinge
CC       regions. Repeat 24 and the second hinge domain are important for
CC       dimer formation. Filamin repeat 20 interacts with filamin repeat
CC       21 masking the ligand binding site on filamin repeat 21, resulting
CC       in an autoinhibited conformation (PubMed:17690686). The
CC       autoinhibition can be relieved by ligands like ITGB7 or FBLIM1
CC       (PubMed:21524097). Filamin repeats 19 and 21 can simultaneously
CC       engage ligands (PubMed:21524097). {ECO:0000269|PubMed:17690686,
CC       ECO:0000269|PubMed:21524097}.
CC   -!- PTM: Phosphorylation at Ser-2152 is negatively regulated by the
CC       autoinhibited conformation of filamin repeats 19-21. Ligand
CC       binding induces a conformational switch triggering phosphorylation
CC       at Ser-2152 by PKA. {ECO:0000269|PubMed:25666618}.
CC   -!- PTM: Phosphorylation extent changes in response to cell
CC       activation.
CC   -!- PTM: Polyubiquitination in the CH1 domain by a SCF-like complex
CC       containing ASB2 leads to proteasomal degradation. Prior
CC       dissociation from actin may be required to expose the target
CC       lysines (PubMed:24052262). Ubiquitinated in endothelial cells by
CC       RNF213 downstream of the non-canonical Wnt signaling pathway,
CC       leading to its degradation by the proteasome (PubMed:26766444).
CC       {ECO:0000269|PubMed:24052262, ECO:0000269|PubMed:26766444}.
CC   -!- DISEASE: Periventricular nodular heterotopia 1 (PVNH1)
CC       [MIM:300049]: A developmental disorder characterized by the
CC       presence of periventricular nodules of cerebral gray matter,
CC       resulting from a failure of neurons to migrate normally from the
CC       lateral ventricular proliferative zone, where they are formed, to
CC       the cerebral cortex. PVNH1 is an X-linked dominant form.
CC       Heterozygous females have normal intelligence but suffer from
CC       seizures and various manifestations outside the central nervous
CC       system, especially related to the vascular system. Hemizygous
CC       affected males die in the prenatal or perinatal period.
CC       {ECO:0000269|PubMed:11532987, ECO:0000269|PubMed:11914408,
CC       ECO:0000269|PubMed:15249610, ECO:0000269|PubMed:15668422,
CC       ECO:0000269|PubMed:15994863, ECO:0000269|PubMed:16299064}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Otopalatodigital syndrome 1 (OPD1) [MIM:311300]: X-linked
CC       dominant multiple congenital anomalies disease mainly
CC       characterized by a generalized skeletal dysplasia, mild mental
CC       retardation, hearing loss, cleft palate, and typical facial
CC       anomalies. OPD1 belongs to a group of X-linked skeletal dysplasias
CC       known as oto-palato-digital syndrome spectrum disorders that also
CC       include OPD2, Melnick-Needles syndrome (MNS), and
CC       frontometaphyseal dysplasia (FMD). Remodeling of the cytoskeleton
CC       is central to the modulation of cell shape and migration. FLNA is
CC       a widely expressed protein that regulates re-organization of the
CC       actin cytoskeleton by interacting with integrins, transmembrane
CC       receptor complexes and second messengers. Males with OPD1 have
CC       cleft palate, malformations of the ossicles causing deafness and
CC       milder bone and limb defects than those associated with OPD2.
CC       Obligate female carriers of mutations causing both OPD1 and OPD2
CC       have variable (often milder) expression of a similar phenotypic
CC       spectrum. {ECO:0000269|PubMed:12612583,
CC       ECO:0000269|PubMed:15940695, ECO:0000269|PubMed:27193221}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Otopalatodigital syndrome 2 (OPD2) [MIM:304120]:
CC       Congenital bone disorder that is characterized by abnormally
CC       modeled, bowed bones, small or absent first digits and, more
CC       variably, cleft palate, posterior fossa brain anomalies,
CC       omphalocele and cardiac defects. {ECO:0000269|PubMed:12612583,
CC       ECO:0000269|PubMed:17431908, ECO:0000269|PubMed:27193221}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Frontometaphyseal dysplasia 1 (FMD1) [MIM:305620]: An X-
CC       linked disease characterized by generalized skeletal dysplasia,
CC       deafness, and urogenital defects. {ECO:0000269|PubMed:12612583,
CC       ECO:0000269|PubMed:16596676, ECO:0000269|PubMed:27193221}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Melnick-Needles syndrome (MNS) [MIM:309350]: Severe
CC       congenital bone disorder characterized by typical facies
CC       (exophthalmos, full cheeks, micrognathia and malalignment of
CC       teeth), flaring of the metaphyses of long bones, s-like curvature
CC       of bones of legs, irregular constrictions in the ribs, and
CC       sclerosis of base of skull. {ECO:0000269|PubMed:12612583,
CC       ECO:0000269|PubMed:27193221}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Intestinal pseudoobstruction, neuronal, chronic
CC       idiopathic, X-linked (IPOX) [MIM:300048]: A disease characterized
CC       by a severe abnormality of gastrointestinal motility due to
CC       primary qualitative defects of enteric ganglia and nerve fibers.
CC       Affected individuals manifest recurrent signs of intestinal
CC       obstruction in the absence of any mechanical lesion.
CC       {ECO:0000269|PubMed:17357080}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: FG syndrome 2 (FGS2) [MIM:300321]: FG syndrome (FGS) is
CC       an X-linked disorder characterized by mental retardation, relative
CC       macrocephaly, hypotonia and constipation.
CC       {ECO:0000269|PubMed:17632775}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Terminal osseous dysplasia (TOD) [MIM:300244]: A rare X-
CC       linked dominant male-lethal disease characterized by skeletal
CC       dysplasia of the limbs, pigmentary defects of the skin and
CC       recurrent digital fibroma during infancy. A significant phenotypic
CC       variability is observed in affected females.
CC       {ECO:0000269|PubMed:20598277}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Cardiac valvular dysplasia X-linked (CVDX) [MIM:314400]:
CC       A rare X-linked heart disease characterized by mitral and/or
CC       aortic valve regurgitation. The histologic features include
CC       fragmentation of collagenous bundles within the valve fibrosa and
CC       accumulation of proteoglycans, which produces excessive valve
CC       tissue leading to billowing of the valve leaflets.
CC       {ECO:0000269|PubMed:17190868}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=Defects in FLNA may be a cause of
CC       macrothrombocytopenia, a disorder characterized by subnormal
CC       levels of blood platelets. Blood platelets are abnormally enlarged
CC       (PubMed:21960593). {ECO:0000269|PubMed:21960593}.
CC   -!- DISEASE: Congenital short bowel syndrome, X-linked (CSBSX)
CC       [MIM:300048]: A disease characterized by a shortened small
CC       intestine, and malabsorption. The mean length of the small
CC       intestine in affected individuals is approximately 50 cm, compared
CC       with a normal length at birth of 190-280 cm. It is associated with
CC       significant mortality and morbidity. Infants usually present with
CC       failure to thrive, recurrent vomiting, and diarrhea.
CC       {ECO:0000269|PubMed:23037936}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the filamin family. {ECO:0000305}.
CC   -!- CAUTION: Variant Thr-1764 has been originally associated with
CC       periventricular nodular heterotopia. It has been subsequently
CC       reported as a benign polymorphism. {ECO:0000305|PubMed:12612583}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC03408.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X53416; CAA37495.1; -; mRNA.
DR   EMBL; L44140; AAA92644.1; -; Genomic_DNA.
DR   EMBL; X70082; CAA49687.1; -; Genomic_DNA.
DR   EMBL; X70085; CAA49690.1; -; Genomic_DNA.
DR   EMBL; GU727643; ADU87644.1; -; mRNA.
DR   EMBL; AK090427; BAC03408.2; ALT_INIT; mRNA.
DR   EMBL; AB593010; BAJ83965.1; -; mRNA.
DR   EMBL; BX664723; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX936346; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471172; EAW72745.1; -; Genomic_DNA.
DR   EMBL; CH471172; EAW72746.1; -; Genomic_DNA.
DR   CCDS; CCDS44021.1; -. [P21333-2]
DR   CCDS; CCDS48194.1; -. [P21333-1]
DR   PIR; A37098; A37098.
DR   RefSeq; NP_001104026.1; NM_001110556.1. [P21333-1]
DR   RefSeq; NP_001447.2; NM_001456.3. [P21333-2]
DR   UniGene; Hs.195464; -.
DR   PDB; 2AAV; NMR; -; A=1863-1956.
DR   PDB; 2BP3; X-ray; 2.32 A; A/B=1863-1956.
DR   PDB; 2BRQ; X-ray; 2.10 A; A/B=2236-2329.
DR   PDB; 2J3S; X-ray; 2.50 A; A/B=2045-2329.
DR   PDB; 2JF1; X-ray; 2.20 A; A=2236-2329.
DR   PDB; 2K3T; NMR; -; A=2427-2522.
DR   PDB; 2K7P; NMR; -; A=1772-1956.
DR   PDB; 2K7Q; NMR; -; A=1954-2141.
DR   PDB; 2MTP; NMR; -; A=2236-2330.
DR   PDB; 2W0P; X-ray; 1.90 A; A/B=2236-2329.
DR   PDB; 2WFN; X-ray; 3.20 A; A/B=1-278.
DR   PDB; 3CNK; X-ray; 1.65 A; A/B=2559-2647.
DR   PDB; 3HOC; X-ray; 2.30 A; A/B=2-269.
DR   PDB; 3HOP; X-ray; 2.30 A; A/B=2-269.
DR   PDB; 3HOR; X-ray; 2.70 A; A/B=2-269.
DR   PDB; 3ISW; X-ray; 2.80 A; A/B=2236-2329.
DR   PDB; 3RGH; X-ray; 2.44 A; A/B=1158-1252.
DR   PDB; 4M9P; X-ray; 1.72 A; A=478-766.
DR   PDB; 4P3W; X-ray; 2.00 A; A/B/C/D/E/F=2152-2329.
DR   PDBsum; 2AAV; -.
DR   PDBsum; 2BP3; -.
DR   PDBsum; 2BRQ; -.
DR   PDBsum; 2J3S; -.
DR   PDBsum; 2JF1; -.
DR   PDBsum; 2K3T; -.
DR   PDBsum; 2K7P; -.
DR   PDBsum; 2K7Q; -.
DR   PDBsum; 2MTP; -.
DR   PDBsum; 2W0P; -.
DR   PDBsum; 2WFN; -.
DR   PDBsum; 3CNK; -.
DR   PDBsum; 3HOC; -.
DR   PDBsum; 3HOP; -.
DR   PDBsum; 3HOR; -.
DR   PDBsum; 3ISW; -.
DR   PDBsum; 3RGH; -.
DR   PDBsum; 4M9P; -.
DR   PDBsum; 4P3W; -.
DR   ProteinModelPortal; P21333; -.
DR   SMR; P21333; -.
DR   BioGrid; 108605; 289.
DR   CORUM; P21333; -.
DR   DIP; DIP-1136N; -.
DR   IntAct; P21333; 243.
DR   MINT; P21333; -.
DR   STRING; 9606.ENSP00000358866; -.
DR   TCDB; 8.A.66.1.4; the dystrophin (dystrophin) family.
DR   CarbonylDB; P21333; -.
DR   iPTMnet; P21333; -.
DR   PhosphoSitePlus; P21333; -.
DR   SwissPalm; P21333; -.
DR   BioMuta; FLNA; -.
DR   DMDM; 116241365; -.
DR   OGP; P21333; -.
DR   EPD; P21333; -.
DR   MaxQB; P21333; -.
DR   PaxDb; P21333; -.
DR   PeptideAtlas; P21333; -.
DR   PRIDE; P21333; -.
DR   Ensembl; ENST00000360319; ENSP00000353467; ENSG00000196924. [P21333-2]
DR   Ensembl; ENST00000369850; ENSP00000358866; ENSG00000196924. [P21333-1]
DR   Ensembl; ENST00000422373; ENSP00000416926; ENSG00000196924. [P21333-2]
DR   GeneID; 2316; -.
DR   KEGG; hsa:2316; -.
DR   UCSC; uc004fkk.3; human. [P21333-1]
DR   CTD; 2316; -.
DR   DisGeNET; 2316; -.
DR   EuPathDB; HostDB:ENSG00000196924.14; -.
DR   GeneCards; FLNA; -.
DR   GeneReviews; FLNA; -.
DR   H-InvDB; HIX0017150; -.
DR   HGNC; HGNC:3754; FLNA.
DR   HPA; CAB000356; -.
DR   HPA; HPA000368; -.
DR   HPA; HPA001016; -.
DR   HPA; HPA001115; -.
DR   HPA; HPA002925; -.
DR   MalaCards; FLNA; -.
DR   MIM; 300017; gene.
DR   MIM; 300048; phenotype.
DR   MIM; 300049; phenotype.
DR   MIM; 300244; phenotype.
DR   MIM; 300321; phenotype.
DR   MIM; 304120; phenotype.
DR   MIM; 305620; phenotype.
DR   MIM; 309350; phenotype.
DR   MIM; 311300; phenotype.
DR   MIM; 314400; phenotype.
DR   neXtProt; NX_P21333; -.
DR   OpenTargets; ENSG00000196924; -.
DR   Orphanet; 2301; Congenital short bowel syndrome.
DR   Orphanet; 1864; Congenital valvular dysplasia.
DR   Orphanet; 82004; Ehlers-Danlos syndrome with periventricular heterotopia.
DR   Orphanet; 323; FG syndrome.
DR   Orphanet; 1826; Frontometaphyseal dysplasia.
DR   Orphanet; 99811; Neuronal intestinal pseudoobstruction.
DR   Orphanet; 2484; Osteodysplasty, Melnick-Needles type.
DR   Orphanet; 90650; Otopalatodigital syndrome type 1.
DR   Orphanet; 90652; Otopalatodigital syndrome type 2.
DR   Orphanet; 98892; Periventricular nodular heterotopia.
DR   Orphanet; 88630; Terminal osseous dysplasia - pigmentary defects.
DR   PharmGKB; PA28172; -.
DR   eggNOG; KOG0518; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   GeneTree; ENSGT00900000140842; -.
DR   HOGENOM; HOG000044235; -.
DR   HOVERGEN; HBG004163; -.
DR   InParanoid; P21333; -.
DR   KO; K04437; -.
DR   OMA; PYEAGTY; -.
DR   OrthoDB; EOG091G00U5; -.
DR   PhylomeDB; P21333; -.
DR   TreeFam; TF313685; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   Reactome; R-HSA-430116; GP1b-IX-V activation signalling.
DR   Reactome; R-HSA-446353; Cell-extracellular matrix interactions.
DR   Reactome; R-HSA-5627123; RHO GTPases activate PAKs.
DR   SignaLink; P21333; -.
DR   SIGNOR; P21333; -.
DR   ChiTaRS; FLNA; human.
DR   EvolutionaryTrace; P21333; -.
DR   GeneWiki; FLNA; -.
DR   GenomeRNAi; 2316; -.
DR   PMAP-CutDB; P21333; -.
DR   PRO; PR:P21333; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000196924; -.
DR   CleanEx; HS_FLNA; -.
DR   ExpressionAtlas; P21333; baseline and differential.
DR   Genevisible; P21333; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005884; C:actin filament; IEA:Ensembl.
DR   GO; GO:0097440; C:apical dendrite; IEA:Ensembl.
DR   GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB.
DR   GO; GO:0030863; C:cortical cytoskeleton; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0043198; C:dendritic shaft; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0031523; C:Myb complex; IDA:MGI.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IMP:CACAO.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0030018; C:Z disc; ISS:BHF-UCL.
DR   GO; GO:0051015; F:actin filament binding; IDA:BHF-UCL.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0034988; F:Fc-gamma receptor I complex binding; IDA:BHF-UCL.
DR   GO; GO:0001664; F:G-protein coupled receptor binding; IPI:UniProtKB.
DR   GO; GO:0051020; F:GTPase binding; IPI:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IPI:BHF-UCL.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0031852; F:mu-type opioid receptor binding; IEA:Ensembl.
DR   GO; GO:0015459; F:potassium channel regulator activity; IDA:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL.
DR   GO; GO:0048365; F:Rac GTPase binding; IDA:BHF-UCL.
DR   GO; GO:0017160; F:Ral GTPase binding; IDA:BHF-UCL.
DR   GO; GO:0017048; F:Rho GTPase binding; IDA:BHF-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0004871; F:signal transducer activity; HMP:UniProtKB.
DR   GO; GO:0046332; F:SMAD binding; IEA:Ensembl.
DR   GO; GO:0031267; F:small GTPase binding; IDA:BHF-UCL.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0051764; P:actin crosslink formation; IDA:BHF-UCL.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; IDA:BHF-UCL.
DR   GO; GO:0007195; P:adenylate cyclase-inhibiting dopamine receptor signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0034329; P:cell junction assembly; TAS:Reactome.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0060271; P:cilium assembly; IMP:UniProtKB.
DR   GO; GO:0051220; P:cytoplasmic sequestering of protein; IMP:BHF-UCL.
DR   GO; GO:0045184; P:establishment of protein localization; IDA:BHF-UCL.
DR   GO; GO:0021943; P:formation of radial glial scaffolds; IEA:Ensembl.
DR   GO; GO:0090307; P:mitotic spindle assembly; IDA:MGI.
DR   GO; GO:0042789; P:mRNA transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:CACAO.
DR   GO; GO:0043433; P:negative regulation of DNA binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; IMP:BHF-UCL.
DR   GO; GO:0016479; P:negative regulation of transcription by RNA polymerase I; IDA:CACAO.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0070527; P:platelet aggregation; HMP:UniProtKB.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; HMP:UniProtKB.
DR   GO; GO:2001046; P:positive regulation of integrin-mediated signaling pathway; IMP:CACAO.
DR   GO; GO:2000179; P:positive regulation of neural precursor cell proliferation; IEA:Ensembl.
DR   GO; GO:2001224; P:positive regulation of neuron migration; IEA:Ensembl.
DR   GO; GO:1901381; P:positive regulation of potassium ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IMP:CACAO.
DR   GO; GO:0042993; P:positive regulation of transcription factor import into nucleus; IMP:UniProtKB.
DR   GO; GO:0034394; P:protein localization to cell surface; IDA:BHF-UCL.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0050821; P:protein stabilization; IMP:BHF-UCL.
DR   GO; GO:0043113; P:receptor clustering; IDA:BHF-UCL.
DR   GO; GO:0030334; P:regulation of cell migration; IDA:UniProtKB.
DR   GO; GO:1905000; P:regulation of membrane repolarization during atrial cardiac muscle cell action potential; IC:BHF-UCL.
DR   GO; GO:1905031; P:regulation of membrane repolarization during cardiac muscle cell action potential; ISS:BHF-UCL.
DR   GO; GO:0071526; P:semaphorin-plexin signaling pathway; IGI:WormBase.
DR   GO; GO:0044319; P:wound healing, spreading of cells; IDA:UniProtKB.
DR   CDD; cd00014; CH; 2.
DR   Gene3D; 1.10.418.10; -; 2.
DR   Gene3D; 2.60.40.10; -; 24.
DR   InterPro; IPR001589; Actinin_actin-bd_CS.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR017868; Filamin/ABP280_repeat-like.
DR   InterPro; IPR001298; Filamin/ABP280_rpt.
DR   InterPro; IPR028559; FLN_A.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   PANTHER; PTHR43998:SF6; PTHR43998:SF6; 1.
DR   Pfam; PF00307; CH; 2.
DR   Pfam; PF00630; Filamin; 23.
DR   SMART; SM00033; CH; 2.
DR   SMART; SM00557; IG_FLMN; 24.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   SUPFAM; SSF81296; SSF81296; 24.
DR   PROSITE; PS00019; ACTININ_1; 1.
DR   PROSITE; PS00020; ACTININ_2; 1.
DR   PROSITE; PS50021; CH; 2.
DR   PROSITE; PS50194; FILAMIN_REPEAT; 24.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Alternative splicing;
KW   Cilium biogenesis/degradation; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Deafness; Direct protein sequencing; Disease mutation;
KW   Isopeptide bond; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|Ref.9}.
FT   CHAIN         2   2647       Filamin-A.
FT                                /FTId=PRO_0000087296.
FT   DOMAIN       43    149       Calponin-homology (CH) 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00044}.
FT   DOMAIN      166    269       Calponin-homology (CH) 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00044}.
FT   REPEAT      276    374       Filamin 1.
FT   REPEAT      376    474       Filamin 2.
FT   REPEAT      475    570       Filamin 3.
FT   REPEAT      571    663       Filamin 4.
FT   REPEAT      667    763       Filamin 5.
FT   REPEAT      764    866       Filamin 6.
FT   REPEAT      867    965       Filamin 7.
FT   REPEAT      966   1061       Filamin 8.
FT   REPEAT     1062   1154       Filamin 9.
FT   REPEAT     1155   1249       Filamin 10.
FT   REPEAT     1250   1349       Filamin 11.
FT   REPEAT     1350   1442       Filamin 12.
FT   REPEAT     1443   1539       Filamin 13.
FT   REPEAT     1540   1636       Filamin 14.
FT   REPEAT     1649   1740       Filamin 15.
FT   REPEAT     1779   1860       Filamin 16.
FT   REPEAT     1861   1950       Filamin 17.
FT   REPEAT     1951   2039       Filamin 18.
FT   REPEAT     2042   2131       Filamin 19.
FT   REPEAT     2132   2230       Filamin 20.
FT   REPEAT     2233   2325       Filamin 21.
FT   REPEAT     2327   2420       Filamin 22.
FT   REPEAT     2424   2516       Filamin 23.
FT   REPEAT     2552   2646       Filamin 24.
FT   REGION        2    274       Actin-binding.
FT   REGION     1490   1607       Interaction with furin. {ECO:0000250}.
FT   REGION     1741   1778       Hinge 1.
FT   REGION     2517   2647       Self-association site, tail.
FT   REGION     2517   2551       Hinge 2.
FT   SITE       1761   1762       Cleavage; by calpain.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|Ref.9}.
FT   MOD_RES      11     11       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     376    376       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BTM8}.
FT   MOD_RES     508    508       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     700    700       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     781    781       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     837    837       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     865    865       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BTM8}.
FT   MOD_RES     906    906       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BTM8}.
FT   MOD_RES     968    968       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BTM8}.
FT   MOD_RES    1055   1055       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1071   1071       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BTM8}.
FT   MOD_RES    1071   1071       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BTM8}.
FT   MOD_RES    1081   1081       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1084   1084       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17924679,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1089   1089       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17081983}.
FT   MOD_RES    1301   1301       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1338   1338       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1372   1372       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BTM8}.
FT   MOD_RES    1459   1459       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19367720,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1533   1533       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1538   1538       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BTM8}.
FT   MOD_RES    1630   1630       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1734   1734       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1835   1835       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1967   1967       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2053   2053       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES    2128   2128       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2152   2152       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:25666618,
FT                                ECO:0000269|PubMed:26460884}.
FT   MOD_RES    2158   2158       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2163   2163       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2180   2180       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BTM8}.
FT   MOD_RES    2284   2284       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2327   2327       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2329   2329       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BTM8}.
FT   MOD_RES    2336   2336       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:25666618}.
FT   MOD_RES    2338   2338       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2370   2370       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BTM8}.
FT   MOD_RES    2414   2414       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES    2510   2510       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2523   2523       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BTM8}.
FT   MOD_RES    2526   2526       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BTM8}.
FT   MOD_RES    2569   2569       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BTM8}.
FT   MOD_RES    2569   2569       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BTM8}.
FT   MOD_RES    2575   2575       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BTM8}.
FT   MOD_RES    2599   2599       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q8BTM8}.
FT   MOD_RES    2607   2607       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    2621   2621       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   CROSSLNK     42     42       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:24052262}.
FT   CROSSLNK     43     43       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:24052262}.
FT   CROSSLNK    135    135       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:24052262}.
FT   CROSSLNK    299    299       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK    299    299       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ    1649   1656       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_035454.
FT   VARIANT      39     39       A -> G (in PVNH1; dbSNP:rs137853313).
FT                                {ECO:0000269|PubMed:15668422}.
FT                                /FTId=VAR_022734.
FT   VARIANT      82     82       E -> V (in PVNH1; dbSNP:rs28935169).
FT                                {ECO:0000269|PubMed:11914408}.
FT                                /FTId=VAR_015699.
FT   VARIANT     102    102       M -> V (in PVNH1).
FT                                {ECO:0000269|PubMed:15249610}.
FT                                /FTId=VAR_031305.
FT   VARIANT     128    128       A -> V (in PVNH1; dbSNP:rs137853315).
FT                                {ECO:0000269|PubMed:15994863}.
FT                                /FTId=VAR_031306.
FT   VARIANT     149    149       S -> F (in PVNH1).
FT                                {ECO:0000269|PubMed:15249610}.
FT                                /FTId=VAR_031307.
FT   VARIANT     170    170       Q -> P (in OPD2; dbSNP:rs863223628).
FT                                {ECO:0000269|PubMed:12612583}.
FT                                /FTId=VAR_015713.
FT   VARIANT     172    172       L -> F (in OPD1).
FT                                {ECO:0000269|PubMed:12612583}.
FT                                /FTId=VAR_015714.
FT   VARIANT     187    187       N -> S (in OPD2; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27193221}.
FT                                /FTId=VAR_076500.
FT   VARIANT     196    196       R -> G (in OPD2).
FT                                {ECO:0000269|PubMed:12612583,
FT                                ECO:0000269|PubMed:27193221}.
FT                                /FTId=VAR_015715.
FT   VARIANT     196    196       R -> W (in OPD1; dbSNP:rs137853317).
FT                                {ECO:0000269|PubMed:12612583}.
FT                                /FTId=VAR_015716.
FT   VARIANT     200    200       A -> S (in OPD2).
FT                                {ECO:0000269|PubMed:12612583}.
FT                                /FTId=VAR_015717.
FT   VARIANT     203    203       D -> Y (in OPD1; dbSNP:rs137853314).
FT                                {ECO:0000269|PubMed:15940695}.
FT                                /FTId=VAR_031308.
FT   VARIANT     207    207       P -> L (in OPD1; dbSNP:rs28935469).
FT                                {ECO:0000269|PubMed:12612583,
FT                                ECO:0000269|PubMed:27193221}.
FT                                /FTId=VAR_015700.
FT   VARIANT     210    210       C -> F (in OPD2; dbSNP:rs137853318).
FT                                {ECO:0000269|PubMed:17431908}.
FT                                /FTId=VAR_058720.
FT   VARIANT     254    254       E -> K (in OPD2; dbSNP:rs28935470).
FT                                {ECO:0000269|PubMed:12612583}.
FT                                /FTId=VAR_015701.
FT   VARIANT     267    267       A -> T (in OPD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27193221}.
FT                                /FTId=VAR_076501.
FT   VARIANT     273    273       A -> P (in OPD2).
FT                                {ECO:0000269|PubMed:12612583}.
FT                                /FTId=VAR_015718.
FT   VARIANT     288    288       G -> R (in CVDX; dbSNP:rs267606816).
FT                                {ECO:0000269|PubMed:17190868}.
FT                                /FTId=VAR_064156.
FT   VARIANT     320    320       V -> A (in dbSNP:rs1064816).
FT                                /FTId=VAR_012831.
FT   VARIANT     370    370       F -> L (in dbSNP:rs1064817).
FT                                /FTId=VAR_012832.
FT   VARIANT     429    429       T -> M (in dbSNP:rs36051194).
FT                                {ECO:0000269|PubMed:12612583}.
FT                                /FTId=VAR_069803.
FT   VARIANT     528    528       V -> M (in dbSNP:rs143873938).
FT                                {ECO:0000269|PubMed:12410386,
FT                                ECO:0000269|PubMed:20844545}.
FT                                /FTId=VAR_031309.
FT   VARIANT     552    552       V -> A (in dbSNP:rs730319).
FT                                /FTId=VAR_012833.
FT   VARIANT     555    555       T -> K (in OPD2; dbSNP:rs782611953).
FT                                {ECO:0000269|PubMed:12612583}.
FT                                /FTId=VAR_015719.
FT   VARIANT     637    637       P -> Q (in CVDX; dbSNP:rs267606815).
FT                                {ECO:0000269|PubMed:17190868}.
FT                                /FTId=VAR_064157.
FT   VARIANT     656    656       L -> F (in PVNH1; dbSNP:rs137853311).
FT                                {ECO:0000269|PubMed:11532987}.
FT                                /FTId=VAR_012834.
FT   VARIANT     711    711       V -> D (in CVDX; dbSNP:rs267606817).
FT                                {ECO:0000269|PubMed:17190868}.
FT                                /FTId=VAR_064158.
FT   VARIANT     804    804       V -> D (in OPD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27193221}.
FT                                /FTId=VAR_076502.
FT   VARIANT    1012   1012       S -> L (in dbSNP:rs17091204).
FT                                /FTId=VAR_031310.
FT   VARIANT    1142   1142       D -> V (in FMD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27193221}.
FT                                /FTId=VAR_076503.
FT   VARIANT    1159   1159       D -> A (in FMD1; does not inhibit
FT                                interaction with MIS18BP1;
FT                                dbSNP:rs28935471).
FT                                {ECO:0000269|PubMed:12612583,
FT                                ECO:0000269|PubMed:21228480}.
FT                                /FTId=VAR_015702.
FT   VARIANT    1163   1163       V -> L (in MNS; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27193221}.
FT                                /FTId=VAR_076504.
FT   VARIANT    1184   1184       D -> E (in MNS; dbSNP:rs80338837).
FT                                {ECO:0000269|PubMed:12612583}.
FT                                /FTId=VAR_015720.
FT   VARIANT    1186   1186       S -> L (in FMD1; dbSNP:rs137853312).
FT                                {ECO:0000269|PubMed:12612583,
FT                                ECO:0000269|PubMed:16596676,
FT                                ECO:0000269|PubMed:27193221}.
FT                                /FTId=VAR_015721.
FT   VARIANT    1188   1188       A -> T (in MNS; does not inhibit
FT                                interaction with MIS18BP1;
FT                                dbSNP:rs28935472).
FT                                {ECO:0000269|PubMed:12612583,
FT                                ECO:0000269|PubMed:21228480,
FT                                ECO:0000269|PubMed:27193221}.
FT                                /FTId=VAR_015703.
FT   VARIANT    1199   1199       S -> L (in MNS; does not inhibit
FT                                interaction with MIS18BP1;
FT                                dbSNP:rs28935473).
FT                                {ECO:0000269|PubMed:12612583,
FT                                ECO:0000269|PubMed:21228480}.
FT                                /FTId=VAR_015704.
FT   VARIANT    1291   1291       P -> L (in FGS2; dbSNP:rs137853319).
FT                                {ECO:0000269|PubMed:17632775}.
FT                                /FTId=VAR_058721.
FT   VARIANT    1419   1419       A -> G (in dbSNP:rs35504556).
FT                                /FTId=VAR_032083.
FT   VARIANT    1620   1620       Missing (in FMD1).
FT                                {ECO:0000269|PubMed:12612583}.
FT                                /FTId=VAR_015722.
FT   VARIANT    1635   1637       Missing (in otopalatodigital spectrum
FT                                disorder). {ECO:0000269|PubMed:15654694}.
FT                                /FTId=VAR_031311.
FT   VARIANT    1645   1645       C -> F (in OPD2).
FT                                {ECO:0000269|PubMed:12612583}.
FT                                /FTId=VAR_015723.
FT   VARIANT    1724   1739       Missing (in TOD).
FT                                {ECO:0000269|PubMed:20598277}.
FT                                /FTId=VAR_064159.
FT   VARIANT    1728   1728       G -> C (in FMD1; dbSNP:rs137853316).
FT                                {ECO:0000269|PubMed:16596676}.
FT                                /FTId=VAR_031312.
FT   VARIANT    1764   1764       A -> T (in dbSNP:rs57108893).
FT                                {ECO:0000269|PubMed:11532987,
FT                                ECO:0000269|PubMed:12612583}.
FT                                /FTId=VAR_012835.
FT   VARIANT    1803   1803       E -> K (probable disease-associated
FT                                mutation found in a patient with
FT                                macrothrombocytopenia;
FT                                dbSNP:rs368750879).
FT                                {ECO:0000269|PubMed:21960593}.
FT                                /FTId=VAR_067251.
FT   VARIANT    1840   1840       H -> R (in FMD1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27193221}.
FT                                /FTId=VAR_076505.
FT   VARIANT    2391   2391       R -> H (in OPD1; unknown pathological
FT                                significance; dbSNP:rs727503930).
FT                                {ECO:0000269|PubMed:27193221}.
FT                                /FTId=VAR_076506.
FT   MUTAGEN      42     42       K->R: Abrogates ASB2alpha-mediated
FT                                degradation without altering ASB2alpha
FT                                binding; when associated with R-43 and R-
FT                                135. {ECO:0000269|PubMed:24052262}.
FT   MUTAGEN      43     43       K->R: Abrogates ASB2alpha-mediated
FT                                degradation without altering ASB2alpha
FT                                binding; when associated with R-42 and R-
FT                                135. {ECO:0000269|PubMed:24052262}.
FT   MUTAGEN     135    135       K->R: Abrogates ASB2alpha-mediated
FT                                degradation without altering ASB2alpha
FT                                binding; when associated with R-42 and R-
FT                                43. {ECO:0000269|PubMed:24052262}.
FT   CONFLICT     44     44       I -> T (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   1772   1772       A -> G (in Ref. 11; CAA49687).
FT                                {ECO:0000305}.
FT   CONFLICT   2341   2341       Q -> R (in Ref. 5; BAC03408).
FT                                {ECO:0000305}.
FT   CONFLICT   2634   2634       D -> H (in Ref. 2; CAA37495).
FT                                {ECO:0000305}.
FT   HELIX        40     43       {ECO:0000244|PDB:3HOC}.
FT   HELIX        44     57       {ECO:0000244|PDB:3HOC}.
FT   HELIX        58     60       {ECO:0000244|PDB:3HOC}.
FT   TURN         67     73       {ECO:0000244|PDB:3HOC}.
FT   HELIX        75     85       {ECO:0000244|PDB:3HOC}.
FT   HELIX       100    116       {ECO:0000244|PDB:3HOC}.
FT   HELIX       126    130       {ECO:0000244|PDB:3HOC}.
FT   HELIX       134    149       {ECO:0000244|PDB:3HOC}.
FT   STRAND      157    159       {ECO:0000244|PDB:3HOP}.
FT   HELIX       168    179       {ECO:0000244|PDB:3HOC}.
FT   STRAND      181    183       {ECO:0000244|PDB:3HOR}.
FT   HELIX       190    192       {ECO:0000244|PDB:3HOC}.
FT   STRAND      193    195       {ECO:0000244|PDB:3HOR}.
FT   HELIX       196    205       {ECO:0000244|PDB:3HOC}.
FT   HELIX       213    215       {ECO:0000244|PDB:3HOC}.
FT   HELIX       221    236       {ECO:0000244|PDB:3HOC}.
FT   HELIX       244    247       {ECO:0000244|PDB:3HOC}.
FT   HELIX       254    261       {ECO:0000244|PDB:3HOC}.
FT   HELIX       263    266       {ECO:0000244|PDB:3HOP}.
FT   HELIX       480    482       {ECO:0000244|PDB:4M9P}.
FT   STRAND      484    487       {ECO:0000244|PDB:4M9P}.
FT   HELIX       488    490       {ECO:0000244|PDB:4M9P}.
FT   STRAND      501    506       {ECO:0000244|PDB:4M9P}.
FT   STRAND      515    521       {ECO:0000244|PDB:4M9P}.
FT   STRAND      529    534       {ECO:0000244|PDB:4M9P}.
FT   STRAND      537    542       {ECO:0000244|PDB:4M9P}.
FT   STRAND      548    556       {ECO:0000244|PDB:4M9P}.
FT   STRAND      565    571       {ECO:0000244|PDB:4M9P}.
FT   STRAND      579    583       {ECO:0000244|PDB:4M9P}.
FT   HELIX       584    586       {ECO:0000244|PDB:4M9P}.
FT   STRAND      588    590       {ECO:0000244|PDB:4M9P}.
FT   STRAND      595    604       {ECO:0000244|PDB:4M9P}.
FT   STRAND      609    617       {ECO:0000244|PDB:4M9P}.
FT   STRAND      620    625       {ECO:0000244|PDB:4M9P}.
FT   STRAND      627    636       {ECO:0000244|PDB:4M9P}.
FT   STRAND      639    649       {ECO:0000244|PDB:4M9P}.
FT   STRAND      658    664       {ECO:0000244|PDB:4M9P}.
FT   HELIX       672    674       {ECO:0000244|PDB:4M9P}.
FT   STRAND      676    679       {ECO:0000244|PDB:4M9P}.
FT   HELIX       680    682       {ECO:0000244|PDB:4M9P}.
FT   STRAND      683    685       {ECO:0000244|PDB:4M9P}.
FT   STRAND      693    698       {ECO:0000244|PDB:4M9P}.
FT   STRAND      707    712       {ECO:0000244|PDB:4M9P}.
FT   STRAND      714    716       {ECO:0000244|PDB:4M9P}.
FT   STRAND      721    725       {ECO:0000244|PDB:4M9P}.
FT   STRAND      727    735       {ECO:0000244|PDB:4M9P}.
FT   STRAND      739    749       {ECO:0000244|PDB:4M9P}.
FT   STRAND      758    762       {ECO:0000244|PDB:4M9P}.
FT   HELIX      1160   1162       {ECO:0000244|PDB:3RGH}.
FT   STRAND     1164   1167       {ECO:0000244|PDB:3RGH}.
FT   HELIX      1168   1170       {ECO:0000244|PDB:3RGH}.
FT   STRAND     1172   1174       {ECO:0000244|PDB:3RGH}.
FT   STRAND     1179   1184       {ECO:0000244|PDB:3RGH}.
FT   STRAND     1193   1198       {ECO:0000244|PDB:3RGH}.
FT   STRAND     1206   1211       {ECO:0000244|PDB:3RGH}.
FT   STRAND     1213   1222       {ECO:0000244|PDB:3RGH}.
FT   STRAND     1225   1235       {ECO:0000244|PDB:3RGH}.
FT   STRAND     1244   1250       {ECO:0000244|PDB:3RGH}.
FT   TURN       1785   1787       {ECO:0000244|PDB:2K7P}.
FT   STRAND     1791   1796       {ECO:0000244|PDB:2K7P}.
FT   STRAND     1804   1809       {ECO:0000244|PDB:2K7P}.
FT   STRAND     1819   1822       {ECO:0000244|PDB:2K7P}.
FT   STRAND     1824   1832       {ECO:0000244|PDB:2K7P}.
FT   STRAND     1838   1846       {ECO:0000244|PDB:2K7P}.
FT   STRAND     1855   1860       {ECO:0000244|PDB:2K7P}.
FT   STRAND     1865   1867       {ECO:0000244|PDB:2K7P}.
FT   STRAND     1869   1872       {ECO:0000244|PDB:2BP3}.
FT   HELIX      1873   1875       {ECO:0000244|PDB:2BP3}.
FT   STRAND     1877   1879       {ECO:0000244|PDB:2BP3}.
FT   STRAND     1884   1889       {ECO:0000244|PDB:2BP3}.
FT   TURN       1891   1893       {ECO:0000244|PDB:2AAV}.
FT   STRAND     1895   1906       {ECO:0000244|PDB:2BP3}.
FT   STRAND     1909   1914       {ECO:0000244|PDB:2BP3}.
FT   STRAND     1916   1925       {ECO:0000244|PDB:2BP3}.
FT   STRAND     1930   1938       {ECO:0000244|PDB:2BP3}.
FT   STRAND     1947   1953       {ECO:0000244|PDB:2BP3}.
FT   STRAND     1959   1967       {ECO:0000244|PDB:2K7Q}.
FT   STRAND     1980   1988       {ECO:0000244|PDB:2K7Q}.
FT   STRAND     1998   2001       {ECO:0000244|PDB:2K7Q}.
FT   STRAND     2007   2010       {ECO:0000244|PDB:2K7Q}.
FT   STRAND     2014   2025       {ECO:0000244|PDB:2K7Q}.
FT   STRAND     2034   2039       {ECO:0000244|PDB:2K7Q}.
FT   HELIX      2041   2043       {ECO:0000244|PDB:2K7Q}.
FT   HELIX      2047   2049       {ECO:0000244|PDB:2J3S}.
FT   STRAND     2051   2054       {ECO:0000244|PDB:2J3S}.
FT   HELIX      2055   2057       {ECO:0000244|PDB:2J3S}.
FT   STRAND     2059   2061       {ECO:0000244|PDB:2J3S}.
FT   STRAND     2066   2071       {ECO:0000244|PDB:2J3S}.
FT   STRAND     2075   2077       {ECO:0000244|PDB:2J3S}.
FT   STRAND     2080   2088       {ECO:0000244|PDB:2J3S}.
FT   STRAND     2091   2096       {ECO:0000244|PDB:2J3S}.
FT   STRAND     2100   2107       {ECO:0000244|PDB:2J3S}.
FT   STRAND     2112   2120       {ECO:0000244|PDB:2J3S}.
FT   STRAND     2129   2136       {ECO:0000244|PDB:2J3S}.
FT   STRAND     2139   2148       {ECO:0000244|PDB:2J3S}.
FT   STRAND     2161   2165       {ECO:0000244|PDB:4P3W}.
FT   HELIX      2171   2173       {ECO:0000244|PDB:4P3W}.
FT   STRAND     2174   2179       {ECO:0000244|PDB:4P3W}.
FT   STRAND     2185   2187       {ECO:0000244|PDB:4P3W}.
FT   STRAND     2189   2192       {ECO:0000244|PDB:4P3W}.
FT   STRAND     2194   2201       {ECO:0000244|PDB:4P3W}.
FT   STRAND     2208   2216       {ECO:0000244|PDB:4P3W}.
FT   STRAND     2225   2229       {ECO:0000244|PDB:4P3W}.
FT   STRAND     2234   2236       {ECO:0000244|PDB:4P3W}.
FT   HELIX      2238   2240       {ECO:0000244|PDB:2W0P}.
FT   STRAND     2242   2245       {ECO:0000244|PDB:2W0P}.
FT   HELIX      2246   2248       {ECO:0000244|PDB:2W0P}.
FT   STRAND     2257   2262       {ECO:0000244|PDB:2W0P}.
FT   HELIX      2264   2266       {ECO:0000244|PDB:2W0P}.
FT   STRAND     2271   2279       {ECO:0000244|PDB:2W0P}.
FT   STRAND     2282   2287       {ECO:0000244|PDB:2W0P}.
FT   STRAND     2293   2298       {ECO:0000244|PDB:2W0P}.
FT   STRAND     2303   2311       {ECO:0000244|PDB:2W0P}.
FT   STRAND     2320   2326       {ECO:0000244|PDB:2W0P}.
FT   TURN       2429   2431       {ECO:0000244|PDB:2K3T}.
FT   STRAND     2433   2436       {ECO:0000244|PDB:2K3T}.
FT   HELIX      2437   2439       {ECO:0000244|PDB:2K3T}.
FT   STRAND     2441   2443       {ECO:0000244|PDB:2K3T}.
FT   STRAND     2448   2453       {ECO:0000244|PDB:2K3T}.
FT   TURN       2455   2457       {ECO:0000244|PDB:2K3T}.
FT   STRAND     2462   2470       {ECO:0000244|PDB:2K3T}.
FT   STRAND     2472   2479       {ECO:0000244|PDB:2K3T}.
FT   STRAND     2482   2489       {ECO:0000244|PDB:2K3T}.
FT   STRAND     2491   2506       {ECO:0000244|PDB:2K3T}.
FT   STRAND     2511   2518       {ECO:0000244|PDB:2K3T}.
FT   STRAND     2561   2564       {ECO:0000244|PDB:3CNK}.
FT   HELIX      2565   2567       {ECO:0000244|PDB:3CNK}.
FT   STRAND     2576   2581       {ECO:0000244|PDB:3CNK}.
FT   STRAND     2590   2595       {ECO:0000244|PDB:3CNK}.
FT   STRAND     2597   2599       {ECO:0000244|PDB:3CNK}.
FT   STRAND     2602   2610       {ECO:0000244|PDB:3CNK}.
FT   STRAND     2613   2619       {ECO:0000244|PDB:3CNK}.
FT   STRAND     2624   2632       {ECO:0000244|PDB:3CNK}.
FT   STRAND     2641   2646       {ECO:0000244|PDB:3CNK}.
SQ   SEQUENCE   2647 AA;  280739 MW;  6C1A07041DF50142 CRC64;
     MSSSHSRAGQ SAAGAAPGGG VDTRDAEMPA TEKDLAEDAP WKKIQQNTFT RWCNEHLKCV
     SKRIANLQTD LSDGLRLIAL LEVLSQKKMH RKHNQRPTFR QMQLENVSVA LEFLDRESIK
     LVSIDSKAIV DGNLKLILGL IWTLILHYSI SMPMWDEEED EEAKKQTPKQ RLLGWIQNKL
     PQLPITNFSR DWQSGRALGA LVDSCAPGLC PDWDSWDASK PVTNAREAMQ QADDWLGIPQ
     VITPEEIVDP NVDEHSVMTY LSQFPKAKLK PGAPLRPKLN PKKARAYGPG IEPTGNMVKK
     RAEFTVETRS AGQGEVLVYV EDPAGHQEEA KVTANNDKNR TFSVWYVPEV TGTHKVTVLF
     AGQHIAKSPF EVYVDKSQGD ASKVTAQGPG LEPSGNIANK TTYFEIFTAG AGTGEVEVVI
     QDPMGQKGTV EPQLEARGDS TYRCSYQPTM EGVHTVHVTF AGVPIPRSPY TVTVGQACNP
     SACRAVGRGL QPKGVRVKET ADFKVYTKGA GSGELKVTVK GPKGEERVKQ KDLGDGVYGF
     EYYPMVPGTY IVTITWGGQN IGRSPFEVKV GTECGNQKVR AWGPGLEGGV VGKSADFVVE
     AIGDDVGTLG FSVEGPSQAK IECDDKGDGS CDVRYWPQEA GEYAVHVLCN SEDIRLSPFM
     ADIRDAPQDF HPDRVKARGP GLEKTGVAVN KPAEFTVDAK HGGKAPLRVQ VQDNEGCPVE
     ALVKDNGNGT YSCSYVPRKP VKHTAMVSWG GVSIPNSPFR VNVGAGSHPN KVKVYGPGVA
     KTGLKAHEPT YFTVDCAEAG QGDVSIGIKC APGVVGPAEA DIDFDIIRND NDTFTVKYTP
     RGAGSYTIMV LFADQATPTS PIRVKVEPSH DASKVKAEGP GLSRTGVELG KPTHFTVNAK
     AAGKGKLDVQ FSGLTKGDAV RDVDIIDHHD NTYTVKYTPV QQGPVGVNVT YGGDPIPKSP
     FSVAVSPSLD LSKIKVSGLG EKVDVGKDQE FTVKSKGAGG QGKVASKIVG PSGAAVPCKV
     EPGLGADNSV VRFLPREEGP YEVEVTYDGV PVPGSPFPLE AVAPTKPSKV KAFGPGLQGG
     SAGSPARFTI DTKGAGTGGL GLTVEGPCEA QLECLDNGDG TCSVSYVPTE PGDYNINILF
     ADTHIPGSPF KAHVVPCFDA SKVKCSGPGL ERATAGEVGQ FQVDCSSAGS AELTIEICSE
     AGLPAEVYIQ DHGDGTHTIT YIPLCPGAYT VTIKYGGQPV PNFPSKLQVE PAVDTSGVQC
     YGPGIEGQGV FREATTEFSV DARALTQTGG PHVKARVANP SGNLTETYVQ DRGDGMYKVE
     YTPYEEGLHS VDVTYDGSPV PSSPFQVPVT EGCDPSRVRV HGPGIQSGTT NKPNKFTVET
     RGAGTGGLGL AVEGPSEAKM SCMDNKDGSC SVEYIPYEAG TYSLNVTYGG HQVPGSPFKV
     PVHDVTDASK VKCSGPGLSP GMVRANLPQS FQVDTSKAGV APLQVKVQGP KGLVEPVDVV
     DNADGTQTVN YVPSREGPYS ISVLYGDEEV PRSPFKVKVL PTHDASKVKA SGPGLNTTGV
     PASLPVEFTI DAKDAGEGLL AVQITDPEGK PKKTHIQDNH DGTYTVAYVP DVTGRYTILI
     KYGGDEIPFS PYRVRAVPTG DASKCTVTVS IGGHGLGAGI GPTIQIGEET VITVDTKAAG
     KGKVTCTVCT PDGSEVDVDV VENEDGTFDI FYTAPQPGKY VICVRFGGEH VPNSPFQVTA
     LAGDQPSVQP PLRSQQLAPQ YTYAQGGQQT WAPERPLVGV NGLDVTSLRP FDLVIPFTIK
     KGEITGEVRM PSGKVAQPTI TDNKDGTVTV RYAPSEAGLH EMDIRYDNMH IPGSPLQFYV
     DYVNCGHVTA YGPGLTHGVV NKPATFTVNT KDAGEGGLSL AIEGPSKAEI SCTDNQDGTC
     SVSYLPVLPG DYSILVKYNE QHVPGSPFTA RVTGDDSMRM SHLKVGSAAD IPINISETDL
     SLLTATVVPP SGREEPCLLK RLRNGHVGIS FVPKETGEHL VHVKKNGQHV ASSPIPVVIS
     QSEIGDASRV RVSGQGLHEG HTFEPAEFII DTRDAGYGGL SLSIEGPSKV DINTEDLEDG
     TCRVTYCPTE PGNYIINIKF ADQHVPGSPF SVKVTGEGRV KESITRRRRA PSVANVGSHC
     DLSLKIPEIS IQDMTAQVTS PSGKTHEAEI VEGENHTYCI RFVPAEMGTH TVSVKYKGQH
     VPGSPFQFTV GPLGEGGAHK VRAGGPGLER AEAGVPAEFS IWTREAGAGG LAIAVEGPSK
     AEISFEDRKD GSCGVAYVVQ EPGDYEVSVK FNEEHIPDSP FVVPVASPSG DARRLTVSSL
     QESGLKVNQP ASFAVSLNGA KGAIDAKVHS PSGALEECYV TEIDQDKYAV RFIPRENGVY
     LIDVKFNGTH IPGSPFKIRV GEPGHGGDPG LVSAYGAGLE GGVTGNPAEF VVNTSNAGAG
     ALSVTIDGPS KVKMDCQECP EGYRVTYTPM APGSYLISIK YGGPYHIGGS PFKAKVTGPR
     LVSNHSLHET SSVFVDSLTK ATCAPQHGAP GPGPADASKV VAKGLGLSKA YVGQKSSFTV
     DCSKAGNNML LVGVHGPRTP CEEILVKHVG SRLYSVSYLL KDKGEYTLVV KWGDEHIPGS
     PYRVVVP
//
ID   Q5HY54_HUMAN            Unreviewed;      2607 AA.
AC   Q5HY54;
DT   15-FEB-2005, integrated into UniProtKB/TrEMBL.
DT   15-FEB-2005, sequence version 1.
DT   25-APR-2018, entry version 111.
DE   SubName: Full=Filamin-A {ECO:0000313|Ensembl:ENSP00000358863};
GN   Name=FLNA {ECO:0000313|Ensembl:ENSP00000358863};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000358863, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [2] {ECO:0000313|Ensembl:ENSP00000358863}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [4] {ECO:0000213|PubMed:16964243}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [5] {ECO:0000213|PubMed:17924679}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [6] {ECO:0000213|PubMed:18088087}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schutz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [7] {ECO:0000213|PubMed:18220336}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.D., Yates J.R.;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [8] {ECO:0000213|PubMed:19367720}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [9] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [13] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [15] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [17] {ECO:0000313|Ensembl:ENSP00000358863}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2012) to UniProtKB.
RN   [18] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20] {ECO:0000213|PubMed:25218447}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [21] {ECO:0000213|PubMed:25114211}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [22] {ECO:0000213|PubMed:25772364}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 Orchestrates Chromatin Modifiers in Response to DNA Damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [23] {ECO:0000213|PubMed:25755297}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurethsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide Analysis of SUMOylation Dynamics in Response to
RT   Replication Stress Reveals Novel Small Ubiquitin-like Modified Target
RT   Proteins and Acceptor Lysines Relevant for Genome Stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [24] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [25] {ECO:0000213|PubMed:28112733}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- INTERACTION:
CC       P07148:FABP1; NbExp=3; IntAct=EBI-3959725, EBI-2115989;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC245140; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_011529430.1; XM_011531128.1.
DR   UniGene; Hs.195464; -.
DR   ProteinModelPortal; Q5HY54; -.
DR   IntAct; Q5HY54; 3.
DR   EPD; Q5HY54; -.
DR   MaxQB; Q5HY54; -.
DR   PeptideAtlas; Q5HY54; -.
DR   PRIDE; Q5HY54; -.
DR   Ensembl; ENST00000344736; ENSP00000358863; ENSG00000196924.
DR   GeneID; 2316; -.
DR   UCSC; uc065cce.1; human.
DR   CTD; 2316; -.
DR   EuPathDB; HostDB:ENSG00000196924.14; -.
DR   HGNC; HGNC:3754; FLNA.
DR   OpenTargets; ENSG00000196924; -.
DR   eggNOG; KOG0518; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   GeneTree; ENSGT00900000140842; -.
DR   HOGENOM; HOG000044235; -.
DR   HOVERGEN; HBG004163; -.
DR   ChiTaRS; FLNA; human.
DR   GenomeRNAi; 2316; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000196924; -.
DR   ExpressionAtlas; Q5HY54; baseline and differential.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   CDD; cd00014; CH; 2.
DR   Gene3D; 1.10.418.10; -; 2.
DR   Gene3D; 2.60.40.10; -; 24.
DR   InterPro; IPR001589; Actinin_actin-bd_CS.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR017868; Filamin/ABP280_repeat-like.
DR   InterPro; IPR001298; Filamin/ABP280_rpt.
DR   InterPro; IPR028559; FLN_A.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   PANTHER; PTHR43998:SF6; PTHR43998:SF6; 2.
DR   Pfam; PF00307; CH; 2.
DR   Pfam; PF00630; Filamin; 23.
DR   SMART; SM00033; CH; 2.
DR   SMART; SM00557; IG_FLMN; 24.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   SUPFAM; SSF81296; SSF81296; 24.
DR   PROSITE; PS00019; ACTININ_1; 1.
DR   PROSITE; PS00020; ACTININ_2; 1.
DR   PROSITE; PS50021; CH; 2.
DR   PROSITE; PS50194; FILAMIN_REPEAT; 24.
PE   1: Evidence at protein level;
KW   Actin-binding {ECO:0000256|SAAS:SAAS00782879};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:Q5HY54,
KW   ECO:0000213|MaxQB:Q5HY54, ECO:0000213|PeptideAtlas:Q5HY54};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|SAAS:SAAS00782917}.
FT   DOMAIN       43    149       Calponin-homology (CH).
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   DOMAIN      166    266       Calponin-homology (CH).
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   REPEAT      276    374       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      376    474       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      475    570       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      571    663       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      667    763       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      764    866       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      867    965       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      966   1061       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1062   1154       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1155   1249       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1250   1349       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1350   1442       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1443   1539       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1540   1636       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1637   1732       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1728   1820       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1820   1912       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1910   1999       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     2002   2094       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     2092   2190       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     2193   2285       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     2287   2380       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     2384   2476       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     2512   2606       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
SQ   SEQUENCE   2607 AA;  276550 MW;  9691C5901BD9DE59 CRC64;
     MSSSHSRAGQ SAAGAAPGGG VDTRDAEMPA TEKDLAEDAP WKKIQQNTFT RWCNEHLKCV
     SKRIANLQTD LSDGLRLIAL LEVLSQKKMH RKHNQRPTFR QMQLENVSVA LEFLDRESIK
     LVSIDSKAIV DGNLKLILGL IWTLILHYSI SMPMWDEEED EEAKKQTPKQ RLLGWIQNKL
     PQLPITNFSR DWQSGRALGA LVDSCAPGLC PDWDSWDASK PVTNAREAMQ QADDWLGIPQ
     VITPEEIVDP NVDEHSVMTY LSQFPKAKLK PGAPLRPKLN PKKARAYGPG IEPTGNMVKK
     RAEFTVETRS AGQGEVLVYV EDPAGHQEEA KVTANNDKNR TFSVWYVPEV TGTHKVTVLF
     AGQHIAKSPF EVYVDKSQGD ASKVTAQGPG LEPSGNIANK TTYFEIFTAG AGTGEVEVVI
     QDPMGQKGTV EPQLEARGDS TYRCSYQPTM EGVHTVHVTF AGVPIPRSPY TVTVGQACNP
     SACRAVGRGL QPKGVRVKET ADFKVYTKGA GSGELKVTVK GPKGEERVKQ KDLGDGVYGF
     EYYPMVPGTY IVTITWGGQN IGRSPFEVKV GTECGNQKVR AWGPGLEGGV VGKSADFVVE
     AIGDDVGTLG FSVEGPSQAK IECDDKGDGS CDVRYWPQEA GEYAVHVLCN SEDIRLSPFM
     ADIRDAPQDF HPDRVKARGP GLEKTGVAVN KPAEFTVDAK HGGKAPLRVQ VQDNEGCPVE
     ALVKDNGNGT YSCSYVPRKP VKHTAMVSWG GVSIPNSPFR VNVGAGSHPN KVKVYGPGVA
     KTGLKAHEPT YFTVDCAEAG QGDVSIGIKC APGVVGPAEA DIDFDIIRND NDTFTVKYTP
     RGAGSYTIMV LFADQATPTS PIRVKVEPSH DASKVKAEGP GLSRTGVELG KPTHFTVNAK
     AAGKGKLDVQ FSGLTKGDAV RDVDIIDHHD NTYTVKYTPV QQGPVGVNVT YGGDPIPKSP
     FSVAVSPSLD LSKIKVSGLG EKVDVGKDQE FTVKSKGAGG QGKVASKIVG PSGAAVPCKV
     EPGLGADNSV VRFLPREEGP YEVEVTYDGV PVPGSPFPLE AVAPTKPSKV KAFGPGLQGG
     SAGSPARFTI DTKGAGTGGL GLTVEGPCEA QLECLDNGDG TCSVSYVPTE PGDYNINILF
     ADTHIPGSPF KAHVVPCFDA SKVKCSGPGL ERATAGEVGQ FQVDCSSAGS AELTIEICSE
     AGLPAEVYIQ DHGDGTHTIT YIPLCPGAYT VTIKYGGQPV PNFPSKLQVE PAVDTSGVQC
     YGPGIEGQGV FREATTEFSV DARALTQTGG PHVKARVANP SGNLTETYVQ DRGDGMYKVE
     YTPYEEGLHS VDVTYDGSPV PSSPFQVPVT EGCDPSRVRV HGPGIQSGTT NKPNKFTVET
     RGAGTGGLGL AVEGPSEAKM SCMDNKDGSC SVEYIPYEAG TYSLNVTYGG HQVPGSPFKV
     PVHDVTDASK VKCSGPGLSP GMVRANLPQS FQVDTSKAGV APLQVKVQGP KGLVEPVDVV
     DNADGTQTVN YVPSREGPYS ISVLYGDEEV PRSPFKVKVL PTHDASKVKA SGPGLNTTGV
     PASLPVEFTI DAKDAGEGLL AVQITDPEGK PKKTHIQDNH DGTYTVAYVP DVTGRYTILI
     KYGGDEIPFS PYRVRAVPTG DASKCTVTGA GIGPTIQIGE ETVITVDTKA AGKGKVTCTV
     CTPDGSEVDV DVVENEDGTF DIFYTAPQPG KYVICVRFGG EHVPNSPFQV TAPERPLVGV
     NGLDVTSLRP FDLVIPFTIK KGEITGEVRM PSGKVAQPTI TDNKDGTVTV RYAPSEAGLH
     EMDIRYDNMH IPGSPLQFYV DYVNCGHVTA YGPGLTHGVV NKPATFTVNT KDAGEGGLSL
     AIEGPSKAEI SCTDNQDGTC SVSYLPVLPG DYSILVKYNE QHVPGSPFTA RVTGDDSMRM
     SHLKVGSAAD IPINISETDL SLLTATVVPP SGREEPCLLK RLRNGHVGIS FVPKETGEHL
     VHVKKNGQHV ASSPIPVVIS QSEIGDASRV RVSGQGLHEG HTFEPAEFII DTRDAGYGGL
     SLSIEGPSKV DINTEDLEDG TCRVTYCPTE PGNYIINIKF ADQHVPGSPF SVKVTGEGRV
     KESITRRRRA PSVANVGSHC DLSLKIPEIS IQDMTAQVTS PSGKTHEAEI VEGENHTYCI
     RFVPAEMGTH TVSVKYKGQH VPGSPFQFTV GPLGEGGAHK VRAGGPGLER AEAGVPAEFS
     IWTREAGAGG LAIAVEGPSK AEISFEDRKD GSCGVAYVVQ EPGDYEVSVK FNEEHIPDSP
     FVVPVASPSG DARRLTVSSL QESGLKVNQP ASFAVSLNGA KGAIDAKVHS PSGALEECYV
     TEIDQDKYAV RFIPRENGVY LIDVKFNGTH IPGSPFKIRV GEPGHGGDPG LVSAYGAGLE
     GGVTGNPAEF VVNTSNAGAG ALSVTIDGPS KVKMDCQECP EGYRVTYTPM APGSYLISIK
     YGGPYHIGGS PFKAKVTGPR LVSNHSLHET SSVFVDSLTK ATCAPQHGAP GPGPADASKV
     VAKGLGLSKA YVGQKSSFTV DCSKAGNNML LVGVHGPRTP CEEILVKHVG SRLYSVSYLL
     KDKGEYTLVV KWGDEHIPGS PYRVVVP
//
ID   Q60FE5_HUMAN            Unreviewed;      2620 AA.
AC   Q60FE5; E9PHF0;
DT   23-NOV-2004, integrated into UniProtKB/TrEMBL.
DT   23-NOV-2004, sequence version 1.
DT   25-APR-2018, entry version 110.
DE   SubName: Full=Filamin-A {ECO:0000313|EMBL:BAD52436.1, ECO:0000313|Ensembl:ENSP00000358872};
GN   Name=FLNA {ECO:0000313|EMBL:BAD52436.1,
GN   ECO:0000313|Ensembl:ENSP00000358872};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD52436.1};
RN   [1] {ECO:0000313|EMBL:BAD52436.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=16106752; DOI=10.1093/dnares/12.1.53;
RA   Kato S., Ohtoko K., Ohtake H., Kimura T.;
RT   "Vector-capping: a simple method for preparing a high-quality full-
RT   length cDNA library.";
RL   DNA Res. 12:53-62(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3] {ECO:0000313|Ensembl:ENSP00000358872}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [5] {ECO:0000213|PubMed:16964243}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [6] {ECO:0000213|PubMed:17924679}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [7] {ECO:0000313|EMBL:BAG48303.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=18487259; DOI=10.1093/dnares/dsn010;
RA   Oshikawa M., Sugai Y., Usami R., Ohtoko K., Toyama S., Kato S.;
RT   "Fine expression profiling of full-length transcripts using a size-
RT   unbiased cDNA library prepared with the vector-capping method.";
RL   DNA Res. 15:123-136(2008).
RN   [8] {ECO:0000213|PubMed:18088087}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schutz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [9] {ECO:0000213|PubMed:18220336}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.D., Yates J.R.;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [10] {ECO:0000213|PubMed:19367720}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [11] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [14] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [15] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [16] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [18] {ECO:0000313|Ensembl:ENSP00000358872}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [19] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21] {ECO:0000213|PubMed:25218447}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [22] {ECO:0000213|PubMed:25114211}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [23] {ECO:0000213|PubMed:25772364}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 Orchestrates Chromatin Modifiers in Response to DNA Damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [24] {ECO:0000213|PubMed:25755297}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurethsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide Analysis of SUMOylation Dynamics in Response to
RT   Replication Stress Reveals Novel Small Ubiquitin-like Modified Target
RT   Proteins and Acceptor Lysines Relevant for Genome Stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [25] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [26] {ECO:0000213|PubMed:28112733}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC245140; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB191260; BAD52436.1; -; mRNA.
DR   EMBL; AB371574; BAG48303.1; -; mRNA.
DR   EMBL; AB371576; BAG48305.1; -; mRNA.
DR   RefSeq; NP_001104026.1; NM_001110556.1.
DR   RefSeq; NP_001447.2; NM_001456.3.
DR   UniGene; Hs.195464; -.
DR   IntAct; Q60FE5; 4.
DR   PeptideAtlas; Q60FE5; -.
DR   Ensembl; ENST00000369856; ENSP00000358872; ENSG00000196924.
DR   GeneID; 2316; -.
DR   KEGG; hsa:2316; -.
DR   UCSC; uc065cca.1; human.
DR   CTD; 2316; -.
DR   EuPathDB; HostDB:ENSG00000196924.14; -.
DR   HGNC; HGNC:3754; FLNA.
DR   OpenTargets; ENSG00000196924; -.
DR   PharmGKB; PA28172; -.
DR   eggNOG; KOG0518; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   GeneTree; ENSGT00900000140842; -.
DR   HOVERGEN; HBG004163; -.
DR   KO; K04437; -.
DR   ChiTaRS; FLNA; human.
DR   GenomeRNAi; 2316; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000196924; -.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   CDD; cd00014; CH; 2.
DR   Gene3D; 1.10.418.10; -; 2.
DR   Gene3D; 2.60.40.10; -; 24.
DR   InterPro; IPR001589; Actinin_actin-bd_CS.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR017868; Filamin/ABP280_repeat-like.
DR   InterPro; IPR001298; Filamin/ABP280_rpt.
DR   InterPro; IPR028559; FLN_A.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   PANTHER; PTHR43998:SF6; PTHR43998:SF6; 1.
DR   Pfam; PF00307; CH; 2.
DR   Pfam; PF00630; Filamin; 23.
DR   SMART; SM00033; CH; 2.
DR   SMART; SM00557; IG_FLMN; 24.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   SUPFAM; SSF81296; SSF81296; 24.
DR   PROSITE; PS00019; ACTININ_1; 1.
DR   PROSITE; PS00020; ACTININ_2; 1.
DR   PROSITE; PS50021; CH; 2.
DR   PROSITE; PS50194; FILAMIN_REPEAT; 24.
PE   1: Evidence at protein level;
KW   Actin-binding {ECO:0000256|SAAS:SAAS00782879};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:Q60FE5,
KW   ECO:0000213|MaxQB:Q60FE5, ECO:0000213|PeptideAtlas:Q60FE5};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|SAAS:SAAS00782917}.
FT   DOMAIN       16    122       Calponin-homology (CH).
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   DOMAIN      139    239       Calponin-homology (CH).
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   REPEAT      249    347       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      349    447       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      448    543       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      544    636       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      640    736       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      737    839       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      840    938       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      939   1034       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1035   1127       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1128   1222       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1223   1322       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1323   1415       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1416   1512       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1513   1609       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1622   1713       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1752   1833       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1833   1925       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     1923   2012       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     2015   2107       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     2105   2203       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     2206   2298       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     2300   2393       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     2397   2489       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT     2525   2619       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
SQ   SEQUENCE   2620 AA;  278226 MW;  9C1ABFC44B1B32B4 CRC64;
     MPATEKDLAE DAPWKKIQQN TFTRWCNEHL KCVSKRIANL QTDLSDGLRL IALLEVLSQK
     KMHRKHNQRP TFRQMQLENV SVALEFLDRE SIKLVSIDSK AIVDGNLKLI LGLIWTLILH
     YSISMPMWDE EEDEEAKKQT PKQRLLGWIQ NKLPQLPITN FSRDWQSGRA LGALVDSCAP
     GLCPDWDSWD ASKPVTNARE AMQQADDWLG IPQVITPEEI VDPNVDEHSV MTYLSQFPKA
     KLKPGAPLRP KLNPKKARAY GPGIEPTGNM VKKRAEFTVE TRSAGQGEVL VYVEDPAGHQ
     EEAKVTANND KNRTFSVWYV PEVTGTHKVT VLFAGQHIAK SPFEVYVDKS QGDASKVTAQ
     GPGLEPSGNI ANKTTYFEIF TAGAGTGEVE VVIQDPMGQK GTVEPQLEAR GDSTYRCSYQ
     PTMEGVHTVH VTFAGVPIPR SPYTVTVGQA CNPSACRAVG RGLQPKGVRV KETADFKVYT
     KGAGSGELKV TVKGPKGEER VKQKDLGDGV YGFEYYPMVP GTYIVTITWG GQNIGRSPFE
     VKVGTECGNQ KVRAWGPGLE GGVVGKSADF VVEAIGDDVG TLGFSVEGPS QAKIECDDKG
     DGSCDVRYWP QEAGEYAVHV LCNSEDIRLS PFMADIRDAP QDFHPDRVKA RGPGLEKTGV
     AVNKPAEFTV DAKHGGKAPL RVQVQDNEGC PVEALVKDNG NGTYSCSYVP RKPVKHTAMV
     SWGGVSIPNS PFRVNVGAGS HPNKVKVYGP GVAKTGLKAH EPTYFTVDCA EAGQGDVSIG
     IKCAPGVVGP AEADIDFDII RNDNDTFTVK YTPRGAGSYT IMVLFADQAT PTSPIRVKVE
     PSHDASKVKA EGPGLSRTGV ELGKPTHFTV NAKAAGKGKL DVQFSGLTKG DAVRDVDIID
     HHDNTYTVKY TPVQQGPVGV NVTYGGDPIP KSPFSVAVSP SLDLSKIKVS GLGEKVDVGK
     DQEFTVKSKG AGGQGKVASK IVGPSGAAVP CKVEPGLGAD NSVVRFLPRE EGPYEVEVTY
     DGVPVPGSPF PLEAVAPTKP SKVKAFGPGL QGGSAGSPAR FTIDTKGAGT GGLGLTVEGP
     CEAQLECLDN GDGTCSVSYV PTEPGDYNIN ILFADTHIPG SPFKAHVVPC FDASKVKCSG
     PGLERATAGE VGQFQVDCSS AGSAELTIEI CSEAGLPAEV YIQDHGDGTH TITYIPLCPG
     AYTVTIKYGG QPVPNFPSKL QVEPAVDTSG VQCYGPGIEG QGVFREATTE FSVDARALTQ
     TGGPHVKARV ANPSGNLTET YVQDRGDGMY KVEYTPYEEG LHSVDVTYDG SPVPSSPFQV
     PVTEGCDPSR VRVHGPGIQS GTTNKPNKFT VETRGAGTGG LGLAVEGPSE AKMSCMDNKD
     GSCSVEYIPY EAGTYSLNVT YGGHQVPGSP FKVPVHDVTD ASKVKCSGPG LSPGMVRANL
     PQSFQVDTSK AGVAPLQVKV QGPKGLVEPV DVVDNADGTQ TVNYVPSREG PYSISVLYGD
     EEVPRSPFKV KVLPTHDASK VKASGPGLNT TGVPASLPVE FTIDAKDAGE GLLAVQITDP
     EGKPKKTHIQ DNHDGTYTVA YVPDVTGRYT ILIKYGGDEI PFSPYRVRAV PTGDASKCTV
     TVSIGGHGLG AGIGPTIQIG EETVITVDTK AAGKGKVTCT VCTPDGSEVD VDVVENEDGT
     FDIFYTAPQP GKYVICVRFG GEHVPNSPFQ VTALAGDQPS VQPPLRSQQL APQYTYAQGG
     QQTWAPERPL VGVNGLDVTS LRPFDLVIPF TIKKGEITGE VRMPSGKVAQ PTITDNKDGT
     VTVRYAPSEA GLHEMDIRYD NMHIPGSPLQ FYVDYVNCGH VTAYGPGLTH GVVNKPATFT
     VNTKDAGEGG LSLAIEGPSK AEISCTDNQD GTCSVSYLPV LPGDYSILVK YNEQHVPGSP
     FTARVTGDDS MRMSHLKVGS AADIPINISE TDLSLLTATV VPPSGREEPC LLKRLRNGHV
     GISFVPKETG EHLVHVKKNG QHVASSPIPV VISQSEIGDA SRVRVSGQGL HEGHTFEPAE
     FIIDTRDAGY GGLSLSIEGP SKVDINTEDL EDGTCRVTYC PTEPGNYIIN IKFADQHVPG
     SPFSVKVTGE GRVKESITRR RRAPSVANVG SHCDLSLKIP EISIQDMTAQ VTSPSGKTHE
     AEIVEGENHT YCIRFVPAEM GTHTVSVKYK GQHVPGSPFQ FTVGPLGEGG AHKVRAGGPG
     LERAEAGVPA EFSIWTREAG AGGLAIAVEG PSKAEISFED RKDGSCGVAY VVQEPGDYEV
     SVKFNEEHIP DSPFVVPVAS PSGDARRLTV SSLQESGLKV NQPASFAVSL NGAKGAIDAK
     VHSPSGALEE CYVTEIDQDK YAVRFIPREN GVYLIDVKFN GTHIPGSPFK IRVGEPGHGG
     DPGLVSAYGA GLEGGVTGNP AEFVVNTSNA GAGALSVTID GPSKVKMDCQ ECPEGYRVTY
     TPMAPGSYLI SIKYGGPYHI GGSPFKAKVT GPRLVSNHSL HETSSVFVDS LTKATCAPQH
     GAPGPGPADA SKVVAKGLGL SKAYVGQKSS FTVDCSKAGN NMLLVGVHGP RTPCEEILVK
     HVGSRLYSVS YLLKDKGEYT LVVKWGDEHI PGSPYRVVVP
//
ID   Q6NXF2_HUMAN            Unreviewed;       983 AA.
AC   Q6NXF2;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   31-JAN-2018, entry version 77.
DE   SubName: Full=FLNA protein {ECO:0000313|EMBL:AAH67111.1};
DE   Flags: Fragment;
GN   Name=FLNA {ECO:0000313|EMBL:AAH67111.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH67111.1};
RN   [1] {ECO:0000313|EMBL:AAH67111.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin {ECO:0000313|EMBL:AAH67111.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC067111; AAH67111.1; -; mRNA.
DR   RefSeq; NP_001104026.1; NM_001110556.1.
DR   RefSeq; NP_001447.2; NM_001456.3.
DR   UniGene; Hs.195464; -.
DR   ProteinModelPortal; Q6NXF2; -.
DR   PeptideAtlas; Q6NXF2; -.
DR   PRIDE; Q6NXF2; -.
DR   GeneID; 2316; -.
DR   KEGG; hsa:2316; -.
DR   CTD; 2316; -.
DR   PharmGKB; PA28172; -.
DR   eggNOG; KOG0518; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   HOVERGEN; HBG074524; -.
DR   KO; K04437; -.
DR   ChiTaRS; FLNA; human.
DR   GenomeRNAi; 2316; -.
DR   Genevisible; Q6NXF2; HS.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 10.
DR   InterPro; IPR017868; Filamin/ABP280_repeat-like.
DR   InterPro; IPR001298; Filamin/ABP280_rpt.
DR   InterPro; IPR028559; FLN_A.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   PANTHER; PTHR43998:SF6; PTHR43998:SF6; 1.
DR   Pfam; PF00630; Filamin; 9.
DR   SMART; SM00557; IG_FLMN; 10.
DR   SUPFAM; SSF81296; SSF81296; 10.
DR   PROSITE; PS50194; FILAMIN_REPEAT; 10.
PE   2: Evidence at transcript level;
FT   REPEAT        1     76       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      115    196       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      196    288       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      286    375       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      378    470       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      468    566       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      569    661       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      663    756       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      760    852       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   REPEAT      888    982       Filamin. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00087}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAH67111.1}.
SQ   SEQUENCE   983 AA;  104164 MW;  8B944332B1AC27F3 CRC64;
     QIGEETVITV DTKAAGKGKV TCTVCTPDGS EVDVDVVENE DGTFDIFYTA PQPGKYVICV
     RFGGEHVPNS PFQVTALAGD QPSVQPPLRS QQLAPQYTYA QGGQQTWAPE RPLVGVNGLD
     VTSLRPFDLV IPFTIKKGEI TGEVRMPSGK VAQPTITDNK DGTVTVRYAP SEAGLHEMDI
     RYDNMHIPGS PLQFYVDYVN CGHVTAYGPG LTHGVVNKPA TFTVNTKDAG EGGLSLAIEG
     PSKAEISCTD NQDGTCSVSY LPVLPGDYSI LVKYNEQHVP GSPFTARVTG DDSMRMSHLK
     VGSAADIPIN ISETDLSLLT ATVVPPSGRE EPCLLKRLRN GHVGISFVPK ETGEHLVHVK
     KNGQHVASSP IPVVISQSEI GDASRVRVSG QGLHEGHTFE PAEFIIDTRD AGYGGLSLSI
     EGPSKVDINT EDLEDGTCRV TYCPTEPGNY IINIKFADQH VPGSPFSVKV TGEGRVKESI
     TRRRRAPSVA NVGSHCDLSL KIPEISIQDM TAQVTSPSGK THEAEIVEGE NHTYCIRFVP
     AEMGTHTVSV KYKGQHVPGS PFQFTVGPLG EGGAHKVRAG GPGLERAEAG VPAEFSIWTR
     EAGAGGLAIA VEGPSKAEIS FEDRKDGSCG VAYVVQEPGD YEVSVKFNEE HIPDSPFVVP
     VASPSGDARR LTVSSLQESG LKVNQPASFA VSLNGAKGAI DAKVHSPSGA LEECYVTEID
     QDKYAVRFIP RENGVYLIDV KFNGTHIPGS PFKIRVGEPG HGGDPGLVSA YGAGLEGGVT
     GNPAEFVVNT SNAGAGALSV TIDGPSKVKM DCQECPEGYR VTYTPMAPGS YLISIKYGGP
     YHIGGSPFKA KVTGPRLVSN HSLHETSSVF VDSLTKATCA PQHGAPGPGP ADASKVVAKG
     LGLSKAYVGQ KSSFTVDCSK AGNNMLLVGV HGPRTPCEEI LVKHVGSRLY SVSYLLKDKG
     EYTLVVKWGD EHIPGSPYRV VVP
//
ID   ISX_HUMAN               Reviewed;         245 AA.
AC   Q2M1V0; Q68DJ5;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   29-MAY-2007, sequence version 2.
DT   28-MAR-2018, entry version 108.
DE   RecName: Full=Intestine-specific homeobox;
DE   AltName: Full=RAX-like homeobox;
GN   Name=ISX; Synonyms=RAXLX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon carcinoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLY-28 AND
RP   SER-57.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Transcription factor that regulates gene expression in
CC       intestine. May participate in vitamin A metabolism most likely by
CC       regulating BCO1 expression in the intestine (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       P78424:POU6F2; NbExp=4; IntAct=EBI-6426064, EBI-12029004;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CR749372; CAH18225.1; -; mRNA.
DR   EMBL; Z83853; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL024494; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC112212; AAI12213.1; -; mRNA.
DR   EMBL; BC113633; AAI13634.1; -; mRNA.
DR   CCDS; CCDS33640.1; -.
DR   RefSeq; NP_001290437.1; NM_001303508.1.
DR   UniGene; Hs.567637; -.
DR   ProteinModelPortal; Q2M1V0; -.
DR   SMR; Q2M1V0; -.
DR   BioGrid; 124838; 4.
DR   IntAct; Q2M1V0; 2.
DR   STRING; 9606.ENSP00000311492; -.
DR   PhosphoSitePlus; Q2M1V0; -.
DR   BioMuta; ISX; -.
DR   DMDM; 150387849; -.
DR   PaxDb; Q2M1V0; -.
DR   PeptideAtlas; Q2M1V0; -.
DR   PRIDE; Q2M1V0; -.
DR   DNASU; 91464; -.
DR   Ensembl; ENST00000308700; ENSP00000311492; ENSG00000175329.
DR   Ensembl; ENST00000404699; ENSP00000386037; ENSG00000175329.
DR   GeneID; 91464; -.
DR   KEGG; hsa:91464; -.
DR   UCSC; uc003anj.4; human.
DR   CTD; 91464; -.
DR   DisGeNET; 91464; -.
DR   EuPathDB; HostDB:ENSG00000175329.12; -.
DR   GeneCards; ISX; -.
DR   HGNC; HGNC:28084; ISX.
DR   HPA; HPA060328; -.
DR   MIM; 612019; gene.
DR   neXtProt; NX_Q2M1V0; -.
DR   OpenTargets; ENSG00000175329; -.
DR   PharmGKB; PA147357909; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   GeneTree; ENSGT00900000140809; -.
DR   HOGENOM; HOG000052524; -.
DR   HOVERGEN; HBG096596; -.
DR   InParanoid; Q2M1V0; -.
DR   OMA; CCEAPKK; -.
DR   OrthoDB; EOG091G0NQL; -.
DR   PhylomeDB; Q2M1V0; -.
DR   TreeFam; TF315976; -.
DR   GenomeRNAi; 91464; -.
DR   PRO; PR:Q2M1V0; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000175329; -.
DR   CleanEx; HS_ISX; -.
DR   Genevisible; Q2M1V0; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISM:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Complete proteome; DNA-binding; Homeobox; Nucleus;
KW   Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    245       Intestine-specific homeobox.
FT                                /FTId=PRO_0000288602.
FT   DNA_BIND     82    141       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VARIANT      28     28       S -> G (in dbSNP:rs361863).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_032448.
FT   VARIANT      57     57       P -> S (in dbSNP:rs362090).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_032449.
FT   VARIANT      83     83       R -> Q (in dbSNP:rs8140287).
FT                                /FTId=VAR_032450.
FT   VARIANT     158    158       A -> V (in dbSNP:rs7291048).
FT                                /FTId=VAR_032451.
SQ   SEQUENCE   245 AA;  27011 MW;  361FB0447DC6C02D CRC64;
     MCAEVGPALC RGMERNSLGC CEAPKKLSLS FSIEAILKRP ARRSDMDRPE GPGEEGPGEA
     AASGSGLEKP PKDQPQEGRK SKRRVRTTFT TEQLHELEKI FHFTHYPDVH IRSQLAARIN
     LPEARVQIWF QNQRAKWRKQ EKIGNLGAPQ QLSEASVALP TNLDVAGPTW TSTALRRLAP
     PTSCCPSAQD QLASAWFPAW ITLLPAHPWE TQPVPGLPIH QTCIPVLCIL PPPHPKWGSI
     CATST
//
ID   ITAV_HUMAN              Reviewed;        1048 AA.
AC   P06756; A0AV67; B0LPF4; B7Z883; B7ZLX0; D3DPG8; E7EWZ6; Q53SK4;
AC   Q59EB7; Q6LD15;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 2.
DT   28-MAR-2018, entry version 219.
DE   RecName: Full=Integrin alpha-V;
DE   AltName: Full=Vitronectin receptor {ECO:0000312|HGNC:HGNC:6150};
DE   AltName: Full=Vitronectin receptor subunit alpha;
DE   AltName: CD_antigen=CD51;
DE   Contains:
DE     RecName: Full=Integrin alpha-V heavy chain;
DE   Contains:
DE     RecName: Full=Integrin alpha-V light chain;
DE   Flags: Precursor;
GN   Name=ITGAV {ECO:0000312|HGNC:HGNC:6150};
GN   Synonyms=MSK8 {ECO:0000312|HGNC:HGNC:6150},
GN   VNRA {ECO:0000312|HGNC:HGNC:6150}, VTNR {ECO:0000312|HGNC:HGNC:6150};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ILE-783.
RX   PubMed=2443500;
RA   Suzuki S., Argraves W.S., Arai H., Languino L.R., Pierschbacher M.D.,
RA   Ruoslahti E.;
RT   "Amino acid sequence of the vitronectin receptor alpha subunit and
RT   comparative expression of adhesion receptor mRNAs.";
RL   J. Biol. Chem. 262:14080-14085(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10965141;
RA   Sims M.A., Field S., Barnes M.R., Shaikh N., Ellington K.,
RA   Murphy K.E., Spurr N.K., Campbell D.A.;
RT   "Cloning and characterisation of ITGAV, the genomic sequence for human
RT   cell adhesion protein (vitronectin) receptor alpha subunit, CD51.";
RL   Cytogenet. Cell Genet. 89:268-271(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   ILE-783.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   ILE-783.
RC   TISSUE=Aortic endothelium;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ILE-783.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ILE-783.
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   ILE-783.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-62.
RX   PubMed=7522056; DOI=10.1016/0167-4781(94)90278-X;
RA   Donahue J.P., Sugg N., Hawiger J.;
RT   "The integrin alpha v gene: identification and characterization of the
RT   promoter region.";
RL   Biochim. Biophys. Acta 1219:228-232(1994).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 413-1048, AND VARIANT ILE-783.
RX   PubMed=2430295; DOI=10.1073/pnas.83.22.8614;
RA   Suzuki S., Argraves W.S., Pytela R., Arai H., Krusius T.,
RA   Pierschbacher M.D., Ruoslahti E.;
RT   "cDNA and amino acid sequences of the cell adhesion protein receptor
RT   recognizing vitronectin reveal a transmembrane domain and homologies
RT   with other adhesion protein receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:8614-8618(1986).
RN   [11]
RP   PROTEIN SEQUENCE OF 31-41.
RX   PubMed=2467745; DOI=10.1016/0092-8674(89)90172-4;
RA   Cheresh D.A., Smith J.W., Cooper H.M., Quaranta V.;
RT   "A novel vitronectin receptor integrin (alpha v beta x) is responsible
RT   for distinct adhesive properties of carcinoma cells.";
RL   Cell 57:59-69(1989).
RN   [12]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH COXSACKIEVIRUS A9
RP   CAPSID PROTEINS.
RX   PubMed=7519807; DOI=10.1006/viro.1994.1494;
RA   Roivainen M., Piirainen L., Hovi T., Virtanen I., Riikonen T.,
RA   Heino J., Hyypiae T.;
RT   "Entry of coxsackievirus A9 into host cells: specific interactions
RT   with alpha v beta 3 integrin, the vitronectin receptor.";
RL   Virology 203:357-365(1994).
RN   [13]
RP   INTERACTION WITH COXSACKIEVIRUS B1 CAPSID PROTEINS.
RX   PubMed=9426447; DOI=10.1006/viro.1997.8831;
RA   Agrez M.V., Shafren D.R., Gu X., Cox K., Sheppard D., Barry R.D.;
RT   "Integrin alpha v beta 6 enhances coxsackievirus B1 lytic infection of
RT   human colon cancer cells.";
RL   Virology 239:71-77(1997).
RN   [14]
RP   INTERACTION WITH HIV-1 TAT.
RX   PubMed=10397733;
RA   Barillari G., Sgadari C., Fiorelli V., Samaniego F., Colombini S.,
RA   Manzari V., Modesti A., Nair B.C., Cafaro A., Stuerzl M., Ensoli B.;
RT   "The Tat protein of human immunodeficiency virus type-1 promotes
RT   vascular cell growth and locomotion by engaging the alpha5beta1 and
RT   alphavbeta3 integrins and by mobilizing sequestered basic fibroblast
RT   growth factor.";
RL   Blood 94:663-672(1999).
RN   [15]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HUMAN
RP   PARECHOVIRUS 1 CAPSID PROTEINS.
RX   PubMed=11160695; DOI=10.1128/JVI.75.4.1958-1967.2001;
RA   Joki-Korpela P., Marjomaki V., Krogerus C., Heino J., Hyypia T.;
RT   "Entry of human parechovirus 1.";
RL   J. Virol. 75:1958-1967(2001).
RN   [16]
RP   INTERACTION WITH NOV.
RX   PubMed=12695522; DOI=10.1074/jbc.M302028200;
RA   Lin C.G., Leu S.J., Chen N., Tebeau C.M., Lin S.X., Yeung C.Y.,
RA   Lau L.F.;
RT   "CCN3 (NOV) is a novel angiogenic regulator of the CCN protein
RT   family.";
RL   J. Biol. Chem. 278:24200-24208(2003).
RN   [17]
RP   FUNCTION, AND INTERACTION WITH FBN1.
RX   PubMed=12807887; DOI=10.1074/jbc.M303159200;
RA   Bax D.V., Bernard S.E., Lomas A., Morgan A., Humphries J.,
RA   Shuttleworth C.A., Humphries M.J., Kielty C.M.;
RT   "Cell adhesion to fibrillin-1 molecules and microfibrils is mediated
RT   by alpha 5 beta 1 and alpha v beta 3 integrins.";
RL   J. Biol. Chem. 278:34605-34616(2003).
RN   [18]
RP   GLYCOSYLATION AT ASN-615.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [19]
RP   DISULFIDE BONDS.
RX   PubMed=14596610; DOI=10.1021/bi034726u;
RA   Krokhin O.V., Cheng K., Sousa S.L., Ens W., Standing K.G.,
RA   Wilkins J.A.;
RT   "Mass spectrometric based mapping of the disulfide bonding patterns of
RT   integrin alpha chains.";
RL   Biochemistry 42:12950-12959(2003).
RN   [20]
RP   INTERACTION WITH COXSACKIEVIRUS A9 CAPSID PROTEINS.
RX   PubMed=15194773; DOI=10.1128/JVI.78.13.6967-6973.2004;
RA   Williams C.H., Kajander T., Hyypia T., Jackson T., Sheppard D.,
RA   Stanway G.;
RT   "Integrin alpha v beta 6 is an RGD-dependent receptor for
RT   coxsackievirus A9.";
RL   J. Virol. 78:6967-6973(2004).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [22]
RP   INTERACTION WITH ADGRA2.
RX   PubMed=16982628; DOI=10.1074/jbc.M605291200;
RA   Vallon M., Essler M.;
RT   "Proteolytically processed soluble tumor endothelial marker (TEM) 5
RT   mediates endothelial cell survival during angiogenesis by linking
RT   integrin alpha(v)beta3 to glycosaminoglycans.";
RL   J. Biol. Chem. 281:34179-34188(2006).
RN   [23]
RP   INTERACTION WITH RAB25.
RX   PubMed=17925226; DOI=10.1016/j.devcel.2007.08.012;
RA   Caswell P.T., Spence H.J., Parsons M., White D.P., Clark K.,
RA   Cheng K.W., Mills G.B., Humphries M.J., Messent A.J., Anderson K.I.,
RA   McCaffrey M.W., Ozanne B.W., Norman J.C.;
RT   "Rab25 associates with alpha5beta1 integrin to promote invasive
RT   migration in 3D microenvironments.";
RL   Dev. Cell 13:496-510(2007).
RN   [24]
RP   FUNCTION, INTERACTION WITH FBN1, AND SUBCELLULAR LOCATION.
RX   PubMed=17158881; DOI=10.1074/jbc.M607008200;
RA   Jovanovic J., Takagi J., Choulier L., Abrescia N.G., Stuart D.I.,
RA   van der Merwe P.A., Mardon H.J., Handford P.A.;
RT   "alphaVbeta6 is a novel receptor for human fibrillin-1. Comparative
RT   studies of molecular determinants underlying integrin-rgd affinity and
RT   specificity.";
RL   J. Biol. Chem. 282:6743-6751(2007).
RN   [25]
RP   FUNCTION, BINDING TO FGF1, AND IDENTIFICATION IN A COMPLEX WITH FGF1
RP   AND FGFR1.
RX   PubMed=18441324; DOI=10.1074/jbc.M801213200;
RA   Mori S., Wu C.Y., Yamaji S., Saegusa J., Shi B., Ma Z., Kuwabara Y.,
RA   Lam K.S., Isseroff R.R., Takada Y.K., Takada Y.;
RT   "Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1
RT   signaling.";
RL   J. Biol. Chem. 283:18066-18075(2008).
RN   [26]
RP   FUNCTION.
RX   PubMed=18635536; DOI=10.1074/jbc.M804835200;
RA   Saegusa J., Akakura N., Wu C.Y., Hoogland C., Ma Z., Lam K.S.,
RA   Liu F.T., Takada Y.K., Takada Y.;
RT   "Pro-inflammatory secretory phospholipase A2 type IIA binds to
RT   integrins alphavbeta3 and alpha4beta1 and induces proliferation of
RT   monocytic cells in an integrin-dependent manner.";
RL   J. Biol. Chem. 283:26107-26115(2008).
RN   [27]
RP   INTERACTION WITH HHV-8 GLYCOPROTEIN B.
RX   PubMed=18045938; DOI=10.1128/JVI.01673-07;
RA   Garrigues H.J., Rubinchikova Y.E., Dipersio C.M., Rose T.M.;
RT   "Integrin alphaVbeta3 Binds to the RGD motif of glycoprotein B of
RT   Kaposi's sarcoma-associated herpesvirus and functions as an RGD-
RT   dependent entry receptor.";
RL   J. Virol. 82:1570-1580(2008).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [29]
RP   FUNCTION, BINDING TO IGF1, AND IDENTIFICATION IN A COMPLEX WITH IGF1
RP   AND IGF1R.
RX   PubMed=19578119; DOI=10.1074/jbc.M109.013201;
RA   Saegusa J., Yamaji S., Ieguchi K., Wu C.Y., Lam K.S., Liu F.T.,
RA   Takada Y.K., Takada Y.;
RT   "The direct binding of insulin-like growth factor-1 (IGF-1) to
RT   integrin alphavbeta3 is involved in IGF-1 signaling.";
RL   J. Biol. Chem. 284:24106-24114(2009).
RN   [30]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-74; ASN-615; ASN-704 AND
RP   ASN-874.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [31]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-74 AND ASN-874.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [32]
RP   FUNCTION, BINDING TO NRG1, AND IDENTIFICATION IN A COMPLEX WITH NRG1
RP   AND ERBB3.
RX   PubMed=20682778; DOI=10.1074/jbc.M110.113878;
RA   Ieguchi K., Fujita M., Ma Z., Davari P., Taniguchi Y., Sekiguchi K.,
RA   Wang B., Takada Y.K., Takada Y.;
RT   "Direct binding of the EGF-like domain of neuregulin-1 to integrins
RT   ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB
RT   signaling.";
RL   J. Biol. Chem. 285:31388-31398(2010).
RN   [33]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH ADENOVIRUS TYPE C
RP   PENTON PROTEIN.
RX   PubMed=20615244; DOI=10.1186/1743-422X-7-148;
RA   Lyle C., McCormick F.;
RT   "Integrin alphavbeta5 is a primary receptor for adenovirus in CAR-
RT   negative cells.";
RL   Virol. J. 7:148-148(2010).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [35]
RP   FUNCTION, BINDING TO CX3CL1, AND IDENTIFICATION IN A COMPLEX WITH
RP   CX3CR1 AND CX3CL1.
RX   PubMed=23125415; DOI=10.4049/jimmunol.1200889;
RA   Fujita M., Takada Y.K., Takada Y.;
RT   "Integrins alphavbeta3 and alpha4beta1 act as coreceptors for
RT   fractalkine, and the integrin-binding defective mutant of fractalkine
RT   is an antagonist of CX3CR1.";
RL   J. Immunol. 189:5809-5819(2012).
RN   [36]
RP   INTERACTION WITH CIB1.
RX   PubMed=24011356; DOI=10.1021/bi400678y;
RA   Freeman T.C. Jr., Black J.L., Bray H.G., Dagliyan O., Wu Y.I.,
RA   Tripathy A., Dokholyan N.V., Leisner T.M., Parise L.V.;
RT   "Identification of novel integrin binding partners for calcium and
RT   integrin binding protein 1 (CIB1): structural and thermodynamic basis
RT   of CIB1 promiscuity.";
RL   Biochemistry 52:7082-7090(2013).
RN   [37]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HERPES SIMPLEX
RP   VIRUS 1 ENVELOPE GLYCOPROTEIN H.
RX   PubMed=24367260; DOI=10.1371/journal.ppat.1003806;
RA   Gianni T., Salvioli S., Chesnokova L.S., Hutt-Fletcher L.M.,
RA   Campadelli-Fiume G.;
RT   "alphavbeta6- and alphavbeta8-integrins serve as interchangeable
RT   receptors for HSV gH/gL to promote endocytosis and activation of
RT   membrane fusion.";
RL   PLoS Pathog. 9:E1003806-E1003806(2013).
RN   [38]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH WEST NILE VIRUS
RP   ENVELOPE PROTEIN E.
RX   PubMed=23658209; DOI=10.1099/vir.0.052613-0;
RA   Schmidt K., Keller M., Bader B.L., Korytar T., Finke S., Ziegler U.,
RA   Groschup M.H.;
RT   "Integrins modulate the infection efficiency of West Nile virus into
RT   cells.";
RL   J. Gen. Virol. 94:1723-1733(2013).
RN   [39]
RP   FUNCTION.
RX   PubMed=25398877; DOI=10.1074/jbc.M114.579946;
RA   Fujita M., Zhu K., Fujita C.K., Zhao M., Lam K.S., Kurth M.J.,
RA   Takada Y.K., Takada Y.;
RT   "Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces
RT   integrin activation through direct binding to a newly identified
RT   binding site (site 2) in integrins alphavbeta3, alpha4beta1, and
RT   alpha5beta1.";
RL   J. Biol. Chem. 290:259-271(2015).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 31-987.
RX   PubMed=11546839; DOI=10.1126/science.1064535;
RA   Xiong J.P., Stehle T., Diefenbach B., Zhang R., Dunker R., Scott D.L.,
RA   Joachimiak A., Goodman S.L., Arnaout M.A.;
RT   "Crystal structure of the extracellular segment of integrin alpha
RT   Vbeta3.";
RL   Science 294:339-345(2001).
CC   -!- FUNCTION: The alpha-V (ITGAV) integrins are receptors for
CC       vitronectin, cytotactin, fibronectin, fibrinogen, laminin, matrix
CC       metalloproteinase-2, osteopontin, osteomodulin, prothrombin,
CC       thrombospondin and vWF. They recognize the sequence R-G-D in a
CC       wide array of ligands. ITGAV:ITGB3 binds to fractalkine (CX3CL1)
CC       and may act as its coreceptor in CX3CR1-dependent fractalkine
CC       signaling (PubMed:23125415). ITGAV:ITGB3 binds to NRG1 (via EGF
CC       domain) and this binding is essential for NRG1-ERBB signaling
CC       (PubMed:20682778). ITGAV:ITGB3 binds to FGF1 and this binding is
CC       essential for FGF1 signaling (PubMed:18441324). ITGAV:ITGB3 binds
CC       to IGF1 and this binding is essential for IGF1 signaling
CC       (PubMed:19578119). ITGAV:ITGB3 binds to PLA2G2A via a site (site
CC       2) which is distinct from the classical ligand-binding site (site
CC       1) and this induces integrin conformational changes and enhanced
CC       ligand binding to site 1 (PubMed:18635536, PubMed:25398877).
CC       ITGAV:ITGB3 and ITGAV:ITGB6 act as a receptor for fibrillin-1
CC       (FBN1) and mediate R-G-D-dependent cell adhesion to FBN1
CC       (PubMed:12807887, PubMed:17158881). {ECO:0000269|PubMed:12807887,
CC       ECO:0000269|PubMed:17158881, ECO:0000269|PubMed:18441324,
CC       ECO:0000269|PubMed:18635536, ECO:0000269|PubMed:19578119,
CC       ECO:0000269|PubMed:20682778, ECO:0000269|PubMed:23125415,
CC       ECO:0000269|PubMed:25398877}.
CC   -!- FUNCTION: (Microbial infection) Integrin ITGAV:ITGB5 acts as a
CC       receptor for Adenovirus type C. {ECO:0000269|PubMed:20615244}.
CC   -!- FUNCTION: (Microbial infection) Integrin ITGAV:ITGB5 and
CC       ITGAV:ITGB3 act as receptors for Coxsackievirus A9 and B1.
CC       {ECO:0000269|PubMed:15194773, ECO:0000269|PubMed:7519807,
CC       ECO:0000269|PubMed:9426447}.
CC   -!- FUNCTION: (Microbial infection) Integrin ITGAV:ITGB3 acts as a
CC       receptor for Herpes virus 8/HHV-8. {ECO:0000269|PubMed:18045938}.
CC   -!- FUNCTION: (Microbial infection) Integrin ITGAV:ITGB6 acts as a
CC       receptor for herpes simplex 1/HHV-1.
CC       {ECO:0000269|PubMed:24367260}.
CC   -!- FUNCTION: (Microbial infection) Integrin ITGAV:ITGB3 acts as a
CC       receptor for Human parechovirus 1. {ECO:0000269|PubMed:11160695}.
CC   -!- FUNCTION: (Microbial infection) Integrin ITGAV:ITGB3 acts as a
CC       receptor for West nile virus. {ECO:0000269|PubMed:23658209}.
CC   -!- FUNCTION: (Microbial infection) In case of HIV-1 infection, the
CC       interaction with extracellular viral Tat protein seems to enhance
CC       angiogenesis in Kaposi's sarcoma lesions.
CC       {ECO:0000269|PubMed:10397733}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. The alpha
CC       subunit is composed of a heavy and a light chain linked by a
CC       disulfide bond. Alpha-V (ITGAV) associates with either beta-1
CC       (ITGB1), beta-3 (ITGB3), beta-5 (ITGB5), beta-6 (ITGB6) or beta-8
CC       (ITGB8). Interacts with CIB1 (PubMed:24011356). Interacts with
CC       RAB25 (PubMed:17925226). Integrins ITGAV:ITGB3 and ITGAV:ITGB5
CC       interact with FBLN5 (via N-terminus) (By similarity). ITGAV:ITGB3
CC       and ITGAV:ITGB5 interact with NOV (PubMed:12695522). ITGAV:ITGB3
CC       interacts with ADGRA2 (PubMed:16982628). ITGAV:ITGB3 is found in a
CC       ternary complex with CX3CR1 and CX3CL1 (PubMed:23125415).
CC       ITGAV:ITGB3 is found in a ternary complex with NRG1 and ERBB3
CC       (PubMed:20682778). ITGAV:ITGB3 is found in a ternary complex with
CC       FGF1 and FGFR1 (PubMed:18441324). ITGAV:ITGB3 is found in a
CC       ternary complex with IGF1 and IGF1R (PubMed:19578119). ITGAV:ITGB3
CC       and ITGAV:ITGB6 interact with FBN1 (PubMed:12807887,
CC       PubMed:17158881). {ECO:0000250|UniProtKB:P43406,
CC       ECO:0000250|UniProtKB:P80746, ECO:0000269|PubMed:12695522,
CC       ECO:0000269|PubMed:12807887, ECO:0000269|PubMed:16982628,
CC       ECO:0000269|PubMed:17158881, ECO:0000269|PubMed:17925226,
CC       ECO:0000269|PubMed:18441324, ECO:0000269|PubMed:19578119,
CC       ECO:0000269|PubMed:20615244, ECO:0000269|PubMed:20682778,
CC       ECO:0000269|PubMed:23125415, ECO:0000269|PubMed:23658209,
CC       ECO:0000269|PubMed:24011356}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB3 interacts with
CC       herpes virus 8/HHV-8 envelope glycoprotein B.
CC       {ECO:0000269|PubMed:18045938}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB3 and
CC       ITGAV:ITGB6 bind to coxsackievirus A9 and coxsackievirus B1 capsid
CC       proteins (PubMed:9426447, PubMed:15194773, PubMed:7519807).
CC       {ECO:0000269|PubMed:15194773, ECO:0000269|PubMed:7519807,
CC       ECO:0000269|PubMed:9426447}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB6 interacts with
CC       herpes simplex 1/HHV-1 envelope glycoprotein H.
CC       {ECO:0000269|PubMed:24367260}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB5 interacts with
CC       adenovirus type C penton protein. {ECO:0000269|PubMed:20615244}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB3 interacts with
CC       Human parechovirus 1 capsid proteins.
CC       {ECO:0000269|PubMed:11160695}.
CC   -!- SUBUNIT: (Microbial infection) Integrin ITGAV:ITGB3 interacts with
CC       West nile virus envelope protein E. {ECO:0000269|PubMed:23658209}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HIV-1 Tat.
CC       {ECO:0000269|PubMed:10397733}.
CC   -!- INTERACTION:
CC       P05106:ITGB3; NbExp=13; IntAct=EBI-298282, EBI-702847;
CC       P18084:ITGB5; NbExp=2; IntAct=EBI-298282, EBI-1223434;
CC       P18564:ITGB6; NbExp=7; IntAct=EBI-298282, EBI-2568070;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein. Cell junction, focal adhesion
CC       {ECO:0000269|PubMed:17158881}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P06756-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P06756-2; Sequence=VSP_024351;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P06756-3; Sequence=VSP_044914;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the integrin alpha chain family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD93131.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M14648; AAA36808.1; -; mRNA.
DR   EMBL; AF251841; AAG03000.1; -; Genomic_DNA.
DR   EMBL; AF251818; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251819; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251820; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251821; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251822; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251823; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251824; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251825; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251826; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251827; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251828; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251829; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251830; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251831; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251832; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251833; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251834; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251835; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251836; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251837; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251838; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251839; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AF251840; AAG03000.1; JOINED; Genomic_DNA.
DR   EMBL; AK302990; BAH13869.1; -; mRNA.
DR   EMBL; AB209894; BAD93131.1; ALT_INIT; mRNA.
DR   EMBL; AC017101; AAY24257.1; -; Genomic_DNA.
DR   EMBL; EU332844; ABY87533.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX10934.1; -; Genomic_DNA.
DR   EMBL; BC126231; AAI26232.1; -; mRNA.
DR   EMBL; BC136442; AAI36443.1; -; mRNA.
DR   EMBL; BC144100; AAI44101.1; -; mRNA.
DR   EMBL; U07375; AAA61631.1; -; Genomic_DNA.
DR   CCDS; CCDS2292.1; -. [P06756-1]
DR   CCDS; CCDS46470.1; -. [P06756-2]
DR   CCDS; CCDS46471.1; -. [P06756-3]
DR   PIR; A27421; A27421.
DR   RefSeq; NP_001138471.1; NM_001144999.2.
DR   RefSeq; NP_001138472.1; NM_001145000.2.
DR   RefSeq; NP_002201.1; NM_002210.4.
DR   UniGene; Hs.436873; -.
DR   PDB; 1JV2; X-ray; 3.10 A; A=31-987.
DR   PDB; 1L5G; X-ray; 3.20 A; A=31-987.
DR   PDB; 1M1X; X-ray; 3.30 A; A=31-987.
DR   PDB; 1U8C; X-ray; 3.10 A; A=31-987.
DR   PDB; 3IJE; X-ray; 2.90 A; A=31-997.
DR   PDB; 4G1E; X-ray; 3.00 A; A=31-989.
DR   PDB; 4G1M; X-ray; 2.90 A; A=31-989.
DR   PDB; 4MMX; X-ray; 3.32 A; A=31-989.
DR   PDB; 4MMY; X-ray; 3.18 A; A=31-989.
DR   PDB; 4MMZ; X-ray; 3.10 A; A=31-989.
DR   PDB; 4O02; X-ray; 3.60 A; A=31-992.
DR   PDB; 4UM8; X-ray; 2.85 A; A/C=31-625.
DR   PDB; 4UM9; X-ray; 2.50 A; A/C=31-625.
DR   PDB; 5FFG; X-ray; 2.25 A; A=31-625.
DR   PDB; 5FFO; X-ray; 3.49 A; A/E=31-625.
DR   PDB; 5NEM; EM; 3.10 A; A=31-624.
DR   PDB; 5NER; EM; 3.10 A; A=31-624.
DR   PDB; 5NET; EM; 3.10 A; A=31-624.
DR   PDB; 5NEU; EM; 3.10 A; A=31-624.
DR   PDB; 6AVQ; EM; 35.00 A; A=31-987.
DR   PDB; 6AVR; EM; 35.00 A; A=31-987.
DR   PDB; 6AVU; EM; 35.00 A; A=31-987.
DR   PDBsum; 1JV2; -.
DR   PDBsum; 1L5G; -.
DR   PDBsum; 1M1X; -.
DR   PDBsum; 1U8C; -.
DR   PDBsum; 3IJE; -.
DR   PDBsum; 4G1E; -.
DR   PDBsum; 4G1M; -.
DR   PDBsum; 4MMX; -.
DR   PDBsum; 4MMY; -.
DR   PDBsum; 4MMZ; -.
DR   PDBsum; 4O02; -.
DR   PDBsum; 4UM8; -.
DR   PDBsum; 4UM9; -.
DR   PDBsum; 5FFG; -.
DR   PDBsum; 5FFO; -.
DR   PDBsum; 5NEM; -.
DR   PDBsum; 5NER; -.
DR   PDBsum; 5NET; -.
DR   PDBsum; 5NEU; -.
DR   PDBsum; 6AVQ; -.
DR   PDBsum; 6AVR; -.
DR   PDBsum; 6AVU; -.
DR   ProteinModelPortal; P06756; -.
DR   SMR; P06756; -.
DR   BioGrid; 109891; 71.
DR   CORUM; P06756; -.
DR   DIP; DIP-31785N; -.
DR   ELM; P06756; -.
DR   IntAct; P06756; 21.
DR   MINT; P06756; -.
DR   STRING; 9606.ENSP00000261023; -.
DR   BindingDB; P06756; -.
DR   ChEMBL; CHEMBL3660; -.
DR   DrugBank; DB00098; Anti-thymocyte Globulin (Rabbit).
DR   GuidetoPHARMACOLOGY; 2453; -.
DR   TCDB; 8.A.54.1.4; the integrin (integrin) family.
DR   iPTMnet; P06756; -.
DR   PhosphoSitePlus; P06756; -.
DR   DMDM; 143811408; -.
DR   EPD; P06756; -.
DR   MaxQB; P06756; -.
DR   PaxDb; P06756; -.
DR   PeptideAtlas; P06756; -.
DR   PRIDE; P06756; -.
DR   Ensembl; ENST00000261023; ENSP00000261023; ENSG00000138448. [P06756-1]
DR   Ensembl; ENST00000374907; ENSP00000364042; ENSG00000138448. [P06756-2]
DR   Ensembl; ENST00000433736; ENSP00000404291; ENSG00000138448. [P06756-3]
DR   GeneID; 3685; -.
DR   KEGG; hsa:3685; -.
DR   UCSC; uc002upq.5; human. [P06756-1]
DR   CTD; 3685; -.
DR   DisGeNET; 3685; -.
DR   EuPathDB; HostDB:ENSG00000138448.11; -.
DR   GeneCards; ITGAV; -.
DR   HGNC; HGNC:6150; ITGAV.
DR   HPA; CAB002499; -.
DR   HPA; HPA004856; -.
DR   MIM; 193210; gene.
DR   neXtProt; NX_P06756; -.
DR   OpenTargets; ENSG00000138448; -.
DR   PharmGKB; PA37336; -.
DR   eggNOG; ENOG410IPB5; Eukaryota.
DR   eggNOG; ENOG410YR19; LUCA.
DR   GeneTree; ENSGT00760000118782; -.
DR   HOGENOM; HOG000231603; -.
DR   HOVERGEN; HBG006186; -.
DR   InParanoid; P06756; -.
DR   KO; K06487; -.
DR   OMA; SCFNVRF; -.
DR   OrthoDB; EOG091G05Z4; -.
DR   PhylomeDB; P06756; -.
DR   TreeFam; TF105391; -.
DR   Reactome; R-HSA-1236973; Cross-presentation of particulate exogenous antigens (phagosomes).
DR   Reactome; R-HSA-1566948; Elastic fibre formation.
DR   Reactome; R-HSA-210990; PECAM1 interactions.
DR   Reactome; R-HSA-2129379; Molecules associated with elastic fibres.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000157; Laminin interactions.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-HSA-445144; Signal transduction by L1.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; P06756; -.
DR   SIGNOR; P06756; -.
DR   ChiTaRS; ITGAV; human.
DR   EvolutionaryTrace; P06756; -.
DR   GeneWiki; ITGAV; -.
DR   GenomeRNAi; 3685; -.
DR   PMAP-CutDB; B0LPF4; -.
DR   PRO; PR:P06756; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000138448; -.
DR   CleanEx; HS_ITGAV; -.
DR   ExpressionAtlas; P06756; baseline and differential.
DR   Genevisible; P06756; HS.
DR   GO; GO:0035868; C:alphav-beta3 integrin-HMGB1 complex; IDA:BHF-UCL.
DR   GO; GO:0035867; C:alphav-beta3 integrin-IGF-1-IGF1R complex; IDA:BHF-UCL.
DR   GO; GO:0035866; C:alphav-beta3 integrin-PKCalpha complex; NAS:BHF-UCL.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031527; C:filopodium membrane; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0034683; C:integrin alphav-beta3 complex; IDA:UniProtKB.
DR   GO; GO:0034684; C:integrin alphav-beta5 complex; IDA:UniProtKB.
DR   GO; GO:0034685; C:integrin alphav-beta6 complex; IEA:Ensembl.
DR   GO; GO:0034686; C:integrin alphav-beta8 complex; IDA:UniProtKB.
DR   GO; GO:0008305; C:integrin complex; IDA:BHF-UCL.
DR   GO; GO:0031258; C:lamellipodium membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:BHF-UCL.
DR   GO; GO:0031528; C:microvillus membrane; IDA:UniProtKB.
DR   GO; GO:0045335; C:phagocytic vesicle; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0032587; C:ruffle membrane; IDA:UniProtKB.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0015026; F:coreceptor activity; TAS:UniProtKB.
DR   GO; GO:0050840; F:extracellular matrix binding; IDA:UniProtKB.
DR   GO; GO:1990430; F:extracellular matrix protein binding; IDA:UniProtKB.
DR   GO; GO:0001968; F:fibronectin binding; IDA:UniProtKB.
DR   GO; GO:0005178; F:integrin binding; IPI:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0001846; F:opsonin binding; IEA:Ensembl.
DR   GO; GO:0042277; F:peptide binding; IEA:Ensembl.
DR   GO; GO:0002020; F:protease binding; IDA:UniProtKB.
DR   GO; GO:0005080; F:protein kinase C binding; IEA:Ensembl.
DR   GO; GO:0050431; F:transforming growth factor beta binding; ISS:BHF-UCL.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IEP:UniProtKB.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0038027; P:apolipoprotein A-I-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0043277; P:apoptotic cell clearance; IGI:BHF-UCL.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IDA:BHF-UCL.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; IDA:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0031589; P:cell-substrate adhesion; IMP:UniProtKB.
DR   GO; GO:0035987; P:endodermal cell differentiation; IMP:UniProtKB.
DR   GO; GO:0052066; P:entry of symbiont into host cell by promotion of host phagocytosis; NAS:BHF-UCL.
DR   GO; GO:0070371; P:ERK1 and ERK2 cascade; ISS:BHF-UCL.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; ISS:BHF-UCL.
DR   GO; GO:0034113; P:heterotypic cell-cell adhesion; IMP:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; NAS:UniProtKB.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0050919; P:negative chemotaxis; IMP:UniProtKB.
DR   GO; GO:2000536; P:negative regulation of entry of bacterium into host cell; IDA:BHF-UCL.
DR   GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0010888; P:negative regulation of lipid storage; IMP:BHF-UCL.
DR   GO; GO:0032369; P:negative regulation of lipid transport; IMP:BHF-UCL.
DR   GO; GO:0050748; P:negative regulation of lipoprotein metabolic process; IMP:BHF-UCL.
DR   GO; GO:0045715; P:negative regulation of low-density lipoprotein particle receptor biosynthetic process; IMP:BHF-UCL.
DR   GO; GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IDA:BHF-UCL.
DR   GO; GO:0030335; P:positive regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl.
DR   GO; GO:0033690; P:positive regulation of osteoblast proliferation; IEA:Ensembl.
DR   GO; GO:0050764; P:regulation of phagocytosis; IDA:BHF-UCL.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:UniProtKB.
DR   GO; GO:0038044; P:transforming growth factor-beta secretion; IEA:Ensembl.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0001570; P:vasculogenesis; IEA:Ensembl.
DR   GO; GO:0046718; P:viral entry into host cell; IMP:UniProtKB.
DR   Gene3D; 2.130.10.130; -; 1.
DR   InterPro; IPR013517; FG-GAP.
DR   InterPro; IPR013519; Int_alpha_beta-p.
DR   InterPro; IPR000413; Integrin_alpha.
DR   InterPro; IPR013649; Integrin_alpha-2.
DR   InterPro; IPR018184; Integrin_alpha_C_CS.
DR   InterPro; IPR028994; Integrin_alpha_N.
DR   InterPro; IPR032695; Integrin_dom_sf.
DR   Pfam; PF01839; FG-GAP; 3.
DR   Pfam; PF00357; Integrin_alpha; 1.
DR   Pfam; PF08441; Integrin_alpha2; 1.
DR   PRINTS; PR01185; INTEGRINA.
DR   SMART; SM00191; Int_alpha; 5.
DR   SUPFAM; SSF69179; SSF69179; 3.
DR   PROSITE; PS51470; FG_GAP; 7.
DR   PROSITE; PS00242; INTEGRIN_ALPHA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell adhesion;
KW   Cell junction; Cleavage on pair of basic residues; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Host cell receptor for virus entry; Host-virus interaction; Integrin;
KW   Membrane; Metal-binding; Polymorphism; Receptor; Reference proteome;
KW   Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     30       {ECO:0000269|PubMed:2467745}.
FT   CHAIN        31   1048       Integrin alpha-V.
FT                                /FTId=PRO_0000016301.
FT   CHAIN        31    889       Integrin alpha-V heavy chain.
FT                                /FTId=PRO_0000016302.
FT   CHAIN       891   1048       Integrin alpha-V light chain.
FT                                /FTId=PRO_0000016303.
FT   TOPO_DOM     31    992       Extracellular. {ECO:0000255}.
FT   TRANSMEM    993   1016       Helical. {ECO:0000255}.
FT   TOPO_DOM   1017   1048       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       32     98       FG-GAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      109    170       FG-GAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      173    225       FG-GAP 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      237    291       FG-GAP 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      292    357       FG-GAP 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      358    415       FG-GAP 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   REPEAT      419    482       FG-GAP 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00803}.
FT   CA_BIND     260    268       {ECO:0000255}.
FT   CA_BIND     314    322       {ECO:0000255}.
FT   CA_BIND     379    387       {ECO:0000255}.
FT   CA_BIND     443    451       {ECO:0000255}.
FT   MOTIF      1019   1023       GFFKR motif.
FT   CARBOHYD     74     74       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    290    290       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    296    296       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    488    488       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    554    554       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    615    615       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    704    704       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    835    835       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    851    851       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    874    874       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    945    945       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    973    973       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    980    980       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     89     97       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    138    158       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    172    185       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    491    502       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    508    565       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    626    632       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    698    711       {ECO:0000269|PubMed:14596610}.
FT   DISULFID    852    914       Interchain (between heavy and light
FT                                chains). {ECO:0000269|PubMed:14596610}.
FT   DISULFID    904    909       {ECO:0000269|PubMed:14596610}.
FT   VAR_SEQ       1     62       MAFPPRRRLRLGPRGLPLLLSGLLLPLCRAFNLDVDSPAEY
FT                                SGPEGSYFGFAVDFFVPSASS -> MLLGTLLLILYILMLC
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044914.
FT   VAR_SEQ     175    211       QDIDADGQGFCQGGFSIDFTKADRVLLGGPGSFYWQG ->
FT                                R (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_024351.
FT   VARIANT     405    405       I -> V (in dbSNP:rs3738918).
FT                                /FTId=VAR_024289.
FT   VARIANT     548    548       S -> A (in dbSNP:rs2230615).
FT                                /FTId=VAR_055970.
FT   VARIANT     783    783       V -> I (in dbSNP:rs2230616).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:2430295,
FT                                ECO:0000269|PubMed:2443500,
FT                                ECO:0000269|Ref.4, ECO:0000269|Ref.6,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_031547.
FT   CONFLICT    425    425       W -> R (in Ref. 2; AAG03000).
FT                                {ECO:0000305}.
FT   CONFLICT    700    700       F -> L (in Ref. 8; AAI44101).
FT                                {ECO:0000305}.
FT   CONFLICT   1039   1039       H -> R (in Ref. 2; AAG03000).
FT                                {ECO:0000305}.
FT   STRAND       39     42       {ECO:0000244|PDB:5FFG}.
FT   TURN         45     50       {ECO:0000244|PDB:5FFG}.
FT   STRAND       51     56       {ECO:0000244|PDB:5FFG}.
FT   STRAND       60     62       {ECO:0000244|PDB:4UM9}.
FT   STRAND       65     70       {ECO:0000244|PDB:5FFG}.
FT   STRAND       85     95       {ECO:0000244|PDB:5FFG}.
FT   STRAND       97    100       {ECO:0000244|PDB:5FFG}.
FT   STRAND      109    111       {ECO:0000244|PDB:5FFG}.
FT   STRAND      114    118       {ECO:0000244|PDB:5FFG}.
FT   STRAND      126    131       {ECO:0000244|PDB:5FFG}.
FT   STRAND      134    139       {ECO:0000244|PDB:5FFG}.
FT   STRAND      147    150       {ECO:0000244|PDB:5FFG}.
FT   STRAND      157    162       {ECO:0000244|PDB:5FFG}.
FT   STRAND      165    169       {ECO:0000244|PDB:5FFG}.
FT   STRAND      174    176       {ECO:0000244|PDB:5FFG}.
FT   TURN        178    184       {ECO:0000244|PDB:5FFG}.
FT   STRAND      189    193       {ECO:0000244|PDB:5FFG}.
FT   STRAND      197    203       {ECO:0000244|PDB:5FFG}.
FT   HELIX       206    209       {ECO:0000244|PDB:5FFG}.
FT   STRAND      211    217       {ECO:0000244|PDB:5FFG}.
FT   HELIX       218    223       {ECO:0000244|PDB:5FFG}.
FT   STRAND      235    239       {ECO:0000244|PDB:4G1E}.
FT   HELIX       245    247       {ECO:0000244|PDB:5FFG}.
FT   STRAND      254    259       {ECO:0000244|PDB:5FFG}.
FT   STRAND      261    266       {ECO:0000244|PDB:5FFG}.
FT   STRAND      268    273       {ECO:0000244|PDB:5FFG}.
FT   HELIX       276    279       {ECO:0000244|PDB:5FFG}.
FT   STRAND      282    286       {ECO:0000244|PDB:5FFG}.
FT   TURN        288    290       {ECO:0000244|PDB:5FFG}.
FT   STRAND      293    298       {ECO:0000244|PDB:5FFG}.
FT   STRAND      308    313       {ECO:0000244|PDB:5FFG}.
FT   STRAND      316    319       {ECO:0000244|PDB:5FFG}.
FT   STRAND      322    327       {ECO:0000244|PDB:5FFG}.
FT   STRAND      331    333       {ECO:0000244|PDB:5FFG}.
FT   STRAND      335    337       {ECO:0000244|PDB:4G1M}.
FT   STRAND      339    341       {ECO:0000244|PDB:5FFG}.
FT   STRAND      344    350       {ECO:0000244|PDB:5FFG}.
FT   STRAND      352    354       {ECO:0000244|PDB:3IJE}.
FT   STRAND      356    362       {ECO:0000244|PDB:5FFG}.
FT   STRAND      364    368       {ECO:0000244|PDB:1JV2}.
FT   HELIX       370    372       {ECO:0000244|PDB:1U8C}.
FT   STRAND      374    378       {ECO:0000244|PDB:5FFG}.
FT   STRAND      383    385       {ECO:0000244|PDB:5FFG}.
FT   STRAND      387    392       {ECO:0000244|PDB:5FFG}.
FT   HELIX       397    399       {ECO:0000244|PDB:5FFG}.
FT   STRAND      402    409       {ECO:0000244|PDB:5FFG}.
FT   STRAND      410    413       {ECO:0000244|PDB:4UM8}.
FT   STRAND      418    422       {ECO:0000244|PDB:5FFG}.
FT   STRAND      428    430       {ECO:0000244|PDB:4UM9}.
FT   STRAND      436    442       {ECO:0000244|PDB:5FFG}.
FT   STRAND      447    449       {ECO:0000244|PDB:5FFG}.
FT   STRAND      451    456       {ECO:0000244|PDB:5FFG}.
FT   HELIX       457    459       {ECO:0000244|PDB:5FFG}.
FT   STRAND      461    465       {ECO:0000244|PDB:5FFG}.
FT   STRAND      470    485       {ECO:0000244|PDB:5FFG}.
FT   STRAND      494    499       {ECO:0000244|PDB:3IJE}.
FT   STRAND      502    512       {ECO:0000244|PDB:5FFG}.
FT   STRAND      514    516       {ECO:0000244|PDB:5FFG}.
FT   STRAND      519    528       {ECO:0000244|PDB:5FFG}.
FT   TURN        529    532       {ECO:0000244|PDB:5FFG}.
FT   STRAND      535    537       {ECO:0000244|PDB:4G1M}.
FT   STRAND      541    543       {ECO:0000244|PDB:5FFG}.
FT   TURN        544    546       {ECO:0000244|PDB:5FFG}.
FT   STRAND      547    558       {ECO:0000244|PDB:5FFG}.
FT   STRAND      559    561       {ECO:0000244|PDB:4MMY}.
FT   STRAND      564    572       {ECO:0000244|PDB:5FFG}.
FT   HELIX       575    577       {ECO:0000244|PDB:5FFG}.
FT   STRAND      585    593       {ECO:0000244|PDB:5FFG}.
FT   TURN        595    597       {ECO:0000244|PDB:4UM9}.
FT   STRAND      601    603       {ECO:0000244|PDB:4G1E}.
FT   STRAND      610    612       {ECO:0000244|PDB:5FFG}.
FT   STRAND      614    623       {ECO:0000244|PDB:5FFG}.
FT   TURN        627    630       {ECO:0000244|PDB:3IJE}.
FT   STRAND      636    641       {ECO:0000244|PDB:3IJE}.
FT   STRAND      646    648       {ECO:0000244|PDB:3IJE}.
FT   STRAND      653    663       {ECO:0000244|PDB:3IJE}.
FT   STRAND      668    670       {ECO:0000244|PDB:3IJE}.
FT   STRAND      672    676       {ECO:0000244|PDB:3IJE}.
FT   STRAND      681    686       {ECO:0000244|PDB:3IJE}.
FT   STRAND      691    693       {ECO:0000244|PDB:4G1E}.
FT   STRAND      697    701       {ECO:0000244|PDB:3IJE}.
FT   STRAND      703    705       {ECO:0000244|PDB:3IJE}.
FT   STRAND      708    712       {ECO:0000244|PDB:3IJE}.
FT   STRAND      715    717       {ECO:0000244|PDB:3IJE}.
FT   STRAND      722    731       {ECO:0000244|PDB:3IJE}.
FT   STRAND      735    737       {ECO:0000244|PDB:4G1E}.
FT   STRAND      739    748       {ECO:0000244|PDB:3IJE}.
FT   STRAND      752    754       {ECO:0000244|PDB:3IJE}.
FT   STRAND      760    767       {ECO:0000244|PDB:3IJE}.
FT   STRAND      772    786       {ECO:0000244|PDB:3IJE}.
FT   TURN        798    802       {ECO:0000244|PDB:3IJE}.
FT   STRAND      805    814       {ECO:0000244|PDB:3IJE}.
FT   STRAND      816    818       {ECO:0000244|PDB:3IJE}.
FT   STRAND      820    833       {ECO:0000244|PDB:3IJE}.
FT   STRAND      839    856       {ECO:0000244|PDB:3IJE}.
FT   STRAND      900    902       {ECO:0000244|PDB:3IJE}.
FT   TURN        904    906       {ECO:0000244|PDB:3IJE}.
FT   STRAND      907    916       {ECO:0000244|PDB:3IJE}.
FT   STRAND      923    933       {ECO:0000244|PDB:3IJE}.
FT   HELIX       935    938       {ECO:0000244|PDB:3IJE}.
FT   STRAND      941    944       {ECO:0000244|PDB:3IJE}.
FT   STRAND      948    960       {ECO:0000244|PDB:3IJE}.
FT   STRAND      964    966       {ECO:0000244|PDB:4G1E}.
FT   STRAND      971    982       {ECO:0000244|PDB:3IJE}.
SQ   SEQUENCE   1048 AA;  116038 MW;  364EE25C5303A2D7 CRC64;
     MAFPPRRRLR LGPRGLPLLL SGLLLPLCRA FNLDVDSPAE YSGPEGSYFG FAVDFFVPSA
     SSRMFLLVGA PKANTTQPGI VEGGQVLKCD WSSTRRCQPI EFDATGNRDY AKDDPLEFKS
     HQWFGASVRS KQDKILACAP LYHWRTEMKQ EREPVGTCFL QDGTKTVEYA PCRSQDIDAD
     GQGFCQGGFS IDFTKADRVL LGGPGSFYWQ GQLISDQVAE IVSKYDPNVY SIKYNNQLAT
     RTAQAIFDDS YLGYSVAVGD FNGDGIDDFV SGVPRAARTL GMVYIYDGKN MSSLYNFTGE
     QMAAYFGFSV AATDINGDDY ADVFIGAPLF MDRGSDGKLQ EVGQVSVSLQ RASGDFQTTK
     LNGFEVFARF GSAIAPLGDL DQDGFNDIAI AAPYGGEDKK GIVYIFNGRS TGLNAVPSQI
     LEGQWAARSM PPSFGYSMKG ATDIDKNGYP DLIVGAFGVD RAILYRARPV ITVNAGLEVY
     PSILNQDNKT CSLPGTALKV SCFNVRFCLK ADGKGVLPRK LNFQVELLLD KLKQKGAIRR
     ALFLYSRSPS HSKNMTISRG GLMQCEELIA YLRDESEFRD KLTPITIFME YRLDYRTAAD
     TTGLQPILNQ FTPANISRQA HILLDCGEDN VCKPKLEVSV DSDQKKIYIG DDNPLTLIVK
     AQNQGEGAYE AELIVSIPLQ ADFIGVVRNN EALARLSCAF KTENQTRQVV CDLGNPMKAG
     TQLLAGLRFS VHQQSEMDTS VKFDLQIQSS NLFDKVSPVV SHKVDLAVLA AVEIRGVSSP
     DHVFLPIPNW EHKENPETEE DVGPVVQHIY ELRNNGPSSF SKAMLHLQWP YKYNNNTLLY
     ILHYDIDGPM NCTSDMEINP LRIKISSLQT TEKNDTVAGQ GERDHLITKR DLALSEGDIH
     TLGCGVAQCL KIVCQVGRLD RGKSAILYVK SLLWTETFMN KENQNHSYSL KSSASFNVIE
     FPYKNLPIED ITNSTLVTTN VTWGIQPAPM PVPVWVIILA VLAGLLLLAV LVFVMYRMGF
     FKRVRPPQEE QEREQLQPHE NGEGNSET
//
ID   M21D2_HUMAN             Reviewed;         491 AA.
AC   Q8IYB1; Q86VD8;
DT   13-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2006, sequence version 3.
DT   25-APR-2018, entry version 115.
DE   RecName: Full=Protein MB21D2;
DE   AltName: Full=Mab-21 domain-containing protein 2;
GN   Name=MB21D2; Synonyms=C3orf59;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Hippocampus, Liver, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 76-126; 231-242; 326-333; 424-430 AND 457-468, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Hepatoma;
RA   Bienvenut W.V., Dhillon A.S., Kolch W.;
RL   Submitted (FEB-2008) to UniProtKB.
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- INTERACTION:
CC       Q9UP95:SLC12A4; NbExp=4; IntAct=EBI-11323212, EBI-7244836;
CC   -!- SIMILARITY: Belongs to the mab-21 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH13123.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH45582.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC090025; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117416; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC013123; AAH13123.1; ALT_INIT; mRNA.
DR   EMBL; BC036194; AAH36194.3; -; mRNA.
DR   EMBL; BC045582; AAH45582.1; ALT_INIT; mRNA.
DR   CCDS; CCDS3302.2; -.
DR   RefSeq; NP_848591.2; NM_178496.3.
DR   UniGene; Hs.151443; -.
DR   ProteinModelPortal; Q8IYB1; -.
DR   SMR; Q8IYB1; -.
DR   BioGrid; 127413; 28.
DR   IntAct; Q8IYB1; 28.
DR   MINT; Q8IYB1; -.
DR   STRING; 9606.ENSP00000376246; -.
DR   iPTMnet; Q8IYB1; -.
DR   PhosphoSitePlus; Q8IYB1; -.
DR   BioMuta; MB21D2; -.
DR   EPD; Q8IYB1; -.
DR   MaxQB; Q8IYB1; -.
DR   PaxDb; Q8IYB1; -.
DR   PeptideAtlas; Q8IYB1; -.
DR   PRIDE; Q8IYB1; -.
DR   Ensembl; ENST00000392452; ENSP00000376246; ENSG00000180611.
DR   GeneID; 151963; -.
DR   KEGG; hsa:151963; -.
DR   UCSC; uc011bsp.3; human.
DR   CTD; 151963; -.
DR   DisGeNET; 151963; -.
DR   EuPathDB; HostDB:ENSG00000180611.6; -.
DR   GeneCards; MB21D2; -.
DR   HGNC; HGNC:30438; MB21D2.
DR   HPA; HPA044026; -.
DR   neXtProt; NX_Q8IYB1; -.
DR   OpenTargets; ENSG00000180611; -.
DR   PharmGKB; PA143485335; -.
DR   eggNOG; KOG3963; Eukaryota.
DR   eggNOG; ENOG410XNRJ; LUCA.
DR   GeneTree; ENSGT00530000063769; -.
DR   HOVERGEN; HBG081021; -.
DR   InParanoid; Q8IYB1; -.
DR   OMA; EGTINKW; -.
DR   OrthoDB; EOG091G06D0; -.
DR   PhylomeDB; Q8IYB1; -.
DR   TreeFam; TF329089; -.
DR   ChiTaRS; MB21D2; human.
DR   GenomeRNAi; 151963; -.
DR   PRO; PR:Q8IYB1; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000180611; -.
DR   CleanEx; HS_C3orf59; -.
DR   Genevisible; Q8IYB1; HS.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:MGI.
DR   InterPro; IPR024810; Mab-21_dom.
DR   Pfam; PF03281; Mab-21; 1.
DR   SMART; SM01265; Mab-21; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Direct protein sequencing; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN         1    491       Protein MB21D2.
FT                                /FTId=PRO_0000239303.
FT   MOD_RES     435    435       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q8C525}.
FT   MOD_RES     436    436       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8C525}.
FT   MOD_RES     439    439       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8C525}.
FT   MOD_RES     442    442       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8C525}.
SQ   SEQUENCE   491 AA;  55800 MW;  7AF79038FE3D4534 CRC64;
     MKMAAPTANK AASLGCNNKP AFPELDFRSG ARVEELNKLI QEFTKHDQRE YDDQRALEIH
     TAKDFIFSML GMVQKLDQKL PVANEYLLLS GGVREGVVDL DLDELNVYAR GTDYDMDFTL
     LVPALKLHDR NQPVTLDMRH SALCHSWLSL RLFDEGTISK WKDCCTIVDH INGATNYFFS
     PTKVADWFYD SISIVLSEIQ KKPQRGMPKV EKVEKNGTII SIILGVGSSR MLYDIVPVVS
     FKGWPAVAQS WLMENHFWDG KITEEEVISG FYLVPACSYK GKKDNEWRLS FARSEVQLKK
     CISSSLMQAY QACKAIIIKL LSRPKAISPY HLRSMMLWAC DRLPANYLAQ EDYAAHFLLG
     LIDDLQHCLV NKMCPNYFIP QCNMLEHLSE ETVMLHARKL SSVRSDPAEH LRTAIEHVKA
     ANRLTLELQR RGSTTSIPSP QSDGGDPNQP DDRLAKKLQQ LVTENPGKSI SVFINPDDVT
     RPHFRIDDKF F
//
ID   B3KXQ8_HUMAN            Unreviewed;      1558 AA.
AC   B3KXQ8;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   28-MAR-2018, entry version 66.
DE   SubName: Full=cDNA FLJ45892 fis, clone OCBBF3023175, highly similar to Protein neurobeachin {ECO:0000313|EMBL:BAG54570.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG54570.1};
RN   [1] {ECO:0000313|EMBL:BAG54570.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG54570.1};
RA   Ota T., Nakagawa S., Senoh A., Mizuguchi H., Inagaki H., Sugiyama T.,
RA   Irie R., Otsuki T., Sato H., Wakamatsu A., Ishii S., Yamamoto J.,
RA   Isono Y., Kawai-Hio Y., Saito K., Nishikawa T., Kimura K.,
RA   Yamashita H., Matsuo K., Nakamura Y., Sekine M., Kikuchi H., Kanda K.,
RA   Wagatsuma M., Murakawa K., Kanehori K., Takahashi-Fujii A., Oshima A.,
RA   Sugiyama A., Kawakami B., Suzuki Y., Sugano S., Nagahari K.,
RA   Masuho Y., Nagai K., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK127791; BAG54570.1; -; mRNA.
DR   RefSeq; NP_056493.3; NM_015678.4.
DR   UniGene; Hs.491172; -.
DR   ProteinModelPortal; B3KXQ8; -.
DR   PeptideAtlas; B3KXQ8; -.
DR   PRIDE; B3KXQ8; -.
DR   GeneID; 26960; -.
DR   KEGG; hsa:26960; -.
DR   CTD; 26960; -.
DR   PharmGKB; PA31454; -.
DR   eggNOG; KOG1786; Eukaryota.
DR   eggNOG; ENOG410XNQC; LUCA.
DR   HOGENOM; HOG000082375; -.
DR   HOVERGEN; HBG059380; -.
DR   SignaLink; B3KXQ8; -.
DR   GenomeRNAi; 26960; -.
DR   Genevisible; B3KXQ8; HS.
DR   CDD; cd06071; Beach; 1.
DR   CDD; cd01201; PH_BEACH; 1.
DR   Gene3D; 1.10.1540.10; -; 1.
DR   InterPro; IPR000409; BEACH_dom.
DR   InterPro; IPR036372; BEACH_dom_sf.
DR   InterPro; IPR010508; DUF1088.
DR   InterPro; IPR023362; PH-BEACH_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   Pfam; PF02138; Beach; 1.
DR   Pfam; PF06469; DUF1088; 1.
DR   Pfam; PF14844; PH_BEACH; 1.
DR   SMART; SM01026; Beach; 1.
DR   SMART; SM00320; WD40; 5.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   SUPFAM; SSF81837; SSF81837; 1.
DR   PROSITE; PS50197; BEACH; 1.
DR   PROSITE; PS51783; PH_BEACH; 1.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP};
KW   WD repeat {ECO:0000256|PROSITE-ProRule:PRU00221}.
FT   SIGNAL        1     18       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        19   1558       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002790421.
FT   DOMAIN      759    867       BEACH-type PH.
FT                                {ECO:0000259|PROSITE:PS51783}.
FT   DOMAIN      886   1175       BEACH. {ECO:0000259|PROSITE:PS50197}.
FT   DOMAIN     1470   1553       WD_REPEATS_REGION.
FT                                {ECO:0000259|PROSITE:PS50294}.
SQ   SEQUENCE   1558 AA;  173087 MW;  77F416F15A881CB4 CRC64;
     MVDNIIIACG GILPLLSAAT SPTGSKTELE NIEVTQGMSA ETAVTFLSRL MAMVDVLVFA
     SSLNFSEIEA EKNMSSGGLM RQCLRLVCCV AVRNCLECRQ RQRDRGNKSS HGSSKPQEVP
     QSVTATAASK TPLENVPGNL SPIKDPDRLL QDVDINRLRA VVFRDVDDSK QAQFLALAVV
     YFISVLMVSK YRDILEPQRE TTRTGSQPGR NIRQEINSPT STVVVIPSIP HPSLNHGFLA
     KLIPEQSFGH SFYKETPAAF PDTIKEKETP TPGEDIQVES SIPHTDSGIG EEQVASILNG
     AELETSTGPD AMSELLSTLS SEVKKSQESL TENPSETLKP ATSISSISQT KGINVKEILK
     SLVAAPVEIA ECGPEPIPYP DPALKRETQA ILPMQFHSFD RSVVVPVKKP PPGSLAVTTV
     GATTAGSGLP TGSTSNIFAA TGATPKSMIN TTGAVDSGSS SSSSSSSFVN GATSKNLPAV
     QTVAPMPEDS AENMSITAKL ERALEKVAPL LREIFVDFAP FLSRTLLGSH GQELLIEGLV
     CMKSSTSVVE LVMLLCSQEW QNSIQKNAGL AFIELINEGR LLCHAMKDHI VRVANEAEFI
     LNRQRAEDVH KHAEFESQCA QYAADRREEE KMCDHLISAA KHRDHVTANQ LKQKILNILT
     NKHGAWGAVS HSQLHDFWRL DYWEDDLRRR RRFVRNAFGS THAEALLKAA IEYGTEEDVV
     KSKKTFRSQA IVNQNAETEL MLEGDDDAVS LLQEKEIDNL AGPVVLSTPA QLIAPVVVAK
     GTLSITTTEI YFEVDEDDSA FKKIDTKVLA YTEGLHGKWM FSEIRAVFSR RYLLQNTALE
     VFMANRTSVM FNFPGQATVK KVVYSLPRVG VGTSYGLPQA RRISLATPRQ LYKSSNMTQR
     WQRREISNFE YLMFLNTIAG RTYNDLNQYP VFPWVLTNYE SEELDLTLPG NFRDLSKPIG
     ALNPKRAVFY AERYETWEDD QSPPYHYNTH YSTATSTLSW LVRIEPFTTF FLNANDGKFD
     HPDRTFSSVA RSWRTSQRDT SDVKELIPEF YYLPEMFVNS NGYNLGVRED EVVVNDVDLP
     PWAKKPEDFV RINRMALESE FVSCQLHQWI DLIFGYKQRG PEAVRALNVF HYLTYEGSVN
     LDSITDPVLR EAMEAQIQNF GQTPSQLLIE PHPPRSSAMH LCFLPQSPLM FKDQMQQDVI
     MVLKFPSNSP VTHVAANTLP HLTIPAVVTV TCSRLFAVNR WHNTVGLRGA PGYSLDQAHH
     LPIEMDPLIA NNSGVNKRQI TDLVDQSIQI NAHCFVVTAD NRYILICGFW DKSFRVYSTE
     TGKLTQIVFG HWDVVTCLAR SESYIGGDCY IVSGSRDATL LLWYWSGRHH IIGDNPNSSD
     YPAPRAVLTG YDHEVVCVSV CAELGLVISG AKEGPCLVHT ITGDLLRALE GPENCLFPRL
     ISVSSEGHCI IYYERGRFSN FSINGKLLAQ MEINDSTRAI LLSSDGQNLV TGGDNGVVEV
     WQACDFKQLY IYPGCDAGIR AMDLSHDQRT LITGMASGSI VAFNIDFNRW HYEHQNRY
//
ID   Q5T321_HUMAN            Unreviewed;      2943 AA.
AC   Q5T321;
DT   05-FEB-2008, integrated into UniProtKB/TrEMBL.
DT   05-FEB-2008, sequence version 1.
DT   25-APR-2018, entry version 106.
DE   SubName: Full=Neurobeachin {ECO:0000313|Ensembl:ENSP00000369271};
DE   SubName: Full=Neurobeachin, isoform CRA_e {ECO:0000313|EMBL:EAX08545.1};
GN   Name=NBEA {ECO:0000313|EMBL:EAX08545.1,
GN   ECO:0000313|Ensembl:ENSP00000369271};
GN   ORFNames=hCG_2019985 {ECO:0000313|EMBL:EAX08545.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000369271, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAX08545.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [3] {ECO:0000313|Ensembl:ENSP00000369271}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4] {ECO:0000313|EMBL:EAX08545.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [6] {ECO:0000313|Ensembl:ENSP00000369271}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL138690; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL139083; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL159160; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL161718; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL161902; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356430; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL357083; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL390071; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471075; EAX08545.1; -; Genomic_DNA.
DR   RefSeq; XP_006719869.1; XM_006719806.3.
DR   UniGene; Hs.491172; -.
DR   MaxQB; Q5T321; -.
DR   Ensembl; ENST00000379939; ENSP00000369271; ENSG00000172915.
DR   GeneID; 26960; -.
DR   UCSC; uc021ric.2; human.
DR   CTD; 26960; -.
DR   EuPathDB; HostDB:ENSG00000172915.18; -.
DR   HGNC; HGNC:7648; NBEA.
DR   OpenTargets; ENSG00000172915; -.
DR   eggNOG; KOG1786; Eukaryota.
DR   eggNOG; ENOG410XNQC; LUCA.
DR   GeneTree; ENSGT00760000119083; -.
DR   HOGENOM; HOG000082375; -.
DR   HOVERGEN; HBG012582; -.
DR   ChiTaRS; NBEA; human.
DR   GenomeRNAi; 26960; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000172915; -.
DR   CDD; cd06071; Beach; 1.
DR   CDD; cd01201; PH_BEACH; 1.
DR   Gene3D; 1.10.1540.10; -; 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000409; BEACH_dom.
DR   InterPro; IPR036372; BEACH_dom_sf.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR010508; DUF1088.
DR   InterPro; IPR031570; DUF4704.
DR   InterPro; IPR023362; PH-BEACH_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   Pfam; PF02138; Beach; 1.
DR   Pfam; PF06469; DUF1088; 1.
DR   Pfam; PF15787; DUF4704; 1.
DR   Pfam; PF14844; PH_BEACH; 1.
DR   SMART; SM01026; Beach; 1.
DR   SMART; SM00320; WD40; 5.
DR   SUPFAM; SSF48371; SSF48371; 2.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   SUPFAM; SSF81837; SSF81837; 1.
DR   PROSITE; PS50197; BEACH; 1.
DR   PROSITE; PS51783; PH_BEACH; 1.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:Q5T321,
KW   ECO:0000213|PeptideAtlas:Q5T321};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   WD repeat {ECO:0000256|PROSITE-ProRule:PRU00221}.
FT   DOMAIN     2144   2252       BEACH-type PH.
FT                                {ECO:0000259|PROSITE:PS51783}.
FT   DOMAIN     2271   2560       BEACH. {ECO:0000259|PROSITE:PS50197}.
FT   DOMAIN     2855   2938       WD_REPEATS_REGION.
FT                                {ECO:0000259|PROSITE:PS50294}.
FT   COILED      951    971       {ECO:0000256|SAM:Coils}.
FT   NON_TER    2943   2943       {ECO:0000313|EMBL:EAX08545.1}.
SQ   SEQUENCE   2943 AA;  327549 MW;  154F518F5D9C2527 CRC64;
     MASEKPGPGP GLEPQPVGLI AVGAAGGGGG GSGGGGTGGS GMGELRGASG SGSVMLPAGM
     INPSVPIRNI RMKFAVLIGL IQVGEVSNRD IVETVLNLLV GGEFDLEMNF IIQDAESITC
     MTELLEHCDV TCQAEIWSMF TAILRKSVRN LQTSTEVGLI EQVLLKMSAV DDMIADLLVD
     MLGVLASYSI TVKELKLLFS MLRGESGIWP RHAVKLLSVL NQMPQRHGPD TFFNFPGCSA
     AAIALPPIAK WPYQNGFTLN TWFRMDPLNN INVDKDKPYL YCFRTSKGVG YSAHFVGNCL
     IVTSLKSKGK GFQHCVKYDF QPRKWYMISI VHIYNRWRNS EIRCYVNGQL VSYGDMAWHV
     NTNDSYDKCF LGSSETADAN RVFCGQLGAV YVFSEALNPA QIFAIHQLGP GYKSTFKFKS
     ESDIHLAEHH KQVLYDGKLA SSIAFTYNAK ATDAQLCLES SPKENASIFV HSPHALMLQD
     VKAIVTHSIH SAIHSIGGIQ VLFPLFAQLD NRQLNDSQVE TTVCATLLAF LVELLKSSVA
     MQEQMLGGKG FLVIGYLLEK SSRVHITRAV LEQFLSFAKY LDGLSHGAPL LKQLCDHILF
     NPAIWIHTPA KVQLSLYTYL SAEFIGTATI YTTIRRVGTV LQLMHTLKYY YWVINPADSS
     GITPKGLDGP RPSQKEIISL RAFMLLFLKQ LILKDRGVKE DELQSILNYL LTMHEDENIH
     DVLQLLVALM SEHPASMIPA FDQRNGIRVI YKLLASKSES IWVQALKVLG YFLKHLGHKR
     KVEIMHTHSL FTLLGERLML HTNTVTVTTY NTLYEILTEQ VCTQVVHKPH PEPDSTVKIQ
     NPMILKVVAT LLKNSTPSAE LMEVRRLFLS DMIKLFSNSR ENRRCLLQCS VWQDWMFSLG
     YINPKNSEEQ KITEMVYNIF RILLYHAIKY EWGGWRVWVD TLSIAHSKVT YEAHKEYLAK
     MYEEYQRQEE ENIKKGKKGN VSTISGLSSQ TTGAKGGMEI REIEDLSQSQ SPESETDYPV
     STDTRDLLMS TKVSDDILGN SDRPGSGVHV EVHDLLVDIK AEKVEATEVK LDDMDLSPET
     LVGGENGALV EVESLLDNVY SAAVEKLQNN VHGSVGIIKK NEEKDNGPLI TLADEKEDLP
     NSSTSFLFDK IPKQEEKLLP ELSSNHIIPN IQDTQVHLGV SDDLGLLAHM TGSVDLTCTS
     SIIEEKEFKI HTTSDGMSSI SERDLASSTK GLEYAEMTAT TLETESSSSK IVPNIDAGSI
     ISDTERSDDG KESGKEIRKI QTTTTTQAVQ GRSITQQDRD LRVDLGFRGM PMTEEQRRQF
     SPGPRTTMFR IPEFKWSPMH QRLLTDLLFA LETDVHVWRS HSTKSVMDFV NSNENIIFVH
     NTIHLISQMV DNIIIACGGI LPLLSAATSP TTELENIEVT QGMSAETAVT FLSRLMAMVD
     VLVFASSLNF SEIEAEKNMS SGGLMRQCLR LVCCVAVRNC LECRQRQRDR GNKSSHGSSK
     PQEVPQSVTA TAASKTPLEN VPGNLSPIKD PDRLLQDVDI NRLRAVVFRD VDDSKQAQFL
     ALAVVYFISV LMVSKYRDIL EPQRETTRTG SQPGRNIRQE INSPTSTVVV IPSIPHPSLN
     HGFLAKLIPE QSFGHSFYKE TPAAFPDTIK EKETPTPGED IQVESSIPHT DSGIGEEQVA
     SILNGAELET STGPDAMSEL LSTLSSEVKK SQESLTENPS ETLKPATSIS SISQTKGINV
     KEILKSLVAA PVEIAECGPE PIPYPDPALK RETQAILPMQ FHSFDRSVVV PVKKPPPGSL
     AVTTVGATTA GSGLPTGSTS NIFAATGATP KSMINTTGAV DSGSSSSSSS SSFVNGATSK
     NLPAVQTVAP MPEDSAENMS ITAKLERALE KVAPLLREIF VDFAPFLSRT LLGSHGQELL
     IEGLVCMKSS TSVVELVMLL CSQEWQNSIQ KNAGLAFIEL INEGRLLCHA MKDHIVRVAN
     EAEFILNRQR AEDVHKHAEF ESQCAQYAAD RREEEKMCDH LISAAKHRDH VTANQLKQKI
     LNILTNKHGA WGAVSHSQLH DFWRLDYWED DLRRRRRFVR NAFGSTHAEA LLKAAIEYGT
     EEDVVKSKKT FRSQAIVNQN AETELMLEGD DDAVSLLQEK EIDNLAGPVV LSTPAQLIAP
     VVVAKGTLSI TTTEIYFEVD EDDSAFKKID TKVLAYTEGL HGKWMFSEIR AVFSRRYLLQ
     NTALEVFMAN RTSVMFNFPD QATVKKVVYS LPRVGVGTSY GLPQARRISL ATPRQLYKSS
     NMTQRWQRRE ISNFEYLMFL NTIAGRTYND LNQYPVFPWV LTNYESEELD LTLPGNFRDL
     SKPIGALNPK RAVFYAERYE TWEDDQSPPY HYNTHYSTAT STLSWLVRIE PFTTFFLNAN
     DGKFDHPDRT FSSVARSWRT SQRDTSDVKE LIPEFYYLPE MFVNSNGYNL GVREDEVVVN
     DVDLPPWAKK PEDFVRINRM ALESEFVSCQ LHQWIDLIFG YKQRGPEAVR ALNVFHYLTY
     EGSVNLDSIT DPVLREAMEA QIQNFGQTPS QLLIEPHPPR SSAMHLCFLP QSPLMFKDQM
     QQDVIMVLKF PSNSPVTHVA ANTLPHLTIP AVVTVTCSRL FAVNRWHNTV GLRGAPGYSL
     DQAHHLPIEM DPLIANNSGV NKRQITDLVD QSIQINAHCF VVTADNRYIL ICGFWDKSFR
     VYSTETGKLT QIVFGHWDVV TCLARSESYI GGDCYIVSGS RDATLLLWYW SGRHHIIGDN
     PNSSDYPAPR AVLTGHDHEV VCVSVCAELG LVISGAKEGP CLVHTITGDL LRALEGPENC
     LFPRLISVSS EGHCIIYYER GRFSNFSING KLLAQMEIND STRAILLSSD GQNLVTGGDN
     GVVEVWQACD FKQLYIYPGC DAGIRAMDLS HDQRTLITGM ASGSIVAFNI DFNRWHYEHQ
     NRY
//
ID   NBEA_HUMAN              Reviewed;        2946 AA.
AC   Q8NFP9; B7Z2H9; Q5T320; Q9HCM8; Q9NSU1; Q9NW98; Q9Y6J1;
DT   20-JUN-2003, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   28-MAR-2018, entry version 159.
DE   RecName: Full=Neurobeachin;
DE   AltName: Full=Lysosomal-trafficking regulator 2;
DE   AltName: Full=Protein BCL8B;
GN   Name=NBEA; Synonyms=BCL8B, KIAA1544, LYST2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAM53531.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain {ECO:0000269|PubMed:12160729}, and
RC   Spleen {ECO:0000269|PubMed:12160729};
RX   PubMed=12160729; DOI=10.1006/geno.2002.6822;
RA   Dyomin V.G., Chaganti S.R., Dyomina K., Palanisamy N., Murty V.V.V.S.,
RA   Dalla-Favera R., Chaganti R.S.K.;
RT   "BCL8 is a novel, evolutionarily conserved human gene family encoding
RT   proteins with presumptive protein kinase A anchoring function.";
RL   Genomics 80:158-165(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 606-1118 (ISOFORMS 1/2).
RC   TISSUE=Brain, and Embryonic head;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1919-2946 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes.
RT   XVIII. The complete sequences of 100 new cDNA clones from brain which
RT   code for large proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2393-2946 (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2428-2946 (ISOFORM 1).
RA   Tchernev V.T., McMurtrie E.B., Nguyen Q.A., Mishra V.S.,
RA   Barbosa M.D.F.S., McIndoe R., Kingsmore S.F.;
RT   "Identification of LYST2, a brain-specific member of the Chediak-
RT   Higashi syndrome gene family.";
RL   Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [8] {ECO:0000305}
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 2150-2563.
RX   PubMed=12234919; DOI=10.1093/emboj/cdf502;
RA   Jogl G., Shen Y., Gebauer D., Li J., Wiegmann K., Kashkar H.,
RA   Kroenke M., Tong L.;
RT   "Crystal structure of the BEACH domain reveals an unusual fold and
RT   extensive association with a novel PH domain.";
RL   EMBO J. 21:4785-4795(2002).
CC   -!- FUNCTION: Binds to type II regulatory subunits of protein kinase A
CC       and anchors/targets them to the membrane. May anchor the kinase to
CC       cytoskeletal and/or organelle-associated proteins (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with RII subunit of PKA.
CC       {ECO:0000250|UniProtKB:Q9EPN1}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane
CC       {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1 {ECO:0000305};
CC         IsoId=Q8NFP9-1; Sequence=Displayed;
CC       Name=2 {ECO:0000305};
CC         IsoId=Q8NFP9-2; Sequence=VSP_050538, VSP_050539;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=3;
CC         IsoId=Q8NFP9-3; Sequence=VSP_046397;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Predominant in many brain structures. Also
CC       expressed at medium levels in spleen, thymus, prostate, testis and
CC       ovary. Low level expression is seen in heart, kidney, pancreas,
CC       skeletal muscle and intestine. {ECO:0000269|PubMed:12160729}.
CC   -!- DOMAIN: RII-alpha binding site, predicted to form an amphipathic
CC       helix, could participate in protein-protein interactions with a
CC       complementary surface on the R-subunit dimer.
CC       {ECO:0000250|UniProtKB:Q9EPN1}.
CC   -!- SIMILARITY: Belongs to the WD repeat neurobeachin family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD41633.1; Type=Frameshift; Positions=2900; Evidence={ECO:0000305};
CC       Sequence=BAA91485.1; Type=Erroneous termination; Positions=762; Note=Translated as Trp.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF467288; AAM53531.1; -; mRNA.
DR   EMBL; AL138690; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK001059; BAA91485.1; ALT_SEQ; mRNA.
DR   EMBL; AK294737; BAH11865.1; -; mRNA.
DR   EMBL; AL139083; CAH71883.1; -; Genomic_DNA.
DR   EMBL; AL390071; CAH71883.1; JOINED; Genomic_DNA.
DR   EMBL; AL159160; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL161718; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL161902; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356430; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL357083; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL390071; CAI17183.1; -; Genomic_DNA.
DR   EMBL; AL139083; CAI17183.1; JOINED; Genomic_DNA.
DR   EMBL; AB046764; BAB13370.1; -; mRNA.
DR   EMBL; AL137748; CAB70903.2; -; mRNA.
DR   EMBL; AF072371; AAD41633.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS45026.1; -. [Q8NFP9-1]
DR   CCDS; CCDS55894.1; -. [Q8NFP9-3]
DR   PIR; T46310; T46310.
DR   RefSeq; NP_001191126.1; NM_001204197.1. [Q8NFP9-3]
DR   RefSeq; NP_056493.3; NM_015678.4. [Q8NFP9-1]
DR   UniGene; Hs.491172; -.
DR   PDB; 1MI1; X-ray; 2.90 A; A/B=2150-2563.
DR   PDBsum; 1MI1; -.
DR   ProteinModelPortal; Q8NFP9; -.
DR   SMR; Q8NFP9; -.
DR   BioGrid; 117928; 17.
DR   IntAct; Q8NFP9; 8.
DR   MINT; Q8NFP9; -.
DR   STRING; 9606.ENSP00000383295; -.
DR   iPTMnet; Q8NFP9; -.
DR   PhosphoSitePlus; Q8NFP9; -.
DR   BioMuta; NBEA; -.
DR   DMDM; 296439289; -.
DR   MaxQB; Q8NFP9; -.
DR   PaxDb; Q8NFP9; -.
DR   PeptideAtlas; Q8NFP9; -.
DR   PRIDE; Q8NFP9; -.
DR   Ensembl; ENST00000379922; ENSP00000369254; ENSG00000172915. [Q8NFP9-2]
DR   Ensembl; ENST00000400445; ENSP00000383295; ENSG00000172915. [Q8NFP9-1]
DR   Ensembl; ENST00000537702; ENSP00000440233; ENSG00000172915. [Q8NFP9-3]
DR   GeneID; 26960; -.
DR   KEGG; hsa:26960; -.
DR   UCSC; uc058wka.1; human. [Q8NFP9-1]
DR   CTD; 26960; -.
DR   DisGeNET; 26960; -.
DR   EuPathDB; HostDB:ENSG00000172915.18; -.
DR   GeneCards; NBEA; -.
DR   H-InvDB; HIX0029795; -.
DR   HGNC; HGNC:7648; NBEA.
DR   HPA; HPA039730; -.
DR   HPA; HPA040385; -.
DR   MIM; 604889; gene.
DR   neXtProt; NX_Q8NFP9; -.
DR   OpenTargets; ENSG00000172915; -.
DR   PharmGKB; PA31454; -.
DR   eggNOG; KOG1786; Eukaryota.
DR   eggNOG; ENOG410XNQC; LUCA.
DR   GeneTree; ENSGT00760000119083; -.
DR   HOGENOM; HOG000082375; -.
DR   HOVERGEN; HBG012582; -.
DR   InParanoid; Q8NFP9; -.
DR   PhylomeDB; Q8NFP9; -.
DR   TreeFam; TF313490; -.
DR   SignaLink; Q8NFP9; -.
DR   ChiTaRS; NBEA; human.
DR   EvolutionaryTrace; Q8NFP9; -.
DR   GenomeRNAi; 26960; -.
DR   PRO; PR:Q8NFP9; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000172915; -.
DR   CleanEx; HS_NBEA; -.
DR   ExpressionAtlas; Q8NFP9; baseline and differential.
DR   Genevisible; Q8NFP9; HS.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0012505; C:endomembrane system; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005802; C:trans-Golgi network; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0008104; P:protein localization; IEA:Ensembl.
DR   CDD; cd06071; Beach; 1.
DR   CDD; cd01201; PH_BEACH; 1.
DR   Gene3D; 1.10.1540.10; -; 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000409; BEACH_dom.
DR   InterPro; IPR036372; BEACH_dom_sf.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR010508; DUF1088.
DR   InterPro; IPR031570; DUF4704.
DR   InterPro; IPR023362; PH-BEACH_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   Pfam; PF02138; Beach; 1.
DR   Pfam; PF06469; DUF1088; 1.
DR   Pfam; PF15787; DUF4704; 1.
DR   Pfam; PF14844; PH_BEACH; 1.
DR   SMART; SM01026; Beach; 1.
DR   SMART; SM00320; WD40; 5.
DR   SUPFAM; SSF48371; SSF48371; 2.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   SUPFAM; SSF81837; SSF81837; 1.
DR   PROSITE; PS50197; BEACH; 1.
DR   PROSITE; PS51783; PH_BEACH; 1.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Membrane; Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   WD repeat.
FT   CHAIN         1   2946       Neurobeachin.
FT                                /FTId=PRO_0000051089.
FT   REPEAT     1326   1368       WD 1. {ECO:0000305}.
FT   DOMAIN     2147   2255       BEACH-type PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01119}.
FT   DOMAIN     2274   2563       BEACH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00026, ECO:0000305}.
FT   REPEAT     2718   2761       WD 2. {ECO:0000305}.
FT   REPEAT     2778   2818       WD 3. {ECO:0000305}.
FT   REPEAT     2860   2899       WD 4. {ECO:0000305}.
FT   REPEAT     2902   2941       WD 5. {ECO:0000305}.
FT   MOD_RES    1011   1011       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9EPN1}.
FT   MOD_RES    1014   1014       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9EPN1}.
FT   MOD_RES    1529   1529       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9EPN1}.
FT   MOD_RES    1714   1714       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9EPN1}.
FT   MOD_RES    1717   1717       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9EPN1}.
FT   MOD_RES    2138   2138       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9EPN1}.
FT   MOD_RES    2575   2575       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9EPN1}.
FT   VAR_SEQ       1   2443       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_050538.
FT   VAR_SEQ       1   2207       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046397.
FT   VAR_SEQ    2539   2539       E -> EIPEAYFIRDPHTFLLTKDFIK (in isoform
FT                                2). {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_050539.
FT   VARIANT     569    569       A -> P (in dbSNP:rs5011295).
FT                                /FTId=VAR_047658.
FT   VARIANT    2501   2501       I -> V (in dbSNP:rs11538677).
FT                                /FTId=VAR_047659.
FT   CONFLICT   1658   1658       P -> S (in Ref. 1; AAM53531).
FT                                {ECO:0000305}.
FT   CONFLICT   2564   2564       S -> N (in Ref. 6; AAD41633).
FT                                {ECO:0000305}.
FT   CONFLICT   2706   2706       S -> T (in Ref. 6; AAD41633).
FT                                {ECO:0000305}.
FT   STRAND     2154   2162       {ECO:0000244|PDB:1MI1}.
FT   STRAND     2165   2173       {ECO:0000244|PDB:1MI1}.
FT   STRAND     2175   2182       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2187   2190       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2194   2199       {ECO:0000244|PDB:1MI1}.
FT   STRAND     2206   2208       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2209   2211       {ECO:0000244|PDB:1MI1}.
FT   STRAND     2212   2220       {ECO:0000244|PDB:1MI1}.
FT   STRAND     2223   2231       {ECO:0000244|PDB:1MI1}.
FT   STRAND     2236   2240       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2244   2252       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2269   2273       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2276   2281       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2285   2290       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2296   2306       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2314   2316       {ECO:0000244|PDB:1MI1}.
FT   STRAND     2328   2331       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2337   2339       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2347   2349       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2352   2363       {ECO:0000244|PDB:1MI1}.
FT   STRAND     2374   2377       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2382   2388       {ECO:0000244|PDB:1MI1}.
FT   TURN       2389   2391       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2395   2401       {ECO:0000244|PDB:1MI1}.
FT   TURN       2402   2405       {ECO:0000244|PDB:1MI1}.
FT   TURN       2410   2412       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2417   2426       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2436   2439       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2442   2445       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2474   2485       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2488   2491       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2494   2501       {ECO:0000244|PDB:1MI1}.
FT   STRAND     2506   2508       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2509   2513       {ECO:0000244|PDB:1MI1}.
FT   TURN       2520   2522       {ECO:0000244|PDB:1MI1}.
FT   TURN       2529   2531       {ECO:0000244|PDB:1MI1}.
FT   HELIX      2535   2548       {ECO:0000244|PDB:1MI1}.
SQ   SEQUENCE   2946 AA;  327822 MW;  2E371FDA2F00781E CRC64;
     MASEKPGPGP GLEPQPVGLI AVGAAGGGGG GSGGGGTGGS GMGELRGASG SGSVMLPAGM
     INPSVPIRNI RMKFAVLIGL IQVGEVSNRD IVETVLNLLV GGEFDLEMNF IIQDAESITC
     MTELLEHCDV TCQAEIWSMF TAILRKSVRN LQTSTEVGLI EQVLLKMSAV DDMIADLLVD
     MLGVLASYSI TVKELKLLFS MLRGESGIWP RHAVKLLSVL NQMPQRHGPD TFFNFPGCSA
     AAIALPPIAK WPYQNGFTLN TWFRMDPLNN INVDKDKPYL YCFRTSKGVG YSAHFVGNCL
     IVTSLKSKGK GFQHCVKYDF QPRKWYMISI VHIYNRWRNS EIRCYVNGQL VSYGDMAWHV
     NTNDSYDKCF LGSSETADAN RVFCGQLGAV YVFSEALNPA QIFAIHQLGP GYKSTFKFKS
     ESDIHLAEHH KQVLYDGKLA SSIAFTYNAK ATDAQLCLES SPKENASIFV HSPHALMLQD
     VKAIVTHSIH SAIHSIGGIQ VLFPLFAQLD NRQLNDSQVE TTVCATLLAF LVELLKSSVA
     MQEQMLGGKG FLVIGYLLEK SSRVHITRAV LEQFLSFAKY LDGLSHGAPL LKQLCDHILF
     NPAIWIHTPA KVQLSLYTYL SAEFIGTATI YTTIRRVGTV LQLMHTLKYY YWVINPADSS
     GITPKGLDGP RPSQKEIISL RAFMLLFLKQ LILKDRGVKE DELQSILNYL LTMHEDENIH
     DVLQLLVALM SEHPASMIPA FDQRNGIRVI YKLLASKSES IWVQALKVLG YFLKHLGHKR
     KVEIMHTHSL FTLLGERLML HTNTVTVTTY NTLYEILTEQ VCTQVVHKPH PEPDSTVKIQ
     NPMILKVVAT LLKNSTPSAE LMEVRRLFLS DMIKLFSNSR ENRRCLLQCS VWQDWMFSLG
     YINPKNSEEQ KITEMVYNIF RILLYHAIKY EWGGWRVWVD TLSIAHSKVT YEAHKEYLAK
     MYEEYQRQEE ENIKKGKKGN VSTISGLSSQ TTGAKGGMEI REIEDLSQSQ SPESETDYPV
     STDTRDLLMS TKVSDDILGN SDRPGSGVHV EVHDLLVDIK AEKVEATEVK LDDMDLSPET
     LVGGENGALV EVESLLDNVY SAAVEKLQNN VHGSVGIIKK NEEKDNGPLI TLADEKEDLP
     NSSTSFLFDK IPKQEEKLLP ELSSNHIIPN IQDTQVHLGV SDDLGLLAHM TGSVDLTCTS
     SIIEEKEFKI HTTSDGMSSI SERDLASSTK GLEYAEMTAT TLETESSSSK IVPNIDAGSI
     ISDTERSDDG KESGKEIRKI QTTTTTQAVQ GRSITQQDRD LRVDLGFRGM PMTEEQRRQF
     SPGPRTTMFR IPEFKWSPMH QRLLTDLLFA LETDVHVWRS HSTKSVMDFV NSNENIIFVH
     NTIHLISQMV DNIIIACGGI LPLLSAATSP TGSKTELENI EVTQGMSAET AVTFLSRLMA
     MVDVLVFASS LNFSEIEAEK NMSSGGLMRQ CLRLVCCVAV RNCLECRQRQ RDRGNKSSHG
     SSKPQEVPQS VTATAASKTP LENVPGNLSP IKDPDRLLQD VDINRLRAVV FRDVDDSKQA
     QFLALAVVYF ISVLMVSKYR DILEPQRETT RTGSQPGRNI RQEINSPTST VVVIPSIPHP
     SLNHGFLAKL IPEQSFGHSF YKETPAAFPD TIKEKETPTP GEDIQVESSI PHTDSGIGEE
     QVASILNGAE LETSTGPDAM SELLSTLSSE VKKSQESLTE NPSETLKPAT SISSISQTKG
     INVKEILKSL VAAPVEIAEC GPEPIPYPDP ALKRETQAIL PMQFHSFDRS VVVPVKKPPP
     GSLAVTTVGA TTAGSGLPTG STSNIFAATG ATPKSMINTT GAVDSGSSSS SSSSSFVNGA
     TSKNLPAVQT VAPMPEDSAE NMSITAKLER ALEKVAPLLR EIFVDFAPFL SRTLLGSHGQ
     ELLIEGLVCM KSSTSVVELV MLLCSQEWQN SIQKNAGLAF IELINEGRLL CHAMKDHIVR
     VANEAEFILN RQRAEDVHKH AEFESQCAQY AADRREEEKM CDHLISAAKH RDHVTANQLK
     QKILNILTNK HGAWGAVSHS QLHDFWRLDY WEDDLRRRRR FVRNAFGSTH AEALLKAAIE
     YGTEEDVVKS KKTFRSQAIV NQNAETELML EGDDDAVSLL QEKEIDNLAG PVVLSTPAQL
     IAPVVVAKGT LSITTTEIYF EVDEDDSAFK KIDTKVLAYT EGLHGKWMFS EIRAVFSRRY
     LLQNTALEVF MANRTSVMFN FPDQATVKKV VYSLPRVGVG TSYGLPQARR ISLATPRQLY
     KSSNMTQRWQ RREISNFEYL MFLNTIAGRT YNDLNQYPVF PWVLTNYESE ELDLTLPGNF
     RDLSKPIGAL NPKRAVFYAE RYETWEDDQS PPYHYNTHYS TATSTLSWLV RIEPFTTFFL
     NANDGKFDHP DRTFSSVARS WRTSQRDTSD VKELIPEFYY LPEMFVNSNG YNLGVREDEV
     VVNDVDLPPW AKKPEDFVRI NRMALESEFV SCQLHQWIDL IFGYKQRGPE AVRALNVFHY
     LTYEGSVNLD SITDPVLREA MEAQIQNFGQ TPSQLLIEPH PPRSSAMHLC FLPQSPLMFK
     DQMQQDVIMV LKFPSNSPVT HVAANTLPHL TIPAVVTVTC SRLFAVNRWH NTVGLRGAPG
     YSLDQAHHLP IEMDPLIANN SGVNKRQITD LVDQSIQINA HCFVVTADNR YILICGFWDK
     SFRVYSTETG KLTQIVFGHW DVVTCLARSE SYIGGDCYIV SGSRDATLLL WYWSGRHHII
     GDNPNSSDYP APRAVLTGHD HEVVCVSVCA ELGLVISGAK EGPCLVHTIT GDLLRALEGP
     ENCLFPRLIS VSSEGHCIIY YERGRFSNFS INGKLLAQME INDSTRAILL SSDGQNLVTG
     GDNGVVEVWQ ACDFKQLYIY PGCDAGIRAM DLSHDQRTLI TGMASGSIVA FNIDFNRWHY
     EHQNRY
//
ID   PCBP1_HUMAN             Reviewed;         356 AA.
AC   Q15365; Q13157; Q14975;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   16-FEB-2004, sequence version 2.
DT   25-APR-2018, entry version 183.
DE   RecName: Full=Poly(rC)-binding protein 1;
DE   AltName: Full=Alpha-CP1;
DE   AltName: Full=Heterogeneous nuclear ribonucleoprotein E1;
DE            Short=hnRNP E1;
DE   AltName: Full=Nucleic acid-binding protein SUB2.3;
GN   Name=PCBP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7607214; DOI=10.1111/j.1432-1033.1995.0447h.x;
RA   Leffers H., Dejgaard K., Celis J.E.;
RT   "Characterisation of two major cellular poly(rC)-binding human
RT   proteins, each containing three K-homologous (KH) domains.";
RL   Eur. J. Biochem. 230:447-453(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7556077;
RA   Kiledjian M., Wang X., Liebhaber S.A.;
RT   "Identification of two KH domain proteins in the alpha-globin mRNP
RT   stability complex.";
RL   EMBO J. 14:4357-4364(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Lymphocyte;
RX   PubMed=8152927; DOI=10.1093/nar/22.6.959;
RA   Aasheim H.-C., Loukianova T., Deggerdal A., Smeland E.B.;
RT   "Tissue specific expression and cDNA structure of a human transcript
RT   encoding a nucleic acid binding [oligo(dC)] protein related to the
RT   pre-mRNA binding protein K.";
RL   Nucleic Acids Res. 22:959-964(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 47-70; 79-115; 125-160; 178-200; 298-306 AND
RP   315-346, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [6]
RP   FUNCTION.
RX   PubMed=12414943; DOI=10.1128/JVI.76.23.12008-12022.2002;
RA   Walter B.L., Parsley T.B., Ehrenfeld E., Semler B.L.;
RT   "Distinct poly(rC) binding protein KH domain determinants for
RT   poliovirus translation initiation and viral RNA replication.";
RL   J. Virol. 76:12008-12022(2002).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 AND SER-190, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 AND SER-190, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173; SER-246 AND
RP   SER-264, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 AND SER-273, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-115, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 279-356, AND RNA-BINDING.
RX   PubMed=15731341; DOI=10.1093/nar/gki265;
RA   Sidiqi M., Wilce J.A., Vivian J.P., Porter C.J., Barker A.,
RA   Leedman P.J., Wilce M.C.;
RT   "Structure and RNA binding of the third KH domain of poly(C)-binding
RT   protein 1.";
RL   Nucleic Acids Res. 33:1213-1221(2005).
CC   -!- FUNCTION: Single-stranded nucleic acid binding protein that binds
CC       preferentially to oligo dC. In case of infection by poliovirus,
CC       plays a role in initiation of viral RNA replication in concert
CC       with the viral protein 3CD (PubMed:12414943).
CC       {ECO:0000269|PubMed:12414943}.
CC   -!- INTERACTION:
CC       Q12771:-; NbExp=2; IntAct=EBI-946095, EBI-8609859;
CC       O41951:GAMMAHV.ORF34 (xeno); NbExp=4; IntAct=EBI-946095, EBI-9640556;
CC       Q67020:PA (xeno); NbExp=2; IntAct=EBI-946095, EBI-11514477;
CC       P11940:PABPC1; NbExp=2; IntAct=EBI-946095, EBI-81531;
CC       Q13153:PAK1; NbExp=2; IntAct=EBI-946095, EBI-1307;
CC       Q13153-1:PAK1; NbExp=5; IntAct=EBI-946095, EBI-15628682;
CC       Q15366:PCBP2; NbExp=2; IntAct=EBI-946095, EBI-945799;
CC       Q13427:PPIG; NbExp=2; IntAct=EBI-946095, EBI-396072;
CC       Q6P2Q9:PRPF8; NbExp=2; IntAct=EBI-946095, EBI-538479;
CC       P26599:PTBP1; NbExp=2; IntAct=EBI-946095, EBI-350540;
CC       Q9UHX1:PUF60; NbExp=2; IntAct=EBI-946095, EBI-1053259;
CC       Q96PU8:QKI; NbExp=2; IntAct=EBI-946095, EBI-945792;
CC       P98179:RBM3; NbExp=4; IntAct=EBI-946095, EBI-2949699;
CC       Q14498:RBM39; NbExp=2; IntAct=EBI-946095, EBI-395290;
CC       Q14498-2:RBM39; NbExp=2; IntAct=EBI-946095, EBI-11032687;
CC       P09012:SNRPA; NbExp=5; IntAct=EBI-946095, EBI-607085;
CC       Q96EK4:THAP11; NbExp=4; IntAct=EBI-946095, EBI-1790529;
CC       Q9Y3Q8:TSC22D4; NbExp=2; IntAct=EBI-946095, EBI-739485;
CC       Q9Y2W2:WBP11; NbExp=2; IntAct=EBI-946095, EBI-714455;
CC       Q96NB3:ZNF830; NbExp=2; IntAct=EBI-946095, EBI-3920997;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Loosely bound in
CC       the nucleus. May shuttle between the nucleus and the cytoplasm.
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in skeletal muscle,
CC       thymus and peripheral blood leukocytes while a lower expression is
CC       observed in prostate, spleen, testis, ovary, small intestine,
CC       heart, liver, adrenal and thyroid glands.
CC   -!- PTM: Phosphorylated; lowers poly(rC)-binding activity.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA82631.1; Type=Frameshift; Positions=301; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X78137; CAA55016.1; -; mRNA.
DR   EMBL; U24223; AAA91317.1; -; mRNA.
DR   EMBL; Z29505; CAA82631.1; ALT_FRAME; mRNA.
DR   EMBL; BC039742; AAH39742.1; -; mRNA.
DR   CCDS; CCDS1898.1; -.
DR   RefSeq; NP_006187.2; NM_006196.3.
DR   UniGene; Hs.2853; -.
DR   PDB; 1WVN; X-ray; 2.10 A; A=279-356.
DR   PDB; 1ZTG; X-ray; 3.00 A; A/B/C/D=14-85.
DR   PDB; 3VKE; X-ray; 1.77 A; A/B/C/D=14-86.
DR   PDBsum; 1WVN; -.
DR   PDBsum; 1ZTG; -.
DR   PDBsum; 3VKE; -.
DR   ProteinModelPortal; Q15365; -.
DR   SMR; Q15365; -.
DR   BioGrid; 111126; 184.
DR   DIP; DIP-38136N; -.
DR   IntAct; Q15365; 115.
DR   MINT; Q15365; -.
DR   STRING; 9606.ENSP00000305556; -.
DR   iPTMnet; Q15365; -.
DR   PhosphoSitePlus; Q15365; -.
DR   SwissPalm; Q15365; -.
DR   BioMuta; PCBP1; -.
DR   DMDM; 42560548; -.
DR   OGP; Q15365; -.
DR   REPRODUCTION-2DPAGE; IPI00016610; -.
DR   UCD-2DPAGE; Q15365; -.
DR   EPD; Q15365; -.
DR   PaxDb; Q15365; -.
DR   PeptideAtlas; Q15365; -.
DR   PRIDE; Q15365; -.
DR   TopDownProteomics; Q15365; -.
DR   DNASU; 5093; -.
DR   Ensembl; ENST00000303577; ENSP00000305556; ENSG00000169564.
DR   GeneID; 5093; -.
DR   KEGG; hsa:5093; -.
DR   CTD; 5093; -.
DR   DisGeNET; 5093; -.
DR   EuPathDB; HostDB:ENSG00000169564.6; -.
DR   GeneCards; PCBP1; -.
DR   HGNC; HGNC:8647; PCBP1.
DR   HPA; CAB037113; -.
DR   HPA; HPA043803; -.
DR   HPA; HPA068497; -.
DR   MIM; 601209; gene.
DR   neXtProt; NX_Q15365; -.
DR   OpenTargets; ENSG00000169564; -.
DR   PharmGKB; PA32986; -.
DR   eggNOG; KOG2190; Eukaryota.
DR   eggNOG; ENOG410XNN8; LUCA.
DR   GeneTree; ENSGT00760000119144; -.
DR   HOGENOM; HOG000182823; -.
DR   HOVERGEN; HBG053520; -.
DR   InParanoid; Q15365; -.
DR   KO; K12889; -.
DR   OMA; TLTKLHQ; -.
DR   OrthoDB; EOG091G0DHI; -.
DR   PhylomeDB; Q15365; -.
DR   TreeFam; TF318292; -.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-72203; Processing of Capped Intron-Containing Pre-mRNA.
DR   ChiTaRS; PCBP1; human.
DR   EvolutionaryTrace; Q15365; -.
DR   GeneWiki; PCBP1; -.
DR   GenomeRNAi; 5093; -.
DR   PRO; PR:Q15365; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000169564; -.
DR   CleanEx; HS_PCBP1; -.
DR   ExpressionAtlas; Q15365; baseline and differential.
DR   Genevisible; Q15365; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0003729; F:mRNA binding; IDA:BHF-UCL.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0098847; F:sequence-specific single stranded DNA binding; IEA:Ensembl.
DR   GO; GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0016070; P:RNA metabolic process; TAS:Reactome.
DR   GO; GO:0039694; P:viral RNA genome replication; IDA:UniProtKB.
DR   Gene3D; 3.30.1370.10; -; 3.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   Pfam; PF00013; KH_1; 3.
DR   SMART; SM00322; KH; 3.
DR   SUPFAM; SSF54791; SSF54791; 3.
DR   PROSITE; PS50084; KH_TYPE_1; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; DNA-binding; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Ribonucleoprotein;
KW   RNA-binding; Ubl conjugation; Viral RNA replication.
FT   CHAIN         1    356       Poly(rC)-binding protein 1.
FT                                /FTId=PRO_0000050087.
FT   DOMAIN       13     75       KH 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00117}.
FT   DOMAIN       97    162       KH 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00117}.
FT   DOMAIN      279    343       KH 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00117}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     173    173       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     189    189       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P60335}.
FT   MOD_RES     190    190       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     246    246       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     264    264       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     273    273       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CROSSLNK    115    115       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CONFLICT    205    205       A -> V (in Ref. 1; CAA55016).
FT                                {ECO:0000305}.
FT   CONFLICT    299    300       Missing (in Ref. 3; CAA82631).
FT                                {ECO:0000305}.
FT   STRAND       14     21       {ECO:0000244|PDB:3VKE}.
FT   HELIX        22     29       {ECO:0000244|PDB:3VKE}.
FT   HELIX        31     33       {ECO:0000244|PDB:3VKE}.
FT   HELIX        34     43       {ECO:0000244|PDB:3VKE}.
FT   STRAND       46     49       {ECO:0000244|PDB:3VKE}.
FT   STRAND       55     64       {ECO:0000244|PDB:3VKE}.
FT   HELIX        65     81       {ECO:0000244|PDB:3VKE}.
FT   TURN         82     84       {ECO:0000244|PDB:3VKE}.
FT   STRAND      280    287       {ECO:0000244|PDB:1WVN}.
FT   HELIX       288    290       {ECO:0000244|PDB:1WVN}.
FT   HELIX       291    295       {ECO:0000244|PDB:1WVN}.
FT   HELIX       297    299       {ECO:0000244|PDB:1WVN}.
FT   HELIX       300    309       {ECO:0000244|PDB:1WVN}.
FT   STRAND      312    315       {ECO:0000244|PDB:1WVN}.
FT   STRAND      323    331       {ECO:0000244|PDB:1WVN}.
FT   HELIX       333    346       {ECO:0000244|PDB:1WVN}.
SQ   SEQUENCE   356 AA;  37498 MW;  6D1A261276CA206D CRC64;
     MDAGVTESGL NVTLTIRLLM HGKEVGSIIG KKGESVKRIR EESGARINIS EGNCPERIIT
     LTGPTNAIFK AFAMIIDKLE EDINSSMTNS TAASRPPVTL RLVVPATQCG SLIGKGGCKI
     KEIRESTGAQ VQVAGDMLPN STERAITIAG VPQSVTECVK QICLVMLETL SQSPQGRVMT
     IPYQPMPASS PVICAGGQDR CSDAAGYPHA THDLEGPPLD AYSIQGQHTI SPLDLAKLNQ
     VARQQSHFAM MHGGTGFAGI DSSSPEVKGY WASLDASTQT THELTIPNNL IGCIIGRQGA
     NINEIRQMSG AQIKIANPVE GSSGRQVTIT GSAASISLAQ YLINARLSSE KGMGCS
//
ID   Q53SS8_HUMAN            Unreviewed;       356 AA.
AC   Q53SS8;
DT   24-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   24-MAY-2005, sequence version 1.
DT   25-APR-2018, entry version 109.
DE   SubName: Full=Epididymis secretory protein Li 85 {ECO:0000313|EMBL:ACI46021.1};
DE   SubName: Full=Poly(RC) binding protein 1 {ECO:0000313|EMBL:EAW99834.1};
DE   SubName: Full=cDNA, FLJ94964, highly similar to Homo sapiens poly(rC) binding protein 1 (PCBP1), mRNA {ECO:0000313|EMBL:BAG36897.1};
GN   Name=PCBP1 {ECO:0000313|EMBL:AAX93191.1};
GN   Synonyms=HEL-S-85 {ECO:0000313|EMBL:ACI46021.1};
GN   ORFNames=hCG_1776997 {ECO:0000313|EMBL:EAW99834.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAX93191.1};
RN   [1] {ECO:0000313|EMBL:AAX93191.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hawkins M., Cotton M., Du H.;
RT   "The sequence of Homo sapiens BAC clone RP11-175A7.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:EAW99834.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [3] {ECO:0000313|EMBL:AAX93191.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Waterston R.H.;
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:AAX93191.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Waterston R.;
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:AAX93191.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wilson R.K.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000313|EMBL:EAW99834.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000313|EMBL:BAG36897.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Lung {ECO:0000313|EMBL:BAG36897.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
RN   [8] {ECO:0000313|EMBL:ACI46021.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J., Wang H., Liu J., Liu F.;
RL   Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC016700; AAX93191.1; -; Genomic_DNA.
DR   EMBL; FJ224329; ACI46021.1; -; mRNA.
DR   EMBL; AK314225; BAG36897.1; -; mRNA.
DR   EMBL; CH471053; EAW99834.1; -; Genomic_DNA.
DR   RefSeq; NP_006187.2; NM_006196.3.
DR   UniGene; Hs.2853; -.
DR   DNASU; 5093; -.
DR   GeneID; 5093; -.
DR   KEGG; hsa:5093; -.
DR   UCSC; uc002sgf.4; human.
DR   CTD; 5093; -.
DR   EuPathDB; HostDB:ENSG00000169564.6; -.
DR   PharmGKB; PA32986; -.
DR   eggNOG; KOG2190; Eukaryota.
DR   eggNOG; ENOG410XNN8; LUCA.
DR   HOVERGEN; HBG053520; -.
DR   KO; K12889; -.
DR   OMA; TLTKLHQ; -.
DR   OrthoDB; EOG091G0DHI; -.
DR   ChiTaRS; PCBP1; human.
DR   GenomeRNAi; 5093; -.
DR   Bgee; ENSG00000169564; -.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003723; F:RNA binding; IEA:InterPro.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0098847; F:sequence-specific single stranded DNA binding; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   Gene3D; 3.30.1370.10; -; 3.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   Pfam; PF00013; KH_1; 3.
DR   SMART; SM00322; KH; 3.
DR   SUPFAM; SSF54791; SSF54791; 3.
PE   2: Evidence at transcript level;
FT   DOMAIN       12     80       KH. {ECO:0000259|SMART:SM00322}.
FT   DOMAIN       96    167       KH. {ECO:0000259|SMART:SM00322}.
FT   DOMAIN      278    348       KH. {ECO:0000259|SMART:SM00322}.
SQ   SEQUENCE   356 AA;  37498 MW;  6D1A261276CA206D CRC64;
     MDAGVTESGL NVTLTIRLLM HGKEVGSIIG KKGESVKRIR EESGARINIS EGNCPERIIT
     LTGPTNAIFK AFAMIIDKLE EDINSSMTNS TAASRPPVTL RLVVPATQCG SLIGKGGCKI
     KEIRESTGAQ VQVAGDMLPN STERAITIAG VPQSVTECVK QICLVMLETL SQSPQGRVMT
     IPYQPMPASS PVICAGGQDR CSDAAGYPHA THDLEGPPLD AYSIQGQHTI SPLDLAKLNQ
     VARQQSHFAM MHGGTGFAGI DSSSPEVKGY WASLDASTQT THELTIPNNL IGCIIGRQGA
     NINEIRQMSG AQIKIANPVE GSSGRQVTIT GSAASISLAQ YLINARLSSE KGMGCS
//
ID   B4DIH7_HUMAN            Unreviewed;       756 AA.
AC   B4DIH7;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 58.
DE   SubName: Full=cDNA FLJ50966, highly similar to PMS1 protein homolog 1 {ECO:0000313|EMBL:BAG58489.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG58489.1};
RN   [1] {ECO:0000313|EMBL:BAG58489.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Hippocampus {ECO:0000313|EMBL:BAG58489.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK295602; BAG58489.1; -; mRNA.
DR   RefSeq; NP_001276337.1; NM_001289408.1.
DR   UniGene; Hs.111749; -.
DR   ProteinModelPortal; B4DIH7; -.
DR   PeptideAtlas; B4DIH7; -.
DR   PRIDE; B4DIH7; -.
DR   GeneID; 5378; -.
DR   CTD; 5378; -.
DR   eggNOG; KOG1978; Eukaryota.
DR   eggNOG; COG0323; LUCA.
DR   HOVERGEN; HBG031886; -.
DR   GenomeRNAi; 5378; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-UniRule.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0030983; F:mismatched DNA binding; IEA:InterPro.
DR   GO; GO:0006298; P:mismatch repair; IEA:InterPro.
DR   Gene3D; 1.10.30.10; -; 1.
DR   Gene3D; 3.30.230.10; -; 1.
DR   InterPro; IPR013507; DNA_mismatch_repair_C.
DR   InterPro; IPR009071; HMG_box_dom.
DR   InterPro; IPR036910; HMG_box_dom_sf.
DR   InterPro; IPR031263; PMS1_hom.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   InterPro; IPR014721; Ribosomal_S5_D2-typ_fold_subgr.
DR   PANTHER; PTHR10073:SF43; PTHR10073:SF43; 1.
DR   Pfam; PF01119; DNA_mis_repair; 1.
DR   Pfam; PF00505; HMG_box; 1.
DR   SMART; SM01340; DNA_mis_repair; 1.
DR   SMART; SM00398; HMG; 1.
DR   SUPFAM; SSF47095; SSF47095; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   PROSITE; PS50118; HMG_BOX_2; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00267,
KW   ECO:0000256|SAAS:SAAS00879239};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00267}.
FT   DOMAIN      395    463       HMG box. {ECO:0000259|PROSITE:PS50118}.
FT   DNA_BIND    395    463       HMG box. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00267}.
FT   COILED      445    465       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   756 AA;  86529 MW;  D1EE8A7E375944C3 CRC64;
     MSFGILKPDL RIVFVHNKAV IWQKSRVSDH KMALMSVLGT AVMNNMESFQ YHSEESQIYL
     SGFLPKCDAD HSFTSLSTPE RSFIFINSRP VHQKDILKLI RHHYNLKCLK ESTRLYPVFF
     LKIDVPTADV DVNLTPDKSQ VLLQNKESVL IALENLMTTC YGPLPSTNSY ENNKTDVSAA
     DIVLSKTAET DVLFNKVESS GKNYSNVDTS VIPFQNDMHN DESGKNTDDC LNHQISIGDF
     GYGHCSSEIS NIDKNTKNAF QDISMSNVSW ENSQTEYSKT CFISSVKHTQ SENGNKDHID
     ESGENEEEAG LENSSEISAD EWSRGNILKN SVGENIEPVK ILVPEKSLPC KVSNNNYPIP
     EQMNLNEDSC NKKSNVIDNK SGKVTAYDLL SNRVIKKPMS ASALFVQDHR PQFLIENPKT
     SLEDATLQIE ELWKTLSEEE KLKYEEKATK DLERYNSQMK RAIEQESQMS LKDGRKKIKP
     TSAWNLAQKH KLKTSLSNQP KLDELLQSQI EKRRSQNIKM VQIPFSMKNL KINFKKQNKV
     DLEEKDEPCL IHNLRFPDAW LMTSKTEVML LNPYRVEEAL LFKRLLENHK LPAEPLEKPI
     MLTESLFNGS HYLDVLYKMT ADDQRYSGST YLSDPRLTAN GFKIKLIPGV SITENYLEIE
     GMANCLPFYG VADLKEILNA ILNRNAKEVY ECRPRKVIGY LEGEAVRLSR QLPMYLSKED
     IQDIIYRMKH QFGNEIKECV HGRPFFHHLT YLPETT
//
ID   B7ZAA0_HUMAN            Unreviewed;       756 AA.
AC   B7ZAA0;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   25-APR-2018, entry version 85.
DE   SubName: Full=PMS1 protein homolog 1 {ECO:0000313|Ensembl:ENSP00000398378};
DE   SubName: Full=cDNA, FLJ79114, highly similar to PMS1 protein homolog 1 {ECO:0000313|EMBL:BAH14586.1};
GN   Name=PMS1 {ECO:0000313|Ensembl:ENSP00000398378};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH14586.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000398378, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|EMBL:BAH14586.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000313|Ensembl:ENSP00000398378}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [5] {ECO:0000313|Ensembl:ENSP00000485312}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (OCT-2014) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC008122; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC013468; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK316215; BAH14586.1; -; mRNA.
DR   RefSeq; NP_001276337.1; NM_001289408.1.
DR   RefSeq; NP_001276338.1; NM_001289409.1.
DR   RefSeq; NP_001307973.1; NM_001321044.1.
DR   RefSeq; NP_001307974.1; NM_001321045.1.
DR   RefSeq; NP_001307975.1; NM_001321046.1.
DR   RefSeq; NP_001307976.1; NM_001321047.1.
DR   RefSeq; NP_001307977.1; NM_001321048.1.
DR   RefSeq; XP_011509658.1; XM_011511356.2.
DR   UniGene; Hs.111749; -.
DR   MaxQB; B7ZAA0; -.
DR   PeptideAtlas; B7ZAA0; -.
DR   Ensembl; ENST00000432292; ENSP00000398378; ENSG00000064933.
DR   Ensembl; ENST00000624204; ENSP00000485312; ENSG00000064933.
DR   GeneID; 5378; -.
DR   UCSC; uc010zgc.3; human.
DR   CTD; 5378; -.
DR   EuPathDB; HostDB:ENSG00000064933.16; -.
DR   HGNC; HGNC:9121; PMS1.
DR   OpenTargets; ENSG00000064933; -.
DR   eggNOG; KOG1978; Eukaryota.
DR   eggNOG; COG0323; LUCA.
DR   GeneTree; ENSGT00530000063289; -.
DR   HOVERGEN; HBG031886; -.
DR   ChiTaRS; PMS1; human.
DR   GenomeRNAi; 5378; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000064933; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-UniRule.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0030983; F:mismatched DNA binding; IEA:InterPro.
DR   GO; GO:0006298; P:mismatch repair; IEA:InterPro.
DR   Gene3D; 1.10.30.10; -; 1.
DR   Gene3D; 3.30.230.10; -; 1.
DR   InterPro; IPR013507; DNA_mismatch_repair_C.
DR   InterPro; IPR009071; HMG_box_dom.
DR   InterPro; IPR036910; HMG_box_dom_sf.
DR   InterPro; IPR031263; PMS1_hom.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   InterPro; IPR014721; Ribosomal_S5_D2-typ_fold_subgr.
DR   PANTHER; PTHR10073:SF43; PTHR10073:SF43; 1.
DR   Pfam; PF01119; DNA_mis_repair; 1.
DR   Pfam; PF00505; HMG_box; 1.
DR   SMART; SM01340; DNA_mis_repair; 1.
DR   SMART; SM00398; HMG; 1.
DR   SUPFAM; SSF47095; SSF47095; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   PROSITE; PS50118; HMG_BOX_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00267,
KW   ECO:0000256|SAAS:SAAS00879239};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00267};
KW   Proteomics identification {ECO:0000213|EPD:B7ZAA0,
KW   ECO:0000213|MaxQB:B7ZAA0, ECO:0000213|PeptideAtlas:B7ZAA0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      395    463       HMG box. {ECO:0000259|PROSITE:PS50118}.
FT   DNA_BIND    395    463       HMG box. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00267}.
FT   COILED      445    465       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   756 AA;  86559 MW;  D1FA9E7E234D44C3 CRC64;
     MSFGILKPDL RIVFVHNKAV IWQKSRVSDH KMALMSVLGT AVMNNMESFQ YHSEESQIYL
     SGFLPKCDAD HSFTSLSTPE RSFIFINSRP VHQKDILKLI RHHYNLKCLK ESTRLYPVFF
     LKIDVPTADV DVNLTPDKSQ VLLQNKESVL IALENLMTTC YGPLPSTNSY ENNKTDVSAA
     DIVLSKTAET DVLFNKVESS GKNYSNVDTS VIPFQNDMHN DESGKNTDDC LNHQISIGDF
     GYGHCSSEIS NIDKNTKNAF QDISMSNVSW ENSQTEYSKT CFISSVKHTQ SENGNKDHID
     ESGENEEEAG LENSSEISAD EWSRGNILKN SVGENIEPVK ILVPEKSLPC KVSNNNYPIP
     EQMNLNEDSC NKKSNVIDNK SGKVTAYDLL SNRVIKKPMS ASALFVQDHR PQFLIENPKT
     SLEDATLQIE ELWKTLSEEE KLKYEEKATK DLERYNSQMK RAIEQESQMS LKDGRKKIKP
     TSAWNLAQKH KLKTSLSNQP KLDELLQSQI EKRRSQNIKM VQIPFSMKNL KINFKKQNKV
     DLEEKDEPCL IHNLRFPDAW LMTSKTEVML LNPYRVEEAL LFKRLLENHK LPAEPLEKPI
     MLTESLFNGS HYLDVLYKMT ADDQRYSGST YLSDPRLTAN GFKIKLIPGV SITENYLEIE
     GMANCLPFYG VADLKEILNA ILNRNAKEVY ECRPRKVISY LEGEAVRLSR QLPMYLSKED
     IQDIIYRMKH QFGNEIKECV HGRPFFHHLT YLPETT
//
ID   E9PC40_HUMAN            Unreviewed;       181 AA.
AC   E9PC40;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   28-MAR-2018, entry version 50.
DE   SubName: Full=PMS1 protein homolog 1 {ECO:0000313|Ensembl:ENSP00000386623};
GN   Name=PMS1 {ECO:0000313|Ensembl:ENSP00000386623};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000386623, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000386623, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3] {ECO:0000313|Ensembl:ENSP00000386623}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [4] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC008122; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC013468; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001307978.1; NM_001321049.1.
DR   UniGene; Hs.111749; -.
DR   ProteinModelPortal; E9PC40; -.
DR   EPD; E9PC40; -.
DR   MaxQB; E9PC40; -.
DR   PeptideAtlas; E9PC40; -.
DR   Ensembl; ENST00000409985; ENSP00000386623; ENSG00000064933.
DR   GeneID; 5378; -.
DR   UCSC; uc061qps.1; human.
DR   CTD; 5378; -.
DR   EuPathDB; HostDB:ENSG00000064933.16; -.
DR   HGNC; HGNC:9121; PMS1.
DR   OpenTargets; ENSG00000064933; -.
DR   GeneTree; ENSGT00530000063289; -.
DR   ChiTaRS; PMS1; human.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000064933; -.
DR   ExpressionAtlas; E9PC40; baseline and differential.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR014762; DNA_mismatch_repair_CS.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR031263; PMS1_hom.
DR   PANTHER; PTHR10073:SF43; PTHR10073:SF43; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00058; DNA_MISMATCH_REPAIR_1; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:E9PC40,
KW   ECO:0000213|MaxQB:E9PC40, ECO:0000213|PeptideAtlas:E9PC40};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   181 AA;  19862 MW;  566E0CFE169FC62A CRC64;
     MKQLPAATVR LLSSSQIITS VVSVVKELIE NSLDAGATSV DVKLENYGFD KIEVRDNGEG
     IKAVDAPVMA MKYYTSKINS HEDLENLTTY GFRGEALGSI CCIAEVLITT RTAADNFSTQ
     YVLDGSGHIL SQKPSHLGQG KKVALYTNIL YLFCLNCWFK KKKLLGEYKY IALGLVLIKA
     S
//
ID   I6L9H5_HUMAN            Unreviewed;       669 AA.
AC   I6L9H5;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   31-JAN-2018, entry version 41.
DE   SubName: Full=PMS1 protein {ECO:0000313|EMBL:AAH96331.1};
GN   Name=PMS1 {ECO:0000313|EMBL:AAH96331.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH96331.1};
RN   [1] {ECO:0000313|EMBL:AAH96331.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC096331; AAH96331.1; -; mRNA.
DR   RefSeq; NP_001276338.1; NM_001289409.1.
DR   UniGene; Hs.111749; -.
DR   ProteinModelPortal; I6L9H5; -.
DR   PeptideAtlas; I6L9H5; -.
DR   GeneID; 5378; -.
DR   CTD; 5378; -.
DR   eggNOG; KOG1978; Eukaryota.
DR   eggNOG; COG0323; LUCA.
DR   ChiTaRS; PMS1; human.
DR   GenomeRNAi; 5378; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-UniRule.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0030983; F:mismatched DNA binding; IEA:InterPro.
DR   GO; GO:0006298; P:mismatch repair; IEA:InterPro.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 1.10.30.10; -; 1.
DR   Gene3D; 3.30.230.10; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR013507; DNA_mismatch_repair_C.
DR   InterPro; IPR014762; DNA_mismatch_repair_CS.
DR   InterPro; IPR002099; DNA_mismatch_repair_fam.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR009071; HMG_box_dom.
DR   InterPro; IPR036910; HMG_box_dom_sf.
DR   InterPro; IPR031263; PMS1_hom.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   InterPro; IPR014721; Ribosomal_S5_D2-typ_fold_subgr.
DR   PANTHER; PTHR10073:SF43; PTHR10073:SF43; 2.
DR   Pfam; PF01119; DNA_mis_repair; 1.
DR   Pfam; PF00505; HMG_box; 1.
DR   SMART; SM01340; DNA_mis_repair; 1.
DR   SMART; SM00398; HMG; 1.
DR   SUPFAM; SSF47095; SSF47095; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   TIGRFAMs; TIGR00585; mutl; 1.
DR   PROSITE; PS00058; DNA_MISMATCH_REPAIR_1; 1.
DR   PROSITE; PS50118; HMG_BOX_2; 1.
PE   2: Evidence at transcript level;
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00267,
KW   ECO:0000256|SAAS:SAAS00879239};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00267}.
FT   DOMAIN      571    639       HMG box. {ECO:0000259|PROSITE:PS50118}.
FT   DNA_BIND    571    639       HMG box. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00267}.
SQ   SEQUENCE   669 AA;  74741 MW;  42013A1AF27E2C53 CRC64;
     MKQLPAATVR LLSSSQIITS VVSVVKELIE NSLDAGATSV DVKLENYGFD KIEVRDNGEG
     IKAVDAPVMA MKYYTSKINS HEDLENLTTY GFRGEALGSI CCIAEVLITT RTAADNFSTQ
     YVLDGSGHIL SQKPSHLGQG TTVTALRLFK NLPVRKQFYS TAKKCKDEIK KIQDLLMSFG
     ILKPDLRIVF VHNKAVIWQK SRVSDHKMAL MSVLGTAVMN NMESFQYHSE ESQIYLSGFL
     PKCDADHSFT SLSTPERSFI FINSRPVHQK DILKLIRHHY NLKCLKESTR LYPVFFLKID
     VPTADVDVNL TPDKSQVLLQ NKESVLIALE NLMTTCYGPL PSTNSYENNK TDVSAADIVL
     SKTAETDVLF NKVESSGKNY SNVDTSVIPF QNDMHNDESG KNTDDCLNHQ ISIGDFGYGH
     CSSEISNIDK NTKNAFQDIS MSNVSWENSQ TEYSKTCFIS SVKHTQSENG NKDHIDESGE
     NEEEAGLENS SEISADEWSR GNILKNSVGE NIEPVKILVP EKSLPCKVSN NNYPIPEQMN
     LNEDSCNKKS NVIDNKSGKV TAYDLLSNRV IKKPMSASAL FVQDHRPQFL IENPKTSLED
     ATLQIEELWK TLSEEEKLNL FNGSHYLDVL YKMTADDQRY SGSTYLSDPR LTANGFKIKL
     IPGVSITEN
//
ID   PMS1_HUMAN              Reviewed;         932 AA.
AC   P54277; D3DPI1; Q4VAL4; Q5FBZ3; Q5FBZ6; Q5FBZ8;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   25-OCT-2017, entry version 172.
DE   RecName: Full=PMS1 protein homolog 1;
DE   AltName: Full=DNA mismatch repair protein PMS1;
GN   Name=PMS1; Synonyms=PMSL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Gall bladder;
RX   PubMed=8072530; DOI=10.1038/371075a0;
RA   Nicolaides N.C., Papadopoulos N., Liu B., Wei Y.-F., Carter K.C.,
RA   Ruben S.M., Rosen C.A., Haseltine W.H., Fleischmann R.D., Fraser C.M.,
RA   Adams M.D., Venter J.C., Dunlop M.G., Hamilton S.R., Petersen G.M.,
RA   de la Chapelle A., Vogelstein B., Kinzler K.W.;
RT   "Mutations of two PMS homologues in hereditary nonpolyposis colon
RT   cancer.";
RL   Nature 371:75-80(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4).
RA   Hayashi A., Sameshima E., Tabata Y., Iida K., Mitsuyama M., Kanai S.,
RA   Furuya T., Saito T.;
RT   "PMS1 mRNA, nirs splice variants.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLN-27; LYS-202;
RP   ARG-501; SER-632; ASP-720 AND HIS-793.
RG   NIEHS SNPs program;
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-920 (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, SUBUNIT, AND INTERACTION WITH MLH1.
RX   PubMed=10748105; DOI=10.1074/jbc.M908768199;
RA   Leung W.K., Kim J.J., Wu L., Sepulveda J.L., Sepulveda A.R.;
RT   "Identification of a second MutL DNA mismatch repair complex (hPMS1
RT   and hMLH1) in human epithelial cells.";
RL   J. Biol. Chem. 275:15728-15732(2000).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [10]
RP   STRUCTURE BY NMR OF 571-649.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the HMG domain of human DNA mismatch repair
RT   protein.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [11]
RP   VARIANTS THR-394 AND ARG-501.
RX   PubMed=10480359; DOI=10.1007/s004399900064;
RA   Wang Q., Lasset C., Desseigne F., Saurin J.-C., Maugard C.,
RA   Navarro C., Ruano E., Descos L., Trillet-Lenoir V., Bosset J.-F.,
RA   Puisieux A.;
RT   "Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and
RT   hMSH6 genes in 75 French kindreds with nonpolyposis colorectal
RT   cancer.";
RL   Hum. Genet. 105:79-85(1999).
CC   -!- FUNCTION: Probably involved in the repair of mismatches in DNA.
CC       {ECO:0000269|PubMed:10748105}.
CC   -!- SUBUNIT: The MutL-beta complex is a heterodimer of PMS1 and MLH1.
CC       {ECO:0000269|PubMed:10748105}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00267}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P54277-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P54277-2; Sequence=VSP_042676, VSP_042677;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P54277-3; Sequence=VSP_043371;
CC       Name=4;
CC         IsoId=P54277-4; Sequence=VSP_047692, VSP_043371, VSP_042676,
CC                                  VSP_042677;
CC   -!- SIMILARITY: Belongs to the DNA mismatch repair MutL/HexB family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PMS1ID345ch2q31.html";
CC   -!- WEB RESOURCE: Name=Hereditary non-polyposis colorectal cancer db;
CC       URL="http://www.nfdht.nl/";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/pms1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U13695; AAA63922.1; -; Genomic_DNA.
DR   EMBL; AB102870; BAD89399.1; -; mRNA.
DR   EMBL; AB102872; BAD89401.1; -; mRNA.
DR   EMBL; AB102875; BAD89404.1; -; mRNA.
DR   EMBL; AY267352; AAO89079.1; -; Genomic_DNA.
DR   EMBL; AC008122; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC013468; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471058; EAX10883.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX10885.1; -; Genomic_DNA.
DR   EMBL; BC096330; AAH96330.1; -; mRNA.
DR   EMBL; BC096332; AAH96332.1; -; mRNA.
DR   CCDS; CCDS2302.1; -. [P54277-1]
DR   CCDS; CCDS46473.1; -. [P54277-2]
DR   CCDS; CCDS46474.1; -. [P54277-3]
DR   PIR; S47597; S47597.
DR   RefSeq; NP_000525.1; NM_000534.4. [P54277-1]
DR   RefSeq; NP_001121615.1; NM_001128143.1. [P54277-3]
DR   RefSeq; NP_001121616.1; NM_001128144.1. [P54277-2]
DR   RefSeq; NP_001276337.1; NM_001289408.1.
DR   RefSeq; NP_001307974.1; NM_001321045.1. [P54277-1]
DR   RefSeq; NP_001307975.1; NM_001321046.1.
DR   RefSeq; NP_001307976.1; NM_001321047.1. [P54277-1]
DR   RefSeq; NP_001307977.1; NM_001321048.1. [P54277-1]
DR   RefSeq; XP_016859833.1; XM_017004344.1. [P54277-3]
DR   RefSeq; XP_016859837.1; XM_017004348.1. [P54277-2]
DR   UniGene; Hs.111749; -.
DR   PDB; 2CS1; NMR; -; A=571-649.
DR   PDBsum; 2CS1; -.
DR   ProteinModelPortal; P54277; -.
DR   SMR; P54277; -.
DR   BioGrid; 111391; 64.
DR   CORUM; P54277; -.
DR   IntAct; P54277; 7.
DR   STRING; 9606.ENSP00000406490; -.
DR   iPTMnet; P54277; -.
DR   PhosphoSitePlus; P54277; -.
DR   BioMuta; PMS1; -.
DR   DMDM; 1709683; -.
DR   EPD; P54277; -.
DR   MaxQB; P54277; -.
DR   PaxDb; P54277; -.
DR   PeptideAtlas; P54277; -.
DR   PRIDE; P54277; -.
DR   DNASU; 5378; -.
DR   Ensembl; ENST00000409593; ENSP00000387169; ENSG00000064933. [P54277-4]
DR   Ensembl; ENST00000409823; ENSP00000387125; ENSG00000064933. [P54277-3]
DR   Ensembl; ENST00000441310; ENSP00000406490; ENSG00000064933. [P54277-1]
DR   Ensembl; ENST00000447232; ENSP00000401064; ENSG00000064933. [P54277-2]
DR   GeneID; 5378; -.
DR   KEGG; hsa:5378; -.
DR   UCSC; uc002urh.5; human. [P54277-1]
DR   CTD; 5378; -.
DR   DisGeNET; 5378; -.
DR   EuPathDB; HostDB:ENSG00000064933.16; -.
DR   GeneCards; PMS1; -.
DR   GeneReviews; PMS1; -.
DR   H-InvDB; HIX0029784; -.
DR   HGNC; HGNC:9121; PMS1.
DR   HPA; CAB010233; -.
DR   HPA; HPA031013; -.
DR   MalaCards; PMS1; -.
DR   MIM; 600258; gene.
DR   neXtProt; NX_P54277; -.
DR   OpenTargets; ENSG00000064933; -.
DR   Orphanet; 144; Hereditary nonpolyposis colon cancer.
DR   PharmGKB; PA33447; -.
DR   eggNOG; KOG1978; Eukaryota.
DR   eggNOG; COG0323; LUCA.
DR   GeneTree; ENSGT00530000063289; -.
DR   HOGENOM; HOG000039972; -.
DR   HOVERGEN; HBG031886; -.
DR   InParanoid; P54277; -.
DR   KO; K10864; -.
DR   OMA; HKLPAEP; -.
DR   OrthoDB; EOG091G01Z9; -.
DR   PhylomeDB; P54277; -.
DR   TreeFam; TF300711; -.
DR   SIGNOR; P54277; -.
DR   ChiTaRS; PMS1; human.
DR   EvolutionaryTrace; P54277; -.
DR   GeneWiki; PMS1; -.
DR   GenomeRNAi; 5378; -.
DR   PRO; PR:P54277; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000064933; -.
DR   CleanEx; HS_PMS1; -.
DR   ExpressionAtlas; P54277; baseline and differential.
DR   Genevisible; P54277; HS.
DR   GO; GO:0032389; C:MutLalpha complex; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0016887; F:ATPase activity; IBA:GO_Central.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0030983; F:mismatched DNA binding; IEA:InterPro.
DR   GO; GO:0003697; F:single-stranded DNA binding; IBA:GO_Central.
DR   GO; GO:0006298; P:mismatch repair; IBA:GO_Central.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 1.10.30.10; -; 1.
DR   Gene3D; 3.30.230.10; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR013507; DNA_mismatch_repair_C.
DR   InterPro; IPR014762; DNA_mismatch_repair_CS.
DR   InterPro; IPR002099; DNA_mismatch_repair_fam.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR009071; HMG_box_dom.
DR   InterPro; IPR036910; HMG_box_dom_sf.
DR   InterPro; IPR031263; PMS1_hom.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   InterPro; IPR014721; Ribosomal_S5_D2-typ_fold_subgr.
DR   PANTHER; PTHR10073:SF43; PTHR10073:SF43; 1.
DR   Pfam; PF01119; DNA_mis_repair; 1.
DR   Pfam; PF00505; HMG_box; 1.
DR   SMART; SM01340; DNA_mis_repair; 1.
DR   SMART; SM00398; HMG; 1.
DR   SUPFAM; SSF47095; SSF47095; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   TIGRFAMs; TIGR00585; mutl; 1.
DR   PROSITE; PS00058; DNA_MISMATCH_REPAIR_1; 1.
DR   PROSITE; PS50118; HMG_BOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; DNA damage;
KW   DNA repair; DNA-binding; Hereditary nonpolyposis colorectal cancer;
KW   Nucleus; Polymorphism; Reference proteome; Tumor suppressor.
FT   CHAIN         1    932       PMS1 protein homolog 1.
FT                                /FTId=PRO_0000178004.
FT   DNA_BIND    571    639       HMG box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00267}.
FT   VAR_SEQ       1    176       Missing (in isoform 4).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_047692.
FT   VAR_SEQ     195    233       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_043371.
FT   VAR_SEQ     619    619       K -> N (in isoform 2 and isoform 4).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_042676.
FT   VAR_SEQ     620    781       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_042677.
FT   VARIANT      27     27       E -> Q (in dbSNP:rs5742973).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_019166.
FT   VARIANT     202    202       R -> K (in dbSNP:rs2066459).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_014877.
FT   VARIANT     394    394       M -> T (in dbSNP:rs1145231).
FT                                {ECO:0000269|PubMed:10480359}.
FT                                /FTId=VAR_012967.
FT   VARIANT     501    501       G -> R (in dbSNP:rs1145232).
FT                                {ECO:0000269|PubMed:10480359,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_012968.
FT   VARIANT     632    632       N -> S (in dbSNP:rs2066456).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_014878.
FT   VARIANT     720    720       E -> D (in dbSNP:rs2066455).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_014879.
FT   VARIANT     793    793       Y -> H (in dbSNP:rs1145234).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_014880.
FT   HELIX       577    592       {ECO:0000244|PDB:2CS1}.
FT   HELIX       598    610       {ECO:0000244|PDB:2CS1}.
FT   HELIX       614    625       {ECO:0000244|PDB:2CS1}.
FT   TURN        626    628       {ECO:0000244|PDB:2CS1}.
FT   HELIX       629    638       {ECO:0000244|PDB:2CS1}.
SQ   SEQUENCE   932 AA;  105830 MW;  EC4F402937B616DF CRC64;
     MKQLPAATVR LLSSSQIITS VVSVVKELIE NSLDAGATSV DVKLENYGFD KIEVRDNGEG
     IKAVDAPVMA MKYYTSKINS HEDLENLTTY GFRGEALGSI CCIAEVLITT RTAADNFSTQ
     YVLDGSGHIL SQKPSHLGQG TTVTALRLFK NLPVRKQFYS TAKKCKDEIK KIQDLLMSFG
     ILKPDLRIVF VHNKAVIWQK SRVSDHKMAL MSVLGTAVMN NMESFQYHSE ESQIYLSGFL
     PKCDADHSFT SLSTPERSFI FINSRPVHQK DILKLIRHHY NLKCLKESTR LYPVFFLKID
     VPTADVDVNL TPDKSQVLLQ NKESVLIALE NLMTTCYGPL PSTNSYENNK TDVSAADIVL
     SKTAETDVLF NKVESSGKNY SNVDTSVIPF QNDMHNDESG KNTDDCLNHQ ISIGDFGYGH
     CSSEISNIDK NTKNAFQDIS MSNVSWENSQ TEYSKTCFIS SVKHTQSENG NKDHIDESGE
     NEEEAGLENS SEISADEWSR GNILKNSVGE NIEPVKILVP EKSLPCKVSN NNYPIPEQMN
     LNEDSCNKKS NVIDNKSGKV TAYDLLSNRV IKKPMSASAL FVQDHRPQFL IENPKTSLED
     ATLQIEELWK TLSEEEKLKY EEKATKDLER YNSQMKRAIE QESQMSLKDG RKKIKPTSAW
     NLAQKHKLKT SLSNQPKLDE LLQSQIEKRR SQNIKMVQIP FSMKNLKINF KKQNKVDLEE
     KDEPCLIHNL RFPDAWLMTS KTEVMLLNPY RVEEALLFKR LLENHKLPAE PLEKPIMLTE
     SLFNGSHYLD VLYKMTADDQ RYSGSTYLSD PRLTANGFKI KLIPGVSITE NYLEIEGMAN
     CLPFYGVADL KEILNAILNR NAKEVYECRP RKVISYLEGE AVRLSRQLPM YLSKEDIQDI
     IYRMKHQFGN EIKECVHGRP FFHHLTYLPE TT
//
ID   Q3BDU3_HUMAN            Unreviewed;       659 AA.
AC   Q3BDU3;
DT   22-NOV-2005, integrated into UniProtKB/TrEMBL.
DT   22-NOV-2005, sequence version 1.
DT   25-APR-2018, entry version 113.
DE   SubName: Full=PMS1 protein homolog 1 {ECO:0000313|Ensembl:ENSP00000406225};
DE   SubName: Full=Rhabdomyosarcoma antigen MU-RMS-40.10E {ECO:0000313|EMBL:ABB04020.1};
GN   Name=PMS1 {ECO:0000313|EMBL:ABB04020.1,
GN   ECO:0000313|Ensembl:ENSP00000406225};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABB04020.1};
RN   [1] {ECO:0000313|EMBL:ABB04020.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Embryonal rhabdomyosarcoma {ECO:0000313|EMBL:ABB04020.1};
RA   Behrends U., Gotz C., Mautner J.;
RT   "SEREX-defined rhabdomyosarcoma antigens.";
RL   Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|Ensembl:ENSP00000406225, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [5] {ECO:0000313|Ensembl:ENSP00000406225}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [6] {ECO:0000313|Ensembl:ENSP00000491236}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (APR-2017) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC008122; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC013468; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AY540751; ABB04020.1; -; mRNA.
DR   RefSeq; NP_001307973.1; NM_001321044.1.
DR   UniGene; Hs.111749; -.
DR   MaxQB; Q3BDU3; -.
DR   PeptideAtlas; Q3BDU3; -.
DR   Ensembl; ENST00000450931; ENSP00000406225; ENSG00000064933.
DR   Ensembl; ENST00000639501; ENSP00000491236; ENSG00000064933.
DR   GeneID; 5378; -.
DR   UCSC; uc061qpw.1; human.
DR   CTD; 5378; -.
DR   EuPathDB; HostDB:ENSG00000064933.16; -.
DR   HGNC; HGNC:9121; PMS1.
DR   OpenTargets; ENSG00000064933; -.
DR   GeneTree; ENSGT00530000063289; -.
DR   HOGENOM; HOG000039972; -.
DR   HOVERGEN; HBG031886; -.
DR   ChiTaRS; PMS1; human.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000064933; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-UniRule.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0030983; F:mismatched DNA binding; IEA:InterPro.
DR   GO; GO:0006298; P:mismatch repair; IEA:InterPro.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 1.10.30.10; -; 1.
DR   Gene3D; 3.30.230.10; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR013507; DNA_mismatch_repair_C.
DR   InterPro; IPR014762; DNA_mismatch_repair_CS.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR009071; HMG_box_dom.
DR   InterPro; IPR036910; HMG_box_dom_sf.
DR   InterPro; IPR031263; PMS1_hom.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   InterPro; IPR014721; Ribosomal_S5_D2-typ_fold_subgr.
DR   PANTHER; PTHR10073:SF43; PTHR10073:SF43; 2.
DR   Pfam; PF01119; DNA_mis_repair; 1.
DR   Pfam; PF00505; HMG_box; 1.
DR   SMART; SM01340; DNA_mis_repair; 1.
DR   SMART; SM00398; HMG; 1.
DR   SUPFAM; SSF47095; SSF47095; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00058; DNA_MISMATCH_REPAIR_1; 1.
DR   PROSITE; PS50118; HMG_BOX_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00267,
KW   ECO:0000256|SAAS:SAAS00879239};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00267};
KW   Proteomics identification {ECO:0000213|EPD:Q3BDU3,
KW   ECO:0000213|MaxQB:Q3BDU3, ECO:0000213|PeptideAtlas:Q3BDU3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      532    600       HMG box. {ECO:0000259|PROSITE:PS50118}.
FT   DNA_BIND    532    600       HMG box. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00267}.
FT   COILED      582    602       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   659 AA;  74058 MW;  EF56E207736E2F62 CRC64;
     MKQLPAATVR LLSSSQIITS VVSVVKELIE NSLDAGATSV DVKLENYGFD KIEVRDNGEG
     IKAVDAPVMA MKYYTSKINS HEDLENLTTY GFRGEALGSI CCIAEVLITT RTAADNFSTQ
     YVLDGSGHIL SQKPSHLGQG TTVTALRLFK NLPVRKQFYS TAKKCKDEIK KIQDLLMSFG
     ILKPDLRIVF VHNKIYLSGF LPKCDADHSF TSLSTPERSF IFINSRPVHQ KDILKLIRHH
     YNLKCLKEST RLYPVFFLKI DVPTADVDVN LTPDKSQVLL QNKESVLIAL ENLMTTCYGP
     LPSTNSYENN KTDVSAADIV LSKTAETDVL FNKVESSGKN YSNVDTSVIP FQNDMHNDES
     GKNTDDCLNH QISIGDFGYG HCSSEISNID KNTKNAFQDI SMSNVSWENS QTEYSKTCFI
     SSVKHTQSEN GNKDHIDESG ENEEEAGLEN SSEISADEWS RGNILKNSVG ENIEPVKILV
     PEKSLPCKVS NNNYPIPEQM NLNEDSCNKK SNVIDNKSGK VTAYDLLSNR VIKKPMSASA
     LFVQDHRPQF LIENPKTSLE DATLQIEELW KTLSEEEKLK YEEKATKDLE RYNSQMKRAI
     EQESQMSLKD GRKKIKPTSA WNLAQKHKLK TSLSNQPKLD ELLQSQIEKR RSQNIKMSF
//
ID   Q5XG96_HUMAN            Unreviewed;       165 AA.
AC   Q5XG96;
DT   23-NOV-2004, integrated into UniProtKB/TrEMBL.
DT   23-NOV-2004, sequence version 1.
DT   28-MAR-2018, entry version 109.
DE   SubName: Full=PMS1 protein {ECO:0000313|EMBL:AAH84548.1};
DE   SubName: Full=PMS1 protein homolog 1 {ECO:0000313|Ensembl:ENSP00000363959};
GN   Name=PMS1 {ECO:0000313|EMBL:AAH84548.1,
GN   ECO:0000313|Ensembl:ENSP00000363959};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH84548.1};
RN   [1] {ECO:0000313|EMBL:AAH84548.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin {ECO:0000313|EMBL:AAH84548.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000363959, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [5] {ECO:0000313|Ensembl:ENSP00000363959}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC008122; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC013468; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC084548; AAH84548.1; -; mRNA.
DR   RefSeq; NP_001307980.1; NM_001321051.1.
DR   UniGene; Hs.111749; -.
DR   Ensembl; ENST00000374826; ENSP00000363959; ENSG00000064933.
DR   GeneID; 5378; -.
DR   UCSC; uc061qpv.1; human.
DR   CTD; 5378; -.
DR   EuPathDB; HostDB:ENSG00000064933.16; -.
DR   HGNC; HGNC:9121; PMS1.
DR   OpenTargets; ENSG00000064933; -.
DR   eggNOG; KOG1978; Eukaryota.
DR   eggNOG; COG0323; LUCA.
DR   GeneTree; ENSGT00530000063289; -.
DR   HOGENOM; HOG000249052; -.
DR   HOVERGEN; HBG055685; -.
DR   ChiTaRS; PMS1; human.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000064933; -.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR014762; DNA_mismatch_repair_CS.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR031263; PMS1_hom.
DR   PANTHER; PTHR10073:SF43; PTHR10073:SF43; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00058; DNA_MISMATCH_REPAIR_1; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:Q5XG96,
KW   ECO:0000213|MaxQB:Q5XG96, ECO:0000213|PeptideAtlas:Q5XG96};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   165 AA;  17838 MW;  2E2D124D4EDA8BF6 CRC64;
     MKQLPAATVR LLSSSQIITS VVSVVKELIE NSLDAGATSV DVKLENYGFD KIEVRDNGEG
     IKAVDAPVMA MKYYTSKINS HEDLENLTTY GFRGEALGSI CCIAEVLITT RTAADNFSTQ
     YVLDGSGHIL SQKPSHLGQG SHSVTQAGLQ WHHLGSLQPL PPRLK
//
ID   KPCB_HUMAN              Reviewed;         671 AA.
AC   P05771; C5IFJ8; D3DWF5; O43744; P05127; Q15138; Q93060; Q9UE49;
AC   Q9UE50; Q9UEH8; Q9UJ30; Q9UJ33;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   25-APR-2018, entry version 225.
DE   RecName: Full=Protein kinase C beta type;
DE            Short=PKC-B;
DE            Short=PKC-beta;
DE            EC=2.7.11.13;
GN   Name=PRKCB; Synonyms=PKCB, PRKCB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-II).
RX   PubMed=3755548; DOI=10.1126/science.3755548;
RA   Coussens L., Parker P.J., Rhee L., Yang-Feng T.L., Chen E.,
RA   Waterfield M.D., Francke U., Ullrich A.;
RT   "Multiple, distinct forms of bovine and human protein kinase C suggest
RT   diversity in cellular signaling pathways.";
RL   Science 233:859-866(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS BETA-I AND BETA-II).
RX   PubMed=3666134; DOI=10.1016/0014-5793(87)80524-0;
RA   Kubo K., Ohno S., Suzuki K.;
RT   "Primary structures of human protein kinase C beta I and beta II
RT   differ only in their C-terminal sequences.";
RL   FEBS Lett. 223:138-142(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (APR-2009) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10493829; DOI=10.1006/geno.1999.5927;
RA   Loftus B.J., Kim U.-J., Sneddon V.P., Kalush F., Brandon R.,
RA   Fuhrmann J., Mason T., Crosby M.L., Barnstead M., Cronin L.,
RA   Mays A.D., Cao Y., Xu R.X., Kang H.-L., Mitchell S., Eichler E.E.,
RA   Harris P.C., Venter J.C., Adams M.D.;
RT   "Genome duplications and other features in 12 Mb of DNA sequence from
RT   human chromosome 16p and 16q.";
RL   Genomics 60:295-308(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Hippocampus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-69.
RX   PubMed=7880442; DOI=10.1089/dna.1995.14.213;
RA   Mahajna J., King P., Parker P., Haley J.;
RT   "Autoregulation of cloned human protein kinase C beta and gamma gene
RT   promoters in U937 cells.";
RL   DNA Cell Biol. 14:213-222(1995).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-58.
RX   PubMed=1556124;
RA   Niino Y.S., Ohno S., Suzuki K.;
RT   "Positive and negative regulation of the transcription of the human
RT   protein kinase C beta gene.";
RL   J. Biol. Chem. 267:6158-6163(1992).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-57.
RX   PubMed=1400396;
RA   Obeid L.M., Blobe G.C., Karolak L.A., Hannun Y.A.;
RT   "Cloning and characterization of the major promoter of the human
RT   protein kinase C beta gene. Regulation by phorbol esters.";
RL   J. Biol. Chem. 267:20804-20810(1992).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-19, AND ACETYLATION AT ALA-2.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 97-176.
RA   Greenham J.A., Adams M.D., Doggett N.A., Mole S.E.;
RT   "The genomic structure of the human protein kinase C beta gene
RT   (PRKCB).";
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 609-671.
RC   TISSUE=Fetal brain;
RX   PubMed=3677994; DOI=10.1089/dna.1987.6.389;
RA   Coussens L., Rhee L., Parker P.J., Ullrich A.;
RT   "Alternative splicing increases the diversity of the human protein
RT   kinase C family.";
RL   DNA 6:389-394(1987).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 622-671.
RX   PubMed=3658678; DOI=10.1093/nar/15.17.7179;
RA   Kubo K., Ohno S., Suzuki K.;
RT   "Nucleotide sequence of the 3' portion of a human gene for protein
RT   kinase C beta-I/beta-II.";
RL   Nucleic Acids Res. 15:7179-7180(1987).
RN   [14]
RP   FUNCTION IN PHOSPHORYLATION OF BTK.
RX   PubMed=11598012; DOI=10.1093/emboj/20.20.5692;
RA   Kang S.W., Wahl M.I., Chu J., Kitaura J., Kawakami Y., Kato R.M.,
RA   Tabuchi R., Tarakhovsky A., Kawakami T., Turck C.W., Witte O.N.,
RA   Rawlings D.J.;
RT   "PKCbeta modulates antigen receptor signaling via regulation of Btk
RT   membrane localization.";
RL   EMBO J. 20:5692-5702(2001).
RN   [15]
RP   ENZYME REGULATION.
RX   PubMed=16103100; DOI=10.1158/0008-5472.CAN-05-0071;
RA   Graff J.R., McNulty A.M., Hanna K.R., Konicek B.W., Lynch R.L.,
RA   Bailey S.N., Banks C., Capen A., Goode R., Lewis J.E., Sams L.,
RA   Huss K.L., Campbell R.M., Iversen P.W., Neubauer B.L., Brown T.J.,
RA   Musib L., Geeganage S., Thornton D.;
RT   "The protein kinase Cbeta-selective inhibitor, enzastaurin
RT   (LY317615.HCl), suppresses signaling through the AKT pathway, induces
RT   apoptosis, and suppresses growth of human colon cancer and
RT   glioblastoma xenografts.";
RL   Cancer Res. 65:7462-7469(2005).
RN   [16]
RP   INTERACTION WITH PHLPP1 AND PHLPP2.
RX   PubMed=18162466; DOI=10.1074/jbc.M707319200;
RA   Gao T., Brognard J., Newton A.C.;
RT   "The phosphatase PHLPP controls the cellular levels of protein kinase
RT   C.";
RL   J. Biol. Chem. 283:6300-6311(2008).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [18]
RP   FUNCTION.
RX   PubMed=19176525; DOI=10.1074/jbc.M808719200;
RA   Yamasaki T., Takahashi A., Pan J., Yamaguchi N., Yokoyama K.K.;
RT   "Phosphorylation of activation transcription factor-2 at serine 121 by
RT   protein kinase c controls c-Jun-mediated activation of
RT   transcription.";
RL   J. Biol. Chem. 284:8567-8581(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-504, PHOSPHORYLATION
RP   [LARGE SCALE ANALYSIS] AT THR-641 AND SER-660 (ISOFORM BETA-II), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [20]
RP   FUNCTION IN HISTONE H3 PHOSPHORYLATION, CATALYTIC ACTIVITY,
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH KDM1A; PKN1 AND ANDR.
RX   PubMed=20228790; DOI=10.1038/nature08839;
RA   Metzger E., Imhof A., Patel D., Kahl P., Hoffmeyer K., Friedrichs N.,
RA   Muller J.M., Greschik H., Kirfel J., Ji S., Kunowska N.,
RA   Beisenherz-Huss C., Gunther T., Buettner R., Schule R.;
RT   "Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation
RT   at histone H3K4.";
RL   Nature 464:792-796(2010).
RN   [21]
RP   REVIEW ON FUNCTION.
RX   PubMed=12417015; DOI=10.1093/oxfordjournals.jbchem.a003273;
RA   Kawakami T., Kawakami Y., Kitaura J.;
RT   "Protein kinase C beta (PKC beta): normal functions and diseases.";
RL   J. Biochem. 132:677-682(2002).
RN   [22]
RP   REVIEW ON FUNCTION.
RX   PubMed=20186491; DOI=10.1007/s11154-010-9134-4;
RA   Tabit C.E., Chung W.B., Hamburg N.M., Vita J.A.;
RT   "Endothelial dysfunction in diabetes mellitus: molecular mechanisms
RT   and clinical implications.";
RL   Rev. Endocr. Metab. Disord. 11:61-74(2010).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; THR-17; SER-206;
RP   SER-311; THR-314 AND THR-642, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-641 AND SER-660 (ISOFORM
RP   BETA-II), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 321-660 IN COMPLEX WITH
RP   INHIBITOR, AND PHOSPHORYLATION AT THR-500; THR-642 AND SER-661.
RX   PubMed=17115692; DOI=10.1021/bi061128h;
RA   Grodsky N., Li Y., Bouzida D., Love R., Jensen J., Nodes B.,
RA   Nonomiya J., Grant S.;
RT   "Structure of the catalytic domain of human protein kinase C beta II
RT   complexed with a bisindolylmaleimide inhibitor.";
RL   Biochemistry 45:13970-13981(2006).
RN   [27]
RP   VARIANTS [LARGE SCALE ANALYSIS] MET-144; MET-496 AND HIS-588.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Calcium-activated, phospholipid- and diacylglycerol
CC       (DAG)-dependent serine/threonine-protein kinase involved in
CC       various cellular processes such as regulation of the B-cell
CC       receptor (BCR) signalosome, oxidative stress-induced apoptosis,
CC       androgen receptor-dependent transcription regulation, insulin
CC       signaling and endothelial cells proliferation. Plays a key role in
CC       B-cell activation by regulating BCR-induced NF-kappa-B activation.
CC       Mediates the activation of the canonical NF-kappa-B pathway
CC       (NFKB1) by direct phosphorylation of CARD11/CARMA1 at 'Ser-559',
CC       'Ser-644' and 'Ser-652'. Phosphorylation induces CARD11/CARMA1
CC       association with lipid rafts and recruitment of the BCL10-MALT1
CC       complex as well as MAP3K7/TAK1, which then activates IKK complex,
CC       resulting in nuclear translocation and activation of NFKB1. Plays
CC       a direct role in the negative feedback regulation of the BCR
CC       signaling, by down-modulating BTK function via direct
CC       phosphorylation of BTK at 'Ser-180', which results in the
CC       alteration of BTK plasma membrane localization and in turn
CC       inhibition of BTK activity. Involved in apoptosis following
CC       oxidative damage: in case of oxidative conditions, specifically
CC       phosphorylates 'Ser-36' of isoform p66Shc of SHC1, leading to
CC       mitochondrial accumulation of p66Shc, where p66Shc acts as a
CC       reactive oxygen species producer. Acts as a coactivator of
CC       androgen receptor (ANDR)-dependent transcription, by being
CC       recruited to ANDR target genes and specifically mediating
CC       phosphorylation of 'Thr-6' of histone H3 (H3T6ph), a specific tag
CC       for epigenetic transcriptional activation that prevents
CC       demethylation of histone H3 'Lys-4' (H3K4me) by LSD1/KDM1A. In
CC       insulin signaling, may function downstream of IRS1 in muscle cells
CC       and mediate insulin-dependent DNA synthesis through the RAF1-
CC       MAPK/ERK signaling cascade. May participate in the regulation of
CC       glucose transport in adipocytes by negatively modulating the
CC       insulin-stimulated translocation of the glucose transporter
CC       SLC2A4/GLUT4. Under high glucose in pancreatic beta-cells, is
CC       probably involved in the inhibition of the insulin gene
CC       transcription, via regulation of MYC expression. In endothelial
CC       cells, activation of PRKCB induces increased phosphorylation of
CC       RB1, increased VEGFA-induced cell proliferation, and inhibits
CC       PI3K/AKT-dependent nitric oxide synthase (NOS3/eNOS) regulation by
CC       insulin, which causes endothelial dysfunction. Also involved in
CC       triglyceride homeostasis (By similarity). Phosphorylates ATF2
CC       which promotes cooperation between ATF2 and JUN, activating
CC       transcription. {ECO:0000250, ECO:0000269|PubMed:11598012,
CC       ECO:0000269|PubMed:19176525, ECO:0000269|PubMed:20228790}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:20228790}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000250|UniProtKB:P68403};
CC       Note=Binds 3 Ca(2+) ions per subunit. The ions are bound to the C2
CC       domain. {ECO:0000250|UniProtKB:P68403};
CC   -!- ENZYME REGULATION: Classical (or conventional) PKCs (PRKCA, PRKCB
CC       and PRKCG) are activated by calcium and diacylglycerol (DAG) in
CC       the presence of phosphatidylserine. Three specific sites; Thr-500
CC       (activation loop of the kinase domain), Thr-642 (turn motif) and
CC       Ser-661 (hydrophobic region), need to be phosphorylated for its
CC       full activation. Specifically inhibited by enzastaurin (LY317615).
CC       {ECO:0000269|PubMed:16103100}.
CC   -!- SUBUNIT: Interacts with PDK1 (By similarity). Interacts in vitro
CC       with PRKCBP1. Interacts with PHLPP1 and PHLPP2; both proteins
CC       mediate its dephosphorylation. Interacts with KDM1A/LSD1, PKN1 and
CC       ANDR. {ECO:0000250, ECO:0000269|PubMed:17115692,
CC       ECO:0000269|PubMed:18162466, ECO:0000269|PubMed:20228790}.
CC   -!- INTERACTION:
CC       O60341-1:KDM1A; NbExp=2; IntAct=EBI-5774492, EBI-15599570;
CC       O60346:PHLPP1; NbExp=5; IntAct=EBI-5774511, EBI-2511516;
CC       Q6ZVD8:PHLPP2; NbExp=2; IntAct=EBI-5774511, EBI-2511496;
CC       Q8NEM2:SHCBP1; NbExp=2; IntAct=EBI-706216, EBI-744700;
CC       Q9BSI4:TINF2; NbExp=2; IntAct=EBI-706216, EBI-717399;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000269|PubMed:20228790}. Membrane {ECO:0000250}; Peripheral
CC       membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Beta-I; Synonyms=PRKCB1;
CC         IsoId=P05771-1; Sequence=Displayed;
CC       Name=Beta-II; Synonyms=PRKCB2;
CC         IsoId=P05771-2; Sequence=VSP_004738;
CC         Note=Contains a phosphothreonine at position 641. Contains a
CC         phosphoserine at position 660. {ECO:0000244|PubMed:19369195,
CC         ECO:0000244|PubMed:24275569};
CC   -!- PTM: Phosphorylation on Thr-500 within the activation loop renders
CC       it competent to autophosphorylate. Subsequent autophosphorylation
CC       of Thr-642 maintains catalytic competence, and autophosphorylation
CC       on Ser-661 appears to release the kinase into the cytosol.
CC       Autophosphorylation on other sites i.e. in the N-terminal and
CC       hinge regions have no effect on enzyme activity. Phosphorylation
CC       at Tyr-662 by SYK induces binding with GRB2 and contributes to the
CC       activation of MAPK/ERK signaling cascade (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/prkcb1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M13975; AAA60095.1; -; mRNA.
DR   EMBL; X06318; CAA29634.1; -; mRNA.
DR   EMBL; X07109; CAA30130.1; -; mRNA.
DR   EMBL; FJ907246; ACS14045.1; -; Genomic_DNA.
DR   EMBL; AC130454; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC002299; AAB97933.1; -; Genomic_DNA.
DR   EMBL; AC002299; AAB97934.1; -; Genomic_DNA.
DR   EMBL; CH471145; EAW55797.1; -; Genomic_DNA.
DR   EMBL; CH471145; EAW55798.1; -; Genomic_DNA.
DR   EMBL; BC036472; AAH36472.1; -; mRNA.
DR   EMBL; X62532; CAA44393.1; -; Genomic_DNA.
DR   EMBL; S47311; AAD13852.1; -; Genomic_DNA.
DR   EMBL; D10022; BAA00912.1; -; Genomic_DNA.
DR   EMBL; AJ002799; CAA05725.1; -; Genomic_DNA.
DR   EMBL; AJ002800; CAA05725.1; JOINED; Genomic_DNA.
DR   EMBL; M18254; AAA60096.1; -; Genomic_DNA.
DR   EMBL; M18255; AAA60097.1; -; Genomic_DNA.
DR   EMBL; X05972; CAA29396.1; -; Genomic_DNA.
DR   EMBL; X05971; CAA29395.1; -; Genomic_DNA.
DR   CCDS; CCDS10618.1; -. [P05771-1]
DR   CCDS; CCDS10619.1; -. [P05771-2]
DR   PIR; B24664; KIHUC2.
DR   PIR; S00159; KIHUC1.
DR   RefSeq; NP_002729.2; NM_002738.6. [P05771-2]
DR   RefSeq; NP_997700.1; NM_212535.2. [P05771-1]
DR   UniGene; Hs.460355; -.
DR   PDB; 2I0E; X-ray; 2.60 A; A/B=321-671.
DR   PDBsum; 2I0E; -.
DR   ProteinModelPortal; P05771; -.
DR   SMR; P05771; -.
DR   BioGrid; 111565; 65.
DR   DIP; DIP-34187N; -.
DR   IntAct; P05771; 28.
DR   MINT; P05771; -.
DR   STRING; 9606.ENSP00000305355; -.
DR   BindingDB; P05771; -.
DR   ChEMBL; CHEMBL3045; -.
DR   DrugBank; DB08846; Ellagic Acid.
DR   DrugBank; DB01738; O-Phosphoethanolamine.
DR   DrugBank; DB00675; Tamoxifen.
DR   DrugBank; DB00163; Vitamin E.
DR   GuidetoPHARMACOLOGY; 1483; -.
DR   iPTMnet; P05771; -.
DR   PhosphoSitePlus; P05771; -.
DR   BioMuta; PRKCB; -.
DR   DMDM; 20141488; -.
DR   MaxQB; P05771; -.
DR   PaxDb; P05771; -.
DR   PeptideAtlas; P05771; -.
DR   PRIDE; P05771; -.
DR   DNASU; 5579; -.
DR   Ensembl; ENST00000303531; ENSP00000305355; ENSG00000166501. [P05771-2]
DR   Ensembl; ENST00000321728; ENSP00000318315; ENSG00000166501. [P05771-1]
DR   GeneID; 5579; -.
DR   KEGG; hsa:5579; -.
DR   UCSC; uc002dmd.4; human. [P05771-1]
DR   CTD; 5579; -.
DR   DisGeNET; 5579; -.
DR   EuPathDB; HostDB:ENSG00000166501.12; -.
DR   GeneCards; PRKCB; -.
DR   HGNC; HGNC:9395; PRKCB.
DR   HPA; CAB003843; -.
DR   HPA; HPA048321; -.
DR   HPA; HPA054203; -.
DR   MIM; 176970; gene.
DR   neXtProt; NX_P05771; -.
DR   OpenTargets; ENSG00000166501; -.
DR   PharmGKB; PA33761; -.
DR   eggNOG; KOG0694; Eukaryota.
DR   eggNOG; ENOG410XNPH; LUCA.
DR   GeneTree; ENSGT00820000126964; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; P05771; -.
DR   KO; K19662; -.
DR   OMA; QAHIDRE; -.
DR   OrthoDB; EOG091G0QRS; -.
DR   PhylomeDB; P05771; -.
DR   TreeFam; TF351133; -.
DR   BRENDA; 2.7.11.13; 2681.
DR   Reactome; R-HSA-114516; Disinhibition of SNARE formation.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-416993; Trafficking of GluR2-containing AMPA receptors.
DR   Reactome; R-HSA-418597; G alpha (z) signalling events.
DR   Reactome; R-HSA-4419969; Depolymerisation of the Nuclear Lamina.
DR   Reactome; R-HSA-5099900; WNT5A-dependent internalization of FZD4.
DR   Reactome; R-HSA-5218921; VEGFR2 mediated cell proliferation.
DR   Reactome; R-HSA-76005; Response to elevated platelet cytosolic Ca2+.
DR   Reactome; R-HSA-8939246; RUNX1 regulates transcription of genes involved in differentiation of myeloid cells.
DR   SABIO-RK; P05771; -.
DR   SignaLink; P05771; -.
DR   SIGNOR; P05771; -.
DR   ChiTaRS; PRKCB; human.
DR   EvolutionaryTrace; P05771; -.
DR   GeneWiki; PRKCB1; -.
DR   GenomeRNAi; 5579; -.
DR   PMAP-CutDB; P05771; -.
DR   PRO; PR:P05771; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000166501; -.
DR   ExpressionAtlas; P05771; baseline and differential.
DR   Genevisible; P05771; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0050681; F:androgen receptor binding; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004698; F:calcium-dependent protein kinase C activity; TAS:Reactome.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0042393; F:histone binding; IDA:UniProtKB.
DR   GO; GO:0035403; F:histone kinase activity (H3-T6 specific); IDA:UniProtKB.
DR   GO; GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IMP:UniProtKB.
DR   GO; GO:0004697; F:protein kinase C activity; TAS:Reactome.
DR   GO; GO:0005080; F:protein kinase C binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; EXP:Reactome.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0042113; P:B cell activation; ISS:UniProtKB.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0035408; P:histone H3-T6 phosphorylation; IDA:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0042953; P:lipoprotein transport; TAS:BHF-UCL.
DR   GO; GO:0007077; P:mitotic nuclear envelope disassembly; TAS:Reactome.
DR   GO; GO:0010829; P:negative regulation of glucose transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0046627; P:negative regulation of insulin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISS:UniProtKB.
DR   GO; GO:0050861; P:positive regulation of B cell receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; ISS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0030949; P:positive regulation of vascular endothelial growth factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0045637; P:regulation of myeloid cell differentiation; TAS:Reactome.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; NAS:ProtInc.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00029; C1; 2.
DR   CDD; cd05616; STKc_cPKC_beta; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR034664; cPKC_beta.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR014375; Protein_kinase_C_a/b/g.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000550; PKC_alpha; 1.
DR   PRINTS; PR00360; C2DOMAIN.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Adaptive immunity; Alternative splicing;
KW   Apoptosis; ATP-binding; Calcium; Chromatin regulator;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; Immunity;
KW   Kinase; Membrane; Metal-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transcription;
KW   Transcription regulation; Transferase; Zinc; Zinc-finger.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:12665801}.
FT   CHAIN         2    671       Protein kinase C beta type.
FT                                /FTId=PRO_0000055684.
FT   DOMAIN      173    260       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   DOMAIN      342    600       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      601    671       AGC-kinase C-terminal.
FT   ZN_FING      36     86       Phorbol-ester/DAG-type 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   ZN_FING     101    151       Phorbol-ester/DAG-type 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   NP_BIND     348    356       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    466    466       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   METAL       186    186       Calcium 1; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P68403}.
FT   METAL       187    187       Calcium 1.
FT                                {ECO:0000250|UniProtKB:P68403}.
FT   METAL       187    187       Calcium 2.
FT                                {ECO:0000250|UniProtKB:P68403}.
FT   METAL       193    193       Calcium 2.
FT                                {ECO:0000250|UniProtKB:P68403}.
FT   METAL       246    246       Calcium 1.
FT                                {ECO:0000250|UniProtKB:P68403}.
FT   METAL       246    246       Calcium 2.
FT                                {ECO:0000250|UniProtKB:P68403}.
FT   METAL       247    247       Calcium 2; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P68403}.
FT   METAL       248    248       Calcium 1.
FT                                {ECO:0000250|UniProtKB:P68403}.
FT   METAL       248    248       Calcium 2.
FT                                {ECO:0000250|UniProtKB:P68403}.
FT   METAL       248    248       Calcium 3.
FT                                {ECO:0000250|UniProtKB:P68403}.
FT   METAL       251    251       Calcium 3.
FT                                {ECO:0000250|UniProtKB:P68403}.
FT   METAL       252    252       Calcium 3; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:P68403}.
FT   METAL       254    254       Calcium 1.
FT                                {ECO:0000250|UniProtKB:P68403}.
FT   METAL       254    254       Calcium 3.
FT                                {ECO:0000250|UniProtKB:P68403}.
FT   BINDING     371    371       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000269|PubMed:12665801}.
FT   MOD_RES      11     11       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      16     16       Phosphoserine; by autocatalysis.
FT                                {ECO:0000250|UniProtKB:P68403,
FT                                ECO:0000255}.
FT   MOD_RES      17     17       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     206    206       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     250    250       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     311    311       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     314    314       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     324    324       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250|UniProtKB:P68403,
FT                                ECO:0000255}.
FT   MOD_RES     500    500       Phosphothreonine; by PDPK1.
FT                                {ECO:0000305|PubMed:17115692}.
FT   MOD_RES     504    504       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     635    635       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250|UniProtKB:P68403}.
FT   MOD_RES     642    642       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:17115692}.
FT   MOD_RES     661    661       Phosphoserine; by autocatalysis.
FT                                {ECO:0000269|PubMed:17115692}.
FT   MOD_RES     662    662       Phosphotyrosine; by SYK.
FT                                {ECO:0000250|UniProtKB:P68404}.
FT   VAR_SEQ     622    671       RDKRDTSNFDKEFTRQPVELTPTDKLFIMNLDQNEFAGFSY
FT                                TNPEFVINV -> CGRNAENFDRFFTRHPPVLTPPDQEVIR
FT                                NIDQSEFEGFSFVNSEFLKPEVKS (in isoform
FT                                Beta-II). {ECO:0000303|PubMed:3666134,
FT                                ECO:0000303|PubMed:3755548}.
FT                                /FTId=VSP_004738.
FT   VARIANT     144    144       V -> M (in a colorectal adenocarcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs764534677).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042304.
FT   VARIANT     496    496       V -> M (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042305.
FT   VARIANT     588    588       P -> H (in dbSNP:rs35631544).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042306.
FT   CONFLICT     69     69       V -> G (in Ref. 7; CAA44393).
FT                                {ECO:0000305}.
FT   STRAND      342    351       {ECO:0000244|PDB:2I0E}.
FT   STRAND      354    361       {ECO:0000244|PDB:2I0E}.
FT   STRAND      364    374       {ECO:0000244|PDB:2I0E}.
FT   HELIX       375    380       {ECO:0000244|PDB:2I0E}.
FT   HELIX       384    394       {ECO:0000244|PDB:2I0E}.
FT   STRAND      406    411       {ECO:0000244|PDB:2I0E}.
FT   STRAND      413    421       {ECO:0000244|PDB:2I0E}.
FT   HELIX       428    435       {ECO:0000244|PDB:2I0E}.
FT   HELIX       440    459       {ECO:0000244|PDB:2I0E}.
FT   HELIX       469    471       {ECO:0000244|PDB:2I0E}.
FT   STRAND      472    474       {ECO:0000244|PDB:2I0E}.
FT   STRAND      480    482       {ECO:0000244|PDB:2I0E}.
FT   HELIX       505    507       {ECO:0000244|PDB:2I0E}.
FT   HELIX       510    513       {ECO:0000244|PDB:2I0E}.
FT   HELIX       521    536       {ECO:0000244|PDB:2I0E}.
FT   HELIX       546    555       {ECO:0000244|PDB:2I0E}.
FT   HELIX       566    575       {ECO:0000244|PDB:2I0E}.
FT   HELIX       590    595       {ECO:0000244|PDB:2I0E}.
FT   HELIX       598    600       {ECO:0000244|PDB:2I0E}.
FT   HELIX       605    609       {ECO:0000244|PDB:2I0E}.
FT   HELIX       629    636       {ECO:0000244|PDB:2I0E}.
FT   HELIX       646    651       {ECO:0000244|PDB:2I0E}.
FT   TURN        654    657       {ECO:0000244|PDB:2I0E}.
SQ   SEQUENCE   671 AA;  76869 MW;  3937E7B667108C68 CRC64;
     MADPAAGPPP SEGEESTVRF ARKGALRQKN VHEVKNHKFT ARFFKQPTFC SHCTDFIWGF
     GKQGFQCQVC CFVVHKRCHE FVTFSCPGAD KGPASDDPRS KHKFKIHTYS SPTFCDHCGS
     LLYGLIHQGM KCDTCMMNVH KRCVMNVPSL CGTDHTERRG RIYIQAHIDR DVLIVLVRDA
     KNLVPMDPNG LSDPYVKLKL IPDPKSESKQ KTKTIKCSLN PEWNETFRFQ LKESDKDRRL
     SVEIWDWDLT SRNDFMGSLS FGISELQKAS VDGWFKLLSQ EEGEYFNVPV PPEGSEANEE
     LRQKFERAKI SQGTKVPEEK TTNTVSKFDN NGNRDRMKLT DFNFLMVLGK GSFGKVMLSE
     RKGTDELYAV KILKKDVVIQ DDDVECTMVE KRVLALPGKP PFLTQLHSCF QTMDRLYFVM
     EYVNGGDLMY HIQQVGRFKE PHAVFYAAEI AIGLFFLQSK GIIYRDLKLD NVMLDSEGHI
     KIADFGMCKE NIWDGVTTKT FCGTPDYIAP EIIAYQPYGK SVDWWAFGVL LYEMLAGQAP
     FEGEDEDELF QSIMEHNVAY PKSMSKEAVA ICKGLMTKHP GKRLGCGPEG ERDIKEHAFF
     RYIDWEKLER KEIQPPYKPK ARDKRDTSNF DKEFTRQPVE LTPTDKLFIM NLDQNEFAGF
     SYTNPEFVIN V
//
ID   F8VU11_HUMAN            Unreviewed;       892 AA.
AC   F8VU11;
DT   21-SEP-2011, integrated into UniProtKB/TrEMBL.
DT   26-JUN-2013, sequence version 2.
DT   25-APR-2018, entry version 64.
DE   SubName: Full=PRP40 pre-mRNA processing factor 40 homolog B (Yeast), isoform CRA_a {ECO:0000313|EMBL:EAW58084.1};
DE   SubName: Full=Pre-mRNA-processing factor 40 homolog B {ECO:0000313|Ensembl:ENSP00000448073};
GN   Name=PRPF40B {ECO:0000313|EMBL:EAW58084.1,
GN   ECO:0000313|Ensembl:ENSP00000448073};
GN   ORFNames=hCG_20201 {ECO:0000313|EMBL:EAW58084.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000448073, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW58084.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW58084.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000448073, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RG   Baylor College of Medicine Human Genome Sequencing Center Sequence Production Team;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A., null.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [5] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [6] {ECO:0000313|Ensembl:ENSP00000448073}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [7] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9] {ECO:0000213|PubMed:25755297}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurethsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide Analysis of SUMOylation Dynamics in Response to
RT   Replication Stress Reveals Novel Small Ubiquitin-like Modified Target
RT   Proteins and Acceptor Lysines Relevant for Genome Stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [10] {ECO:0000213|PubMed:28112733}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC020612; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471111; EAW58084.1; -; Genomic_DNA.
DR   RefSeq; NP_001026868.2; NM_001031698.2.
DR   UniGene; Hs.706827; -.
DR   MaxQB; F8VU11; -.
DR   Ensembl; ENST00000548825; ENSP00000448073; ENSG00000110844.
DR   GeneID; 25766; -.
DR   UCSC; uc001rus.3; human.
DR   CTD; 25766; -.
DR   EuPathDB; HostDB:ENSG00000110844.13; -.
DR   HGNC; HGNC:25031; PRPF40B.
DR   OpenTargets; ENSG00000110844; -.
DR   eggNOG; KOG0152; Eukaryota.
DR   eggNOG; COG5104; LUCA.
DR   GeneTree; ENSGT00910000144180; -.
DR   OMA; QAELPNR; -.
DR   OrthoDB; EOG091G06F8; -.
DR   ChiTaRS; PRPF40B; human.
DR   GenomeRNAi; 25766; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000110844; -.
DR   CDD; cd00201; WW; 2.
DR   Gene3D; 1.10.10.440; -; 5.
DR   InterPro; IPR002713; FF_domain.
DR   InterPro; IPR036517; FF_domain_sf.
DR   InterPro; IPR001202; WW_dom.
DR   InterPro; IPR036020; WW_dom_sf.
DR   Pfam; PF01846; FF; 2.
DR   Pfam; PF00397; WW; 2.
DR   SMART; SM00441; FF; 4.
DR   SMART; SM00456; WW; 2.
DR   SUPFAM; SSF51045; SSF51045; 2.
DR   SUPFAM; SSF81698; SSF81698; 5.
DR   PROSITE; PS51676; FF; 6.
DR   PROSITE; PS01159; WW_DOMAIN_1; 1.
DR   PROSITE; PS50020; WW_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:F8VU11,
KW   ECO:0000213|MaxQB:F8VU11, ECO:0000213|PeptideAtlas:F8VU11};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      114    147       WW. {ECO:0000259|PROSITE:PS50020}.
FT   DOMAIN      160    188       WW. {ECO:0000259|PROSITE:PS50020}.
FT   DOMAIN      298    352       FF. {ECO:0000259|PROSITE:PS51676}.
FT   DOMAIN      362    419       FF. {ECO:0000259|PROSITE:PS51676}.
FT   DOMAIN      432    492       FF. {ECO:0000259|PROSITE:PS51676}.
FT   DOMAIN      512    572       FF. {ECO:0000259|PROSITE:PS51676}.
FT   DOMAIN      576    632       FF. {ECO:0000259|PROSITE:PS51676}.
FT   DOMAIN      647    704       FF. {ECO:0000259|PROSITE:PS51676}.
FT   COILED      339    378       {ECO:0000256|SAM:Coils}.
FT   COILED      421    441       {ECO:0000256|SAM:Coils}.
FT   COILED      476    516       {ECO:0000256|SAM:Coils}.
FT   COILED      626    651       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   892 AA;  101351 MW;  BBD54B0BCB698EEE CRC64;
     MSVPDSGPRP PAAPAPFPPG PPMMPPPFMP PPGIPPPFPP MGLPPMSQRP PAIPPMPPGI
     LPPMLPPMGA PPPLTQIPGM VPPMMPGMLM PAVPVTAATA PGADTASSAV AGTGPPRALW
     SEHVAPDGRI YYYNADDKQS VWEKPSVLKS KAELLLSQCP WKEYKSDTGK PYYYNNQSKE
     SRWTRPKDLD DLEVLVKQEA AGKQQQQLPQ TLQPQPPQPQ PDPPPVPPGP TPVPTGLLEP
     EPGGSEDCDV LEATQPLEQG FLQQLEEGPS SSGQHQPQQE EEESKPEPER SGLSWSNREK
     AKQAFKELLR DKAVPSNASW EQAMKMVVTD PRYSALPKLS EKKQAFNAYK AQREKEEKEE
     ARLRAKEAKQ TLQHFLEQHE RMTSTTRYRR AEQTFGELEV WAVVPERDRK EVYDDVLFFL
     AKKEKEQAKQ LRRRNIQALK SILDGMSSVN FQTTWSQAQQ YLMDNPSFAQ DHQLQNMDKE
     DALICFEEHI RALEREEEEE RERARLRERR QQRKNREAFQ TFLDELHETG QLHSMSTWME
     LYPAVSTDVR FANMLGQPGS TPLDLFKFYV EELKARFHDE KKIIKDILKD RGFCVEVNTA
     FEDFAHVISF DKRAAALDAG NIKLTFNSLL EKAEARERER EKEEARRMRR REAAFRSMLR
     QAVPALELGT AWEEVRERFV CDSAFEQITL ESERIRLFRE FLQVLETECQ HLHTKGRKHG
     RKGKKHHHKR SHSPSGSESE EEELPPPSLR PPKRRRRNPS ESGSEPSSSL DSVESGGAAL
     GGRGSPSSHL LGADHGLRKA KKPKKKTKKR RHKSNSPESE TDPEEKAGKE SDEKEQEQDK
     DRELQQAELP NRSPGFGIKK EKTGWDTSES ELSEGELERR RRTLLQQLDD HQ
//
ID   PR40B_HUMAN             Reviewed;         871 AA.
AC   Q6NWY9; O75401; Q6PI09; Q6ZWB3; Q8NCZ1; Q9H5G4; Q9NT95;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   28-FEB-2018, entry version 119.
DE   RecName: Full=Pre-mRNA-processing factor 40 homolog B;
DE   AltName: Full=Huntingtin yeast partner C;
DE   AltName: Full=Huntingtin-interacting protein C;
GN   Name=PRPF40B; Synonyms=HYPC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 494-871 (ISOFORM 3).
RC   TISSUE=Caudate nucleus, and Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 419-871 (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-785 (ISOFORM 3).
RC   TISSUE=Ovary, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 36-179 (ISOFORMS 1/2/3), FUNCTION,
RP   INTERACTION WITH HD, AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=9700202; DOI=10.1093/hmg/7.9.1463;
RA   Faber P.W., Barnes G.T., Srinidhi J., Chen J., Gusella J.F.,
RA   MacDonald M.E.;
RT   "Huntingtin interacts with a family of WW domain proteins.";
RL   Hum. Mol. Genet. 7:1463-1474(1998).
RN   [6]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=10958656; DOI=10.1093/hmg/9.14.2175;
RA   Passani L.A., Bedford M.T., Faber P.W., McGinnis K.M., Sharp A.H.,
RA   Gusella J.F., Vonsattel J.-P., MacDonald M.E.;
RT   "Huntingtin's WW domain partners in Huntington's disease post-mortem
RT   brain fulfill genetic criteria for direct involvement in Huntington's
RT   disease pathogenesis.";
RL   Hum. Mol. Genet. 9:2175-2182(2000).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-148, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-764, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-832, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-764, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-838, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [12]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-175 AND LYS-838, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: May be involved in pre-mRNA splicing.
CC       {ECO:0000269|PubMed:9700202}.
CC   -!- SUBUNIT: Interacts with the N-terminus of HD.
CC       {ECO:0000269|PubMed:9700202}.
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle
CC       {ECO:0000269|PubMed:10958656}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q6NWY9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6NWY9-2; Sequence=VSP_029117, VSP_029118;
CC       Name=3;
CC         IsoId=Q6NWY9-3; Sequence=VSP_029119;
CC       Name=4;
CC         IsoId=Q6NWY9-4; Sequence=VSP_029116, VSP_029120, VSP_029121;
CC   -!- TISSUE SPECIFICITY: Expressed in the striatum and cortex of the
CC       brain (at protein level). Highly expressed in testis, fetal kidney
CC       and fetal brain. Moderately expressed in pancreas, skeletal
CC       muscle, placenta, brain and heart. Weakly expressed in colon,
CC       ileum, ovary, prostate, spleen, kidney and fetal lung.
CC       {ECO:0000269|PubMed:10958656, ECO:0000269|PubMed:9700202}.
CC   -!- SIMILARITY: Belongs to the PRPF40 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH50398.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAB15662.1; Type=Frameshift; Positions=537, 851; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK027117; BAB15662.1; ALT_FRAME; mRNA.
DR   EMBL; AK123353; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL137459; CAB70747.1; -; mRNA.
DR   EMBL; AL834216; CAD38898.1; -; mRNA.
DR   EMBL; CH471111; EAW58085.1; -; Genomic_DNA.
DR   EMBL; BC050398; AAH50398.1; ALT_SEQ; mRNA.
DR   EMBL; BC067364; AAH67364.1; -; mRNA.
DR   EMBL; AF049525; AAC27503.1; -; mRNA.
DR   PIR; T46402; T46402.
DR   RefSeq; NP_001026868.2; NM_001031698.2.
DR   RefSeq; NP_036404.1; NM_012272.2. [Q6NWY9-2]
DR   RefSeq; XP_011536443.1; XM_011538141.1. [Q6NWY9-1]
DR   UniGene; Hs.706827; -.
DR   ProteinModelPortal; Q6NWY9; -.
DR   SMR; Q6NWY9; -.
DR   BioGrid; 117305; 12.
DR   IntAct; Q6NWY9; 4.
DR   STRING; 9606.ENSP00000369634; -.
DR   iPTMnet; Q6NWY9; -.
DR   PhosphoSitePlus; Q6NWY9; -.
DR   BioMuta; PRPF40B; -.
DR   DMDM; 74736936; -.
DR   EPD; Q6NWY9; -.
DR   MaxQB; Q6NWY9; -.
DR   PaxDb; Q6NWY9; -.
DR   PeptideAtlas; Q6NWY9; -.
DR   PRIDE; Q6NWY9; -.
DR   Ensembl; ENST00000261897; ENSP00000261897; ENSG00000110844. [Q6NWY9-2]
DR   Ensembl; ENST00000380281; ENSP00000369634; ENSG00000110844. [Q6NWY9-1]
DR   GeneID; 25766; -.
DR   KEGG; hsa:25766; -.
DR   UCSC; uc058nrq.1; human. [Q6NWY9-1]
DR   CTD; 25766; -.
DR   DisGeNET; 25766; -.
DR   EuPathDB; HostDB:ENSG00000110844.13; -.
DR   GeneCards; PRPF40B; -.
DR   HGNC; HGNC:25031; PRPF40B.
DR   HPA; HPA038426; -.
DR   HPA; HPA038599; -.
DR   neXtProt; NX_Q6NWY9; -.
DR   OpenTargets; ENSG00000110844; -.
DR   PharmGKB; PA143485582; -.
DR   eggNOG; KOG0152; Eukaryota.
DR   eggNOG; COG5104; LUCA.
DR   GeneTree; ENSGT00910000144180; -.
DR   HOVERGEN; HBG059634; -.
DR   InParanoid; Q6NWY9; -.
DR   KO; K12821; -.
DR   PhylomeDB; Q6NWY9; -.
DR   TreeFam; TF318732; -.
DR   SignaLink; Q6NWY9; -.
DR   ChiTaRS; PRPF40B; human.
DR   GeneWiki; PRPF40B; -.
DR   GenomeRNAi; 25766; -.
DR   PRO; PR:Q6NWY9; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000110844; -.
DR   CleanEx; HS_PRPF40B; -.
DR   ExpressionAtlas; Q6NWY9; baseline and differential.
DR   Genevisible; Q6NWY9; HS.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005685; C:U1 snRNP; IBA:GO_Central.
DR   GO; GO:0071004; C:U2-type prespliceosome; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; IBA:GO_Central.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IBA:GO_Central.
DR   CDD; cd00201; WW; 2.
DR   Gene3D; 1.10.10.440; -; 5.
DR   InterPro; IPR002713; FF_domain.
DR   InterPro; IPR036517; FF_domain_sf.
DR   InterPro; IPR001202; WW_dom.
DR   InterPro; IPR036020; WW_dom_sf.
DR   Pfam; PF01846; FF; 2.
DR   Pfam; PF00397; WW; 2.
DR   SMART; SM00441; FF; 4.
DR   SMART; SM00456; WW; 2.
DR   SUPFAM; SSF51045; SSF51045; 2.
DR   SUPFAM; SSF81698; SSF81698; 5.
DR   PROSITE; PS51676; FF; 6.
DR   PROSITE; PS01159; WW_DOMAIN_1; 1.
DR   PROSITE; PS50020; WW_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome; Isopeptide bond;
KW   mRNA processing; mRNA splicing; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Ubl conjugation.
FT   CHAIN         1    871       Pre-mRNA-processing factor 40 homolog B.
FT                                /FTId=PRO_0000309282.
FT   DOMAIN       92    125       WW 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00224}.
FT   DOMAIN      133    166       WW 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00224}.
FT   DOMAIN      276    330       FF 1.
FT   DOMAIN      340    397       FF 2.
FT   DOMAIN      410    470       FF 3.
FT   DOMAIN      490    550       FF 4.
FT   DOMAIN      554    610       FF 5.
FT   DOMAIN      625    682       FF 6.
FT   COMPBIAS      3     72       Pro-rich.
FT   MOD_RES     148    148       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     764    764       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     832    832       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     852    852       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q80W14}.
FT   CROSSLNK    175    175       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    838    838       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1      7       MMPPPFM -> M (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_029117.
FT   VAR_SEQ       1      6       MMPPPF -> M (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_029116.
FT   VAR_SEQ      77    200       TAPGADTASSAVAGTGPPRALWSEHVAPDGRIYYYNADDKQ
FT                                SVWEKPSVLKSKAELLLSQCPWKEYKSDTGKPYYYNNQSKE
FT                                SRWTRPKDLDDLEVLVKQEAAGKQQQQLPQTLQPQPPQPQP
FT                                D -> VSTRGQQVAGSALQSRESDLECRTMTSILSLFSSHP
FT                                PRSPAALPTLKSFSPAMYSALLVSHSSPKAYTFSCYSRALS
FT                                SSLKEHTYPHRATHCGHMNIVLHILFVPRRVSSTWGSCCAF
FT                                LCYRSV (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_029120.
FT   VAR_SEQ     201    871       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_029121.
FT   VAR_SEQ     568    574       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_029118.
FT   VAR_SEQ     685    685       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_029119.
SQ   SEQUENCE   871 AA;  99358 MW;  BB62C95BEFB9D23A CRC64;
     MMPPPFMPPP GIPPPFPPMG LPPMSQRPPA IPPMPPGILP PMLPPMGAPP PLTQIPGMVP
     PMMPGMLMPA VPVTAATAPG ADTASSAVAG TGPPRALWSE HVAPDGRIYY YNADDKQSVW
     EKPSVLKSKA ELLLSQCPWK EYKSDTGKPY YYNNQSKESR WTRPKDLDDL EVLVKQEAAG
     KQQQQLPQTL QPQPPQPQPD PPPVPPGPTP VPTGLLEPEP GGSEDCDVLE ATQPLEQGFL
     QQLEEGPSSS GQHQPQQEEE ESKPEPERSG LSWSNREKAK QAFKELLRDK AVPSNASWEQ
     AMKMVVTDPR YSALPKLSEK KQAFNAYKAQ REKEEKEEAR LRAKEAKQTL QHFLEQHERM
     TSTTRYRRAE QTFGELEVWA VVPERDRKEV YDDVLFFLAK KEKEQAKQLR RRNIQALKSI
     LDGMSSVNFQ TTWSQAQQYL MDNPSFAQDH QLQNMDKEDA LICFEEHIRA LEREEEEERE
     RARLRERRQQ RKNREAFQTF LDELHETGQL HSMSTWMELY PAVSTDVRFA NMLGQPGSTP
     LDLFKFYVEE LKARFHDEKK IIKDILKDRG FCVEVNTAFE DFAHVISFDK RAAALDAGNI
     KLTFNSLLEK AEAREREREK EEARRMRRRE AAFRSMLRQA VPALELGTAW EEVRERFVCD
     SAFEQITLES ERIRLFREFL QVLEQTECQH LHTKGRKHGR KGKKHHHKRS HSPSGSESEE
     EELPPPSLRP PKRRRRNPSE SGSEPSSSLD SVESGGAALG GRGSPSSHLL GADHGLRKAK
     KPKKKTKKRR HKSNSPESET DPEEKAGKES DEKEQEQDKD RELQQAELPN RSPGFGIKKE
     KTGWDTSESE LSEGELERRR RTLLQQLDDH Q
//
ID   RGPD3_HUMAN             Reviewed;        1758 AA.
AC   A6NKT7; B8ZZM4;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   08-MAR-2011, sequence version 2.
DT   28-MAR-2018, entry version 92.
DE   RecName: Full=RanBP2-like and GRIP domain-containing protein 3;
GN   Name=RGPD3; Synonyms=RGP3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1686-1758.
RG   The Cancer Genome Anatomy Project (CGAP) at the National Cancer Institute;
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   RANBP2 CLUSTER.
RX   PubMed=15710750; DOI=10.1101/gr.3266405;
RA   Ciccarelli F.D., von Mering C., Suyama M., Harrington E.D.,
RA   Izaurralde E., Bork P.;
RT   "Complex genomic rearrangements lead to novel primate gene function.";
RL   Genome Res. 15:343-351(2005).
CC   -!- MISCELLANEOUS: One of the 8 copies of RANBP2 clustered close to
CC       the chromosome 2 centromere.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC097527; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC114755; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS46379.1; -.
DR   RefSeq; NP_001137485.1; NM_001144013.1.
DR   UniGene; Hs.726367; -.
DR   ProteinModelPortal; A6NKT7; -.
DR   SMR; A6NKT7; -.
DR   BioGrid; 575821; 16.
DR   IntAct; A6NKT7; 6.
DR   MINT; A6NKT7; -.
DR   STRING; 9606.ENSP00000386588; -.
DR   iPTMnet; A6NKT7; -.
DR   PhosphoSitePlus; A6NKT7; -.
DR   BioMuta; RGPD3; -.
DR   EPD; A6NKT7; -.
DR   MaxQB; A6NKT7; -.
DR   PaxDb; A6NKT7; -.
DR   PRIDE; A6NKT7; -.
DR   Ensembl; ENST00000409886; ENSP00000386588; ENSG00000153165.
DR   GeneID; 653489; -.
DR   KEGG; hsa:653489; -.
DR   UCSC; uc010ywi.2; human.
DR   CTD; 653489; -.
DR   EuPathDB; HostDB:ENSG00000153165.18; -.
DR   GeneCards; RGPD3; -.
DR   H-InvDB; HIX0030036; -.
DR   HGNC; HGNC:32416; RGPD3.
DR   HPA; HPA049497; -.
DR   HPA; HPA051675; -.
DR   HPA; HPA067564; -.
DR   MIM; 612706; gene.
DR   neXtProt; NX_A6NKT7; -.
DR   PharmGKB; PA142671072; -.
DR   eggNOG; KOG0864; Eukaryota.
DR   eggNOG; COG5171; LUCA.
DR   GeneTree; ENSGT00760000119119; -.
DR   HOGENOM; HOG000089994; -.
DR   HOVERGEN; HBG108404; -.
DR   InParanoid; A6NKT7; -.
DR   KO; K12172; -.
DR   PhylomeDB; A6NKT7; -.
DR   TreeFam; TF314797; -.
DR   ChiTaRS; RGPD3; human.
DR   GenomeRNAi; 653489; -.
DR   PRO; PR:A6NKT7; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000153165; -.
DR   CleanEx; HS_RGPD3; -.
DR   ExpressionAtlas; A6NKT7; baseline and differential.
DR   Genevisible; A6NKT7; HS.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0046907; P:intracellular transport; IEA:InterPro.
DR   Gene3D; 1.25.40.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 2.
DR   InterPro; IPR032023; GCC2_Rab_bind.
DR   InterPro; IPR000237; GRIP_dom.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR000156; Ran_bind_dom.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR019734; TPR_repeat.
DR   Pfam; PF01465; GRIP; 1.
DR   Pfam; PF16704; Rab_bind; 1.
DR   Pfam; PF00638; Ran_BP1; 2.
DR   SMART; SM00755; Grip; 1.
DR   SMART; SM00160; RanBD; 2.
DR   SMART; SM00028; TPR; 1.
DR   SUPFAM; SSF48452; SSF48452; 1.
DR   PROSITE; PS50913; GRIP; 1.
DR   PROSITE; PS50196; RANBD1; 2.
DR   PROSITE; PS50005; TPR; 1.
DR   PROSITE; PS50293; TPR_REGION; 1.
PE   3: Inferred from homology;
KW   Coiled coil; Complete proteome; Phosphoprotein; Reference proteome;
KW   Repeat; TPR repeat.
FT   CHAIN         1   1758       RanBP2-like and GRIP domain-containing
FT                                protein 3.
FT                                /FTId=PRO_0000340666.
FT   REPEAT       60     93       TPR 1.
FT   REPEAT      584    617       TPR 2.
FT   DOMAIN     1037   1173       RanBD1 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00164}.
FT   DOMAIN     1334   1470       RanBD1 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00164}.
FT   DOMAIN     1703   1753       GRIP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00250}.
FT   COILED      176    229       {ECO:0000255}.
FT   COILED      805    837       {ECO:0000255}.
FT   COMPBIAS   1262   1267       Poly-Ser.
FT   MOD_RES      21     21       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q99666}.
SQ   SEQUENCE   1758 AA;  197487 MW;  76CCC1934CCD6E48 CRC64;
     MSCSKAYGER YVASVQGSAP SPRKKSTRGF YFAKLYYEAK EYDLAKKYIC TYINVREMDP
     RAHRFLGLLY ELEENTEKAV ECYRRSVELN PTQKDLVLKI AELLCKNDVT DGRAEYWVER
     AAKLFPGSPA IYKLKEQLLD CEGEDGWNKL FDLIQSELYV RPDDVHVNIR LVELYRSTKR
     LKDAVARCHE AERNIALRSS LEWNSCVVQT LKEYLESLQC LESDKSDWRA TNTDLLLAYA
     NLMLLTLSTR DVQESRELLE SFDSALQSAK SSLGGNDELS ATFLEMKGHF YMHAGSLLLK
     MGQHGNNVQW RALSELAALC YLIAFQVPRP KIKLIKGEAG QNLLEMMACD RLSQSGHMLL
     NLSRGKQDFL KVVVETFANK SGQSALYDAL FSSQSPKDTS FLGSDDIGNI DVQEPELEDL
     ARYDVGAIRA HNGSLQHLTW LGLQWNSLPA LPGIRKWLKQ LFHHLPQETS RLETNAPESI
     CILDLEVFLL GVVYTSHLQL KEKCNSHHSS YQPLCLPLPV CKQLCTERQK SWWDAVCTLI
     HRKAVPGNSA KLRLLVQHEI NTLRAQEKHG LQPALLVHWA KCLQKMGSGL NSFYDQREYI
     GRSVHYWKKV LPLLKIIKKK NSIPEPIDPL FKHFHSVDIQ ASEIVEYEED AHVTFAILDA
     VNGNIEDAMT AFESIKSVVS YWNLALIFHR KAEDIANDAL SPEEQEECKN YLRKTRGYLI
     KILDDSDSNL SVVKKLPVPL ESVKEMLKSV MQELENYSEG GPLYKNGSLR NADSEIKHST
     PSPTKYSLSP SKSYKYSPKT PPRWAEDQNS LLKMIRQEVK AIKEEMQELK LNSSKSASHH
     RWPTENYGPD SVPDGYQGSQ TFHGAPLTVA TTGPSVYYSQ SPAYNSQYLL RPAANVTPTK
     GSSNTEFKST KEGFSIPVSA DGFKFGISEP GNQEKKSEKP LENDTGLQAQ DISGRKKGRG
     VIFGQTSSTF TFADVAKSTS GEGFQFGKKD LNFKGFSGAG EKLFSSQYGK MANKANTSGD
     FEKDDDAYKT EDSDDIHFEP VVQMPEKVEL VTGEEGEKVL YSQGVKLFRF DAEVSQWKER
     GLGNLKILKN EVNGKVRMLM QREQVLKVCA NHWITTTMNL KPLSGSDRAW MWSASDFSDG
     DAKLERLAAK FKTPELAEEF KQKFEECQRL LLDIPLQTPH KLVDTGRAAK LIQRAEEMKS
     GLKDFKTFLT NDQTKVAEEE NKGSGTGAAG ASDTTIKPNA ENTGPTLEWD NYDLREDALD
     DSVSSSSVHA SPLASSPVRK NLFHFDESTT GSNFSFKSAL SLSKSPAKLN QSGTSVGTDE
     ESDVTQEEER DGQYFEPVVP LPDLVEVSSG EENEQVVFSH RAEFYRYDKD VGQWKERGIG
     DIKILQNYDN KHVRILMRRD QVLKLCANHR ITPDMSLQNM KGTERVWVWT ACDFADGERK
     VEHLAVRFKL QDVADSFKKI FDEAKTAQEK DSLITPHVSR SSTPRESPCG KIAVAVLEET
     TRERTDVIQG DDVADAASEV EVSSTSETTT KAVVSPPKFV FGSESVKRIF SSEKSKPFAF
     GNSSATGSLF GFSFNAPLKS NNSETSSVAQ SGSESKVEPK KCELSKNSDI EQSSDSKVKN
     LSASFPTEES SINYTFKTPE KEPPLWYAEF TKEELVQKLS STTKSADHLN GLLREIEATN
     AVLMEQIKLL KSEIRRLERN QEQEVSAANV EHLKNVLLQF IFLKPGSERE RLLPVINTML
     QLSLEEKGKL AAVAQGEE
//
ID   B7Z223_HUMAN            Unreviewed;       393 AA.
AC   B7Z223; C9JI86;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   28-FEB-2018, entry version 82.
DE   SubName: Full=cDNA FLJ55428, highly similar to Regulator of G-protein signaling 7 {ECO:0000313|EMBL:BAH11709.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH11709.1};
RN   [1] {ECO:0000313|EMBL:BAH11709.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Amygdala {ECO:0000313|EMBL:BAH11709.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK294234; BAH11709.1; -; mRNA.
DR   RefSeq; XP_016857501.1; XM_017002012.1.
DR   UniGene; Hs.655739; -.
DR   ProteinModelPortal; B7Z223; -.
DR   MaxQB; B7Z223; -.
DR   PeptideAtlas; B7Z223; -.
DR   GeneID; 6000; -.
DR   UCSC; uc057qsf.1; human.
DR   CTD; 6000; -.
DR   EuPathDB; HostDB:ENSG00000182901.15; -.
DR   eggNOG; KOG3589; Eukaryota.
DR   eggNOG; ENOG410YMJD; LUCA.
DR   HOGENOM; HOG000220864; -.
DR   HOVERGEN; HBG007404; -.
DR   Bgee; ENSG00000182901; -.
DR   GO; GO:0005834; C:heterotrimeric G-protein complex; IEA:InterPro.
DR   GO; GO:0004871; F:signal transducer activity; IEA:InterPro.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:InterPro.
DR   CDD; cd00068; GGL; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 1.10.196.10; -; 2.
DR   InterPro; IPR015898; G-protein_gamma-like_dom.
DR   InterPro; IPR036284; GGL_sf.
DR   InterPro; IPR016137; RGS.
DR   InterPro; IPR036305; RGS_sf.
DR   InterPro; IPR024066; RGS_subdom1/3.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00631; G-gamma; 1.
DR   Pfam; PF00615; RGS; 1.
DR   PRINTS; PR01301; RGSPROTEIN.
DR   SMART; SM00224; GGL; 1.
DR   SMART; SM00315; RGS; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF48097; SSF48097; 1.
DR   SUPFAM; SSF48670; SSF48670; 1.
DR   PROSITE; PS50132; RGS; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN      249    364       RGS. {ECO:0000259|PROSITE:PS50132}.
SQ   SEQUENCE   393 AA;  46308 MW;  403C6B087F272D1B CRC64;
     MAAHGYFFPI SDHVLTLKDD GTFYRFQTPY FWPSNCWEPE NTDYAVYLCK RTMQNKARLE
     LADYEAESLA RLQRAFARKW EFIFMQAEAQ AKVDKKRDKI ERKILDSQER AFWDVHRPVP
     GCVNTTEVDI KKSSRMRNPH KTRKSVYGLQ NDIRSHSPTH TPTPETKPPT EDELQQQIKY
     WQIQLDRHRL KMSKVADSLL SYTEQYLEYD PFLLPPDPSN PWLSDDTTFW ELEASKEPSQ
     QRVKRWGFGM DEALKDPVGR EQFLKFLESE FSSENLRFWL AVEDLKKRPI KEVPSRVQEI
     WQEFLAPGAP SAINLDSKSY DKTTQNVKEP GRYTFEDAQE HIYKLMKSDS YPRFIRSSAY
     QELLQAKKKG RNIPIFPCHK NCTPTLRAST NLL
//
ID   B7Z257_HUMAN            Unreviewed;       451 AA.
AC   B7Z257;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   28-FEB-2018, entry version 76.
DE   SubName: Full=cDNA FLJ61685, highly similar to Regulator of G-protein signaling 7 {ECO:0000313|EMBL:BAH11743.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH11743.1};
RN   [1] {ECO:0000313|EMBL:BAH11743.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Amygdala {ECO:0000313|EMBL:BAH11743.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK294354; BAH11743.1; -; mRNA.
DR   RefSeq; XP_016857494.1; XM_017002005.1.
DR   RefSeq; XP_016857495.1; XM_017002006.1.
DR   RefSeq; XP_016857496.1; XM_017002007.1.
DR   UniGene; Hs.655739; -.
DR   ProteinModelPortal; B7Z257; -.
DR   PeptideAtlas; B7Z257; -.
DR   GeneID; 6000; -.
DR   CTD; 6000; -.
DR   eggNOG; KOG3589; Eukaryota.
DR   eggNOG; ENOG410YMJD; LUCA.
DR   HOGENOM; HOG000220864; -.
DR   HOVERGEN; HBG007404; -.
DR   GO; GO:0005834; C:heterotrimeric G-protein complex; IEA:InterPro.
DR   GO; GO:0004871; F:signal transducer activity; IEA:InterPro.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   CDD; cd00068; GGL; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 1.10.196.10; -; 2.
DR   InterPro; IPR000591; DEP_dom.
DR   InterPro; IPR015898; G-protein_gamma-like_dom.
DR   InterPro; IPR036284; GGL_sf.
DR   InterPro; IPR016137; RGS.
DR   InterPro; IPR036305; RGS_sf.
DR   InterPro; IPR024066; RGS_subdom1/3.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00610; DEP; 1.
DR   Pfam; PF00631; G-gamma; 1.
DR   Pfam; PF00615; RGS; 1.
DR   PRINTS; PR01301; RGSPROTEIN.
DR   SMART; SM00049; DEP; 1.
DR   SMART; SM00224; GGL; 1.
DR   SMART; SM00315; RGS; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF48097; SSF48097; 1.
DR   SUPFAM; SSF48670; SSF48670; 1.
DR   PROSITE; PS50186; DEP; 1.
DR   PROSITE; PS50132; RGS; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       11     86       DEP. {ECO:0000259|PROSITE:PS50186}.
FT   DOMAIN      307    422       RGS. {ECO:0000259|PROSITE:PS50132}.
SQ   SEQUENCE   451 AA;  52785 MW;  D3633E6E086B0785 CRC64;
     MEDVIARMQD EKNGIPIRTV KSFLSKIPSV FSGSDIVQWL IKNLTIEDPV EALHLGTLMA
     AHGYFFPISD HVLTLKDDGT FYRFQTPYFW PSNCWEPENT DYAVYLCKRT MQNKARLELA
     DYEAESLARL QRAFARKWEF IFMQAEAQAK VDKKRDKIER KILDSQERAF WDVHRPVPGC
     VNTTEVDIKK SSRMRNPHKT RKSVYGLQND IRSHSPTHTP TPETKPPTED ELQQQIKYWQ
     IQLDRHRLKM SKVADSLLSY TEQYLEYDPF LLPPDPSNPW LSDDTTFWEL EASKEPSQQR
     VKRWGFGMDE ALKDPVGREQ FLKFLESEFS SENLRFWLAV EDLKKRPIKE VPSRVQEIWQ
     EFLAPGAPSA INLDSKSYDK TTQNVKEPGR YTFEDAQEHI YKLMKSDSYP RFIRSSAYQE
     LLQAKKKGRN IPIFPCHKNC TPTLRASTNL L
//
ID   RGS7_HUMAN              Reviewed;         495 AA.
AC   P49802; Q5T3H4; Q8TD66; Q8TD67; Q8WW09; Q9UNU7; Q9Y6B9;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   18-OCT-2001, sequence version 3.
DT   28-FEB-2018, entry version 175.
DE   RecName: Full=Regulator of G-protein signaling 7;
DE            Short=RGS7;
GN   Name=RGS7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), INTERACTION WITH PKD1,
RP   SUBCELLULAR LOCATION, AND UBIQUITINATION.
RC   TISSUE=Brain;
RX   PubMed=10339594; DOI=10.1073/pnas.96.11.6371;
RA   Kim E., Arnould T., Sellin L., Benzing T., Comella N., Kocher O.,
RA   Tsiokas L., Sukhatme V.P., Walz G.;
RT   "Interaction between RGS7 and polycystin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:6371-6376(1999).
RN   [2]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=8548815; DOI=10.1016/S0092-8674(00)80998-8;
RA   Koelle M.R., Horvitz H.R.;
RT   "EGL-10 regulates G protein signaling in the C. elegans nervous system
RT   and shares a conserved domain with many mammalian proteins.";
RL   Cell 84:115-125(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3 AND 4).
RC   TISSUE=Brain;
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5), AND VARIANT
RP   HIS-409.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, INTERACTION WITH GNB5, AND SUBCELLULAR LOCATION.
RX   PubMed=10521509; DOI=10.1074/jbc.274.43.31087;
RA   Posner B.A., Gilman A.G., Harris B.A.;
RT   "Regulators of G protein signaling 6 and 7. Purification of complexes
RT   with gbeta5 and assessment of their effects on g protein-mediated
RT   signaling pathways.";
RL   J. Biol. Chem. 274:31087-31093(1999).
RN   [8]
RP   INTERACTION WITH GNB5, AND MUTAGENESIS OF TRP-306.
RC   TISSUE=Brain;
RX   PubMed=10339615; DOI=10.1073/pnas.96.11.6489;
RA   Snow B.E., Betts L., Mangion J., Sondek J., Siderovski D.P.;
RT   "Fidelity of G protein beta-subunit association by the G protein
RT   gamma-subunit-like domains of RGS6, RGS7, and RGS11.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:6489-6494(1999).
RN   [9]
RP   PHOSPHORYLATION AT SER-434, INTERACTION WITH 14-3-3 PROTEIN YWHAQ, AND
RP   FUNCTION.
RX   PubMed=10862767; DOI=10.1074/jbc.M002905200;
RA   Benzing T., Yaffe M.B., Arnould T., Sellin L., Schermer B.,
RA   Schilling B., Schreiber R., Kunzelmann K., Leparc G.G., Kim E.,
RA   Walz G.;
RT   "14-3-3 interacts with regulator of G protein signaling proteins and
RT   modulates their activity.";
RL   J. Biol. Chem. 275:28167-28172(2000).
RN   [10]
RP   INTERACTION WITH SNAPIN.
RX   PubMed=12659861; DOI=10.1016/S0006-291X(03)00400-5;
RA   Hunt R.A., Edris W., Chanda P.K., Nieuwenhuijsen B., Young K.H.;
RT   "Snapin interacts with the N-terminus of regulator of G protein
RT   signaling 7.";
RL   Biochem. Biophys. Res. Commun. 303:594-599(2003).
RN   [11]
RP   INTERACTION WITH RGS7BP, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=15897264; DOI=10.1083/jcb.200502007;
RA   Drenan R.M., Doupnik C.A., Boyle M.P., Muglia L.J., Huettner J.E.,
RA   Linder M.E., Blumer K.J.;
RT   "Palmitoylation regulates plasma membrane-nuclear shuttling of R7BP, a
RT   novel membrane anchor for the RGS7 family.";
RL   J. Cell Biol. 169:623-633(2005).
RN   [12]
RP   STRUCTURE BY NMR OF 323-448.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the RGS domain of regulator of G-protein
RT   signaling 7.";
RL   Submitted (DEC-2006) to the PDB data bank.
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 320-463, AND INTERACTION
RP   WITH GNAI1.
RX   PubMed=18434541; DOI=10.1073/pnas.0801508105;
RA   Soundararajan M., Willard F.S., Kimple A.J., Turnbull A.P., Ball L.J.,
RA   Schoch G.A., Gileadi C., Fedorov O.Y., Dowler E.F., Higman V.A.,
RA   Hutsell S.Q., Sundstroem M., Doyle D.A., Siderovski D.P.;
RT   "Structural diversity in the RGS domain and its interaction with
RT   heterotrimeric G protein alpha-subunits.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:6457-6462(2008).
CC   -!- FUNCTION: Regulates G protein-coupled receptor signaling cascades.
CC       Inhibits signal transduction by increasing the GTPase activity of
CC       G protein alpha subunits, thereby driving them into their inactive
CC       GDP-bound form (PubMed:10521509, PubMed:10862767). The RGS7/GNB5
CC       dimer enhances GNAO1 GTPase activity (PubMed:10521509). May play a
CC       role in synaptic vesicle exocytosis (PubMed:12659861). Modulates
CC       the activity of potassium channels that are activated by GNAO1 in
CC       response to muscarinic acetylcholine receptor M2/CHRM2 signaling
CC       (PubMed:15897264). {ECO:0000269|PubMed:10521509,
CC       ECO:0000269|PubMed:10862767, ECO:0000269|PubMed:15897264,
CC       ECO:0000305|PubMed:12659861}.
CC   -!- SUBUNIT: Interacts with PKD1; this prevents rapid proteasomal
CC       degradation (PubMed:10339594). Interacts with GNB5
CC       (PubMed:10521509, PubMed:10339615). Interacts with RGS7BP, leading
CC       to regulate the subcellular location of the heterodimer formed
CC       with GNB5 (PubMed:15897264). Interacts (phosphorylated form) with
CC       14-3-3 protein YWHAQ (PubMed:10862767). Interacts with SNAPIN
CC       (PubMed:12659861). Interacts with GNAI1 (PubMed:18434541).
CC       Interacts with GNAO1, GNAI3 and GNAZ (By similarity).
CC       {ECO:0000250|UniProtKB:O54829, ECO:0000250|UniProtKB:P49803,
CC       ECO:0000269|PubMed:10339615, ECO:0000269|PubMed:10521509,
CC       ECO:0000269|PubMed:10862767, ECO:0000269|PubMed:12659861,
CC       ECO:0000269|PubMed:15897264, ECO:0000269|PubMed:18434541}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:10521509}. Cytoplasm
CC       {ECO:0000269|PubMed:10339594, ECO:0000269|PubMed:15897264}. Cell
CC       membrane {ECO:0000269|PubMed:10339594,
CC       ECO:0000269|PubMed:15897264}. Membrane
CC       {ECO:0000269|PubMed:10521509}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:10521509}; Cytoplasmic side {ECO:0000305}.
CC       Note=Interaction with PKD1 promotes location at the cell membrane
CC       (PubMed:10339594). Interaction with RGS7BP promotes location at
CC       the cell membrane (PubMed:15897264). {ECO:0000269|PubMed:10339594,
CC       ECO:0000269|PubMed:15897264}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=A;
CC         IsoId=P49802-1; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=P49802-2; Sequence=VSP_005672;
CC       Name=3;
CC         IsoId=P49802-3; Sequence=VSP_005673;
CC       Name=4;
CC         IsoId=P49802-4; Sequence=VSP_005671, VSP_005673;
CC       Name=5;
CC         IsoId=P49802-5; Sequence=VSP_038388;
CC   -!- PTM: Palmitoylated. {ECO:0000250|UniProtKB:O46470}.
CC   -!- PTM: Ubiquitinated, leading to rapid proteasomal degradation.
CC       {ECO:0000269|PubMed:10339594}.
CC   -!- PTM: Phosphorylation and subsequent interaction with 14-3-3
CC       proteins inhibits GAP activity. {ECO:0000269|PubMed:10862767}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF090116; AAD34290.1; -; mRNA.
DR   EMBL; AF090117; AAD34291.1; -; mRNA.
DR   EMBL; U32439; AAC50351.1; -; mRNA.
DR   EMBL; AF493930; AAM12644.1; -; mRNA.
DR   EMBL; AF493931; AAM12645.1; -; mRNA.
DR   EMBL; AY587875; AAT52231.1; -; mRNA.
DR   EMBL; AL512307; CAH71987.1; -; Genomic_DNA.
DR   EMBL; AL359764; CAH71987.1; JOINED; Genomic_DNA.
DR   EMBL; AL365184; CAH71987.1; JOINED; Genomic_DNA.
DR   EMBL; AL590682; CAH71987.1; JOINED; Genomic_DNA.
DR   EMBL; AL512307; CAH71988.1; -; Genomic_DNA.
DR   EMBL; AL359764; CAH71988.1; JOINED; Genomic_DNA.
DR   EMBL; AL365184; CAH71988.1; JOINED; Genomic_DNA.
DR   EMBL; AL590682; CAH71988.1; JOINED; Genomic_DNA.
DR   EMBL; AL512307; CAH71989.1; -; Genomic_DNA.
DR   EMBL; AL359764; CAH71989.1; JOINED; Genomic_DNA.
DR   EMBL; AL365184; CAH71989.1; JOINED; Genomic_DNA.
DR   EMBL; AL590682; CAH71989.1; JOINED; Genomic_DNA.
DR   EMBL; AL512307; CAH71990.1; -; Genomic_DNA.
DR   EMBL; AL359764; CAH71990.1; JOINED; Genomic_DNA.
DR   EMBL; AL365184; CAH71990.1; JOINED; Genomic_DNA.
DR   EMBL; AL590682; CAH71990.1; JOINED; Genomic_DNA.
DR   EMBL; AL590682; CAH73809.1; -; Genomic_DNA.
DR   EMBL; AL359764; CAH73809.1; JOINED; Genomic_DNA.
DR   EMBL; AL365184; CAH73809.1; JOINED; Genomic_DNA.
DR   EMBL; AL512307; CAH73809.1; JOINED; Genomic_DNA.
DR   EMBL; AL590682; CAH73810.1; -; Genomic_DNA.
DR   EMBL; AL359764; CAH73810.1; JOINED; Genomic_DNA.
DR   EMBL; AL365184; CAH73810.1; JOINED; Genomic_DNA.
DR   EMBL; AL512307; CAH73810.1; JOINED; Genomic_DNA.
DR   EMBL; AL590682; CAH73811.1; -; Genomic_DNA.
DR   EMBL; AL359764; CAH73811.1; JOINED; Genomic_DNA.
DR   EMBL; AL365184; CAH73811.1; JOINED; Genomic_DNA.
DR   EMBL; AL512307; CAH73811.1; JOINED; Genomic_DNA.
DR   EMBL; AL590682; CAH73812.1; -; Genomic_DNA.
DR   EMBL; AL359764; CAH73812.1; JOINED; Genomic_DNA.
DR   EMBL; AL365184; CAH73812.1; JOINED; Genomic_DNA.
DR   EMBL; AL512307; CAH73812.1; JOINED; Genomic_DNA.
DR   EMBL; AL359764; CAI15140.1; -; Genomic_DNA.
DR   EMBL; AL365184; CAI15140.1; JOINED; Genomic_DNA.
DR   EMBL; AL512307; CAI15140.1; JOINED; Genomic_DNA.
DR   EMBL; AL590682; CAI15140.1; JOINED; Genomic_DNA.
DR   EMBL; AL359764; CAI15141.1; -; Genomic_DNA.
DR   EMBL; AL365184; CAI15141.1; JOINED; Genomic_DNA.
DR   EMBL; AL512307; CAI15141.1; JOINED; Genomic_DNA.
DR   EMBL; AL590682; CAI15141.1; JOINED; Genomic_DNA.
DR   EMBL; AL359764; CAI15142.1; -; Genomic_DNA.
DR   EMBL; AL365184; CAI15142.1; JOINED; Genomic_DNA.
DR   EMBL; AL512307; CAI15142.1; JOINED; Genomic_DNA.
DR   EMBL; AL590682; CAI15142.1; JOINED; Genomic_DNA.
DR   EMBL; AL359764; CAI15143.1; -; Genomic_DNA.
DR   EMBL; AL365184; CAI15143.1; JOINED; Genomic_DNA.
DR   EMBL; AL512307; CAI15143.1; JOINED; Genomic_DNA.
DR   EMBL; AL590682; CAI15143.1; JOINED; Genomic_DNA.
DR   EMBL; AL365184; CAI16818.1; -; Genomic_DNA.
DR   EMBL; AL359764; CAI16818.1; JOINED; Genomic_DNA.
DR   EMBL; AL512307; CAI16818.1; JOINED; Genomic_DNA.
DR   EMBL; AL590682; CAI16818.1; JOINED; Genomic_DNA.
DR   EMBL; AL365184; CAI16819.1; -; Genomic_DNA.
DR   EMBL; AL359764; CAI16819.1; JOINED; Genomic_DNA.
DR   EMBL; AL512307; CAI16819.1; JOINED; Genomic_DNA.
DR   EMBL; AL590682; CAI16819.1; JOINED; Genomic_DNA.
DR   EMBL; AL365184; CAI16820.1; -; Genomic_DNA.
DR   EMBL; AL359764; CAI16820.1; JOINED; Genomic_DNA.
DR   EMBL; AL512307; CAI16820.1; JOINED; Genomic_DNA.
DR   EMBL; AL590682; CAI16820.1; JOINED; Genomic_DNA.
DR   EMBL; AL365184; CAI16821.1; -; Genomic_DNA.
DR   EMBL; AL359764; CAI16821.1; JOINED; Genomic_DNA.
DR   EMBL; AL512307; CAI16821.1; JOINED; Genomic_DNA.
DR   EMBL; AL590682; CAI16821.1; JOINED; Genomic_DNA.
DR   EMBL; CH471098; EAW70086.1; -; Genomic_DNA.
DR   EMBL; BC022009; AAH22009.1; -; mRNA.
DR   CCDS; CCDS31071.1; -. [P49802-5]
DR   CCDS; CCDS60457.1; -. [P49802-4]
DR   CCDS; CCDS60458.1; -. [P49802-2]
DR   CCDS; CCDS60459.1; -. [P49802-3]
DR   RefSeq; NP_001269702.1; NM_001282773.1. [P49802-4]
DR   RefSeq; NP_001269704.1; NM_001282775.1. [P49802-3]
DR   RefSeq; NP_001269707.1; NM_001282778.1. [P49802-2]
DR   RefSeq; NP_002915.3; NM_002924.5. [P49802-5]
DR   RefSeq; XP_005273275.1; XM_005273218.3. [P49802-1]
DR   UniGene; Hs.655739; -.
DR   PDB; 2A72; X-ray; 2.00 A; A/B=320-463.
DR   PDB; 2D9J; NMR; -; A=323-448.
DR   PDBsum; 2A72; -.
DR   PDBsum; 2D9J; -.
DR   ProteinModelPortal; P49802; -.
DR   SMR; P49802; -.
DR   BioGrid; 111932; 8.
DR   DIP; DIP-40869N; -.
DR   IntAct; P49802; 6.
DR   STRING; 9606.ENSP00000355523; -.
DR   BindingDB; P49802; -.
DR   iPTMnet; P49802; -.
DR   PhosphoSitePlus; P49802; -.
DR   SwissPalm; P49802; -.
DR   DMDM; 17380284; -.
DR   EPD; P49802; -.
DR   MaxQB; P49802; -.
DR   PaxDb; P49802; -.
DR   PeptideAtlas; P49802; -.
DR   PRIDE; P49802; -.
DR   DNASU; 6000; -.
DR   Ensembl; ENST00000348120; ENSP00000341242; ENSG00000182901. [P49802-4]
DR   Ensembl; ENST00000366563; ENSP00000355521; ENSG00000182901. [P49802-3]
DR   Ensembl; ENST00000366564; ENSP00000355522; ENSG00000182901. [P49802-2]
DR   Ensembl; ENST00000366565; ENSP00000355523; ENSG00000182901. [P49802-5]
DR   GeneID; 6000; -.
DR   KEGG; hsa:6000; -.
DR   UCSC; uc001hyu.4; human. [P49802-1]
DR   CTD; 6000; -.
DR   DisGeNET; 6000; -.
DR   EuPathDB; HostDB:ENSG00000182901.15; -.
DR   GeneCards; RGS7; -.
DR   HGNC; HGNC:10003; RGS7.
DR   HPA; CAB017561; -.
DR   HPA; HPA000688; -.
DR   MIM; 602517; gene.
DR   neXtProt; NX_P49802; -.
DR   OpenTargets; ENSG00000182901; -.
DR   PharmGKB; PA34378; -.
DR   eggNOG; KOG3589; Eukaryota.
DR   eggNOG; ENOG410YMJD; LUCA.
DR   GeneTree; ENSGT00760000119142; -.
DR   HOVERGEN; HBG007404; -.
DR   InParanoid; P49802; -.
DR   KO; K16449; -.
DR   OMA; QQQIKYW; -.
DR   OrthoDB; EOG091G05MO; -.
DR   PhylomeDB; P49802; -.
DR   TreeFam; TF351956; -.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   Reactome; R-HSA-6814122; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding.
DR   SignaLink; P49802; -.
DR   ChiTaRS; RGS7; human.
DR   EvolutionaryTrace; P49802; -.
DR   GeneWiki; RGS7; -.
DR   GenomeRNAi; 6000; -.
DR   PRO; PR:P49802; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000182901; -.
DR   CleanEx; HS_RGS7; -.
DR   ExpressionAtlas; P49802; baseline and differential.
DR   Genevisible; P49802; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005834; C:heterotrimeric G-protein complex; IEA:InterPro.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0031681; F:G-protein beta-subunit binding; IPI:UniProtKB.
DR   GO; GO:0005096; F:GTPase activator activity; IDA:UniProtKB.
DR   GO; GO:0004871; F:signal transducer activity; IEA:InterPro.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0009968; P:negative regulation of signal transduction; IEA:UniProtKB-KW.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IDA:UniProtKB.
DR   GO; GO:0006457; P:protein folding; TAS:Reactome.
DR   CDD; cd00068; GGL; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR000591; DEP_dom.
DR   InterPro; IPR015898; G-protein_gamma-like_dom.
DR   InterPro; IPR036284; GGL_sf.
DR   InterPro; IPR016137; RGS.
DR   InterPro; IPR036305; RGS_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00610; DEP; 1.
DR   Pfam; PF00631; G-gamma; 1.
DR   Pfam; PF00615; RGS; 1.
DR   PRINTS; PR01301; RGSPROTEIN.
DR   SMART; SM00049; DEP; 1.
DR   SMART; SM00224; GGL; 1.
DR   SMART; SM00315; RGS; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF48097; SSF48097; 1.
DR   SUPFAM; SSF48670; SSF48670; 1.
DR   PROSITE; PS50186; DEP; 1.
DR   PROSITE; PS50132; RGS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Cytoplasm; GTPase activation; Lipoprotein; Membrane; Palmitate;
KW   Phosphoprotein; Polymorphism; Reference proteome;
KW   Signal transduction inhibitor; Ubl conjugation.
FT   CHAIN         1    495       Regulator of G-protein signaling 7.
FT                                /FTId=PRO_0000204196.
FT   DOMAIN       37    112       DEP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00066}.
FT   DOMAIN      255    316       G protein gamma.
FT   DOMAIN      333    448       RGS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00171}.
FT   MOD_RES     229    229       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P49803}.
FT   MOD_RES     241    241       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O54829}.
FT   MOD_RES     243    243       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:O54829}.
FT   MOD_RES     434    434       Phosphoserine.
FT                                {ECO:0000269|PubMed:10862767}.
FT   VAR_SEQ      76    128       Missing (in isoform 4).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_005671.
FT   VAR_SEQ     454    495       SGNSMDRRTSFEKFAQNVGRNIPIFPCHKNCTPTLRASTNL
FT                                L -> GKSLTSKRLTSLAQSY (in isoform 2).
FT                                {ECO:0000303|PubMed:10339594,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_005672.
FT   VAR_SEQ     454    471       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_005673.
FT   VAR_SEQ     473    495       RNIPIFPCHKNCTPTLRASTNLL -> KSLTSKRLTSLAQS
FT                                Y (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_038388.
FT   VARIANT     137    137       M -> L (in dbSNP:rs12746550).
FT                                /FTId=VAR_057153.
FT   VARIANT     409    409       Q -> H (in dbSNP:rs17851953).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_060604.
FT   MUTAGEN     306    306       W->F: Diminishes interaction with GNB5.
FT                                {ECO:0000269|PubMed:10339615}.
FT   CONFLICT     26     26       K -> R (in Ref. 3; AAM12645).
FT                                {ECO:0000305}.
FT   CONFLICT    234    234       Q -> R (in Ref. 3; AAM12644).
FT                                {ECO:0000305}.
FT   HELIX       324    329       {ECO:0000244|PDB:2A72}.
FT   HELIX       330    332       {ECO:0000244|PDB:2A72}.
FT   HELIX       334    339       {ECO:0000244|PDB:2A72}.
FT   HELIX       341    353       {ECO:0000244|PDB:2A72}.
FT   HELIX       358    369       {ECO:0000244|PDB:2A72}.
FT   HELIX       374    376       {ECO:0000244|PDB:2A72}.
FT   HELIX       377    388       {ECO:0000244|PDB:2A72}.
FT   HELIX       401    412       {ECO:0000244|PDB:2A72}.
FT   TURN        414    419       {ECO:0000244|PDB:2A72}.
FT   HELIX       420    432       {ECO:0000244|PDB:2A72}.
FT   HELIX       434    440       {ECO:0000244|PDB:2A72}.
FT   HELIX       442    449       {ECO:0000244|PDB:2A72}.
SQ   SEQUENCE   495 AA;  57668 MW;  1FCC2D60622675DE CRC64;
     MAQGNNYGQT SNGVADESPN MLVYRKMEDV IARMQDEKNG IPIRTVKSFL SKIPSVFSGS
     DIVQWLIKNL TIEDPVEALH LGTLMAAHGY FFPISDHVLT LKDDGTFYRF QTPYFWPSNC
     WEPENTDYAV YLCKRTMQNK ARLELADYEA ESLARLQRAF ARKWEFIFMQ AEAQAKVDKK
     RDKIERKILD SQERAFWDVH RPVPGCVNTT EVDIKKSSRM RNPHKTRKSV YGLQNDIRSH
     SPTHTPTPET KPPTEDELQQ QIKYWQIQLD RHRLKMSKVA DSLLSYTEQY LEYDPFLLPP
     DPSNPWLSDD TTFWELEASK EPSQQRVKRW GFGMDEALKD PVGREQFLKF LESEFSSENL
     RFWLAVEDLK KRPIKEVPSR VQEIWQEFLA PGAPSAINLD SKSYDKTTQN VKEPGRYTFE
     DAQEHIYKLM KSDSYPRFIR SSAYQELLQA KKKSGNSMDR RTSFEKFAQN VGRNIPIFPC
     HKNCTPTLRA STNLL
//
ID   ZN429_HUMAN             Reviewed;         674 AA.
AC   Q86V71; A6NLV7; Q9BZE6;
DT   19-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 2.
DT   28-FEB-2018, entry version 139.
DE   RecName: Full=Zinc finger protein 429;
GN   Name=ZNF429;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-623.
RA   Bi A.;
RT   "Zinc finger protein weakly similar to zinc finger protein 85.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-497.
RX   PubMed=7865130; DOI=10.1089/dna.1995.14.125;
RA   Abrink M., Aveskogh M., Hellman L.;
RT   "Isolation of cDNA clones for 42 different Kruppel-related zinc finger
RT   proteins expressed in the human monoblast cell line U-937.";
RL   DNA Cell Biol. 14:125-136(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 545-674.
RC   TISSUE=Chondrosarcoma;
RG   The Cancer Genome Anatomy Project (CGAP) at the National Cancer Institute;
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: May be involved in transcriptional regulation.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK01422.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC       Sequence=AAK01422.1; Type=Miscellaneous discrepancy; Evidence={ECO:0000305};
CC       Sequence=AAP30884.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC       Sequence=AAP30884.1; Type=Miscellaneous discrepancy; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC010615; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AY269786; AAP30884.1; ALT_SEQ; mRNA.
DR   EMBL; AF325191; AAK01422.1; ALT_SEQ; mRNA.
DR   EMBL; BM996292; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS42537.1; -.
DR   RefSeq; NP_001001415.2; NM_001001415.3.
DR   UniGene; Hs.572567; -.
DR   UniGene; Hs.659553; -.
DR   UniGene; Hs.709598; -.
DR   ProteinModelPortal; Q86V71; -.
DR   SMR; Q86V71; -.
DR   STRING; 9606.ENSP00000351280; -.
DR   iPTMnet; Q86V71; -.
DR   PhosphoSitePlus; Q86V71; -.
DR   BioMuta; ZNF429; -.
DR   DMDM; 218511972; -.
DR   EPD; Q86V71; -.
DR   MaxQB; Q86V71; -.
DR   PaxDb; Q86V71; -.
DR   PeptideAtlas; Q86V71; -.
DR   PRIDE; Q86V71; -.
DR   Ensembl; ENST00000358491; ENSP00000351280; ENSG00000197013.
DR   GeneID; 353088; -.
DR   KEGG; hsa:353088; -.
DR   UCSC; uc002nqd.2; human.
DR   CTD; 353088; -.
DR   DisGeNET; 353088; -.
DR   EuPathDB; HostDB:ENSG00000197013.9; -.
DR   GeneCards; ZNF429; -.
DR   HGNC; HGNC:20817; ZNF429.
DR   HPA; HPA004139; -.
DR   neXtProt; NX_Q86V71; -.
DR   OpenTargets; ENSG00000197013; -.
DR   PharmGKB; PA134910790; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00910000145214; -.
DR   HOGENOM; HOG000234617; -.
DR   HOVERGEN; HBG018163; -.
DR   InParanoid; Q86V71; -.
DR   KO; K09228; -.
DR   OMA; IRENTYR; -.
DR   OrthoDB; EOG091G02KC; -.
DR   PhylomeDB; Q86V71; -.
DR   TreeFam; TF342117; -.
DR   Reactome; R-HSA-212436; Generic Transcription Pathway.
DR   ChiTaRS; ZNF429; human.
DR   GenomeRNAi; 353088; -.
DR   PRO; PR:Q86V71; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000197013; -.
DR   CleanEx; HS_ZNF429; -.
DR   ExpressionAtlas; Q86V71; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF01352; KRAB; 1.
DR   SMART; SM00349; KRAB; 1.
DR   SMART; SM00355; ZnF_C2H2; 15.
DR   SUPFAM; SSF109640; SSF109640; 1.
DR   SUPFAM; SSF57667; SSF57667; 10.
DR   PROSITE; PS50805; KRAB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 15.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 17.
PE   2: Evidence at transcript level;
KW   Complete proteome; DNA-binding; Metal-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Transcription; Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN         1    674       Zinc finger protein 429.
FT                                /FTId=PRO_0000047577.
FT   DOMAIN        4     75       KRAB. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00119}.
FT   ZN_FING     145    167       C2H2-type 1; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING     173    195       C2H2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     201    223       C2H2-type 3; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING     229    251       C2H2-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     257    279       C2H2-type 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     285    307       C2H2-type 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     313    335       C2H2-type 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     341    363       C2H2-type 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     369    391       C2H2-type 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     397    419       C2H2-type 10; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   ZN_FING     425    447       C2H2-type 11. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     453    475       C2H2-type 12. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     481    503       C2H2-type 13. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     509    531       C2H2-type 14. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     537    559       C2H2-type 15. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     565    587       C2H2-type 16. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     593    615       C2H2-type 17. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     621    643       C2H2-type 18. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   MOD_RES     605    605       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P17019}.
FT   VARIANT     650    650       H -> Y (in dbSNP:rs2562473).
FT                                /FTId=VAR_047848.
FT   CONFLICT    167    167       H -> Y (in Ref. 2; AAP30884 and 3;
FT                                AAK01422). {ECO:0000305}.
FT   CONFLICT    206    207       FG -> CC (in Ref. 2; AAP30884 and 3;
FT                                AAK01422). {ECO:0000305}.
FT   CONFLICT    249    276       Missing (in Ref. 2; AAP30884 and 3;
FT                                AAK01422). {ECO:0000305}.
FT   CONFLICT    252    252       T -> S (in Ref. 2; AAP30884 and 3;
FT                                AAK01422). {ECO:0000305}.
FT   CONFLICT    337    337       G -> V (in Ref. 2; AAP30884 and 3;
FT                                AAK01422). {ECO:0000305}.
FT   CONFLICT    361    361       V -> I (in Ref. 2; AAP30884 and 3;
FT                                AAK01422). {ECO:0000305}.
FT   CONFLICT    367    367       K -> N (in Ref. 3; AAK01422).
FT                                {ECO:0000305}.
SQ   SEQUENCE   674 AA;  78152 MW;  C48BC76B58059FE7 CRC64;
     MGPLTFTDVA IEFSLEEWQC LDTAQQNLYR NVMLENYRNL VFLGIAVSKP DLITCLEKEK
     EPCKMKRHEM VDEPPVVCSH FAEDFWPEQD IKDSFQKVTL RRYDKRGHEN LQLRKGYKTV
     GDCKLYKGGY NGLNQCLTLT QSKMYHCDIY VKVFYAFSNA DRYKTRHTGK KPFQCKKCGK
     SFCMLSQLTQ HKKIHIRENT YRCKEFGNAF NQSSALTNHK RIYVGEKHYR CEECGKAFNH
     YSTLTNHKRI HTGEKPYKCK ECGKAFSRYS TLTTHKRIHS GEKPYKCDEC GKTFSISSTF
     TKHKIIHTEE KPYKCKECGK AFNRSSTLTS HKRIHTGEKP YKCEECGKAF NWSSTLTKHK
     VIHTGEKPYK CEECGKAFNQ SSRLTRHKKI HTGEEPYKFE KCGRVFTCSS TLTQDKKIHT
     GEKPYNCEEC GKVFTYSSTL TRHKRIHTEE KPYKCNECGK AFNRSSHLTS HRRIHTGEKP
     YKCEECGKAF KQSSNLNSHK KIHSGEKPYK CEECGKAFIL SSRLTQHKKI HTGEKPYKCE
     ECGKAFNRSS RLTQHKKIHT GEKPYKCKQC DKAFTHSSNL SSHKKIHSGE KPYKCEECGK
     AFNRSSRLTQ HKKIHTREKP YKCEECAKAF TRSSRLTQHK KIHRMGVVAH ACNPSTLGGR
     GGRITRSGDR DRPG
//
ID   ZN479_HUMAN             Reviewed;         524 AA.
AC   Q96JC4;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   28-FEB-2018, entry version 136.
DE   RecName: Full=Zinc finger protein 479;
DE   AltName: Full=Zinc finger protein Kr19;
DE            Short=HKr19;
GN   Name=ZNF479;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=11410164; DOI=10.1089/104454901750232472;
RA   Mark C., Looman C., Abrink M., Hellman L.;
RT   "Molecular cloning and preliminary functional analysis of two novel
RT   human KRAB zinc finger proteins, HKr18 and HKr19.";
RL   DNA Cell Biol. 20:275-286(2001).
CC   -!- FUNCTION: May be involved in transcriptional regulation.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed primarily in testis and fetal
CC       tissues. {ECO:0000269|PubMed:11410164}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF277624; AAK61307.1; -; mRNA.
DR   CCDS; CCDS43590.1; -.
DR   RefSeq; NP_150376.1; NM_033273.2.
DR   RefSeq; XP_011513906.1; XM_011515604.2.
DR   RefSeq; XP_011513910.1; XM_011515608.2.
DR   RefSeq; XP_016868266.1; XM_017012777.1.
DR   UniGene; Hs.616660; -.
DR   ProteinModelPortal; Q96JC4; -.
DR   SMR; Q96JC4; -.
DR   BioGrid; 124767; 2.
DR   IntAct; Q96JC4; 6.
DR   STRING; 9606.ENSP00000333776; -.
DR   iPTMnet; Q96JC4; -.
DR   PhosphoSitePlus; Q96JC4; -.
DR   BioMuta; ZNF479; -.
DR   DMDM; 38258829; -.
DR   EPD; Q96JC4; -.
DR   MaxQB; Q96JC4; -.
DR   PaxDb; Q96JC4; -.
DR   PeptideAtlas; Q96JC4; -.
DR   PRIDE; Q96JC4; -.
DR   DNASU; 90827; -.
DR   Ensembl; ENST00000319636; ENSP00000324518; ENSG00000185177.
DR   Ensembl; ENST00000331162; ENSP00000333776; ENSG00000185177.
DR   GeneID; 90827; -.
DR   KEGG; hsa:90827; -.
DR   UCSC; uc010kzo.4; human.
DR   CTD; 90827; -.
DR   EuPathDB; HostDB:ENSG00000185177.12; -.
DR   GeneCards; ZNF479; -.
DR   HGNC; HGNC:23258; ZNF479.
DR   MIM; 617444; gene.
DR   neXtProt; NX_Q96JC4; -.
DR   PharmGKB; PA134903704; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00910000144042; -.
DR   HOVERGEN; HBG018163; -.
DR   InParanoid; Q96JC4; -.
DR   KO; K09228; -.
DR   OMA; CKKCFAD; -.
DR   OrthoDB; EOG091G02KC; -.
DR   PhylomeDB; Q96JC4; -.
DR   TreeFam; TF342117; -.
DR   Reactome; R-HSA-212436; Generic Transcription Pathway.
DR   ChiTaRS; ZNF479; human.
DR   GenomeRNAi; 90827; -.
DR   PRO; PR:Q96JC4; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000185177; -.
DR   CleanEx; HS_ZNF479; -.
DR   ExpressionAtlas; Q96JC4; baseline and differential.
DR   Genevisible; Q96JC4; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF01352; KRAB; 1.
DR   SMART; SM00349; KRAB; 1.
DR   SMART; SM00355; ZnF_C2H2; 12.
DR   SUPFAM; SSF109640; SSF109640; 1.
DR   SUPFAM; SSF57667; SSF57667; 8.
DR   PROSITE; PS50805; KRAB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 11.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 12.
PE   2: Evidence at transcript level;
KW   Complete proteome; DNA-binding; Metal-binding; Nucleus;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Zinc; Zinc-finger.
FT   CHAIN         1    524       Zinc finger protein 479.
FT                                /FTId=PRO_0000047606.
FT   DOMAIN       16     87       KRAB. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00119}.
FT   ZN_FING     185    212       C2H2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     213    235       C2H2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     241    263       C2H2-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     269    291       C2H2-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     297    319       C2H2-type 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     325    347       C2H2-type 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     353    375       C2H2-type 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     381    403       C2H2-type 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     409    431       C2H2-type 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     437    459       C2H2-type 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     465    487       C2H2-type 11. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     493    515       C2H2-type 12. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
SQ   SEQUENCE   524 AA;  60598 MW;  F1AD4929DC67D105 CRC64;
     MAKRPGPPGS REMGLLTFRD IAIEFSLEEW QCLDCAQRNL YRDVMLENYR NLVSLGIAVS
     KPDLITCLEQ NKESQNIKRN EMVAKHPVTR SHFTQDLQPE QGIKDSLQKV IPRTYGKCGH
     EKLQFKKCCK SVGEYEVHKG GYSEVNQCLS TTQNKIFQTH KYVKVFGKFS NSNRDKTRYT
     GNKHFKCNKY GKSFCMLSHL NQHQVIHTRE KSYKCKECGK SFNCSSNHTT HKIIHTGEKP
     YRCEECGKAF SWSANLTRHK RTHTGEKPYT CEECGQAFRR SSALTNHKRI HTGERPYKCE
     ECGKAFSVSS TLTDHKRIHT GEKPCRCEEC GKAFSWSSNL TRHKRIHTRE KPYACEECGQ
     AFSLSSNLMR HRRIHTGEKP YTCEECGQDF RRSSALTIHK RIHTGERPYK CEECGKVFSL
     SSTLTDHKRI HTGERPYKCE ECGKAFSLSS TLTDHKRIHT GERPYTCEEC GKAFNCSSTL
     MQHKRIHTGE KPYKCEECEQ AFKWHSSLAK HKIIHTGEKP YKCE
//
